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ABSTRACT 
 
This thesis has been divided into five sections. The first chapter introduces the main 
themes of this thesis, including the description of the concepts of supramolecular 
chemistry, crystal engineering, hydrogen bonding and graph set analysis. The final 
section of chapter one describes a typical X-ray experiment used to determine the 
structures of the compounds presented in this thesis.    
 
Chapter two describes the synthesis and single crystal structures of copper(I) complexes 
with pyridine- and pyrazine-carboxylic acids. A series of novel solvent inclusion 
compounds of copper(I) complexes with pyridine- and pyrazine-carboxylic acids and 
the hydrogen bonding patterns adopted are also discussed. 
 
Chapter three reports the potential uses of boronic acids as building blocks for the 
design of novel solid-state architectures utilising hydrogen bonds. Novel copper(I) 
pyridine-/pyrazine-carboxylate complexes with boronic acid co-crystals are presented in 
which the heterodimeric boronic···carboxylate R22(8) ring motif is present in all cases. 
 
Chapter four discusses the synthesis of novel ditertiary phosphines bearing functional 
groups with hydrogen bonding potential either via a three-step or single step synthetic 
route which involves a well known method of reductive amination followed by an 
efficient Mannich-based condensation. Complexation studies of these P,P-bidentate 
ligands with various transition metal centres such as Pt(II), Mo(0), Ru(II) and Au(I) are 
also presented. The effect on the structural motifs observed in these series of 
compounds by the regioselective incorporation of functional groups with potential 
hydrogen bonding capability such as hydroxyl and amide is also given. 
 
Finally, chapter five contains the synthesis and coordination studies of new phosphorus 
donor ligands leading to ideas for further work. 
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1.1 Introduction 
 
This chapter will introduce the main themes of this thesis – the concepts of 
supramolecular chemistry, crystal engineering, hydrogen bonding and graph set 
analysis. The final section describes a typical X-ray experiment used to determine the 
structures of the compounds presented in this thesis. Specific introductions regarding 
the chemistry reported are included at the start of each experimental chapter. 
 
 
1.2 Supramolecular Chemistry 
 
The term “supramolecular chemistry” has been defined by Nobel Prize winner Jean-
Marie Lehn, as “chemistry beyond the molecule”,1,2 the association of molecular or ionic 
entities held together reversibly by intermolecular forces to yield organised arrays of 
higher complexity.  
 
Supramolecular chemistry is a multidisciplinary field, encircling the traditionally 
distinct disciplines of organic, inorganic and physical chemistry. Supramolecular self-
assembly of components causes the reversible, spontaneous formation of organised 
structures driven by molecular recognition between two or more units under the 
intermolecular control of relatively labile non-covalent interactions.2,3 The reversibility 
of supramolecular self-assembly is key to form the thermodynamically most favourable 
structure. Biological examples of self-assembly include the DNA double helix in which 
two strands are linked together by hydrogen bonds and π-π stacking interactions and, 
the formation of the quaternary structures of proteins, e.g. in the synthesis of viral 
components.4 Molecular recognition is made possible by the complementarity of the 
subunits, often through the utilisation of the geometric and chemical features of the 
molecular fragments.5 
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Supramolecular, non-covalent bonding interactions include: 
 
• Ion-ion interactions (100-350 kJmol-1) 
• Ion-dipole interactions (50-200 kJmol-1) 
• Dipole-dipole interactions (5-50 kJmol-1) 
• Hydrogen bonding (4-120 kJmol-1) 
• π-π stacking (0-50 kJmol-1) 
• Van der Waals forces (<5 kJmol-1) 
 
As a result of its relative strength and directionality,6 and its importance in biological 
examples of self-assembly, hydrogen bonding has been described as the “masterkey 
interaction in supramolecular chemistry”.5  
 
1.3 Hydrogen Bonding 
 
Hydrogen bonding is a donor-acceptor interaction involving hydrogen atoms.7 The 
necessary criteria for a hydrogen bond are:7-9 
 
• The hydrogen bond donor (D–H), relatively polarised bonds, where D includes 
O, N, F or C, and 
• The hydrogen bond acceptor (A), normally having a basic lone pair or having 
polarisable π electrons; negatively charged acceptors are also common.  
 
The hydrogen bond is symbolised in the rest of this work as D–H···A, where the 
distance D–H is smaller than the distance H···A. The net effect in the D–H···A system is 
a weakening and lengthening in the D–H bond. The strength of hydrogen bonding 
interactions is greater than the van der Waals interactions, but considerably weaker than 
covalent bonding and dependent on its environment.9 Categorisation of the strength of 
hydrogen bonding is itself ambiguous, with many sources having overlapping and 
contradictory categories.5,7 The categories adopted by Desiraju, Steed and Atwood, 
shown in Table 1.1, will be used for the remainder of this work.4,10 
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Table 1.1 Classification of the strength of hydrogen bonding. 
 Very strong Strong Weak 
D···A / Ǻ 2.2-2.5 2.5-3.2 3.2-4.0 
Bond Angles / ° 175-180 130-180 90-180 
Bond energy / kJ mol-1 60-120 16-60 < 12 
 
The weakest of the interactions commonly thought of as hydrogen bonds involve π-
acceptors. For example, D−H donor groups can form hydrogen bond with the π-system 
of a phenyl ring. D−H···π interactions follow a similar pattern in strength to their 
stronger relatives, with the hydrogen bond being weaker when D = N compared to D = 
O, and considerably weaker still when D = C. 
 
Gilli and Gilli have presented the Electrostatic-Covalent H-Bond Model (ECHBM) 
which derives from the systematic analysis of structural and spectroscopic data of a 
large number of homonuclear O–H···O and heteronuclear N–H···O/O–H···N hydrogen 
bonds.11 This model leads to a thorough classification of hydrogen bonds in chemical 
classes which can be used to predict the hydrogen bond strength from the simple 
knowledge of the chemical formula.  
 
1.3.1 The Study of Hydrogen Bonding 
 
Spectroscopic methods, such as NMR spectroscopy, have become standard methods to 
investigate hydrogen bonds in the solid state. However, the effects of weaker hydrogen 
bonds are not generally detected as easily.10 The effect of weak hydrogen bonding can 
be detected by single crystal X-ray diffraction and neutron diffraction. As X-rays 
interact with the electrons in a structure, the placing of electron-poor hydrogen atoms 
within structures containing heavy, electron-rich atoms can be more of a challenge, yet 
the donor atom-acceptor atom distance D···A is still accurately found. Where the 
accurate positioning of hydrogen atoms is needed, neutron diffraction can be used. Here 
the neutrons interact with the nuclei of the system, allowing the hydrogen atoms to be 
accurately located. 
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1.4 Supramolecular Synthons and Crystal Engineering 
 
The combination of hydrogen bonds and/or intermolecular interactions using a 
“designed placement of functional groups” generates supramolecular synthons, some of 
the many examples are shown in Figure 1.1.5,12 Supramolecular synthons allow 
molecular recognition to occur: the chemical nature and geometrical placement of the 
functional groups in the two or more molecular fragments producing intermolecular 
interactions which result in the assembly (self-assembly) of supramolecular arrays.5,6  
 
O
O
R
H O
O
R
H O
O O
O
R
H N
HH
O
O OH O
OH
O
H X
X = CH,
X = N  
 
Figure 1.1 Examples of supramolecular synthons: carboxylic acid head-to-tail; 
carboxylic acid chain and carboxylic acid-pyridine. 
 
Crystal engineering has been defined as the understanding of intermolecular interactions 
in the context of crystal packing and the utilisation of such understanding in the design 
of new solids with desired physical and chemical properties.13 It is a multidisciplinary 
area involving, for example, materials chemistry, supramolecular chemistry, molecular 
recognition and biology. 
 
Crystal engineering concentrates on the use of molecules or ions with exofunctionality 
that are capable of forming one-dimensional, two-dimensional or three-dimensional 
networks; the goal of crystal engineering is to recognise and design synthons that are 
robust enough to be exchanged from one network structure to another, which ensures 
generality and predictability.5 Some authors consider that crystal engineering is not yet 
at the stage where crystal structures are entirely predictable,13-15 with progress needed in 
the areas of target identification, synthetic methodology and synthetic strategy. 
Recently, various computational methods have been developed in order to predict the 
thermodynamically feasible crystal structures of organic molecules.16,17  
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1.5 Graph Set Analysis 
 
Etter et al. have constructed a set of rules for the assignment of nomenclature to 
hydrogen bond patterns displayed in the solid state.18-20 Without these rules, much 
confusion can result, with authors utilising their own nomenclature. The rules, an 
application of graph theory, are termed “graph set analysis” and the graph sets assigned 
to the hydrogen bond patterns take the form: 
 
 
                                  Gad (r) 
 Where 
  
G = pattern designator 
r = degree of the pattern 
a = number of acceptors       
d = number of donors 
 
The pattern designator, G, can take the assignments S, C, R and D: 
 
• S denotes an intramolecular bond 
• C denotes an infinite chain 
• R denotes rings 
• D denotes non-cyclic dimers and other finite hydrogen-bonded sets. 
 
The degree of the pattern, r, is either the number of atoms in the ring or the repeat length 
of the chain, traversing the shortest pathway from the hydrogen atom of the hydrogen 
bond to the acceptor atom of the next. 
 
Etter concluded that all good donor and acceptor groups tend to be used in hydrogen 
bonding, and that the strongest donors tend to hydrogen bond with the strongest 
acceptors.18-20 
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In this work, graph set analysis will be used to describe the hydrogen bonding patterns 
significant to the structures, particularly in comparing motifs between structures. Two 
examples of packing modes of carboxylic acids are termed R22(8) and C(4) (Figure 1.2). 
 
 
 
O
O
R
H O
O
R
H
O O
R
H O O
R
H
12
3
4
R22(8) C(4)
(a) (b)  
 
Figure 1.2 Examples of graph set analysis, applied to the packing modes of carboxylic 
acids. (a) R22(8) ring motif, an eight-membered ring with two donors and two acceptors; 
(b) C(4) chain motif with four atoms in the repeat length. 
 
1.6 The Cambridge Structural Database (CSD) 
 
The Cambridge Structural Database (hereafter “the CSD”) is a crystallographic database 
containing data for approximately 450,000 structures.21,22 While not being a store of 
information on all structurally determined compounds due to the quantity of 
unpublished structures and the ongoing imbalance in journal publication times 
compared to structural data collection times, the CSD is, however, a source of 
information useful in the rationalisation of crystal structures, particularly the geometry 
of molecules and of hydrogen bonding motifs. 
 
1.7 Solvates and Co-crystals 
 
The term co-crystal has not been well-defined and a number of possible definitions such 
as molecular complexes, molecular adducts, clathrates and inclusion compounds have 
been utilised. Often these terms describe the same family of chemical compounds.23 
 
 The work presented below will adhere to the following definitions/rules:23,24  
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• The term co-crystal is used to denote togetherness of two or more molecular 
components that must themselves be solids under ambient conditions, but 
without the implication that either component should retain any degree of its 
individual crystalline identity within the co-crystal.  
 
• The term solvate is used to describe the corresponding solid/liquid 
combination. This in itself is a departure from the accepted understanding of 
a solvate, which is a multi-component molecular crystal that has been 
obtained from solution, where molecules of the crystallisation solvent have 
become incorporated into the crystal (the accompanying special case hydrate 
applies specifically when the solvent is water). 
 
1.8 General X-ray Experimental 
 
The experimental which follows is a generalised description of the single crystal X-ray 
diffraction technique used at Loughborough University to determine the structures 
within this thesis. Where applicable, exceptions to this general X-ray experimental are 
noted in the experimental sections of each chapter, for example where data have been 
collected using X-ray sources other than the laboratory X-ray source. Structural studies 
on small and weakly diffracting materials have been performed at the SRS Daresbury 
Laboratory, on stations 9.8 and 16.2SMX, using synchrotron radiation.   
 
A suitable crystal (typically with dimensions in the range 0.1 to 0.8), which 
extinguished polarised light, was mounted onto a glass fibre on the goniometer head 
using a drop of inert oil. The goniometer head was transferred to the Bruker SMART 
1000 CCD or Bruker APEX 2 CCD diffractometer, and placed in a pre-cooled N2 gas 
stream (typically 150 K). The crystal was centred in the X-ray beam and a set of 3 runs 
of 50 frames each (typically 5 seconds per frame) was collected using graphite-
monochromated Mo-Kα (λ = 0.71073 Å) radiation. The reflections from these frames 
were then indexed automatically using the Bruker SMART or Apex II program to give a 
unit cell and an orientation matrix.25,26 The unit cell was checked against the data stored 
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in the CSD using CrystalWeb and against unit cells determined in the home laboratory 
to prevent replication.27 
 
A full sphere of data was collected using narrow frames (0.3° steps in ω), with the 
exposure time dependent on the intensity of the reflections observed in the initial frames 
collected for indexing, typically ranging from 5 seconds per frame to 40 seconds per 
frame. The data were integrated using the Bruker SAINT program.28 A semi-empirical 
absorption correction was applied using the SADABS program based on equivalent and 
repeated reflections and the data reduction carried out.29 The program XPREP within 
the SHELXTL suite of programs was used to detect any higher, missed symmetry and 
the space group was determined.30 The structure was solved using the program XS 
using either direct methods or Patterson synthesis as appropriate.30 The structure was 
refined using the program SHELXL-97 by full-matrix least-squares methods on F2.30 
Non-hydrogen atoms were initially refined isotropically, then later anisotropically. 
Hydrogen atoms, except hydrogen atoms noted in the further discussion in each chapter, 
were placed in geometrically calculated positions. Uiso(H) values were set to be 1.2 
times Ueq of the carrier atom for aryl CH, methylene CH2 and methine CH, and 1.5 
times Ueq of the carrier atom for OH, NH and CH3. 
 
The program XP was used to produce graphics.31 Hydrogen bonds are shown as thin 
dashed lines in the diagrams within this thesis. Thick dashed lines are used to signify 
the η6-bonding of the arene to the ruthenium(II) metal centre in Chapter IV.  
 
 
 
 
 
 
 
 
 
 
 
 
 10
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
 
Coordination Chemistry Involving Pyridine and Pyrazine Carboxylic 
Acids and Bis(triphenylphosphine)copper(I) Borohydride 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 11
2. Coordination Chemistry Involving Pyridine and Pyrazine 
Carboxylic Acids and Bis(triphenylphosphine)copper(I) Borohydride 
 
2.1. Introduction 
 
The reasons for incorporating metal ions into supramolecular networks are numerous, 
for example, they give access to physical properties that are less common in organic 
compounds, such as magnetic properties, conductivity and catalytic activity.32-36  Metal 
ions also display a range of coordination geometries allowing greater flexibility in 
constructing materials with specific dimensions and topologies.37 
 
Crystal engineering using coordination complexes in general can be broadly categorised 
into three areas: 
 
• Coordination polymers based on covalent-coordinate bonds. 
• Hydrogen-bonded networks of coordination complexes. 
• Hybrid networks based on both coordination and hydrogen bonds. 
 
The first category is self-explanatory, but the latter two are often confused.38 Hydrogen 
bonded networks of coordination complexes contain coordination bonds only within the 
coordination complexes, with no peripheral coordination, so the dimensionality of the 
array is determined by the hydrogen bonding. Hybrid networks based on both 
coordination and hydrogen bonds use a combination of the two types of bond to form 
the array.  
 
2.2 The use of Pyridine- and Pyrazine- Carboxylic Acids in 
Supramolecular Chemistry 
 
Organic compounds displaying exodentate functionality are often utilised as the nodes 
within metal-free networks.39 The nine pyridine- (Figure 2.1) and three pyrazine- 
carboxylic acids (Figure 2.2) display such functionality in the form of their carboxylic 
acids groups, and the variety of angles between these groups have been used in the 
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production of networks. These ligands also possess a nitrogen atom for metal-
coordination which can combine with an acid group at the ortho position to give metal-
chelation. 
 
N
Pyridine-2-carboxylic acid
2-Hpyca
N
Pyridine-3-carboxylic acid
3-Hpyca
N
Pyridine-4-carboxylic acid
4-Hpyca
N
Pyridine-2,3-dicarboxylic acid
2,3-H2pydca
N
Pyridine-2,4-dicarboxylic acid
2,4-H2pydca
N
Pyridine-2,5-dicarboxylic acid
2,5-H2pydca
Pyridine-2,6-dicarboxylic acid
2,6-H2pydca
N
Pyridine-3,4-dicarboxylic acid
3,4-H2pydca
Pyridine-3,5-dicarboxylic acid
3,5-H2pydca
CO2H
CO2H CO2H
CO2H
CO2H
CO2H
CO2H
CO2H
HO2C
N CO2HHO2C
CO2H
CO2H
N
CO2HHO2C
 
 
Figure 2.1 The range of pyridine-carboxylic acids and the abbreviations used in this 
thesis. 
 
N
N N
N
Pyrazine-2,5-dicarboxylic acid
2,5-H2pzdca
Pyrazine-2,3-dicarboxylic acid
2,3-H2pzdca
Pyrazine-2-carboxylic acid
2-Hpzca
N
N
CO2H CO2H
CO2H
CO2H
HO2C
 
 
Figure 2.2 The range of pyrazine-carboxylic acids and abbreviations used in this thesis. 
 
In recent years, pyridine- and pyrazine-carboxylic acids have been extensively studied 
because they can act as excellent building blocks with versatile coordination behaviour 
and their ability to form hydrogen-bonds in the construction of metal-organic 
coordination frameworks (MOF) with porosity, photoluminescent or magnetic 
properties.40-45  
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A search of the Cambridge Structural Database (hereafter “the CSD”, version 5.30, 
November 2008 plus 4 updates) highlights numerous literature examples of single 
crystal structures containing pyridine- and pyrazine-carboxylic acids groups attached to 
transition metals.46-49 In contrast, there is very little documented with regards to 
complexes of Cu(I) with these organic ligands.50-52 A brief survey of copper chemistry 
with pyridine- and pyrazine-carboxylic acids is discussed below. 
 
2.2.1 Copper Complexes with Pyridine Carboxylic Acids  
 
Pyridine-2-carboxylic acid is known to chelate to metal centres including alkali metal 
cations and transition metals through the nitrogen atom as well as through one oxygen 
of the carboxylate group.53-55 This is also seen in pyridine-2,n-dicarboxylic acid, where 
the carboxylic group at the n position may remain protonated (Figure 2.3) or be 
deprotonated and coordinate to a further metal site (Figure 2.4).32,56 
 
 
 
Figure 2.3 View of Cu(2,4-Hpydca)2 in which the CO2H group at the 4-position 
remains protonated.  
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Figure 2.4 View of [Co(2,4pydca)Cu(H2O)4]n in which the CO2H group at the 4-
position is deprotonated and coordinated to Co2+.  
 
The exodentate nature of the 3-pyridine and 4-pyridine carboxylate ions makes them a 
valuable tecton for designing high-dimensional structures. These compounds combine 
the coordination ability of the pyridyl moiety with the various modes of the carboxylato 
group to act as a chelate [Figure 2.5 (a)] and bridging ligand.57-65 Furthermore, 3-
pyridine and 4-pyridine carboxylic acids, nicotinic acid and isonicotinic acid 
respectively, provide potential extension of the dimensionality via the classical cyclic 
hydrogen bonded carboxylic acid ring motif R22(8) [Figure 2.5 (b)].52,66,67  
 
O
O H O
OH
N
NN
M M
M
O
O
M
a b
O
O H O
OH
NNN
O
O
MM M M
 
 
Figure 2.5 (a) Chelating mode of nicotinic and isonicotinic acids; (b) The R22(8) cyclic 
hydrogen bonded carboxylic acid ring motif. 
 
Goher has studied copper(I) halide adducts with nicotinic and isonicotinic acids, but 
only two crystal structures have been reported, Cu(3-Hpyca)2Cl and Cu(4-
Hpyca)Cl.51,52,66 Pyridine-3-carboxylic acid crystallises as a polymeric 2:1 complex 
with copper(I) chloride, Cu(3-Hpyca)2Cl, (Figure 2.6). The coordination geometry 
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about the metal centre is approximately tetrahedral with Cu(I) and Cl ligands arranged 
alternately forming a zigzag chain extending along the a axis.  
 
 
 
Figure 2.6 Zigzag chain of Cu(3-Hpyca)2Cl. Hydrogen atoms have been omitted for 
clarity.  
 
Pyridine-4-carboxylic acid crystallises as a polymeric 1:1 adduct with copper(I) 
chloride, Cu(4-Hpyca)Cl, (Figure 2.7) with the 4-Hpyca ligand bridging two symmetry-
related metal centres forming a ribbon of edge-sharing Cu2Cl2 parallelograms 
propagating along the b axis.  
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Figure 2.7 View of Cu(4-Hpyca)Cl. Hydrogen atoms have been removed for clarity. 
 
Yu has reported another interesting example of copper(I) halides coordinated to 
isonicotinic acid forming also a one-dimensional ribbon-like structure.68 Yu and Goher 
have used a copper(II) halide as a starting material, but only copper(I) is present at the 
end of the reaction as Cu(II) halides are reduced to the corresponding Cu(I) derivative in 
the presence of organic species, particularly compounds containing a pyridine ring.69-71 
 
In contrast to the high occurrence of copper complexes with pyridine-3-carboxylic acid 
in the single crystal X-ray structures contained in the CSD (version 5.30, November 
2008), there is very little reported about pyridine-3,n-dicarboxylic acids. These ligands 
possess two potential carboxylic acid coordinating sites, which can each be 
deprotonated, resulting in a divalent anion, and a third, neutral aromatic nitrogen 
coordinating site. An example showing this three-connected mode of the [3,4-pydca]2- 
has been described by Tong with the synthesis of a three-dimensional coordination 
polymer (NMe4)2n[Cu3(3,4-pydca)4(H2O)4]n·4nH2O.72 The X-ray structure contains two 
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unique doubly deprotonated [3,4-pydca]2- ligands and two crystallographically 
independent Cu(II) atoms, one with five-coordinate square bipyramidal geometry and 
one with six-coordinate octahedral geometry. The five-coordinated Cu(II) centre 
coordinates to two trans carboxylate oxygen atoms and two trans pyridyl nitrogen 
atoms of four [3,4-pydca]2- ligands with a water molecule filling the remaining 
coordination site. The octahedral Cu(II) ion is coordinated to four carboxylate oxygen 
atoms and two trans water ligands (Figure 2.8). There is extensive hydrogen bonding 
between the coordinated water ligands and the carboxylate oxygen atoms of the [3,4-
pydca]2-  ligands which may play a templating role.   
 
 
 
Figure 2.8 View of the coordination geometries around the metal centres in 
(NMe4)2n[Cu3(3,4-pydca)4(H2O)4]n·4nH2O. Hydrogen atoms, NMe4+ ions and non 
coordinated water molecules have been removed for clarity. 
 
One interesting example of the pyridine-3,5-carboxylic acid ligand exhibiting different 
coordination modes and forming different crystal architectures, under similar 
conditions, except for pH has been reported by Wang.73,74 Upon heating a mixture of 
3,5-H2pydca and the Cu(2,2’:6’,2’’-terpyridine) adduct under neutral conditions a one-
dimensional framework, A, with the Cu(tpy) moieties bridging the [3,5-pydca]2- was 
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obtained (Figure 2.9). Interestingly, the nitrogen atom in [3,5-pydca]2- remains 
uncomplexed affording an additional potential complexation site.  
 
 
 
 
Figure 2.9 View of copper(II) complex A obtained under neutral conditions. Hydrogen 
atoms have been removed for clarity.  
 
In contrast, the treatment of complex A with a monovalent metal, [Cu(MeCN)4](PF6), in 
the presence of base afforded a rearranged one-dimensional structure, B, where one of 
the carboxylate moieties is no longer coordinated to a [Cu(tpy)] adduct. The cleaved 
Cu–O covalent bond was replaced by a new Cu–N bond resulting from the coordination 
of the [Cu(tpy)] to the pyridine nitrogen (Figure 2.10). Notably, the crystal structure of 
B shows two crystallographically independent [Cu(tpy)] moieties, one coordinated to a 
carboxylate oxygen atom and a nitrogen atom of two different [3,5-pydca]2- ligands and 
one coordinated to a carboxylic oxygen of a [3,5-pydca]2- ligand and one water 
molecule.  
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Figure 2.10 View of complex B obtained under basic conditions. [PF6]– anions and 
hydrogen atoms have been removed for clarity.  
 
2.2.2 Copper Chemistry of Pyrazine Carboxylic Acids  
 
Pyrazine-2-carboxylic acid is a multidentate ligand which combines the coordination 
properties of the pyridine-2-carboxylic acid acting as a chelating ligand through the 
nitrogen atom and the carboxylate group (Figure 2.11).75 The pyrazine moiety has also 
an additional nitrogen donor site which can further participate in the assembly of a 
polymeric structure by an exo-binding mode to another metal centre or by 
supramolecular interactions with nearby hydrogen-bonding donors (Figure 2.12).6,76 
 
 
 
Figure 2.11 An example of the pyrazine-2-carboxylate acting as a chelating ligand - 
Cu(2-pzca)2.  
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Figure 2.12 Fragment of a copper(II) coordination polymer containing pyrazine-2-
carboxylate ligand – {Cu3(2-pzca)4(H2O)2}. 
 
Pyrazine-2-carboxylate complexes of copper(II) have been used to construct several 
novel mixed-metal and mixed-valent coordination polymers.42,49,77-79 The attractiveness 
of these complexes as a metal-containing building block for the construction of novel 
framework materials of varying dimensionality lies in their donor-acceptor versatility. 
Chelation of the Cu(II) centre by the pyrazine-2-carboxylate ligand leaves a para-N-
donor and one free carboxylate oxygen available for intermolecular bonding and 
supramolecular interactions. 
 
Recently, Liu reported a three dimensional Cu(I)/Cu(II) coordination polymer, 
{[CuICuII(2-pzca)2(N3)]}n, which was isolated under hydrothermal conditions.80 The 
coordination sphere of the copper ions (Figure 2.13) shows each Cu(I) atom situated in 
a tetrahedral environment coordinated to two azide ligands and two nitrogen atoms from 
two pyrazine-2-carboxylate ligands. The Cu(II) ion presents an octahedral geometry 
coordinating to two oxygen atoms and two nitrogen atoms from two chelating pyrazine-
2-carboxylate ligands, an azide ligand and a water molecule.   
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Figure 2.13 View of {[CuICuII(2-pzca)2(N3)]}n. Hydrogen atoms have been removed 
for clarity.  
 
In recent years, the synthesis and characterisation of metal coordination polymers based 
on the pyrazine-2,3-dicarboxylate ligand has evolved rapidly mostly because of two 
reasons. Firstly, the presence of two carboxylate groups as substituents in the N-
heterocyclic pyrazine ring allows multiple coordination modes. Secondly, the steric 
hindrance between these groups (donor O atoms) and the pyrazine ring (donor N 
atoms), which helps to increase the dimensionality of the assembled covalent networks. 
Due to these interesting features, a number of coordination modes of the six donor 
atoms of the 2,3-H2pzdca ligand have been reported (Figure 2.14).43,81-92 A brief 
description of literature examples of copper(II) complexes with pyrazine-2,3-
dicarboxylic acid and their different coordination modes are described. 
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Figure 2.14 Coordination modes of 2,3-H2pzdca. 
 
Xiang has reported the crystal structure of a copper(II) compound, {[Cu(2,3-
Hpzdca)2]·2C3H7NO}n, which is a good example of 2,3-H2pzdca coordination mode 
type I.92  
 
 23
 
 
Figure 2.15 View of {[Cu(2,3-Hpzdca)2]·2C3H7NO}n showing the type I coordination 
environment of the Cu(II) metal centre. Molecules of DMF and hydrogen atoms on 
aromatic rings have been removed for clarity.  
 
Konar has described the crystal structure of compound [Cu(2,3-Hpzdca)(H2O)2]·H2O 
which shows ligand coordination type IV. The copper(II) compound is five-coordinate 
having two [2,3-pzdca]2- ligands coordinated to the metal centre through one pyrazinic 
nitrogen atom and one carboxylate oxygen atom from each ligand. The remaining two 
coordination sites are occupied by water molecules (Figure 2.16).93   
 
 24
 
 
Figure 2.16 View of [Cu(2,3-Hpzdca)(H2O)2]·H2O showing the type IV coordination 
environment of the Cu(II) metal centre. Hydrogen atoms have been removed for clarity.  
  
The copper(II) complexes with 2,5-H2pzdca are the least studied of the pyrazine 
carboxylic acids ligands described in this chapter. In contrast with the 2,3-H2pzdca, the 
pyrazine-2,5-dicarboxylate anion does not present steric hindrance, and as a 
consequence, both carboxylate groups are nearly coplanar with the pyrazine ring.94,95  
 
The work of Boabide aimed at investigating the magnetic properties of transition metal 
complexes based on the 2,5-H2pzdca ligand, has led to the crystallisation of only three 
examples of copper(II) complexes with pyrazine-2,5-dicarboxylic acid reported in the 
CSD (version 5.30, November 2008).40,41 The two first examples, {[Cu(2,5-
pzdca)(NH3)(H2O)]·H2O}n and {[Cu(2,5-pzdca)(NH3)2]·2H2O}n, consist of one-
dimensional polymeric chains in which metal centres are linked by bidentate [2,5-
Hpzdca]2- ligands (Figure 2.17). 
 
The typical Cu(II) octahedral coordination environments in both complexes exhibit 
some differences. Compound {[Cu(2,5-pzdca)(NH3)(H2O)]·H2O}n has one [2,5-
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Hpzdca]2- ligand and two crystallographically independent copper atoms with centres of 
symmetry sited on the metals. The apical positions along the chain are occupied by 
alternate ammonia and water molecules. In contrast, in compound {[Cu(2,5-
pzdca)(NH3)2]·2H2O}n there is only one [2,5-Hpzdca]2- ligand and one copper(II) ion 
crystallographically distinguishable and the centres of symmetry are placed on the metal 
ions and in the centre of the aromatic ring; the ammonia molecule is the unique terminal 
ligand coordinated to the metal ion.  
 
(a) 
 
(b) 
 
 
Figure 2.17 View of a fragment of the one-dimensional chain for compounds {[Cu(2,5-
pzdca)(NH3)(H2O)]·H2O}n (a) and {[Cu(2,5-pzdca)(NH3)2]·2H2O}n (b). Hydrogen 
atoms and water molecules not involved in coordination have been removed for clarity. 
  
The last example of a copper(II) complex with pyrazine-2,5-dicarboxylic acid was 
synthesised by Boabide, [Cu2(2,5-pzdca)(phen)4](NO3)2·10H2O,40 from a mixture of 
2,5-H2pzdca·2H2O, Cu(NO3)2·3H2O and phenanthroline. This complex crystallises as a 
dimeric structure in which a bidentate [2,5-Hpzdca]2- ligand bridges two copper atoms 
with a Cu···Cu distance of 7.112 Å. The distorted octahedral environment around each 
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copper ion is completed by four nitrogen atoms of two phenanthroline ligands (Figure 
2.18). 
 
 
 
Figure 2.18 View of the dimeric compound [Cu2(2,5-pzdca)(phen)4](NO3)2·10H2O. 
Hydrogen atoms, nitrate anions and water molecules have been removed for clarity.  
 
The limited examples of single crystal structures of copper(I) complexes with pyridine- 
and pyrazine-carboxylic acids highlights this area as a suitable target for research. 
Analysis of the different solvates obtained in this study may allow us to get a better 
comprehension of the varied hydrogen bonding patterns they can adopt. It is in this area 
and with these aims that the research in this chapter is presented.  
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2.3 Results and Discussion 
 
2.3.1 The Complexation of Pyridine Carboxylic Acids to the 
[Cu(PPh3)2]+ Fragment 
 
In preliminary work carried out by Cariati,50 copper(I) complexes with pyridine- and 
pyrazine- carboxylic acids were synthesised. This study also reported the two first 
crystal structure examples of [Cu(PPh3)2]+ metal salts of 3-Hpyca and 2,3-H2pydca 
collected at room temperature. In Cu(3-pyca)(PPh3)2, each copper(I) metal centre is 
coordinated to two molecules of triphenylphosphine and two nicotinate anions, one via 
the pyridinic nitrogen atom and the other through one carboxylate oxygen forming a 
polymeric zigzag chain (Figure 2.19). 
   
 
 
Figure 2.19 Zigzag chain of Cu(3-pyca)(PPh3)2. Hydrogen atoms and phenyl rings have 
been removed for clarity. 
 
Compound Cu(2,3-Hpydca)(PPh3)2, crystallises as a discrete unit in which the copper(I) 
atom is in a tetrahedral coordination, being bonded to two molecules of 
triphenylphosphine, chelated to one 2,3-Hpydca anion through the pyridine nitrogen 
atom and to the carboxylate oxygen atom in the ortho position (Figure 2.20).   
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Figure 2.20 Asymmetric unit of Cu(2,3-Hpydca)(PPh3)2. Hydrogen atoms have been 
removed for clarity. 
 
Cariati also predicted the crystal structures of the copper(I) complexes with pyridine- 
and pyrazine-carboxylic acids under study in this chapter, based on infrared 
spectroscopic evidence:50 i) From the values of the νas(COO) and νs(COO) stretching 
vibrations Cariati concluded that compounds shown in Table 2.1 present the same type 
of coordination, the metal atom is being bonded through the nitrogen atom and one of 
the oxygen atoms of the carboxylate group. ii) Compounds Cu(2-pyca)(PPh3)2 and 
Cu(2-pzca)(PPh3)2 form monomeric complexes with five-membered chelate rings. iii) 
Compounds Cu(2,n-pydca)(PPh3)2 (n = 3–6) and Cu(2,3-Hpzdca)(PPh3)2, show similar 
values for νas(COOH) and νas(COO) as compound Cu(2,3-Hpydca)(PPh3)2, therefore 
they probably present the same discrete structure as Cu(2,3-Hpydca)(PPh3)2 described 
above. iv) Pyridine carboxylic acids without carboxylic groups in ortho position with 
respect to the nitrogen atom form polymeric molecular structures like compound Cu(3-
pyca)(PPh3)2 also described above. v) Because compounds Cu(2,3-pzdca)(PPh3)2 and 
Cu(2,5-pzdca)(PPh3)2 do not exhibit the ν(COOH) stretching vibrations, the formation 
of dimeric complexes is expected.  
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Table 2.1 IR spectral data (cm-1) for Cu(I) complexes synthesised by Cariati.50 
 νas(COOH) νs(COOH) νas(COO) νs(COO) Δνa 
Cu(2-pyca)(PPh3)2 - - 1635 1352 283 
Cu(3-pyca)(PPh3)2 - - 1605 1392 213 
Cu(4-pyca)(PPh3)2 - - 1615 1360 255 
Cu(2,3-Hpyca)(PPh3)2 1700 - 1625 1362 263 
Cu(2,4-Hpyca)(PPh3)2 1705 1340 1610 1385 225 
Cu(2,5-Hpyca)(PPh3)2 1705 - 1620 - - 
Cu(2,6-Hpyca)(PPh3)2 1700 - 1602 1360 242 
Cu(3,4-Hpyca)(PPh3)2 1705 - 1600 1355 245 
Cu(3,5-Hpyca)(PPh3)2 1715 - 1650 1375 275 
Cu(2-pzca)(PPh3)2 - - 1640 1350 290 
Cu(2,3-Hpzca)(PPh3)2 1735 1350 1625 1375 250 
Cu(2,3-pzca)(PPh3)2 - - 1625 1350 275 
Cu(2,5-pzca)(PPh3)2 - - 1640 1355 285 
aΔν = νas(COO) – νs(COO) 
 
The work presented below will show the inaccuracy of some of these reported 
statements, support some of the conclusions and also present interesting versatile 
behaviour of these complexes depending on the crystallisation solvent. 
 
2.3.2 Synthesis of (PPh3)2Cu(BH4) 
 
Using a synthetic method first introduced by Cariati and Naldini,96 and later adapted by 
Lippard and Ucko,97 the reduction of copper(II) sulfate hexahydrate with sodium 
borohydride in the presence of triphenylphosphine in warm ethanol affords the 
copper(I) compound, (PPh3)2Cu(BH4), in 82% yield (Equation 2.1). 
 
 
 
Equation 2.1 
 
Cu S O 4 . 6H2O
i) PPh3, EtOH
ii)  NaBH4
Cu(PPh3)2 (B H 4)
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The solid-state structure of (PPh3)2Cu(BH4) has been previously determined by X-ray 
diffraction showing how the borohydride group is bonded to the copper(I) ion through 
two hydrogen atoms giving a distorted tetrahedral geometry at Cu(I) with two 
triphenylphosphine phosphorus atoms occupying the remaining two sites (Figure 
2.21).98,99 
 
 
 
Figure 2.21 View of the asymmetric unit of (PPh3)2Cu(BH4). 
 
The copper(I) complex, (PPh3)2Cu(BH4), is easy to synthesise cleanly in high yield and 
is soluble in many organic solvents. The evolution of its coordination reactions with 
suitable organic ligands can be easily followed using 31P NMR. Therefore, 
(PPh3)2Cu(BH4) is a good choice as starting material for the further complexation 
studies with pyridine- and pyrazine-carboxylic acids as a potential building blocks to 
make polymeric species or units able to link via hydrogen bonds or other weak 
interactions. 
 
2.3.3 Crystallisation of Cu(n-pyca)(PPh3)2 Complexes (n = 2–4) 
 
Initially, the complexation of the pyridine- monocarboxylic acids n-Hpyca (n = 2–4) to 
the [Cu(PPh3)2]+ fragment was attempted stirring the mixture in dichloromethane at 
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room temperature over 12 h (Equation 2.2).50 The products, Cu(2-pyca)(PPh3)2, Cu(3-
pyca)(PPh3)2 and Cu(4-pyca)(PPh3)2, were easy to isolate as yellow precipitates in 
excellent yield, 83-89%, by adding diethyl ether. Later, the same reactions were carried 
out under reflux (assumed to ensure the complete displacement of the [BH4]– unit by the 
pyridine-n-carboxylic acid), resulting in the same high yield of precipitate, but with 
considerably shorter reaction times (within 3 h).  
 
+
N
(PPh3)2Cu(n-pyca)
CH2Cl2
3 h reflux
Cu(PPh3)2(BH4)
CO2H
 
 
Equation 2.2 
 
Most relevant infrared spectroscopic data for compounds Cu(2-pyca)(PPh3)2, Cu(3-
pyca)(PPh3)2 and Cu(4-pyca)(PPh3)2, are presented in Table 2.2. The difference between 
the asymmetric and symmetric stretch, Δν, gives information on the carboxylate 
bonding mode in the complexes obtained. All the compounds show the strong 
carboxylate stretching frequencies νas(COO) and νs(COO) in the characteristic range of 
copper carboxylate compounds in agreement with the data reported by Cariati.50,100,101 
The Δν separation values of ν(COO-) bands indicates that the coordination of the 
carboxylate group is monodentate.102  
 
Table 2.2 IR spectral data (cm-1) for (PPh3)2Cu(I) complexes of 2-Hpyca, 3-Hpyca and 
4-Hpyca ligands 
 ν(COO)as ν(COO)s Δν 
Cu(2-pyca)(PPh3)2 1635 1352 283 
Cu(3-pyca)(PPh3)2 1606 1383 223 
Cu(4-pyca)(PPh3)2 1612 1368 244 
 
2.3.3.1 Solvates of Cu(2-pyca)(PPh3)2 
 
The first aim of this research was to obtain the crystal structures of these copper(I) 
pyridine monocarboxylic acids predicted by Cariati.50 Interestingly, in preliminary work 
carried out by Helena Ascroft and Agnese Cecchin, the structures of Cu(2-
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pyca)(PPh3)2·2MeOH 2.1, Cu(2-pyca)(PPh3)2·EtOH 2.2 and Cu(2-pyca)(PPh3)2·i-PrOH 
2.3 were determined. These studies revealed a solvent dependency with regards to the 
crystallisation conditions. 
 
Compound Cu(2-pyca)(PPh3)2·2MeOH 2.1 was crystallised from a solution containing 
MeOH, including two solvent molecules per complex in the structure (Figure 2.22). The 
carboxylate oxygen is hydrogen bonded to two molecules of MeOH through two strong 
(solvent)O–H···O(carboxylate) hydrogen bonds (Table 2.3).  
 
 
 
Figure 2.22 Asymmetric unit of Cu(2-pyca)(PPh3)2·2MeOH 2.1. Hydrogen atoms not 
involved in hydrogen bonding have been omitted for clarity. 
 
Table 2.3 Selected hydrogen bonding parameters for 2.1. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(4)−H(4)···O(2) 2.875(3) 0.84 2.04 174 
O(3)−H(3)···O(2) 2.748(2) 0.84 1.93 163 
 
While the crystallisation of Cu(2-pyca)(PPh3)2 in the presence of MeOH occurs in a 1:2 
stoichiometry, the inclusion of the next homologues in the alcohols series, EtOH, n-
PrOH and i-PrOH, into the crystal structure of Cu(2-pyca)(PPh3)2 occurs in a 1:1 
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stoichiometry. The solvates Cu(2-pyca)(PPh3)2·X, where X =  EtOH (2.2), n-PrOH (2.3) 
or i-PrOH (2.4) present two independent molecules of Cu(2-pyca)(PPh3)2·X in the 
asymmetric unit, which differ in the disposition of the phenyl rings. Interestingly, while 
the solvent molecules in compounds 2.2 and 2.4 present a similar relative position with 
respect to the Cu(2-pyca)(PPh3)2 complex [Figure 2.23 (a)], in 2.3 the two independent 
molecules also differ in the position of the solvent molecule with respect to the 
copper(I) complex [Figure 2.23 (b)].  
(a) 
 
 
(b) 
 
 
Figure 2.23 Overlay view of the two independent solvate pairs in (a) Cu(2-
pyca)(PPh3)2·EtOH 2.2 (left) and Cu(2-pyca)(PPh3)2·i-PrOH 2.4 (right). (b) Cu(2-
pyca)(PPh3)2·n-PrOH 2.3, solvent disorder components have been omitted for clarity. 
Hydrogen atoms have been omitted for clarity. 
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Compounds 2.2-2.4 crystallise showing a similar (solvent)O–H···O(carboxylate) 
interaction as seen for compound 2.1 (Table 2.4). Solvate Cu(2-pyca)(PPh3)2·i-PrOH 2.4 
contains an almost identical hydrogen bonding pattern to that seen in compounds 2.2 
and 2.3, except that the hydrogen bond (solvent)O–H···O(carboxylate)is slightly longer 
than those observed in 2.2 and 2.3, presumably due to the inclusion of the bulkier, 
branched alcohol, i-PrOH. 
 
Table 2.4 Selected hydrogen bonding parameters for 2.2-24. 
 D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
2.2 
O(5)−H(5)···O(2) 
O(6)−H(6)···O(4) 
2.704(3) 
2.706(3) 
0.884(19) 
0.816(19) 
1.83(2) 
1.891(19) 
172(5) 
176(4) 
2.3 
O(5)−H(5)···O(2) 
O(6)−H(6)···O(4) 
2.734(4) 
2.689(4) 
0.84 
0.90(7) 
1.93 
1.80(7) 
159.3 
169(7) 
2.4 
O(5)−H(5)···O(2) 
O(6)−H(6)···O(4) 
2.759(2) 
2.7694(19) 
0.79(3) 
0.79(3) 
1.98(3) 
1.99(3) 
171(3) 
169(3) 
 
The use of Platon to analyse the solvent accessible voids within the “solvent-free” 
structures of 2.2-2.4 allows the calculation of the percentage volume of each structure 
accessible to the relevant solvents (Table 2.5).103 Compounds 2.1-2.4 have a clear 
correlation in their solvent accessible volume showing an increment with the increasing 
alcohol size. Interestingly, the effect is more pronounced in 2.2 (EtOH) and 2.3 (n-
PrOH) than the one observed in 2.4 (i-PrOH) for a more bulky alcohol. The 1:1 alcohol 
solvate 2.3 (n-PrOH) shows a 2.3% expansion of the unit cell volume with respect to 
solvate 2.2 (EtOH) in order to accommodate a larger solvent. Although i-PrOH is a 
more sterically demanding branched alcohol this effect is less pronounced in 2.4 (i-
PrOH).  
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Table 2.5 Comparison of unit cell dimensions of 2.1-2.4 Cu(2-pyca)(PPh3)2·nSolvent. 
 2.1  2.2 2.3 2.4 
n Solvent 2MeOH EtOH n-PrOH i-PrOH 
a/Å 12.8237(5) 13.9684(7) 14.5287(15) 11.1667(7) 
b/Å 15.7911(6) 15.2341(7) 15.3652(16) 17.5876(11) 
c/Å 19.2068(7) 18.4128(9) 18.4940(19) 20.1282(12) 
α/° 90 74.777(2) 78.366(2) 82.333(2) 
β/° 97.398(2) 82.880(2) 70.820(2) 86.315(2) 
γ/° 90 82.744(2) 87.215(2) 77.497(2) 
Space Group P21/c P⎯1 P⎯1 P⎯1 
Solvent accessible 
volumea/Å3 
238.5 398.4 477.6 481.3 
Cell volume/Å3 3857.0(3) 3733.5(3) 3818.6(7) 3822.3(4) 
Cell volume 
increase %b 
- - 2.3 2.4 
aFor each molecule of solvent. 
bVolume increase as a percentage compared to 2.2. 
 
Attempts to include the larger alcohols tert-butanol or n-butanol into the structure of 
Cu(2-pyca)(PPh3)2, using similar crystallisation conditions to those used in the 
formation of 2.1-2.4, failed to produce a solvate, instead crystallising the monomeric 
solvent-free structure, Cu(2-pyca)(PPh3)2 2.5 (Figure 2.24). Compound 2.5 lies on a 
mirror plane, resulting in the asymmetric unit comprising half of a molecule.  
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Figure 2.24 View of Cu(2-pyca)(PPh3)2 2.5. Hydrogen atoms have been omitted for 
clarity. 
 
Weak C–H···O hydrogen bonds, [where H···O distances are 2.58 Å], maintain the 
packing of 2.5 forming one-dimensional chains by R12(12) motifs along the 
crystallographic b axis (Figure 2.25). 
 
 
 
Figure 2.25 View of the hydrogen bonded chain formed by 2.5. Most phenyl groups 
and hydrogen atoms not involved in hydrogen bonding have been removed for clarity. 
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2.3.3.2 Solvates of Cu(3-pyca)(PPh3)2 
 
Cariati has reported the solvent-free crystal structure of Cu(3-pyca)(PPh3)2 2.6,50 but 
there is no previous literature evidence of this compound forming solvates. Because 
compound Cu(3-pyca)(PPh3)2 shows excellent solubility in the same range of alcohols 
previously used with the Cu(2-pyca)(PPh3)2 system, the potential formation of solvates 
Cu(3-pyca)(PPh3)2·X, where X = MeOH, EtOH, n-PrOH, i-PrOH, n-BuOH and tert-
BuOH has also been investigated.   
 
The slow evaporation of a solution of Cu(3-pyca)(PPh3)2 in methanol leads to the 
formation of colourless plates Cu(3-pyca)(PPh3)2·MeOH 2.7. The copper(I) centre is 
coordinated to two symmetry related [3-pyca]- ligands through one pyridinic nitrogen 
atom and one carboxylate oxygen atom from each ligand forming one-dimensional 
zigzag chains which propagate in the [1 1 0] direction (Figure 2.26). The MeOH 
molecule is hydrogen bonded alternately on either side of the chain to the second 
caboxylate oxygen forming a similar (solvent)O–H···O(carboxylate) interaction as seen 
previously for compounds 2.1-2.4 (Table 2.6).     
 
 
 
Figure 2.26 Zigzag chains of Cu(3-pyca)(PPh3)2·MeOH 2.7 propagating in the [110] 
direction. Phenyl rings and hydrogen atoms not involved in hydrogen bonding have 
been omitted for clarity. 
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Table 2.6 Selected hydrogen bonding parameters for 2.7. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(1) 2.720(3) 0.78(4) 1.94(4) 173(4) 
 
The crystallisation of Cu(3-pyca)(PPh3)2 from an ethanolic solution by Agnese Cecchin 
resulted in the solvate, Cu2(3-pyca)2(PPh3)4·2EtOH 2.8, which is dimeric (Figure 2.27). 
The two symmetry-related copper ions are linked by two bridging [3-pyca]– ligands 
through the pyridinic nitrogen atom and one carboxylate oxygen atom on each ligand, 
forming a twelve-membered ring with a distance of 6.909 Å between symmetry-related 
metal centres. The unique ethanol molecule is hydrogen bonded to the carboxylate 
oxygen, O(2), via one strong (solvent)O–H···O(carboxylate) hydrogen bond (Table 2.7). 
 
 
 
 
Figure 2.27 The dimeric structure of Cu2(3-pyca)2(PPh3)4·2EtOH 2.8. Hydrogen atoms 
not involved in hydrogen bonding have been removed for clarity. 
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Table 2.7 Selected hydrogen bonding parameters for 2.8. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(2) 2.674(3) 0.81(4) 1.86(4) 177(4) 
 
The coordination geometry at the nitrogen atom is highly strained, the angle at nitrogen 
between the ring centroid of the pyridinic ring and the copper atom is 24.7° away from 
the expected linear geometry (Figure 2.28). The distortion is required to prevent 
unfavourable steric interactions between H(1) and H(1A), which are left on different 
planes. Analysis of the Cu–N bond lengths in compounds 2.7 and 2.8 shows similar 
values, 2.1261(19) Å and 2.154(2) Å respectively. 
 
 
 
Figure 2.28 View of 2.8 showing the strained angles in the coordination geometry at 
the nitrogen atoms. Phenyl groups and hydrogen atoms apart from H(1) and H(1A) have 
been omitted for clarity. 
 
Although the solvent-free Cu(3-pyca)(PPh3)2 is known to pack in the crystalline state in 
one-dimensional chains,50 in the presence of EtOH, the formation of the chains is 
prevented and 2.8 packs as a zero-dimensional dimer; behaviour that was not predicted 
by Cariati. 
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Cu(3-pyca)2(PPh3)2 was originally crystallised by Cariati and co-workers from 
dichloromethane, and the structure determined at room temperature.50 In this study 
complex Cu(3-pyca)2(PPh3)2 2.6, has been isolated from a range of different alcohols 
such as, n-PrOH, i-PrOH, n-BuOH and tert-BuOH and the structure re-determined 
using low-temperature single crystal X-ray diffraction (Figure 2.29). The same structure 
is found in each case, ruling out larger solvents being incorporated in this system. The 
re-determination at low temperature (150 K) gives a big improvement in the final R 
value (2.3% compared to 4.1%), with reductions of 0.6, 0.6 and 0.4% in the a, b and c 
unit cell dimensions, resulting in an overall 1.6% contraction in the unit cell volume 
compared to that determined at room temperature.  
 
 
 
Figure 2.29 Cu(3-pyca)(PPh3)2 2.6. Phenyl groups and hydrogen atoms have been 
omitted for clarity. 
 
Attempts to include larger alcohols such as, n-PrOH, i-PrOH into the structure of Cu(3-
pyca)(PPh3)2 as seen previously for structures 2.3 and 2.4 failed to yield solvates, 
instead crystallising as the solvent-free structure 2.6. 
 
2.3.3.3 Solvates of Cu(4-pyca)(PPh3)2 
 
Inspired by the success of the Cu(2-pyca)(PPh3)2 and Cu(3-pyca)(PPh3)2 analogues, 
crystallisation of Cu(4-pyca)(PPh3)2 was attempted using the same alcohols as above. 
Due to the low solubility of Cu(4-pyca)(PPh3)2 2.9 in almost all alcohols, the 
crystallisation of 2.9 was only possible from methanol. 
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The Cu(4-pyca)(PPh3)2 complex was crystallised by Agnese Cecchin, and structurally 
characterised by the author of this thesis, from a solution of methanol, including three 
molecules of solvent (methanol and water) per complex in the structure. The 
asymmetric unit comprises [Cu(PPh3)24-
py(COO)]2·2MeOH·0.765(4)MeOH·0.235(4)H2O 2.9 (Figure 2.30). In Figure 2.30, only 
the version of the structure with three molecules of methanol is shown. The disorder in 
methanol and water solvent molecules involved only one of the possible three 
molecules present in the structure, actually molecules C(87)−O(7)−H(7A) and 
C(85)−O(5)−H(5) are not disordered. Molecule C(86)−O(6)−H(6) was modelled over 
two sets of positions [part MeOH/part water] in the ratio 76.5(4):23.5(4)%. Selected 
hydrogen bonding parameters for 2.9 are shown in Table 2.8. 
 
 
 
 
Figure 2.30 View of the asymmetric unit of solvate 2.9. Water molecule, phenyl groups 
and hydrogen atoms not involved in hydrogen bonding have been removed for clarity.  
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Table 2.8 Selected hydrogen bonding parameters for 2.9. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(5)−H(5)···O(2) 2.725(3) 0.92(5) 1.80(5) 178(5) 
O(6)−H(6)···O(5) 2.827(5) 0.84 2.00 168 
O(7)−H(7A)···O(4) 2.810(3) 0.84 1.99 164 
 
The structure of 2.9 is polymeric, as Cariati predicted, with one-dimensional zigzag 
chains running parallel to the a direction. Neighbouring chains interlock via their phenyl 
groups to form pseudo-sheets in the ac plane through weak C–H···O hydrogen bonds 
[2.53 Å]. These sheets form layers stacked on top of each other in the b orientation 
(Figure 2.31). 
 
 
 
Figure 2.31 Packing plot of compound 2.9, viewed along the crystallographic c axis. 
Water molecules, phenyl groups and hydrogen atoms not involved in hydrogen bonding 
have been omitted for clarity. 
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2.3.3.4 Discussion of the General Structural Features of Complexes 2.1-
2.9 
 
There is little variation in the P−Cu, O−Cu and N−Cu bond lengths in complexes 2.2-
2.9 (Table 2.9) and they are consistent with the values reported for other copper(I) 
complexes.104,105 The P−Cu−P bond angles are similar to reported values for other 
bis(triphenylphosphine)copper(I) compounds.106-109 In all complexes obtained, the 
copper(I) ion is in a distorted tetrahedral environment. The chelated O–Cu–N bite angle 
(79.77-80.16°) is the origin of this distortion. The geometry of complexes 2.2-2.5 are in 
general agreement with the mean values collected from the CSD survey, (Version 5.30, 
November 2008 plus 4 updates), the O−Cu−N bond angle values are similar to those 
reported for other examples of five-membered chelate C–O–Cu–N–C systems (83.50-
76.23º).110-113 
 
Complexes 2.2-2.5 and 2.6 show a large difference between the P−Cu−P bond angles, 
(9.9-13.7º), (Table 2.9). A possible reason for this difference could be: in complex 2.6, 
there are two sets of possible H···H repulsive interactions on the phenyl rings from the 
triphenylphosphine molecules, causing additional opening of the P−Cu−P, while in 
complexes 2.2-2.5 there are two sets of weak edge to face C−H···π attractive phenyl-
phenyl interactions (Table 2.10) contracting the angle to a smaller value (Figure 2.32). 
 
 
 
               a                                                                                     b 
 
Figure 2.32 Space filling plots. a. Complex 2.6, b. Complex 2.4.  
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There is a large difference, (6.9-8.8º), between the P−Cu−P bond angles for the 
complexes 2.6-2.8 (Table 2.9). A possible explanation for this difference in the P−Cu−P 
bond angles between these solvates could be: the structures 2.6 and 2.7 both crystallise 
including molecules of solvent which can be accommodated in the void between the 
phenyl groups at the expense of some angular distortions at the copper(I) tetrahedral 
environment. However, 2.8 crystallises as a solvent-free structure, hence 2.8 does not 
accommodate solvent molecules in the structure giving smaller values for the P−Cu−P 
bond angle. 
 
The values for the α and β parameters [α= angle defined between planes P(1)-Cu(1)-
P(2) or P(1)-Cu(1)-P(1A) and O(1)-Cu(1)-N(1) and β= angle defined between planes 
P(3)-Cu(2)-P(4) and N(2)-Cu(2)-O(3)] (Table 2.9) in 2.2-2.6 show the deviations of 
angles N–Cu–O and P–Cu–P from the tetrahedral environment presented by the 
copper(I) centre in all these structures. As expected, the formation of the strong O–H···O 
hydrogen bond interactions with the solvent molecules may be the reason of the slight 
deviation of these values from 90°.  
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Table 2.9 Selected bond lengths (Å) and bond angles (°) for 2.1-2.9. 
 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 
P–Cu 2.2465(5) 2.254 2.2512(8) 2.2610(5) 2.2608(7) 2.2512(7) 2.2720(8) 2.2589(4) 2.258(7) 
O–Cu 2.1091(13) 2.0792(16) 2.092(2) 2.0908(12) 2.084(2) 2.0497(16) 2.0700(19) 2.1238(11) 2.069(17) 
N–Cu 2.0651(15) 2.102 2.101(2) 2.1055(14) 2.090(3) 2.1261(19) 2.154(2) 2.1299(13) 2.134(2) 
O(1)–Cu(1)–N(1) 79.92(6) 80.13(7) 80.01(8) 79.77(5) 80.16(10) 92.01(7) 90.45(8) 95.10(5) 92.00(7) 
O(3)–Cu(2)–N(2) - 79.73(8) 79.71(9) 79.79(5) - - - - 90.76(7) 
P–Cu(1)–P 124.853(18) 122.33(2) 126.14(3) 124.024(18) 136.05(4) 125.47(3) 123.55(3) 116.656(16) 123.94(3) 
α 97.9 96.6 94.3 90.9 90.0 - - - - 
P(3)–Cu(2)–P(4) - 124.66(2) 123.28(3) 124.014(18) - - - - 118.98(3) 
β - 93.9 94.8 93.1 - - - - - 
α= angle defined between planes P(1)-Cu(1)-P(2) or P(1)-Cu(1)-P(1A) and O(1)-Cu(1)-N(1). 
β= angle defined as described for α but applied to the second molecule of complex in the asymmetric unit. P(3)-Cu(2)-P(4) and N(2)-Cu(2)-O(3). 
 
Table 2.10 Edge to face C−H···π attractive phenyl-phenyl interactions (Å) for 2.2-2.5. 
 2.2 2.3 2.4 2.5 
C−H···π  2.847/3.228 3.091/3.274 2.913/3.184 3.115/3.340 
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2.3.4 Synthesis and Crystallisation of Cu(2,n-Hpyca)(PPh3)2 (n = 3-6) 
Complexes 
 
The reactions of Cu(PPh3)2(BH4) with pyridine-2,n-dicarboxylic acid (n = 3-6) were 
carried out under reflux in dichloromethane yielding compounds 2.10-2.14. The 
reactions took up to 3 h to complete and the products were easily isolated in excellent 
yield as yellow-orange precipitates by addition of light petroleum ether to the 
concentrated reaction mixture (Equation 2.3). 
 
Cu(PPh3)2(BH4) +
N COOH
COOH 3 h   r.t.
CH2Cl2
Cu(2,n-Hpydca)(PPh3)2
 
 
Equation 2.3  
 
Cu(2,3-Hpydca)(PPh3)2 2.10 crystallises with an intramolecular S(7) graph set hydrogen 
bond (Figure 2.33), a common motif for adjacent carboxylic acid groups.114,115 The 
same motif is seen in the zwitterionic form of 2,3-H2pydca,116,117 with very similar 
O···O distances for both of them, 2.408(2) Å in compound 2.10 and 2.400(2) Å in 2,3-
H2pydca, the N,O metal coordination does not create any distortions in the ligand. As 
seen previously in compound 2.7, the re-determination at low temperature (150 K) gives 
a slight improvement in the final R value (4.93% compared to 5.30%).    
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Figure 2.33 View of the asymmetric unit of Cu(2,3-Hpydca)(PPh3)2 2.10. Hydrogen 
atoms except OH have been removed for clarity. 
 
The intramolecular hydrogen bonding of the protonated carboxylic acid group in 2.10 
limits the dimensionality of the packing of the complex, with molecules of 2.10 forming 
centrosymmetric dimers via weak C–H···O hydrogen bonding interactions [where C···O 
distance is 3.50 Å], producing an R22(26) graph set motif with a distance of 9.248 Å 
between symmetry-related metal centres. The dimers are also stabilised by the presence 
of an edge-to-face C–H···π(centroid) interaction (2.490 Å) between the aromatic rings of 
the two symmetry related molecules (Figure 2.34). Selected hydrogen bonding 
parameters for 2.10 are shown in Table 2.11. 
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Figure 2.34 View of the hydrogen bonded dimers of Cu(2,3-Hpydca)(PPh3)2 2.10. 
Phenyl groups and hydrogen atoms not involved in hydrogen bonding have been 
omitted for clarity.  
 
Table 2.11 Selected hydrogen bonding parameters for 2.10. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)–H(3)···O(2) 2.408(2) 0.95(3) 1.47(3) 167(3) 
 
It is interesting to note that the re-determination of the full structure of compound 2.10 
at low temperature allows a better location of the hydrogen atoms in the structure, 
showing the formation of dimers and the presence of the intramolecular hydrogen bond 
which were not discussed by Cariati. Crystallisation of Cu(2,3-Hpydca)(PPh3)2 2.10 was 
also performed from MeOH, EtOH, n-PrOH and i-PrOH with no solvates formed and 
only the solvent-free structure was observed. 
 
Cu(2,4-Hpydca)(PPh3)2·CHCl3 2.11 was crystallised from a chloroform solution (Figure 
2.35). The asymmetric unit of 2.11 contains two molecules of the complex and two 
molecules of chloroform. Careful inspection of the disposition of the two unique 
molecules shows that the compound has crystallised with two similar conformations of 
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the complex molecules and they only differ significantly in the disorder present in one 
of the solvent molecules.  
 
 
 
Figure 2.35 View of one of the two independent Cu(2,4-Hpydca)(PPh3)2·CHCl3 units in 
2.11. Hydrogen atoms not involved in hydrogen bonding and the disordered solvent 
molecule have been omitted for clarity. 
 
The R22(8) head-to-tail carboxylic acid dimer is not found in 2.11 (Figure 2.36); instead 
are series of ring motifs are formed using a combination of strong (acid)O–
H···O(carboxylate) and weak (aromatic)C–H···O(carboxylate) hydrogen bonds (Table 
2.12). The combination of these interactions with a symmetry related molecule results 
in an R22(14) ring motif. The outer carboxyl groups of each molecule also interact with 
a phenyl group producing an R33(11) graph set motif. This creates chains running 
parallel to the b direction and stacking on top of each other in the a orientation. The 
chloroform molecules are located between the chains and hydrogen bond to the 
carboxylic acid group through (solvent)C–H···O(acid) hydrogen bond. 
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Figure 2.36 View of the packing plot of compound 2.11, viewed down the 
crystallographic a axis. Most phenyl groups and hydrogen atoms not involved in 
hydrogen bonding have been removed for clarity.  
 
Table 2.12 Selected hydrogen bonding parameters for 2.11. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(4)−H(4)···O(5A)i 2.511(4) 0.84 1.73 154 
O(8)−H(8)···O(2A)i 2.468(4) 0.84 1.64 166 
Symmetry operation: i-x+1/2, y+1/2, -z+1/2. 
 
The addition of an extra carboxylic acid group compared to 2.1-2.5 provided an 
additional hydrogen bonding group which resulted in the extension of the zero-
dimensional molecular structures into a one-dimensional network through hydrogen 
bonds in 2.11. 
 
The Cu(2,5-Hpydca)(PPh3)2 was crystallised by Agnese Cecchin, and structurally 
characterised by the author of this thesis, from a methanolic solution. It was observed to 
include one molecule of water per molecule of complex, yielding Cu(2,5-
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Hpydca)(PPh3)2·H2O 2.12 (Figure 2.37). The inclusion of water molecules into the 
structure provides suitable OH donors to the system. The H2O molecule hydrogen bonds 
to the two carboxylate oxygen atoms through a bifurcated (solvent)O−H···O(acid) 
hydrogen bond, with the formation of an R21(4) ring motif. Selected hydrogen bonding 
parameters for 2.12 are shown in Table 2.13.  
 
 
 
Figure 2.37 View of the asymmetric unit of Cu(2,5-Hpydca)(PPh3)2·H2O 2.12. 
Hydrogen atoms from the phenyl groups have been removed for clarity.  
 
Table 2.13 Selected hydrogen bonding parameters for Cu(2,5-Hpydca)(PPh3)2·H2O 
2.12. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(4)−H(4)···O(2A)i 2.6009(17) 0.84 1.77 170 
O(5)−H(5B)···O(2) 3.091(2) 0.89(3) 2.27(3) 152(3) 
O(5)−H(5B)···O(1) 3.320(2) 0.89(3) 2.60(3) 139(2) 
O(5)−H(5A)···O(3B)ii 2.864(2) 1.02(3) 1.85(3) 171(3) 
Symmetry operations: ix, -y+1/2, z-1/2 and ii-x+2, -y, -z+1. 
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The molecules of 2.12 form chains via a single, strong (carboxylic 
acid)O−H···O(carboxylate) hydrogen bond propagating parallel to the c axis ( Figure 
2.38). The water molecules of crystallisation then aid the formation of an extended two-
dimensional hydrogen bonding array by donating each of its OH groups to two 
symmetry related molecules of complex via two strong O–H···O hydrogen bonds, with 
the uncoordinated carboxylate O atom from one and one the carboxylic acid O atom 
from the other allowing the formation of R44(22) and R88(36) ring motifs.   
 
 
 
Figure 2.38 Packing plot of compound Cu(2,5-Hpydca)(PPh3)2·H2O 2.12. 
Hydrogen not involved in hydrogen bonding and phenyl groups have been removed for 
clarity. 
 
When Cu(2,5-Hpydca)(PPh3)2 was crystallised via the vapour diffusion of hexane into a 
chloroform/methanol solution; a chloroform solvate, Cu(2,5-Hpydca)(PPh3)2·2CHCl3 
2.13, was isolated (Figure 2.39). 
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Figure 2.39 View of the asymmetric unit of compound Cu(2,5-Hpydca)(PPh3)2·2CHCl3 
2.13. Phenyl groups and hydrogen atoms except OH have been omitted for clarity.  
 
As seen above for 2.12, a single strong (carboxylic)O−H···O(carboxylate)  hydrogen 
bond holds the molecules of 2.13 into chains (Table 2.14) and complementary 
interactions with the solvent molecules, (phenyl)C–H···Cl(solvate) and (solvate)C–
H···O(carboxylic/carboxylate) [2.90 Å, 2.87 Å, 2.46 Å, 2.41 Å], extend the 
dimensionality of the structure into sheets, this disposition is unsurprising considering 
the positioning of the carboxylic group in the molecule (Figure 2.40). The chloroform 
molecules bridge adjacent different chains. Here, chloroform facilitates the formation of 
a supramolecular array, rather than limiting the dimensionality as seen in compound 
2.10.  
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Figure 2.40 Packing of Cu(2,5-Hpydca)(PPh3)2·2CHCl3 2.13. Hydrogen not involved in 
hydrogen bonding and most phenyl groups have been removed for clarity. 
 
Table 2.14 Selected hydrogen bonding parameters for 2.13 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3A)···O(2) 2.553(3) 0.84 1.71 177 
Symmetry operations: ix+1, y, z. 
 
The X-ray diffraction data for compound Cu(2,6-Hpydca)(PPh3)2·H2O 2.14 was 
collected at the EPSRC National X-ray Service at Daresbury Laboratory due to the 
weak intensity of the reflections. The hydrogen atoms of one of the water molecules, 
O(11), could not be located in the Fourier difference map. Compound 2.14 crystallises 
with two formula units in the asymmetric unit and three water molecules of 
crystallisation. The two unique molecules crystallise in two different conformations and 
they also differ in the number of water molecules hydrogen bonded to the complex 
(Figure 2.41).  
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Figure 2.41 View of the asymmetric unit of 2.14. Phenyl groups and hydrogen atoms 
not involved in hydrogen bonding have been removed for clarity.  
 
In the case of compound 2.14, two of the water molecules hydrogen bond to a symmetry 
related molecule and to the carboxylate O of one copper(I) complex molecule, forming 
an R33(8) motif.  The network of strong hydrogen bonds creates a stepped-chain 
structure which extends in the [1 0 1] direction (Figure 2.42). The pyridyl rings of 
neighbouring complex molecules interlock allowing (pyridyl)C–H···O(carboxylate) 
hydrogen bonding interactions (2.563 Å). Selected hydrogen bonding parameters for 
2.14 are shown in Table 2.15. 
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Figure 2.42 View of the hydrogen bonded chain formed by compound 2.14. Phenyl 
groups and hydrogen atoms not involved in hydrogen bonding have been removed for 
clarity.  
 
Table 2.15 Selected hydrogen bonding parameters for 2.14. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(4)−H(4)···O(10) 2.516(8) 0.84 1.69 169 
O(10)−H(10B)···O(9)i 2.767(9) 0.84(2) 2.03(5) 145(7) 
O(9)−H(9B)···O(1) 2.777(8) 0.83(2) 1.95(2) 177(11) 
O(10)−H(10A)···O(2)i 2.635(8) 0.83(2) 1.83(3) 164(10) 
O(8)−H(8)···O(11)ii 2.558(8) 0.84 1.72 173 
Symmetry operations: ix, y+1, z; iix, y-1, z. 
 
Cariati failed to predict the structures of 2.10-2.14, because the reported analysis was 
based on the comparison of the infrared spectra of these compounds: all complexes 
presented very similar υas(COOH) and υas(COO) and Cariati supposed that their 
structures were identical. However, the work has shown that 2.10 crystallises as discrete 
dimers, whereas complexes 2.11-2.14 crystallise as polymeric structures where different 
types of hydrogen bonding patterns, such as single, strong 
(carboxylic)O−H···O(carboxylate) or secondary interactions with solvent molecules, 
hold the molecules together yielding higher dimensionality networks. 
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The coordinated carboxylate group only deviates slightly from co-planarity with the 
pyridine ring of the bidentate ligand in 2.14 bearing [2,6-Hpydca]– (the maximum twist 
angle is 3.1°). However, when the bidentate ligands are [2,3-Hpydca]–, [2,4-Hpydca]– 
and [2,5-Hpydca]–, this deviation is greater, with the greatest twist angle being 18.8°, 
observed in 2.13. With the exception of complex 2.13, the carboxylic acid groups of the 
[2,n-Hpydca]– ligands (n = 3-6) show greater deviations from co-planarity with the 
pyridine ring of the bidentate ligand than do the carboxylate group. The most notable 
example is complex 2.11, where the carboxylic acid group lies at an angle of 36.2° to 
the pyridine ring of the bidentate ligand.      
 
2.3.5 Synthesis and Crystallisation of Cu(3,n-pyca)(PPh3)2 (n = 4, 5) 
Complexes 
 
The next step was to study the hydrogen bonding capability of copper(I) complexes 
containing 3,n-H2pydca (n = 4, 5) ligands. The method used to synthesise them is 
described above for complexes 2.1-2.14 giving good to high yields (Equation 2.4). 
Crystallisation was attempted for both compounds using a wide range of solvent 
systems, however both compounds only crystallised as solvent-free structures. 
Experimental data such as, microanalysis, 1H and 31P NMR spectral data, clearly show 
the presence of the expected compounds in both cases.  
 
Cu(PPh3)2(BH4) +
N
3 h   r.t.
CH2Cl2
Cu(3,n-Hpydca)(PPh3)2
COOH
COOH
 
 
Equation 2.4 
 
The crystal structure of compound Cu(3,4-Hpydca)(PPh3)2 2.15 shows that the 3,4-
pyridine ligand bridges covalently two copper(I) centres through the pyridine nitrogen 
atom and an oxygen from the carboxylate group para to the nitrogen atom forming 
covalently bonded chains. The second carboxylate oxygen is hydrogen bonded to the 
carboxylic acid OH group meta to the nitrogen atom forming a intramolecular S(7) 
graph set strong O−H···O motif (Table 2.16), a common occurrence in 1,2-disubstituted 
dicarboxylic acids in their neutral form and when deprotonated (Figure 2.43).116,118 The 
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coordinated carboxylate and carboxylic acid groups deviate slightly from co-planarity 
with the pyridine ring of the bidentate ligand with the greatest twist angle being 18.1°.   
 
 
 
Figure 2.43 View of the asymmetric unit of compound [Cu(3,4-Hpydca)(PPh3)2]n 2.15. 
Hydrogen atoms not involved in hydrogen bonding have been removed for clarity. 
 
Table 2.16 Selected hydrogen bonding parameters for 2.15. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(2) 2.432(3) 0.84 1.60 170 
O(6)−H(6)···O(7) 2.416(4) 0.84 1.58 176 
 
The intramolecular hydrogen bonding of the protonated carboxylic acid group in 2.15 
limits the dimensionality of the packing of the complex. The one-dimensional 
polymeric zigzag chains propagate parallel to the a axis (Figure 2.44). 
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Figure 2.44 Packing plot of 2.15, viewed along the crystallographic b axis. Phenyl 
groups and hydrogen atoms except OH have been removed for clarity. 
 
Crystals of compound Cu(3,5-Hpydca)(PPh3)2 2.16 were obtained by Helena Ascroft 
and represent the first example of copper(I) coordinated to the 3,5-H2pydca ligand. 
Wang and co-workers have described an example of a copper(II) complex with 3,5-
H2pydca ligand presenting a similar hydrogen bonding pattern to the one observed in 
2.16 where the metal centers are coordinated to the O atoms from the 
carboxylic/carboxylate functionalities instead of involving also the pyridyl N which is 
more common.73,119 Compound 2.16 crystallises forming zigzag chains where each 
copper(I) atom is tetrahedrally coordinated by two molecules of triphenylphosphine, 
one carboxylate oxygen from one [3,5-Hpydca]– ligand and by one carboxylic oxygen 
from a symmetry related [3,5-Hpydca]– ligand (Figure 2.45). Complex 2.16 shows 
smaller deviations from co-planarity of the pyridine ring with the carboxylate and 
carboxylic acid groups than the ones observed in 2.15 (the maximum twist angle in 2.16 
is 9.8°).  
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Figure 2.45 View of the zigzag chains of Cu(3,5-Hpydca)(PPh3)2 2.16. Phenyl groups 
and hydrogen atoms not involved in hydrogen bonding have been removed for clarity. 
 
The carboxylic acid and the carboxylate oxygen of the [3,5-Hpydca]– do indeed 
participate in hydrogen bonding, forming the R11(8) carboxylic acid-carboxylate graph 
set motif through one strong O−H···O hydrogen bond (Table 2.17). 
 
Table 2.17 Selected hydrogen bonding parameters for 2.16. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(4)−H(4)···O(2C)i 2.442(4) 0.84 1.62 164 
O(4B)−H(4B)···O(2)ii 2.452(4) 0.84 1.65 160 
Symmetry operations: ix+1/2, -y+1, z; iix+1/2, -y+2, z. 
 
Cariati predictions for compounds without groups in the ortho position with respect to 
the pyridinic nitrogen such as, 2.15 and 2.16 were proved correct as they do crystallise 
forming polymeric structures.  
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2.3.5 Synthesis and Crystallisation of Copper(I)-Pyrazinecarboxylic 
Acid Complexes 
 
 As seen previously, pyridine carboxylate ligands bind well to metal centres and, 
therefore, have been extensively used in the construction of metal/organic networks. 
The functionalised homologues, the pyrazine carboxylates, although less used,93,120 are 
another class of very good ligands for the construction of new framework materials 
because of their extensive bonding versatility. In pyrazine carboxylate ligands, two 
coordination sites, neutral and/or charged, chelate to the metal centre while the 
remaining donor sites can further participate in the assembly of a polymeric structure by 
an exo-binding mode to other metal centres or by supramolecular interactions to nearby 
H-bonding donors.  
 
All compounds described below, Cu(2-pzca)(PPh3)2 2.17, Cu(2,3-Hpzdca)(PPh3)2 2.18, 
Cu(2,3-pzdca)(PPh3)4 2.19 and Cu(2,5-pzdca)(PPh3)2 2.20, have been synthesised 
following the same reaction conditions described previously in this chapter. The 
crystallisation of pyrazine copper(I) complexes 2.17-2.20 all proceeded smoothly, 
through slow vapour diffusion into a saturated complex solution or by simple 
evaporation. Interestingly, in the case of compound Cu(2-pzca)(PPh3)2 2.17, the 
crystallisation of two different polymorphic forms was observed depending on the 
solvent system. The first polymorph of 2.17 which was obtained by slow vapour 
diffusion of hexane into a chloroform solution of Cu(2-pzca)(PPh3)2, crystallises in the 
triclinic crystal system while the second polymorph, which was obtained using diethyl 
ether instead of hexane, crystallises as monoclinic. Both forms crystallise as solvent-
free structures with one molecule of 2.17 in the asymmetric unit (Figure 2.46).  
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Figure 2.46 View of the asymmetric unit of the triclinic polymorph of Cu(2-
pzca)(PPh3)2 2.17. Hydrogen atoms have been omitted for clarity.  
 
Carboxylate oxygen atoms are involved in weak secondary hydrogen bond (phenyl)C–
H···O(carboxylate) interactions, H···O = 2.52 Å and 2.44 Å, producing alternate R44(30) 
and R22(20) motifs, which creates a one dimensional stepped structure extending 
parallel to the b direction (Figure 2.47).   
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Figure 2.47 View of the stepped chain motif in 2.17. Most phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been omitted for clarity.  
 
In contrast to the solvent dependency trend observed in 2.1-2.5, attempts to include the 
same alcohols, MeOH, EtOH, n-PrOH and i-PrOH, into the structure of Cu(2-
pzca)(PPh3)2 2.17 failed to produce solvates, crystallising instead as the solvent-free 
triclinic polymorph 2.17A. 
 
The reaction of one equivalent of (PPh3)2Cu(BH4) with one equivalent of 2,3-H2pzdca 
yields compound Cu(2,3-Hpzdca)(PPh3)2 2.18. Complex 2.18 crystallises with the 
carboxylate group involved in chelation almost coplanar with the pyrazine ring 
[dihedral angle of 3.3°] and the carboxylic acid group almost perpendicular to the 
pyrazine ring [dihedral angle of 95.1°] preventing the formation of the intramolecular 
O–H···O hydrogen bond observed in Cu(2,3-Hpydca)(PPh3)2 2.9 (Figure 2.48).  
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Figure 2.48 View of the asymmetric unit of 2.18. Hydrogen atoms except OH have 
been omitted for clarity.  
 
Instead, O–H···O hydrogen bonds generate dimers in which two monomers of complex 
2.18 are held in an R22(14) motif, with a distance of 11.920 Å between symmetry-
related copper atoms (Figure 2.49). Cariati predictions of compound 2.18 crystallising 
as discrete units also failed as seen previously for Cu(2,3-Hpydca)(PPh3)2 2.10. Selected 
hydrogen bonding parameters for 2.18 are shown in Table 2.18. 
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Figure 2.49 View of the R22(14) graph set motif between monomers of 2.18, producing 
dimers. Phenyl groups and hydrogen atoms except those involved in hydrogen bonding 
have been omitted for clarity. 
  
Table 2.18 Hydrogen bonding parameters for 2.18. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3A)···O(2)i 2.600(3) 0.77(4) 1.87(5) 159(5) 
Symmetry operation: i-x+1, -y+1, -z. 
 
When one equivalent of 2,3-H2pzdca was reacted with two equivalents of 
(PPh3)2Cu(BH4), the pyrazine ligand bridges two metal centres yielding Cu2(2,3-
pzdca)(PPh3)4 2.19. The same compound, 2.19, was also obtained by adding one 
equivalent of (PPh3)2Cu(BH4) to 2.18. Compound 2.19 presents a two-fold axis, 
resulting in the asymmetric unit comprising half of a molecule (Figure 2.50). The 
asymmetric unit also contains two methanol molecules of crystallisation, one of them 
disordered across a two-fold axis. The hydrogen atoms of the disordered methanol 
molecule could not be located in the Fourier difference map. As expected, electronic 
repulsions force the adjacent carboxylate groups away from the plane of the pyrazine 
ring, with a dihedral angle of 31.2°. Selected hydrogen bonding parameters for 2.19 are 
shown in Table 2.19. 
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Figure 2.50 View of Cu2(2,3-pzdca)(PPh3)4 2.19.  Phenyl groups and hydrogen not 
involved in hydrogen bonding have been removed for clarity. Only one of the 
components of the disordered methanol C41–O4 is shown for clarity.  
 
Table 2.19 Selected hydrogen bonding parameters for 2.19. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(2) 2.609(10) 0.84 2.06 123 
O(3)−H(3)···O(4X) 2.93(2) 0.84 2.51 112 
 
Complex Cu2(2,5-pzdca)(PPh3)4 2.20 shows similarities with the reported compound 
Cu2[(2,5-pzdca)(phen)4](NO3)2·10H2O reported by Beobide and co-workers, but 
without any included solvent in this case.40 Both compounds crystallise on a 
crystallographic centre of symmetry where the bidentate [2,5-pzdca]2- ligand bridges 
two copper atoms with a Cu···Cu distance slightly smaller for 2.20, 6.852 Å, than the 
one reported for Cu2[(2,5-pzdca)(phen)4](NO3)2·10H2O, 7.112 Å (Figure 2.51). 
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Figure 2.51 View of centro-symmetric compound 2.20. Hydrogen atoms have been 
omitted for clarity. 
 
The hydrogen bonded undulating chains, produced as a result of the 2,5-substitution of 
2.20, extend in the ab plane through weak C–H···O hydrogen bonds [where C···O 
distances are 3.09 Å, 3.12 Å and 3.19 Å] forming R22(14) and R22(22) graph set motifs 
(Figure 2.52). 
 
 
 
 
Figure 2.52 View of Cu2(2,5-pzdca)(PPh3)4 2.20. Most phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity.   
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The copper(I) complexes with 2,3-H2pzdca and 2,5-H2pzdca described in this chapter  
have similar pK1 and pK2 values.50 However, while the crystallisation of the 1:1 and 1:2 
adducts, ligand:[Cu(PPh3)2]+, was possible using 2,3-H2pzdca as a ligand, only the 1:2 
adduct was crystallised from the reaction with 2,5-H2pzdca. An explanation for this 
behaviour may be that the Cu(2,3-Hpzdca)(PPh3)2 2.18 complex in solution, like other 
1,2-disubstituted acids, adopts the favourable cyclic arrangement via intramolecular 
hydrogen bonding, and this slows the process of losing the second proton making 
possible the isolation of the 1:1 adduct. In contrast, the structure of pyrazine-2,5-
dicarboxylic acid prevents the formation of intramolecular hydrogen bonds, therefore 
both protons are equivalent and the isolation of 1:1 adduct was not possible. 
 
The infrared spectrum of 2.18 confirms the formation of the 1:1 adduct, with strong 
asymmetric and symmetric carboxylate absorptions at 1626 and 1353 cm–1 respectively, 
in addition to an absorption at 1737 cm–1 corresponding to the carbonyl double bond of 
the protonated carboxylic acid group.    
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2.4 Conclusions 
 
The crystal structures of eighteen novel copper(I) complexes with pyridine and pyrazine 
carboxylic acids and the re-determination at low temperature for compounds, Cu(3-
pyca)(PPh3)2 and Cu(2,3-Hpydca)(PPh3)2, have been presented in this chapter. 
 
Compounds Cu(2-pyca)(PPh3)2 and Cu(2-pzca)(PPh3)2 crystallise as the molecular 
structures Cariati predicted, forming monomeric complexes with five-membered chelate 
rings being coordinated to the metal ion through the nitrogen atom and the unidentate 
carboxylic group. Interestingly, the use of a varied range of solvent systems has allowed 
the crystallisation of Cu(2-pyca)(PPh3)2 solvates, 2.1-2.5, displaying a solvent 
dependency not seen in compound Cu(2-pzca)(PPh3)2 2.17, where the change of solvent 
system only led to the isolation of two different, triclinic and monoclinic, polymorphic 
forms. Solvents such as, n-BuOH and tert-BuOH failed to produce Cu(2-pyca)(PPh3)2 
solvate structures suggesting that these molecules are too large to comfortably fill the 
voids in the crystal lattice used by the smaller homologues. Therefore, the adjustability 
of the void size is probably a limiting factor determining which solvents can be 
accommodated. 
 
Structural analysis of 2.1-2.5 shows that these structures are very flexible in order to 
accommodate the solvent molecules, the bond angles at the copper ion can take quite a 
range of values; e.g. P−Cu−P 116.66-136.05º. Solvates structures 2.1-2.5 exhibit similar 
(solvate)O–H···O(carboxylate) hydrogen-bonding motifs with comparable distances and 
angles. 
 
Although compounds Cu(3-pyca)(PPh3)2 2.6 and Cu(3-pyca)(PPh3)2·MeOH 2.7 pack in 
the crystalline state in one-dimensional chains as Cariati predicted, in the presence of 
EtOH, the formation of the chains is prevented and Cu(3-pyca)(PPh3)2·EtOH 2.8 packs 
as a zero-dimensional dimer; behaviour that was not predicted by Cariati. The 
modification of the solvent causes a variation in the hydrogen bonding array of the 
Cu(3-pyca)(PPh3)2 molecules, with the resulting solvates having zero-dimensional or 
one-dimensional architectures. Following on from the inclusion of solvent molecules 
into the lattices of Cu(2-pyca)(PPh3)2 and Cu(3-pyca)(PPh3)2, the incorporation of 
solvents such as, EtOH, n-PrOH, i-PrOH failed for Cu(4-pyca)(PPh3)2, only being 
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possible the isolation of [Cu(PPh3)24-py(COO)]2·2MeOH·0.765(4)MeOH·0.235(4)H2O 
2.9. The poor solubility of Cu(4-pyca)(PPh3)2 in these solvents may be the reason for 
this failure. 
 
The structures of compounds 2.10-2.14 could not be predicted from infrared 
spectroscopic evidence and from the trend seen in Cu(2,3-Hpyca)(PPh3)2 previously 
reported by Cariati.50 These structures provide an insight into the structural diversity 
that these copper(I) complexes can exhibit.  
 
Extensive hydrogen bonding exists in 2.10-2.14, with the strong (carboxylic 
acid)O−H···O(carboxylate) hydrogen bond interaction present in all cases forming 
intramolecular S(7) graph set or one-dimensional zig-zag chains depending on the 
disposition of the carboxylic groups in the pyridine ring. The combination of this 
O−H···O interaction with weaker interactions involving molecules of solvent, varying 
geometries and substitution pattern of carboxylic acid of the pyridine carboxylic acids 
employed, has led to the creation of a range of supramolecular arrays, from zero-
dimensional to two-dimensional supramolecular structures.  
 
Cariati predictions also failed for compound Cu(2,3-Hpzdca)(PPh3)2 2.18 which 
crystallises as a dimer through O–H···O hydrogen bonds instead of discrete units. Once 
more, the structure of compound 2.18 could not be predicted from infrared 
spectroscopic evidence.  
 
The analysis of the compounds presented here provides information on the varied 
hydrogen bonding patterns they can adopt, which can only contribute to the current 
level of understanding in solid state structure prediction. 
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2.5 EXPERIMENTAL 
 
Starting Materials 
 
The starting materials (2-Hpyca, 3-Hpyca, 4-Hpyca, 2,3-H2pydca, 2,4-H2pydca, 2,5-
H2pydca, 2,6-H2pydca, 3,4-H2pydca, 2,5-H2pydca, 2-Hpzca, 2,3-H2pzdca, 2,5-H2pzdca 
Cu(SO4)·6H2O, were purchased from commercial sources Aldrich, Lancaster, Avocado 
and Acros. All solvents were purchased from Aldrich, Fisher or Lancaster. CH2Cl2 was 
distilled from CaH2 under nitrogen, and diethyl ether distilled from Na under nitrogen. 
 
Physical Measurements 
 
All NMR spectra were recorded in CDCl3 unless otherwise stated. NMR spectra (1H 
and 31P) were obtained on a Bruker DPX-400 MHz operating at 400.13 MHz for 1H 
with chemical shifts (δ) in ppm relative to SiMe4 and operating at 161.98 MHz for 31P 
with chemical shifts (δ) in ppm relative to 85% H3PO4. Infrared spectra were recorded 
as KBr disks in the range 4000 – 200 cm-1 on a Perkin-Elmer System 2000 Fourier 
transform spectrometer. Elemental analyses (Perkin-Elmer 2400 CHN elemental 
analyser) were carried out by the Loughborough University Analytical Service within 
the Department of Chemistry. 
 
Syntheses 
 
Cu(PPh3)2(BH4) 2.1 Hydrated copper(II) sulfate (1.500 g, 5.607 mmol; previously 
ground to a fine powder using a pestle and mortar) was added to a solution of 
triphenylphosphine (7.567 g, 28.84 mmol) in absolute ethanol (100 ml). The mixture 
was stirred and warmed on a hotplate for 15 min until all the copper(II) sulfate 
dissolved. Powdered sodium borohydride (1.498 g, 39.63 mmol) was added whilst 
carefully stirring for 1 h, until the effervescence stopped and precipitation was 
complete. The crude white solid product was filtered off and stirred with chloroform (75 
ml). The mixture was filtered and the filtrate warmed to 50 ºC on a hot plate at which 
point absolute ethanol (75 ml) was added dropwise until the initial faint cloudiness 
became fine white crystals. The mixture was cooled and the product isolated. The white 
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crystals were washed with a small amount of diethylether and dried in air. Yield 2.741 
g, 82%, mp 164-165 ºC (lit. 165-166 ºC).97 
 
1H NMR (400 MHz, CDCl3) δ 7.70-7.23 (30H, m, ArH).  
31P NMR: δ -1.20 ppm.  
Analysis calculated for C36H34CuP2B: C, 71.71; H, 5.68. Found:  C, 71.63; H, 5.54%. 
 
Unless stated otherwise, the following method was used for the synthesis of all 
compounds presented in this chapter. To a stirring solution of Cu(PPh3)2(BH4) 2.1 in 
DCM was added either pyridine-n-carboxylic acid (n = 2, 3, 4), pyrazine-2-carboxylic 
acid, pyridine-2,n-dicarboxylic acid (n = 3–6) (0.5 eq.), pyridine-3,n-dicarboxylic acid 
(n = 4, 5) (0.5 eq.) or pyrazine-2,n-dicarboxylic acid (n = 3, 5) (0.5 eq.) respectively. 
The resulting mixtures were then refluxed for 3 h. The products were isolated by 
concentration of the reaction solution to ≈ 5 ml and precipitation of the solids through 
the addition of Et2O (≈ 15 ml). The precipitates were washed with Et2O and dried in air 
before storage in a desiccator containing silica gel.50 
 
Compound Cu(2-pyca)(PPh3)2 
Yield 0.4811 g, 89%. 
IR υmax (KBr)/cm–1 3049 (Ar C-H), 1610 (asymm. CO2⎯), 1435 (C-O), 1382 (symm. 
CO2⎯), 841, 757 and 739 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 8.28 (1H, d, J 4 Hz), 7.91 (1H, d, J 2.4 Hz), 8.25 (1H, d, 
J 7.6 Hz) 7.09-7.63 (31H, m). 
31P NMR data: δ -2.08 ppm. 
Analysis calculated for C42H34NCuO2P2·H2O: C, 69.27; H, 4.98; N, 1.92. Found:  C, 
69.36; H, 4.93; N, 2.06%.     
  
Compound Cu(2-pyca)(PPh3)2 was crystallised from different solvents, methanol, 
ethanol, i-propanol, n-propanol to yield the solvates 2.1, 2.2, 2.3 and 2.4 respectively, 
when t-butanol and n-butanol were used as crystallisation solvents, the same compound 
2.5 was obtained. 
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Compound Cu(3-pyca)(PPh3)2  
Yield 0.515 g, 88%. 
IR υmax (KBr)/cm–1 3050 (Ar C-H), 1615 (asymm. CO2⎯), 1436 (C-O), 1383 (symm. 
CO2⎯), 843, 834, 757 and 739 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 9.22 (1H, bs), 8.60 (1H, bs), 8.25 (1H, d, J 7.6 Hz) 7.00-
7.62 (31H, m). 
31P NMR data: δ -1.95 ppm. 
Analysis calculated for C42H34NCuO2P2·0.5H2O: C, 70.15; H, 4.90; N, 1.95. Found:  C, 
70.17; H, 4.84; N, 1.88%.    
 
Compound Cu(3-pyca)(PPh3)2 was crystallised from different solvents, such as 
methanol, ethanol to yield the solvates 2.6 and 2.7 respectively. When i-propanol, n-
propanol, t-butanol and n-butanol were used as crystallisation solvents, the same 
compound 2.8 was obtained. 
     
Compound Cu(4-pyca)(PPh3)2 
Yield 0.497 g, 83%. 
IR υmax (KBr)/cm–1 3050 (Ar C-H), 1609 (asymm. CO2⎯), 1435 (C-O), 1368 (symm. 
CO2⎯), 863, 838, 774 and 741 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 8.60 (2H, bs), 7.80 (2H, bs), 7.00-7.65 (30H, m). 
31P NMR data: δ -1.80 ppm.  
Analysis calculated for C42H34NCuO2P2·0.5H2O: C, 70.15; H, 4.56; N, 1.95. Found:  C, 
70.46; H, 4.56; N, 1.74%.     
 
X-ray quality crystals for compound 2.9 were grown by the slow evaporation of a 
solution of Cu(4-pyca)(PPh3)2 in methanol. 
  
Compound Cu(2,3-Hpydca)(PPh3)2 
Yield 0.494 g, 73%. 
IR υmax (KBr)/cm–1 3051 (Ar C-H), 1697 (asymm. CO2⎯), 1432 (C-O), 1363 (symm. 
CO2⎯), 854, 838, 812 and 744 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 8.90 (1H, dd, J 1.6, 8.0 Hz), 8.14 (1H, dd, J 1.6, 5.2 Hz), 
7.00-7.65 (31H, m). 
31P NMR data: δ 0.34 ppm.  
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Analysis calculated for C43H34NCuO4P2: C, 68.48; H, 4.54; N, 1.86. Found:  C, 68.51; 
H, 4.76; N, 1.95%. 
 
X-ray quality crystals for compound 2.10 were grown by the slow evaporation of a 
solution of Cu(2,3-Hpydca)(PPh3)2 in chloroform. 
 
Compound Cu(2,4-Hpydca)(PPh3)2 
Yield 0.542 g, 80%. 
IR υmax (KBr)/cm–1 3050 (Ar C-H), 1716 (C=O, acid), 1621 (broad, asymm. CO2⎯), 
1360 (symm. CO2⎯), 883, 813, 793 and 742 (Ar C-H). 
1H NMR (400 MHz, CDCl3) δ 9.03 (1H, s), 8.05 (1H, d, J 4.0 Hz), 7.83 (1H, d, J 4.8 
Hz) 7.60-7.07 (30H, m). 
31P NMR data: δ -0.34 ppm.  
Analysis calculated for C43H34NCuO4P2: C, 68.48; H, 4.54; N, 1.86. Found:  C, 68.36; 
H, 4.61; N, 2.04%.     
 
X-ray quality crystals for compound 2.11 were grown by vapour diffusion of hexane 
into a chloroform solution of Cu(2,4-Hpydca)(PPh3)2. 
 
Compound Cu(2,5-Hpydca)(PPh3)2 
Yield 0.291 g, 52%. 
IR υmax (KBr)/cm–1 3052 (Ar C-H), 1706 (C=O, acid), 1597 (asymm. CO2⎯), 1434 (C-
O), 1365 (symm. CO2⎯), 884, 818, 781 and 744 (Ar C-H). 
1H NMR (400 MHz, CDCl3) δ 7.00-7.68 (33H, m). 
31P NMR data: δ 3.25 ppm.  
Analysis calculated for C43H34NCuO4P2: C, 68.48; H, 4.54; N, 1.86. Found:  C, 68.52; 
H, 4.99; N, 1.80%.     
 
X-ray quality crystals of solvate 2.12 were grown from slow evaporation of a methanol 
solution of Cu(2,5-Hpydca)(PPh3)2. X-ray quality crystals for compound 2.13 were 
grown by vapour diffusion of hexane into a chloroform/methanol solution of Cu(2,5-
Hpydca)(PPh3)2. 
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Compound Cu(2,6-Hpydca)(PPh3)2 
Yield 0.238 g, 94%. 
IR υmax (KBr)/cm–1 3052 (Ar C-H), 1696 (broad, asymm. CO2⎯), 1432 (C-O), 1373 
(symm. CO2⎯), 896, 880, 849, 797 and 742 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 8.17 (2H, bs), 6.70-7.61 (31H, m). 
31P NMR data: δ -1.27 ppm.  
Analysis calculated for C43H34NCuO4P2: C, 68.48; H, 4.54; N, 1.86. Found:  C, 68.16; 
H, 4.95; N, 1.80%.     
 
X-ray quality crystals for compound 2.14 were grown from recrystallisation of Cu(2,6-
Hpydca)(PPh3)2 in the minimum amount of methanol. 
 
Compound Cu(3,4-Hpydca)(PPh3)2 
Yield 0.257 g, 71%. 
IR υmax (KBr)/cm–1 3051 (Ar C-H), 1650 (broad, asymm. CO2⎯), 1434 (C-O), 1361 
(symm. CO2⎯), 849, 809 and 742 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 8.33 (1H, d, J 5.2 Hz), 8.07 (1H, d, J 5.2 Hz), 7.54-7.07 
(31H, m). 
31P NMR data: δ -0.54 ppm.  
Analysis calculated for C43H34NCuO4P2: C, 68.48; H, 4.54; N, 1.86. Found:  C, 68.37; 
H, 4.13; N, 1.84%.     
 
X-ray quality crystals for compound 2.15 were grown by vapour diffusion of diethyl 
ether into a dichloromethane solution of Cu(3,4-Hpydca)(PPh3)2. 
 
Compound Cu(3,5-Hpydca)(PPh3)2 
Yield 0.514 g, 85%. 
IR υmax (KBr)/cm–1 3048 (Ar C-H), 1650 (broad, asymm. CO2⎯), 1434 (C-O), 1372 
(symm. CO2⎯), 878, 820, 794 and 743 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 9.20 (2H, bs), 8.82 (1H, t, J 1.8 Hz), 7.62-7.23 (30H, m). 
31P NMR data: δ -1.95 ppm.  
Analysis calculated for C43H34NCuO4P2: C, 68.48; H, 4.54; N, 1.86. Found:  C, 68.46; 
H, 4.49; N, 1.89%.     
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X-ray quality crystals for compound 2.16 were grown from recrystallisation of Cu(3,5-
Hpydca)(PPh3)2 in the minimum amount of methanol. 
 
Compound Cu(2-pzca)(PPh3)2 
Yield 0.435 g, 74%. 
IR υmax (KBr)/cm–1 3050 (Ar C-H), 1645 (asymm. CO2⎯), 1433 (C-O), 1343 (symm. 
CO2⎯), 865, 839, 792 and 748 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 9.47 (1H, d, J 1.6 Hz), 8.43 (1H, d, J 2.8 Hz), 7.77 (1H, 
dd, J 2.8, 1.6 Hz), 7.62-7.11 (30H, m). 
 31P NMR data: -0.23 ppm.  
Analysis calculated for C41H33N2O2P2Cu: C, 69.24; H, 4.68; N, 3.94. Found: C, 68.98; 
H, 4.63; N, 3.72%. 
 
 X-ray quality crystals for compound 2.17 were grown by vapour diffusion of hexane 
into a chloroform solution of Cu(2-pzca)(PPh3)2. 
 
Compound Cu(2,3-Hpzdca)(PPh3)2 
Yield 0.226 g, 64%. 
IR υmax (KBr)/cm–1 3053 (Ar C-H), 1737 (C=O, acid), 1626 (asymm. CO2⎯), 1434 (C-
O), 1353 (symm. CO2⎯), 871, 844, 794 and 748 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 8.78 (1H, bs), 8.27 (1H, bs), 7.70-7.01 (30H, m). 
 31P NMR data: 1.31 ppm.  
Analysis calculated for C41H33N2O2P2Cu: C, 66.80; H, 4.40; N, 3.71. Found: C, 66.48; 
H, 4.06; N, 3.67%. 
 
X-ray quality crystals for compound 2.18 were grown by vapour diffusion of hexane 
into a chloroform solution of Cu(2,3-Hpzdca)(PPh3)2. 
 
Compound Cu2(2,3-pzdca)(PPh3)4 
Yield 0.448 g, 73%. 
IR υmax (KBr)/cm–1 1715 (broad, asymm. CO2⎯), 1445 (C-O), 1356 (symm. CO2⎯), 869, 
835, 792 and 746 (Ar C-H).  
1H NMR (400 MHz, CDCl3) δ 7.00-7.60 (62H, m). 
31P NMR data: 1.44 ppm.  
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Analysis calculated for C42H33N2O4P2Cu: C, 66.80; H, 4.40; N, 3.71. Found: C, 66.21; 
H, 4.44; N, 3.80%. 
 
X-ray quality crystals for compound 2.19 were grown by slow evaporation of a solution 
of Cu2(2,3-pzdca)(PPh3)4 in chloroform. 
 
Compound Cu2(2,5-pzdca)(PPh3)4 
Yield 0.124 g, 73%.  
IR υmax (KBr)/cm–1 3050 (Ar C-H), 1641 (asymm. CO2⎯), 1434 (C-O), 814 and 742 (Ar 
C-H).  
1H NMR (400 MHz, CDCl3) δ 8.78 (2H, s), 7.00-7.63 (60H, m). 
31P NMR data: 0.34 ppm. 
Analysis calculated for C78H62N2O4P4Cu2·2MeOH·CH2Cl2: C, 65.23; H, 4.87; N, 1.88. 
Found: C, 65.62; H, 4.95; N, 2.17%. 
 
X-ray quality crystals for compound 2.20 were grown by vapour diffusion of diethyl 
ether into a dichloromethane solution of Cu2(2,5-pzdca)(PPh3)4. 
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2.6 Crystallographic Experimental 
 
Data for compounds 2.1-2.13, 2.16, 2.17, 2.19 and 2.20 were collected using a Bruker 
SMART 1000 CCD diffractometer using graphite-monochromated Mo-Kα radiation (λ 
= 0.71073 Å). Data for compounds 2.14 and 2.15 was collected using a Bruker APEX 2 
CCD diffractometer using synchrotron radiation (λ = 0.8457 Å) at Daresbury SRS 
Station 16.2SMX. Data for compound 2.18 was collected using a Bruker APEX 2 CCD 
diffractometer using synchrotron radiation (λ = 0.6910 Å) at Daresbury SRS Station 9.8. 
Data for compound 2.21 was collected using a Bruker-Nonius 95 mm CCD camera on 
κ-goniostat diffractometer using graphite-monochromated Mo-Kα radiation (λ = 
0.71073 Å). 
 
All structures were solved by direct methods (except structures 2.3, 2.4, 2.10, 2.11, 2.14 
and 2.20 which were solved using Patterson synthesis) and refined by full-matrix least-
squares methods on F2, producing CIF files which have been checked using the IUCr 
CheckCif routines. All H atoms, except water H atoms, were initially placed in 
geometrically calculated positions and were refined using a riding model (aryl C–H 0.95 
Å, methyl C–H 0.98 Å, methylene C–H 0.99 Ǻ, methine C–H 1.00 Ǻ and hydroxyl O–
H 0.84 Ǻ). Uiso(H) values were set to be 1.2 times Ueq of the carrier atom for aryl CH, 
methylene and methine CH, and 1.5 times Ueq of the carrier atom for OH and CH3. 
Water H atoms in 2.12 were located in the difference Fourier map and the coordinates 
allowed to freely refine, however water H atoms could not be located in 2.9. The 
coordinates of OH hydrogen atoms in compounds 2.4, 2.6, 2.7, 2.10 and 2.19 were then 
allowed to refine freely. 
 
Unless stated, all structural determinations proceeded without the need for further 
restraints or disorder modelling.   
 
Compound 2.1 was found to contain a disordered methanol molecule with the C–O 
fragment modelled over two sets of positions, with refined occupancies major:minor = 
74.7(5):25.3(5)%. The solvent H atom for the minor component was not located in the 
difference Fourier map.  
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Disorder in one of the two ethanol molecules in the asymmetric unit was modelled in 
compound 2.2. The C2H5 fragment was modelled over two sets of positions, with 
refined occupancies 56.8(9):43.2(9)% with O(6) common to the two fragments. 
Compound 2.3 was found to contain a disordered phenyl ring, which was modelled over 
two sets of positions 59.7(9):40.3(9)%. It also contains a highly disordered ethanol 
molecule which was modelled over three sets of positions 55.7(6):28.9(6):15.4(6)% 
with OH group coincident. The ethanolic H(6) atom was located in the difference 
Fourier map and coordinates allowed to freely refine. The remaining OH hydrogen atom 
was placed in a geometrical position.      
 
Compound 2.9 was found to contain disorder in methanol and water molecules 
involving only two of the possible three molecules in the structure. While methanol 
molecule C(87)–O(7)–H(7A) is not disordered, it was found to have either C(85)–O(5)–
H(5) and C(86)–O(6)–H(6) for 76.5% of the time or C(85X)–O(5)–H(5) and O(7) for 
23.5% of the time. The methanolic H(5) atom was located in the difference Fourier map 
and the coordinates allowed to freely refine. The remaining OH hydrogen atoms were 
placed in geometric positions. 
 
Compound 2.11 was found to contain a disordered chloroform molecule with the Cl and 
H atoms modelled over two sets of positions, with refined occupancies 
62.1(6):37.9(6)% with C(88) common to the two fragments. The disordered chloroform 
molecule in compound 2.13 was modelled over two sets of positions 69.2(3):30.8(3)%.  
 
Water H atoms in compound 2.14 were located in the difference Fourier map and the 
coordinates allowed to freely refine, however hydrogen atoms were not located on the 
water molecule containing O(11) which also presents disorder but no satisfactory model 
could be found. Compound 2.14 showed a disordered phenyl ring, which was modelled 
over two sets of positions 50.1(11):49.9(11)%. H atoms were not found on the 
disordered MeOH molecule in 2.20 which was modelled over two sets of positions 
54.0(19):46(19)%. 
 
Programs used during data collection, data reduction, refinement and production of 
graphics were Bruker SMART, Bruker APEX 2, SAINT, SHELXTL and local 
programs.25,26,28,121-123   
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3. Novel Crystal Engineering Studies Using Boronic Acids 
 
3.1 Introduction 
 
Boronic acids continue to receive widespread attention for their versatile behaviour in 
diverse areas such as organic synthesis, catalytic transformations, as fire retardants, as 
chemosensors for the recognition of carbohydrates and as therapeutic agents for Boron 
Neutron Capture Therapy.124-133 An area of particular current interest is the use of 
boronic acids as building blocks for the design of novel solid-state architectures 
utilising hydrogen bonds or via covalent interactions when used directly as a ligands.134-
136  
 
The most common hydrogen bond motif formed by boronic acids [Figure 3.1 (I)] is 
very similar to the cyclic head-to-tail carboxylic acid ring motif R22(8) [Figure 3.1 (II)]. 
The energies of the carboxylic and boronic acid dimers are also comparable (-19.3 
kcal/mol and -53.9 kJ/mol respectively).137  
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Figure 3.1 (I) Dimers of boronic acids. (II) The R22(8) cyclic hydrogen bonded 
carboxylic acid ring motif. 
 
The two additional hydrogen atoms in boronic acid dimers allow the interaction of 
homodimeric units in the solid state through hydrogen bonding, which is not available 
to carboxylic acid dimers. An example of this type of connectivity is shown by 2-
bromophenylboronic acid where each dimer is interacting with other dimers by 
hydrogen bonds forming ribbons generating the hydrogen bonding motif III (Figure 
3.2).138 
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Figure 3.2 Schematic representation of the homodimeric 2-bromophenylboronic acid 
dimers in the solid state [R = 2-BrPh–]. 
 
The R–B(OH)2 moiety adopts mainly three different conformations, as shown in Figure 
3.3, which yield different hydrogen-bonding networks. Among these arrangements, 
while the syn-anti conformation is observed in a majority of structures, the syn-syn and 
anti-anti conformations are relatively uncommon.139 
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Figure 3.3 Conformations of the –B(OH)2 moiety. 
 
Due to the close similarity between the –B(OH)2 and –COOH groups, efforts have been 
made to synthesise the hetero-dimeric hydrogen-bonded motifs (Figure 3.4).  
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Figure 3.4 Schematics of the hetero-dimeric boronic acid-carboxylate IV and boronic 
acid-carboxylic acid V motifs.   
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Rodríguez-Cuamatzi and co-workers studied the hydrogen bonding interaction energies 
for the homo- and hetero-dimers I, II, IV and V.137 The results show that the stability of 
these systems decrease in the following order: RB(OH)2···–OOCR (IV) > 
RCOOH···HOOCR (II) > RB(OH)2···HOOCR (V) > RB(OH)2···(OH)2BR (I), where R 
= Me, Ph. The robust boronic acid-carboxylate synthon IV is also capable of competing 
successfully with strong interactions such as the charge assisted N–H+···O– hydrogen 
bond.140 Although the hetero-dimeric RB(OH)2···–OOCR system presents an interesting 
alternative to the use of carboxylic acid dimers in supramolecular synthesis and crystal 
engineering, only a few literature examples have been described making it an interesting 
target for study.141  
 
The RB(OH)2···–OOCR (IV) interaction has also been reported as a highly efficient 
carrier system for the transport of amino acids from neutral aqueous solutions across 
organic media.142 It is based on the synergistic action of arylboronic acids/crown ethers, 
which bind the carboxylate and ammonium moieties, respectively, the zwitterionic form 
of amino acids being lipophilised by formation of a three-component supramolecular 
species (Figure 3.5).  
 
 
 
Figure 3.5 Molecular structure of the three-component system. 
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A search of the CSD (version 5.30, plus 4 updates, November 2008) shows a recent 
increase of attention toward the use of boronic acids in supramolecular chemistry. 
Interestingly, many of these supramolecular systems containing boronic acids do not 
contain any transition metal complexes.137,143 This is rather surprising given the unique 
ability to tune various properties of transition metal complexes by ligand manipulation 
thereby influencing factors such as metal oxidation state, coordination numbers, 
solubility and charge. Literature examples of supramolecular work utilising boronic 
acids in the design of organometallic assemblies are presented below.  
 
3.1.1 Boronic Acids in the Design of Metal Containing Supramolecular 
Assemblies  
 
A recent approach whereby transition metals have been investigated, includes the 
organometallic studies with ferrocene-derived boronic acids, [Fe{η5-C5H4(B(OH)2}2] 
and [Fe(η5-C5H4-4-C5H4N){η5-C5H4-(B(OH)2}2], reported by Braga and co-workers.144 
Ferrocene-1,1’-diboronic acid, [Fe{η5-C5H4(B(OH)2}2], was prepared following a 
reported procedure from 1,1’-dilithioferrocene and tri-n-butyl borate, followed by 
hydrolysis of the resulting dibutylboronate.145 In the X-ray structure of [Fe{η5-
C5H4(B(OH)2}2] the two boronic acid groups bridge adjacent ferrocenyl moieties into 
chains through the boronic acid R22(8) dimer. These chains criss-cross in the crystal 
structure creating a two-dimensional corrugated sheet arrangement via lateral hydrogen 
bonding with –B(OH)2 moieties adopting anti conformation producing R66(16) ring 
motifs (Figure 3.6). 
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Figure 3.6 View of the sheet structure of [Fe{η5-C5H4(B(OH)2}2]. 
 
The simultaneous presence of one boronic acid group and one pyridyl group in the 
compound [Fe(η5-C5H4-4-C5H4N){η5-C5H4-(B(OH)2}2] generates several 
supramolecular bonding options for this molecule. The –B(OH)2 unit is capable of 
multiple hydrogen bonding donations as seen above with [Fe{η5-C5H4(B(OH)2}2], and  
the pyridyl ligand can donate an electron pair to a suitable Lewis acid or act as a 
hydrogen bond acceptor from a suitable proton donor. Compound [Fe(η5-C5H4-4-
C5H4N){η5-C5H4-(B(OH)2}2] has been shown, by single X-ray analysis, to form three 
different forms depending on the crystallisation conditions. Single crystals of the 
anhydrous form A were obtained by slow evaporation of a dichloromethane-methanol 
solution of 1'-(4-pyridyl)ferrocene-1-boronic acid at low temperature. Interestingly, the 
R22(8) head-to-tail boronic acid dimer is not found in A (Figure 3.7); in its place the 
ferrocenyl moieties form dimers via strong O–H···N interactions. The dimers are linked 
in a secondary pattern by single lateral O–H···N hydrogen bonds.   
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Figure 3.7 View of [Fe(η5-C5H4-4-C5H4N){η5-C5H4-(B(OH)2}2] as the anhydrous form 
A. 
 
Monohydrated form B was obtained by slow evaporation at room temperature from a 
solution of [Fe(η5-C5H4-4-C5H4N){η5-C5H4-(B(OH)2}2] in acetone-water. In form B, 
the primary motif is the R22(8) boronic acid dimer based on O–H···O intermolecular 
bonds, while dimers are formed through O–H···N interactions between the lateral O–H 
groups and the pyridyl acceptors (Figure 3.8). Although compound B is a hydrated 
form, the water molecules do not seem to play any particular role in the packing.  
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Figure 3.8 View of the zigzag chain structure of form B. Water molecules have been 
omitted for clarity. 
 
Finally, form C, which is obtained from the slow evaporation of a solution of [Fe(η5-
C5H4-4-C5H4N){η5-C5H4-(B(OH)2}2] in acetone-NH3(aq) at low temperature, has an 
almost intermediate topology between the two forms described above. Although the 
molecules adopt the conformation seen in B, based on O–H···O interactions forming 
R22(8) boronic acid rings, there are also lateral O–H···O bonds, previously seen in A 
leading to a complex two-dimensional pattern (Figure 3.9).  
 
 
 
Figure 3.9 View of [Fe(η5-C5H4-4-C5H4N){η5-C5H4-(B(OH)2}2] as form C. 
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Batsanov and Norrild have independently investigated two other interesting examples of 
ferrocene derived boronic acids.146,147 Both authors synthesised aminoarylboronic acid 
systems based on a ferrocene framework in which the formation of an intramolecular 
hydrogen bond, which determines the orientation of the ferrocene substituents, seems to 
prevail over a conceivable B–N bond. This observed behaviour may allow these two 
functional groups to act cooperatively in potential catalytic processes, including the 
important area of in situ direct amide formation from amines and carboxylic acids.148  
 
Recently, SeethaLekshmi and Pedireddi crystallised the first examples of metal hybrids 
of (4-carboxyphenyl)boronic acid with Mn(II), Co(II) and Ni(II).149 The failure to form 
complexes between phenylboronic acid and transition metals ions was also highlighted. 
Using a substituted phenylboronic acid containing a carboxylate functional group, the 
desired complexes were obtained: compounds [Co(H2O)6]2+·4H2O·2{C6H4[B(OH)2]4-
CO2–}, [Mn(H2O)6]2+·4H2O·2{C6H4[B(OH)2]4-CO2–} and  
[Ni(H2O)6]2+·4H2O·2{C6H4[B(OH)2]4-CO2–} are isomorphic and isostructural. Analysis 
of the molecular arrangement of these compounds reveals that the (4-
carboxyphenyl)boronic acid is not covalently coordinated to the metal ions. Instead, the 
metal centres are coordinated to six water molecules. The water molecules of 
crystallisation maintain an extensive hydrogen array through hydrogen bond 
interactions with the (4-carboxyphenyl)boronic acid (Figure 3.10).  
 
 
 
Figure 3.10 View of [Mn(H2O)6]2+·4H2O·2{C6H4[B(OH)2]4-CO2–}. 
 
Kara and co-workers utilised isomeric pyridinium boronic acid cations, (Figure 3.11), in 
the crystallisation of a series of salts with the square-planar metal bis-dithiooxalate 
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dianions [M(S2C2O2)2]2– (where M = Cu, Ni, Pd and Pt).150 The use of VI and VII 
allowed for the importance of the geometry of the hydrogen bond donor groups in the 
design of different supramolecular architectures to be probed. 
 
NH+ B
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VI VII  
 
Figure 3.11 4-pyridinium boronic acid cation, [C5H4B(OH)24-NH]+ (VI) and 3-
pyridinium boronic acid cation, [C5H4B(OH)23-NH]+ (VII). 
 
Crystals of [C5H4B(OH)24-NH]2[M(S2C2O2)2]·2H2O (where M = Cu, Ni, Pd and Pt) are 
isostructural and isomorphous. The cations [C5H4B(OH)24-NH]+ VI are linked in pairs 
through strong hydrogen bonds between their boronic acid moiety and two water 
molecules forming R33(8) motifs. The planar dianions [M(S2C2O2)2]2– are hydrogen 
bonded by a N+–H···O interaction at both ends creating two R21(5) synthons. As a result, 
a neutral hydrogen bonded ribbon is formed (Figure 3.12). 
 
 
 
Figure 3.12 View of [C5H4B(OH)24-NH]2[Pt(S2C2O2)2]·2H2O. 
 
In contrast, isostructural salts of the isomeric cation VII, [C5H4B(OH)23-
NH]2[M(S2C2O2)2] (where M = Cu, Ni, Pd and Pt), crystallise as solvent-free structures. 
The boronic acid groups are involved in O–H···O hydrogen bonding with the 
thiocarboxylate moieties (through the carboxylate oxygen atoms) of neighbouring 
molecules, generating the expected head-to-tail R22(8) dimer for boronic acids in the syn 
conformation.137,139,140 The pyridinium ion forms the N+–H···O interaction with the 
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carboxylate oxygen atoms as seen previously. The resulting one-dimensional structure 
has large R86(18) ring motifs and a stepped chain appearance (Figure 3.13).        
 
 
 
Figure 3.13 View of [C5H4B(OH)23-NH]2[Pt(S2C2O2)2]. 
 
Other notable examples where the boric acid is used as a template to synthesise 
zincophosphates under hydrothermal conditions have been independently described by 
Zhong and Wiebcke.151,152 In both examples, the trigonal planar boric acid molecules 
form centrosymmetric dimers by strong hydrogen bonding interactions linking two 
adjacent zincophosphate layers into a two-dimensional network. It is important to note 
the critical role of boric acid in the growth and stabilisation of these compounds as no 
crystals were obtained of the reaction product in the absence of B(OH)3. 
 
3.1.2 Uses of Boronic Acids 
 
Boronic acids have been used in the field of medicinal chemistry as boron neutron 
capture (BNCT) therapy agents,153 for the development of enzyme inhibitors like 
protease inhibitors,154 antibody mimics for polysaccharides,155 and as antibacterial 
agents.156 Boron neutron capture therapy is a binary methodology for treating tumours 
in which a chemical agent containing at least one 10B atom and thermal or isothermal 
neutrons are directed to a tumour where they combine to release a lethal dose of 
radiation to the cell. The development of 10B-containing compounds for the treatment of 
tumours by BNCT requires the synthesis and evaluation of non-toxic agents that 
selectively target malignant cells rather than adjacent normal tissue and are retained 
intracellulary. Hatanaka and Mishima independently reported the first clinical results 
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demonstrating the effectiveness of this binary system, for the treatment of malignant 
gliomas and melanoma, respectively, using sodium 
mercaptoundecahydrododecaboronate (Na2B12H11SH) and L-p-boronophenylalanine (L-
p-BPA). More recently, second generation boron compounds, initially provided by 
DuPont Co., have been shown to cure a particular type of gliomas, and further research 
is ongoing in this field.128,157 
 
Boronic acid-containing molecules have been utilised as chemosensors for the 
recognition of carbohydrates as they are known to reversibly bind diols with high 
affinity to form cyclic esters.158. There has been much interest focused on the design of 
boronic acid-containing fluorescent glucose sensors that operate under physiological 
conditions.159-161 Gamsey and Cordes have highlighted the use of bidentate binding with 
diboronic acids to increase the selectivity toward glucose over other physiologically 
significant monosaccharides, such as fructose, and develop a successful in vivo boronic 
acid-based glucose sensor.162,163 The spacing between the boronic acids could be 
adjusted through synthetic modifications in order to create a glucose-specific binding 
pocket.131  
 
The uses of boronic acids are renowned in organic synthesis,164,165 especially covering a 
number of cross-coupling reactions.166,167 Parry and co-workers have described the 
syntheses of heteroaryl-substituted pyridines through the derivation of air-stable 
pyridylboronic acids under Suzuki cross-coupling conditions.168 Recently, Liebeskind 
and Srogl developed a novel carbon–carbon cross-coupling protocol, involving the 
Pd(0)-catalysed, Cu(I)-mediated coupling of a variety of different thio-compounds with 
boronic acids under neutral conditions.169-171 The Liebeskind-Srogl cross-coupling 
protocol can also be applied to cyclic thioureas and thioamides.172 Recently, Billingsley 
and Buchwald have successfully developed a highly active catalyst system for the 
Suzuki-Miyaura cross-coupling of heteroaryl boronic acids and esters using dialkyl 
phosphine ligands.173  
   
In recent years, boronic acids have also been used as building blocks in crystal 
engineering.140,141 Following these studies, the main scope of the present chapter 
concentrates on obtaining and characterising new co-crystal systems including a range 
of boronic acids, –R(OH)2, aiming to contribute to the understanding of less common 
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hydrogen bonding functionalities such as RB(OH)2···–OOCR (IV). This could provide 
alternatives, in terms of robustness and transferability, to the strong hydrogen bonding 
groups usually employed to link organometallic building blocks in molecular crystals.    
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3.2 Results and Discussion 
 
3.2.1 Co-crystallisation of Cu(2-pyca)(PPh3)2, Cu(2-pzca)(PPh3)2 and 
Cu2(2,5-pzdca)(PPh3)4 with Boric Acid  
 
The range of copper(I) complexes discussed in Chapter II shows interesting 
supramolecular behaviour linking complexes together either via hydrogen bonds using 
the non-coordinated carboxylic acid groups in pyridine and pyrazine carboxylates or 
through hydrogen bonding interactions with suitable solvent molecules of 
crystallisation. In one occurrence during the previous studies, compound Cu(2-
pyca)(PPh3)2·B(OH)3 3.1 was isolated as X-ray quality single crystals from the reaction 
of 2-Hpyca with (PPh3)2Cu(BH4) in a mixture of dichloromethane and tert-BuOH 
(Figure 3.14). Boric acid may have been derived from the hydrolysis of borane BH3, a 
by-product of the reaction, or borohydride in the presence of trace amounts of water.  
 
 
 
Figure 3.14 Dimers of Cu(2-pyca)(PPh3)2·B(OH)3 3.1. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity. 
 
In the crystal structure of Cu(2-pyca)(PPh3)2·B(OH)3 3.1, two symmetry related boric 
acids in the syn conformation bridge adjacent Cu(2-pyca)(PPh3)2 moieties into dimers 
through two different centrosymmetric head-to-tail R22(8) hydrogen bond motifs (Table 
3.1). It is notable that the Etter system does not differentiate between them.18,19 
Although boric acid is capable of multiple hydrogen bonding donations,174 in compound 
3.1 the threefold symmetry of the B(OH)3 molecule is destroyed by the strong O–H···O 
hydrogen bonding with the carboxylate oxygen atoms which limits the dimensionality 
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of the packing of the complex. Therefore, 3.1 is essentially zero-dimensional as no 
further propagation of hydrogen bonds is possible here.  
  
Table 3.1 Selected hydrogen bonding parameters for 3.1. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(1) 2.6701(15) 0.80(2) 1.88(2) 174(2) 
O(4)−H(4)···O(2) 2.8120(18) 0.82(3) 2.00(3) 171(3) 
O(5)−H(5)···O(3A)i 2.818(2) 0.76(3) 2.06(3) 175(3) 
Symmetry operation: i-x+1, -y+2, -z+1. 
 
The intentional synthesis of the 1:1 Cu(2-pyca)(PPh3)2·B(OH)3 adduct, 3.1, was 
achieved upon adding a stoichiometric amount of boric acid to the reaction mixture 
(Equation 3.1). Due to the poor solubility of boric acid in CH2Cl2, the reaction was 
carried out in a mixture of dichloromethane and tert-BuOH. While at room temperature 
the reaction was complete after 48 h (analysis of the bulk material, by IR spectroscopy, 
obtained after 4, 12 and 24 h showed the presence of starting material), heating the 
mixture under reflux considerably shortened the reaction time (about 4 h). Crystals of 
compound 3.1 were isolated after slow evaporation of the saturated solution. The 
alcohol was also carefully chosen as competition could occur between small alcohols: 
MeOH, EtOH, i-PrOH and n-PrOH, and boric acid in the co-crystallisation with the 
copper(I) complex Cu(2-pyca)(PPh3)2 as seen previously in Chapter II.  
 
Cu(2-pyca)(PPh3)2 + B(OH)3
Reflux
CH2Cl2/tBuOH
Cu(2-pyca)(PPh3)2.B(OH)3
 
 
Equation 3.1  
 
Microanalyses and IR spectroscopy all indicate that the boric acid was present in the 
bulk samples.  
 
In order to evaluate whether boric acid could be co-crystallised with similar metal 
complexes, Cu(2-pzca)(PPh3)2 2.17 and Cu2(2,5-pzdca)(PPh3)4 2.20 were selected. 
These complexes are attractive for a number of reasons: (i) they contain two or four 
carboxylate oxygen atom sites, that can be used in hydrogen bonding, as seen 
previously in 3.1, (ii) these copper(I) compounds are easily synthesised following the 
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synthetic procedure described in Chapter II and III with the Cu(2-pyca)(PPh3)2 
successfully co-crystallised with boric acid, it was clear that co-crystallisation of the 
boric acid with Cu(2-pzca)(PPh3)2 and Cu2(2,5-pzdca)(PPh3)4 could be possible.  
 
Compounds Cu2(2,5-pzdca)(PPh3)4·2B(OH)3 3.2 and Cu(2-pzca)(PPh3)2Cl·B(OH)3 3.3 
were obtained in the same manner as 3.1. One or two equivalents of boric acid were 
used, depending on the pyrazine copper(I) complex under study, using reflux to fully 
dissolve the mixture as described above for compound 3.1. 
 
The co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 2.20 with boric acid yields yellow 
crystals of Cu2(2,5-pzdca)(PPh3)4·2B(OH)3 3.2 (Figure 3.15). The symmetrical nature of 
the Cu2(2,5-pzdca)(PPh3)4 lends itself to its position on a centre of inversion, with the 
unique molecule of boric acid in the asymmetric unit hydrogen-bonded to the 
coordinated carboxylate group via the hetero-dimeric boric acid-carboxylate R22(8) 
dimer.  
 
 
Figure 3.15 Chains of Cu2(2,5-pzdca)(PPh3)4·2B(OH)3 3.2. Phenyl rings and hydrogen 
atoms except OH have been omitted for clarity. 
 
Complex 3.2 exhibits a similar trend to that observed in 3.1 but by virtue of the second 
carboxylate group further H-bonding can be observed leading to the formation of a 1-D 
structure propagating along the [1 1 0] direction. Selected hydrogen bonding parameters 
for 3.2 are shown in Table 3.2. 
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Table 3.2 Selected hydrogen bonding parameters for 3.2. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(2) 2.6528(19) 0.77(3) 1.88(3) 175(3) 
O(4)−H(4)···O(1) 2.8002(19) 0.82(3) 1.98(3) 178(3) 
O(5)−H(5)···O(3B)i 2.781(2) 0.76(3) 2.02(3) 173(3) 
Symmetry operations: i-x+1, -y+1, -z+1. 
 
The infrared spectrum of compound 3.2 shows the vibration modes of B(OH)3 at ν = 
1366 and 1432 cm–1 which belong to the vibrations of B–O bonds in triangular 
coordination mode.151 The ν = 1432 cm–1 vibration should have contributions from the 
stretching vibration ν(C–O) of the carboxylate group. 
 
Compound Cu(2-pzca)(PPh3)2 2.17 crystallises incorporating one molecule of 
dichloromethane in the crystal structure yielding Cu2(2-pzca)(PPh3)4Cl·B(OH)3·CH2Cl2 
3.3. The 2-pyrazine carboxylate acts as a bridging ligand between Cu(I) centres and 
leaves a potentially reactive chloride metal-coordinated maintaining charge neutrality 
(Figure 3.16). The solvent molecule did not change the packing of 3.3 which exhibits 
equivalent R22(8) motifs to those observed previously for compounds 3.1 and 3.2 (Table 
3.3). There are two crystallographically independent Cu(I) centres which have different 
coordination environments. At Cu(2) the [2-pzca]– ligand coordinates through the N 
atom with two molecules of PPh3 and a chloride completing the pseudo-tetrahedral 
geometry. The same [2-pzca]– ligand coordinates to Cu(1) in a bidentate fashion via the 
other N atom and a carboxylate O atom, the remaining coordination sites are occupied 
by two triphenylphosphine ligands. 
 
 
 
Figure 3.16 Cu2(2-pzca)(PPh3)4Cl·B(OH)3·CH2Cl2 3.3. Phenyl groups, dichloromethane 
and hydrogen atoms not involved in hydrogen bonding have been omitted for clarity. 
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Table 3.3 Selected hydrogen bonding parameters for 3.3. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(H3A)···O(1) 2.742(3) 0.84 1.93 163 
O(4)−H(4)···O(2) 2.684(3) 0.84 1.85 170 
O(5)−H(5)···O(3A)i 2.740(3) 0.84 1.96 154 
Symmetry operations: i-x+1, -y, -z+1. 
 
The chloride ligand forms a bifurcated (aromatic)C–H···Cl weak hydrogen bond, H···Cl 
2.58 Å and 2.90 Å, with a symmetry generated molecule and vice versa, producing 
R12(10) and R22(12) ring motifs (Figure 3.17).  
 
 
 
Figure 3.17 View of the hydrogen bonding motifs in 3.3. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity. 
 
The CH2Cl2 molecules are found on alternate sides of the one-dimensional structure and 
are also involved in weak (aromatic)C–H···Cl hydrogen bonds, 2.89 Å. The weak 
hydrogen bonding combined with the R22(8) motifs yields a pseudo-layer parallel to [0 1 
1]. Further chemistry can be explored in order to extend the dimensionality of 
compound Cu2(2-pzca)(PPh3)4Cl·B(OH)3·CH2Cl2 3.3 involving the chloride as a 
potential acceptor.175-177 
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3.2.2 Co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with Organoboronic 
Acids 
     
Having successfully reproduced the co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with 
boric acid yielding compound 3.2, which exhibits an extended one-dimensional 
hydrogen bonding network, further investigations were made in order to extend the 
dimensionality of this system. For this purpose, the co-crystallisation of Cu2(2,5-
pzdca)(PPh3)4 was attempted with a variety of commercially available boronic acids 
which bear functional moieties such as, –COOH, –NH2, −Br or an extra −B(OH)2 
(Figure 3.18). 
 
B(OH)2 (HO)2B B(OH)2
B(OH)2
Br
B(OH)2H3C
B(OH)2HOOC B(OH)2
H2N
B(OH)2Br
 
 
Figure 3.18 Boronic acids used in this study. 
 
The synthesis of compounds 3.4–3.11 followed the same experimental conditions 
described above for compounds 3.1–3.3 with X-ray quality crystals obtained by slow 
evaporation of the saturated solutions.   
 
Initially, the study was focused on the comparison between two similar boronic acid 
systems: (i) aliphatic methylboronic acid, CH3B(OH)2 and (ii) aromatic phenylboronic 
acid, C6H5B(OH)2. Although both molecules lack other hydrogen bond 
acceptors/donors other than the −B(OH)2 group, phenyl boronic acid could potentially 
be involved in weaker supramolecular interactions such as π-π interactions with phenyl 
rings of neighbouring molecules.178,179   
 
3.2.2.1 Co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with Methylboronic Acid  
 
Attempts to co-crystallise methylboronic acid with Cu2(2,5-pzdca)(PPh3)4 using similar 
synthetic procedures to those used in the formation of 3.1–3.3, failed to produce the 
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desired co-crystal, instead crystallising a polymorphic form of 3.2, Cu2(2,5-
pzdca)(PPh3)4·2B(OH)3 3.4. The boric acid may have been present as a by-product in 
the original synthesis of Cu2(2,5-pzdca)(PPh3)4 from the hydrolysis of borane BH3 or 
[BH4]– in the presence of trace amounts of water. In the presence of both boronic acids, 
CH3B(OH)2 and B(OH)3, the co-crystallisation with the latter appears more favourable 
under the crystallisation conditions used. Both polymorphic forms, 3.2 and 3.4, 
crystallise in the triclinic crystal system. They differ in the number of molecules of 
Cu2(2,5-pzdca)(PPh3)4 and boric acid present in the asymmetric unit. While 3.2 
crystallises with one half-molecule of Cu2(2,5-pzdca)(PPh3)4 and one molecule of boric 
acid in the asymmetric unit. Compound 3.4 presents two molecules of Cu2(2,5-
pzdca)(PPh3)4 in the asymmetric unit lying on centres of inversion, with two unique 
boric acid molecules hydrogen bonded to the carboxylate group via the (boric 
acid)O−H···O(carboxylate) R22(8) graph set motif (Figure 3.19).  
 
 
 
Figure 3.19 View of co-crystal Cu2(2,5-pzdca)(PPh3)4·2B(OH)3 3.4. Phenyl groups and 
hydrogen atoms not involved in hydrogen bonding have been omitted for clarity.  
 
The two unique molecules exhibit identical hydrogen bonding patterns but differ 
geometrically making the one-dimensional polymeric zigzag chains obtained propagate 
in approximately perpendicular directions (Figure 2.44). Selected hydrogen bonding 
parameters for 3.4 are shown in Table 3.4. 
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Figure 3.20 View of the hydrogen bonding motifs in co-crystal 3.4. Phenyl groups and 
hydrogen atoms not involved in hydrogen bonding have been omitted for clarity. 
 
Table 3.4 Selected hydrogen bonding parameters for 3.4. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(5)−H(5)···O(1) 2.687(2) 0.83(3) 1.86(3) 176(3) 
O(6)−H(6)···O(2) 2.707(3) 0.74(3) 1.97(3) 173(4) 
O(7)−H(7)···O(5)i 2.733(3) 0.84(4) 1.90(4) 173(4) 
O(8)−H(8)···O(3) 2.826(3) 0.93(4) 1.90(4) 177(4) 
O(9)−H(9)···O(4) 2.631(3) 0.89(3) 1.75(3) 176(3) 
O(10)−H(10)···O(9)ii 2.715(3) 1.00(4) 1.72(4) 175(3) 
Symmetry operations: i-x+1, -y+1, -z+1, ii-x+1, -y, -z+2. 
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Although microanalyses of bulk powdered samples indicate the presence of 
CH3B(OH)2, numerous attempts to obtain crystals of compound Cu2(2,5-
pzdca)(PPh3)4·2CH3B(OH)2 failed. 
 
3.2.2.2 Co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with Phenylboronic Acid  
 
Phenylboronic acid has been co-crystallised with various aza-donor molecules such as, 
4,4’-bipyridine (bpy) and trans-1,2-bis(4-pyridyl)ethane, by Pedireddi and 
SeethaLekshmi, producing a variety of networks in the form of sandwich, ladder and 
molecular blocks.135 Interestingly, previous attempts to co-crystallise metal complexes 
with phenylboronic acid have failed.149  
 
[Cu2(2,5-pzdca)(PPh3)4·2C6H5(B(OH)2)][Cu2(2,5-pzdca)(PPh3)4] 3.5 represents the first 
example of a metal complex co-crystallised with phenylboronic acid (CSD, version 
5.30, plus 4 updates, November 2008). In contrast to the 1:2 copper(I) complex:boric 
acid stoichiometry observed in 3.4, compound 3.5 crystallises in a 1:1 stoichiometry 
where only one of  the two independent molecules of Cu2(2,5-pzdca)(PPh3)4 present in 
the asymmetric co-crystallises with two phenylboronic acid molecules (Figure 3.21). 
Attempts to include two more molecules of phenylboronic acid in the asymmetric unit 
using an excess of the boronic acid during the synthesis were not successful yielding 
crystals of 3.5. Compound 3.5 exhibits the expected hydrogen bonding R22(8) graph set 
motif seen previously for compounds 3.1-3.4 (Table 3.5). The –B(OH)2 group only 
deviates slightly from planarity with respect to the aromatic ring (5.2°).  
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Figure 3.21 View of compound [Cu2(2,5-pzdca)(PPh3)4·2C6H5(B(OH)2)][Cu2(2,5-
pzdca)(PPh3)4] 3.5. Phenyl groups and hydrogen atoms not involved in hydrogen 
bonding have been omitted for clarity. 
 
Table 3.5 Selected hydrogen bonding parameters for 3.5. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(6)−H(6)···O(2) 2.856(7) 0.93(3) 1.94(3) 166(7) 
O(5)−H(5)···O(1) 2.729(6) 0.85(3) 1.90(4) 162(8) 
 
Although aromatic rings are present in compound 3.5, no face-to-face or edge-to-face 
stacking interactions are observed. However, packing of molecules in the crystal lattice 
of 3.5 is stabilised by weak (aromatic)C–H···O(carboxylate) interactions, H···O 2.45 Å 
and 2.50 Å, creating cavities where the phenylboronic acid molecules reside (Figure 
3.22). 
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Figure 3.22 View of co-crystal 3.5 showing the hydrogen bonding motifs. Phenyl 
groups and hydrogen atoms not involved in hydrogen bonding have been omitted for 
clarity. 
 
The infrared spectrum of pure phenylboronic acid contains a broad O–H stretching band 
at ν = 3279 cm–1 which appears as one broad band at ν = 3421 cm–1 on formation of 
RB(OH)2···–OOCR in compound 3.5. The band characteristic for the asymmetric 
stretching vibration of the carboxylate group appears at ν = 1647 cm–1. The broad band 
at ν = 1368 cm–1 should have contributions of the symmetric stretching vibration 
ν(COO–) and ν(B–O) stretching vibration, which for the pure phenylboronic acid is 
located at ν = 1348 cm–1.   
 
 3.2.2.3 Co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with 1,4-Phenyldiboronic Acid  
 
The successful co-crystallisation of phenylboronic acid with Cu2(2,5-pzdca)(PPh3)4 2.20 
led to the consideration of 1,4-phenyldiboronic acid as the addition of an extra −B(OH)2 
group compared to 3.5 could provide an additional hydrogen bonding group. 
    
The structure of Cu2(2,5-pzdca)(PPh3)4·C6H4{1,4-B(OH)2} 3.6 was determined using 
synchrotron radiation on station 9.8 at the SRS, Daresbury Laboratory, due to the small 
crystal dimensions. In contrast with the phenylboronic acid, the inclusion of 1,4-
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phenyldiboronic acid into the crystal structure of the Cu2(2,5-pzdca)(PPh3)4 occurs in a 
1:1 ratio. As observed previously in 3.1-3.5, Cu2(2,5-pzdca)(PPh3)4·C6H4{1,4-B(OH)2} 
3.6 exhibits the typical (boronic acid)O−H···O(carboxylate) hydrogen bonds, producing 
an R22(8) graph set motif. The symmetrical nature of both 1,4-phenyldiboronic acid and 
[Cu2(2,5-pzdca)(PPh3)4] lend themselves to their positions on inversion centres. 
Although the weak (aromatic)C–H···O(carboxylate) interactions observed in the solid 
state structure of 3.5 are not seen in 3.6, the addition of an extra −B(OH)2 provides an 
additional hydrogen bonding group resulting in the formation of one-dimensional chains 
propagating in the [1 0 1] direction (Figure 3.23). Selected hydrogen bonding 
parameters for 3.6 are shown in Table 3.6. 
 
 
 
Figure 3.23 Chains of co-crystal 3.6. Phenyl groups and hydrogen atoms not involved 
in hydrogen bonding have been omitted for clarity. 
 
Table 3.6 Selected hydrogen bonding parameters for 3.6. 
D-H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(2) 2.748(3) 0.838(10) 1.94(2) 163(7) 
O(4)−H(4)···O(1) 2.763(3) 0.833(10) 1.931(11) 176(5) 
 
While the twists of the –B(OH)2 groups out of the mean plane of the phenyl group in 
1,4-phenylenediboronic acid and its tetrahydrate are 35° and 7° respectively,180 the twist 
for compound 3.6 has an intermediate value of 19.4°, apparently as a result of the 
hydrogen bonding requirements. 
  
 Comparing the infrared spectra of the starting materials and 3.6, similar changes to the 
cases discussed above were observed. Also, in this case the band at ν = 1366 cm–1 is 
broad and should have the contributions from the symmetric stretching vibration 
ν(COO–) and ν(B–O).  
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3.2.2.4 Co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with 2-Bromophenylboronic 
Acid  
 
Cu2(2,5-pzdca)(PPh3)4 co-crystallises with 2-bromophenylboronic acid in a 1:1 ratio 
yielding Cu2(2,5-pzdca)(PPh3)4·C6H4{B(OH)2}2-Br 3.7, which was obtained by slow 
diffusion of diethyl ether into a dichloromethane solution containing 3.7 (Figure 3.24). 
The Cu2(2,5-pzdca)(PPh3)4 molecule lies on a crystallographic centre of symmetry. The 
crystal structure of 3.7 shows, as seen previously, that the −B(OH)2 group is strongly 
hydrogen bonded as a double donor to the two carboxylate oxygen atoms in the Cu(I) 
complex (Table 3.7). Although the 2-bromophenylboronic acid possesses a halogen 
atom in the ortho position which can act as a good hydrogen-bonding acceptor,181,182 
due to the lack of strong hydrogen bond donors, extending the dimensionality of the 
system was unsuccessful, the structure of 3.7 is essentially zero-dimensional.  
 
 
 
Figure 3.24 View of 3.7. Phenyl groups and hydrogen atoms not involved in hydrogen 
bonding have been omitted for clarity. 
 
While the –Br group is essentially coplanar with the C6H4 ring, the plane formed by 
O(3)/B(1)/O(4) is twisted out of the C6H4 plane by 64.1°, this distortion is more severe 
than that observed in the solid state structure of 2-bromophenylboronic acid, 34.0°.138 It 
appears reasonable to ascribe this distortion to the sterically more demanding ortho-Br 
group in 3.7. 
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Table 3.7 Selected hydrogen bonding parameters for 3.7. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(3)−H(3)···O(1) 2.763(2) 0.84 1.94 168 
O(4)−H(4)···O(2) 2.694(2) 0.84 1.86 170 
 
While 4-bromophenylboronic acid is known to form an extended intermolecular 
hydrogen bonding network through (boronic acid)O–H···O(boronic acid) and Br···Br 
interactions,183,184 numerous attempts to co-crystallise it with the copper(I) complex to 
yield Cu2(2,5-pzdca)(PPh3)4·C6H4{B(OH)2}4-Br 3.8 failed.  
 
3.2.2.5 Co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with 3-Aminophenylboronic 
Acid  
 
The simultaneous presence of one –B(OH)2 and one –NH2 group in 3-
aminophenylboronic acid generates several supramolecular bonding options for this 
molecule. From the failure to extend the dimensionality of our systems with 3.7, a 
boronic acid containing an –NH2 group in the meta position as a hydrogen bonding 
donor was studied. The co-crystal of Cu2(2,5-pzdca)(PPh3)4 with 3-aminophenylboronic 
acid also includes additional molecules of water and dichloromethane in the lattice, 
giving the asymmetric unit [Cu2(2,5-pzdca)(PPh3)4·C6H4{B(OH)2}3-NH2][Cu2(2,5-
pzdca)(PPh3)4]·H2O·CH2Cl2 3.9 (Figure 3.25). The hydrogen atoms of the water 
molecule O(7) could not be located in the Fourier difference map.  
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Figure 3.25 View of compound 3.9. Phenyl groups and hydrogen atoms not involved in 
hydrogen bonding have been omitted for clarity. 
  
The –NH2 group of the 3-aminophenylboronic acid interacts with a carboxylate O atom 
through an intermolecular N−H···O hydrogen bond. This cooperates with the common 
boronic···carboxylate R22(8) ring motif formed in all the co-crystals described above, 
producing one-dimensional polymeric chains (Figure 3.26). As seen with 3.5, the  
–B(OH)2 group is almost co-planar (4.6°) with the aromatic ring. Selected hydrogen 
bonding parameters for 3.9 are shown in Table 3.8. 
 
 
 
Figure 3.26 View of co-crystal 3.9, showing a hydrogen bonded chain. Phenyl groups 
and hydrogen atoms not involved in hydrogen bonding have been removed for clarity.   
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Table 3.8 Selected hydrogen bonding parameters for 3.9. 
D−H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(5)−H(5A)···O(1) 2.686(2) 0.84 1.88 160 
O(6)−H(6A)···O(2) 2.859(2) 0.84 2.03 171 
N(3)−H(3B)···O(4B)i 3.093(3) 0.84(3) 2.29(3) 160(3) 
Symmetry operations: i-x+3, -y+1, -z+1. 
 
While the dichloromethane molecule in 3.3 does not participate in the extension of the 
dimensionality of the supramolecular array formed, in compound 3.9 the solvent 
molecules interact with the Cu2(2,5-pzdca)(PPh3)4 molecules using a combination of 
(phenyl)C–H···Cl(solvent), (solvent)C–H···O(carboxylate), (solvent)C–H···O(solvent) 
and (phenyl)C–H···O(solvent) hydrogen bonds, [2.87 Å, 2.38 Å, 2.20 Å and 2.56 Å], in 
order to form a two-dimensional architecture (Figure 3.27). 
 
 
 
Figure 3.27 View of the hydrogen bonding motifs in co-crystal 3.9. Phenyl groups and 
hydrogen atoms not involved in hydrogen bonding have been omitted for clarity. Close 
O···O [2.73 Å] contacts involving O(7B) are shown with dashed lines. 
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The infrared spectrum of 3.9 contains a broad band at ν = 3373 cm–1 assigned to 
contributions of the O–H and N–H vibrations. The strong bands at ν = 1631 and 1368 
cm–1 should also have contributions from ν(asymm. CO2–)/ν(N-H) vibrations, and the 
ν(symm. COO–)/ν(B–O) stretching vibration respectively. 
 
Attempts to obtain suitable crystals for X-ray crystallography for Cu2(2,5-
pzdca)(PPh3)4·C6H4(1-COOH){4-B(OH)2} 3.10 from organic solvents by different 
crystallisation methods such as (i) slow evaporation of dichloromethane/tBuOH solution 
of 3.10 (ii) slow vapour diffusion of hexane into a dichloromethane solution of 3.10 (iii) 
slow vapour diffusion of diethyl ether into a dichloromethane solution of 3.10 were not 
successful. 
 
Numerous attempts to co-crystallise the boronic acids described above with Cu(2-
pyca)(PPh3)2 and Cu(2-pzca)(PPh3)2 complexes, such as Cu(2-
pzca)(PPh3)2·C6H4(B(OH)2) 3.11, using the same crystallisation conditions described for 
3.9 failed. Crystallisation of the reaction mixtures gave crystals of the starting materials 
only. Elemental analysis data and IR spectroscopy indicate the presence of 3.10 and 
3.11 (Experimental section). Further work could be done on the optimisation of the 
crystallisation method for these compounds. 
 
While the CO2–/B(OH)2 R22(8) synthon has relatively few examples reported in the 
CSD compared with the analogous, well studied, carboxylic acid-carboxylate R22(8) 
synthon, the majority of the CSD structures containing the carboxylate-boronic acid 
group synthon do involve boric acid or phenylboronic acid, indicating the more general 
carboxylate-boronic acid group as a supramolecular synthon worthy of study. Possible 
future work could include the co-crystallisation of pyrazine- and pyridine-carboxylic 
acids with other poly(boronic) acid analogues (Figure 3.28).134,136,185  
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Figure 3.28 Examples of poly(boronic) acids that could be used in future studies. 
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The controlled and efficient synthesis of molecules of this type would provide synthetic 
underpinning for the molecular-engineering approach to design and construction of 
complex two and three-dimensional architectures. 
 
3.2.3 Discussion of the General Structural Features of Compounds 3.1-
3.7, 3.9 and 3.10 
 
In the solid state, compounds 3.1-3.7, 3.9 and 3.10 aggregate and present the common 
boronic···carboxylate R22(8) centrosymmetric dimer (Figure 3.29), formed by a pair of 
complementary O–H···O hydrogen bonding interactions characterised by O···O 
distances of 2.65-2.86 Å and O–H···O angles of 154-178° which are comparable to 
existing examples.137,140,149,174,180 Deprotonation of the carboxylic acids, through metal 
chelation, converted them into perfect ditopic hydrogen bond acceptors for boronic 
acids in a syn conformation. 
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Figure 3.29 Common synthon in compounds 3.1-3.7, 3.9 and 3.10. 
 
In all cases except compounds 3.6 and 3.7 the –B(OH)2 groups are approximately co-
planar with the C6 ring (dihedral angles are all less than 6°). The heterodimeric unit 
RB(OH)2···–OOCR (Figure 3.29) is non planar as shown by the α and β, (boronic 
acid)B–O···O–C(carboxylate), torsion angles shown in Table 3.9. These values are in 
good agreement with those observed in the literature.137 
 
Table 3.9 Torsion angles (°) of compounds 3.1-3.7 and 3.9.i 
 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.9 
α 9.0 12.4 8.9 9.5 16.5 15.1 23.7 21.1 
β 0.5 12.7 14.0 15.6 12.0 11.8 29.1 19.8 
i Where α and β = torsion angles (boronic acid)B–O···O–C(carboxylate). 
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Selected bond lengths and angles for the structurally characterised co-crystals 3.1-3.7, 
3.9 and 3.10 are shown in Table 3.10. There is little difference between these 
parameters for this series of complexes, and these bond lengths compare well with those 
in Cu2(2-pyca)(PPh3)2·X, (X = MeOH, EtOH, n-PrOH or i-PrOH) 2.1-2.4, (Table 2.10), 
Cu(2-pzca)(PPh3)2 2.17 and Cu2(2,5-pzdca)(PPh3)4 2.20. The B–O and O–B–O values 
are also in good agreement with those observed in the literature.140,142,186 The small 
differences may be caused by the dissimilarity of the hydrogen bonding shell around the 
carboxylate group and the different steric environments. 
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Table 3.10 Selected bond lengths (Å) and angles (°) for compounds 3.1-3.7, 3.9 and 
comparison with those of 2.1-2.4, 2.17 and 2.20. 
 B−Oa O−B−Oi C−O Cu−O O−Cu−N 
3.1 1.365 117.27(18) 
118.82(18) 
123.89(16) 
1.2751(18) 
1.2380(18) 
2.0961(10) 78.92(4) 
3.2 1.363 116.29(18) 
119.92(18) 
123.77(18) 
1.265(2) 
1.238(2) 
2.1517(12) 79.44(5) 
3.3 1.362 115.8(3) 
119.6(3) 
124.5(3) 
1.242(3) 
1.263(3) 
2.175(2) 79.66(8) 
3.4 1.35(4) 
[1.362(4)] 
117.3(3)/[118.2(3)] 
119.2(3)/[124.3(3)] 
123.5(3)/[117.4(3)]
1.268(3)/[1.267(3)] 
1.236(3)/[1.245(3)]
2.1395(17) 
[2.1252(18)] 
78.88(7) 
[79.39(8)] 
3.5 1.360 123.6(8) 1.280(8) 
1.248(8) 
2.142(5) 78.3(2) 
3.6 1.351 124.3(3) 1.264(3) 
1.238(3) 
2.126(2) 78.74(8) 
3.7 1.344 125.6(2) 1.270(3) 
1.235(3) 
2.1622(15) 78.61(6) 
3.9 1.363(3) 123.8(2) 1.273(3) 
1.236(3) 
2.1183(17) 78.25(7) 
2.1 - - 1.259(2) 
1.254(2) 
2.1091(13) 79.92(6) 
2.2 - - 1.264(3) 
1.249(3) 
2.0792(16) 79.73(8) 
2.3 - - 1.266(3) 
1.243(3) 
2.092(2) 79.71(9) 
2.4 - - 1.264(2) 
1.245(2) 
2.0908(12) 79.77(5) 
2.17 - - 1.262(3) 
1.239(3) 
2.0698(17) 80.14(7) 
2.20 - - 1.2652(17) 
1.2327(17) 
2.0802(9) 81.32(4) 
aO−H average distances; i Values in square brackets are for the second molecule in the 
asymmetric unit. 
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3.2.4 Discussion of Powder Diffraction Studies of Compound 3.2  
 
Unfortunately, accurate characterisation of the bulk material for compounds 3.1-3.12 
proved challenging to obtain. Powder X-ray diffraction (XRD) data were collected on 
compound 3.2 in order to determine the phases present in this sample. The powder XRD 
pattern collected from the bulk sample of 3.2, shows a complicated mixture of phases to 
be present. Only two phases could be identified (Figure 3.30) through searching the 
International Centre for Diffraction Data (ICDD) Powder Diffraction File (PDF); the 
starting material Cu(PPh3)2(BH4), represented as purple lines in Figure 3.30 and boric 
acid, shown as green lines.  
 
 
 
Figure 3.30 Powder diffraction patterns of 3.2, Cu(PPh3)2(BH4) and B(OH)3. 
  
Using the structural model determined through single crystal analysis of compound 3.2, 
a theoretical powder XRD pattern was calculated. Comparison of this with the observed 
data is shown in Figure 3.31 and it is clear that either this phase is not present in the 
bulk sample, only present in very small quantities too small to be detected by powder 
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XRD experiments or is very poorly crystalline and does not exhibit sharp diffraction 
peaks.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.31 Powder diffraction patterns of 3.2 theoretical pattern and 3.2. 
 
The presence of Cu(PPh3)2(BH4) may come from the synthesis of Cu2(2,5-
pzdca)(PPh3)4 2.20. In order to obtain a sample without starting materials, compound 
2.20 was re-crystallised from dichloromethane. Comparison of compound 2.20 before 
and after the re-crystallisation shows that the intense diffraction peaks in the 2θ region 
4-8°, which belong to an unidentified phase, reduce in intensity. The powder diffraction 
pattern also shows that the amount of Cu(PPh3)2(BH4) present is slightly reduced 
(Figure 3.32).   
 
                                                                                               3.2 Predicted 
                                                                                              3.2 Observed
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Figure 3.32 Powder diffraction patterns of 2.20, 2.20 re-crystallised and 
Cu(PPh3)2(BH4).  
 
As found previously for 3.2, comparison between the theoretical and observed XRD 
patterns of 2.20 shows that some reflections can be identified as known phases, but 
there are still many unidentified peaks relating to the presence of, perhaps, several 
unknown phases (Figure 3.33). 
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Figure 3.33 Powder diffraction patterns of 2.20 theoretical pattern, 2.20 and 2.20 re-
crystallised.  
 
Compound 3.2 was synthesised using the Cu2(2,5-pzdca)(PPh3)4 2.20 obtained from the 
re-crystallisation and the powder X-ray diffraction data collected is shown in Figure 
3.34.  
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Figure 3.34 Powder diffraction patterns of 3.2, 3.2 from recrystallisation, 
Cu(PPh3)2(BH4) and B(OH)3.  
 
The re-crystallisation experiment shows that the amount of Cu(PPh3)2(BH4) and boric 
acid present in the sample have been reduced dramatically, the diffraction peaks for 
Cu(PPh3)2(BH4) are shifted slightly due to small changes in the unit cell parameters 
between that of the standard pattern and the sample present 3.2. Although there are 
phases in the diffraction pattern which have not been identified, the reduction in the 
amount of boric acid indicates that Cu(PPh3)2(BH4) and B(OH)3 are directly related  and 
boric acid may come from two different sources: (i) added as a reagent for the co-
crystallisation reactions and (ii) from the hydrolysis of borohydride [BH4]–.  
 
 
 
 
 
 
 
 
 
2Theta8.0 12.0 16.0 20.0 24.0 28.0 32.0 36.00 
400
800
1200 
1600 
2000 
2400 
2800 
Ab
so
lu
te
 In
te
ns
ity
3.2 Crystals
[30-199] B ( O H )3 
Cu(PPh3)2(BH)4
3.2 Solid Recrystallised 
 118
3.3 Conclusion 
 
Low temperature single X-ray diffraction has enabled the elucidation of eight examples 
of copper(I)pyridine-/pyrazine-carboxylate complexes with boronic acid co-crystals, 
which represent novel contributions to the research into the occurrence of the 
carboxylate-boronic acid motif in co-crystals. Extensive hydrogen bonding exists within 
the structures, with the heterodimeric boronic···carboxylate R22(8) ring motif present in 
all cases. Therefore, the family of co-crystals presented in this chapter provide some 
insight on the supramolecular behaviour of these systems. Boronic···carboxylate R22(8) 
motifs are present in all crystal structures indicating the robust and predictable character 
of this synthon when using simple boronic acids in combination with carboxylate 
functional groups. Furthermore all boronic acids studied display a syn configuration, 
which provides a perfect geometric complement with a carboxylate acceptor (Figure 
3.35). Compounds 3.1-3.4 combine the common boronic···carboxylate R22(8) dimer 
motif with the boronic acid···boronic acid R22(8) synthon displaying the same type of 
hydrogen bonding pattern.  
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Figure 3.35 Boronic···carboxylate R22(8) motifs with the boronic acid in syn 
configuration. 
 
The co-crystallisation of boronic acids with the copper(I) pyrazine-2,5-dicarboxylate 
complex studied here (3.2, 3.4, 3.6 and 3.7) occur in a 1:2 ratio [metal complex:boronic 
acid] in all cases; exceptions to this trend were observed in compounds 3.5 and 3.9 
where the co-crystallisation occurs in a 1:1 ratio. Use of a varied range of solvents and 
crystallisation conditions has failed to allow the crystallisation of compounds 3.8, 3.10 
and 3.11. The co-crystallisation of Cu2(2,5-pzdca)(PPh3)4 with methylboronic acid has 
proved to be troublesome with the crystallisation of a second polymorph of compound 
Cu2(2,5-pzdca)(PPh3)4·2B(OH)3 3.2 instead of the desired co-crystal. 
 
The range of boronic acids discussed in this chapter is somewhat limited in hydrogen 
bonding potential due to the limited commercial availability of boronic acids bearing, at 
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most, one extra donor/acceptor hydrogen bonding functionality therefore affording only 
one-dimensional structures. Only compound 3.9 presents a more extended structure due 
to the inclusion of water and dichloromethane molecules which help to produce a two-
dimensional architecture. The weak hydrogen bond interactions in 3.9 play a very 
important role in extending the dimensionality of the systems. The co-crystallisation of 
Cu2(2,5-pzdca)(PPh3)4 with boronic acids bearing further hydrogen bonding 
functionalities other than the –B(OH)2 fails to produce arrays exhibiting higher 
dimensionality. 
 
Analysis of the powder diffraction data for 3.2 shows the presence of phases other than 
that identified in the single crystal experiment. Although two phases could be identified, 
Cu(PPh3)2(BH4) and boric acid, and the sources of boric acid present in the samples 
could be identified, further investigations to identify the unknown phases in the sample 
are worthy of study to contribute to the current level of understanding. 
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3.4 EXPERIMENTAL 
 
Materials 
 
The starting materials pyridine-2-carboxylic acid, pyrazine-2-carboxylic acid, pyrazine-
2,5-dicarboxylic acid, Cu(SO4)·6H2O, boric acid, phenylboronic acid, 3-
aminophenylboronic acid, 2-bromophenylboronic acid, 4-bromophenylboronic acid, 4-
carboxyphenylboronic acid, benzene-1,4-diboronic acid and methylboronic acid were 
purchased from commercial sources Aldrich, Lancaster and Acros. All solvents were 
purchased from Aldrich, Fisher or Lancaster. CH2Cl2 was distilled from CaH2 under 
nitrogen.Et2O was pre-dried using sodium wire before use. 
 
Physical Measurements 
 
Physical measurements were carried out using methods described in the preceding 
chapter. FT-IR spectra for compounds 3.1-3.11 were collected in the range 4000-500 
cm–1 using a Shimadzu 8400S spectrometer. Powder X-ray measurements were 
performed using Cu-Kα radiation (λ = 1.5418 Å) on a Bruker D8 diffractometer in 
reflection geometry and a Braun position sensitive detector. The sample was loaded 
onto a silicon zero background substrate and the data were collected in the range 5 < 2θ 
< 40° with a step time of 1 second and step width of 0.014°.   
 
Syntheses 
 
X-ray quality crystals of the desired compounds were obtained in very low yields 
preventing the acquisition of further data. Compounds 3.8, 3.10 and 3.11 have not been 
crystallised and microanalysis and IR spectroscopy data show that the expected 
compounds have been obtained. Recrystallisation of the bulk material for all the 
compounds presented in this chapter was done using Et2O and hexane. In all cases, 
microanalysis data were collected from the bulk materials which were dried in air 
before storage in a desiccator containing silica gel. 
 
X-ray quality crystals of compounds 3.1, 3.3, 3.5-3.7 and 3.9-3.10 were obtained by 
slow evaporation of the dichloromethane saturated solutions at room temperature. For 
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compounds 3.2 and 3.4, suitable X-ray quality crystals were obtained by allowing 
diethyl ether to diffuse into dichloromethane saturated solutions of the respectively 
compounds. 
 
Characterisation Data 
 
Compound 3.1 Cu(2-pyca)(PPh3)2·B(OH)3 
 
Colourless crystals. 
Analysis calculated for C42H37NO5P2BCu·Et2O·0.5CH2Cl2·H2O: C, 61.85; H, 5.52; N, 
1.53. Found: C, 61.62; H, 5.80; N, 1.24%. 
IR υmax (KBr)/cm–1 3215 (br, O-H), 3054 (Ar C-H), 1621 (asymm. CO2⎯), 1434 (C-O) 
and 1362 (B–O).    
 
Compound 3.2 Cu2(2,5-pzdca)(PPh3)4·2B(OH)3 
 
Orange crystals. 
Analysis calculated for C78H65N2O7P4BCu2·0.5CH2Cl2·: C, 65.35; H, 4.58; N, 1.93. 
Found: C, 65.37; H, 4.68; N, 2.05%. 
IR υmax (KBr)/cm–1 3374 (br, O-H), 3052 (Ar C-H), 1636 (asymm. CO2⎯), 1432 (C-O) 
and 1366 (B–O).    
 
Compound 3.3 Cu(2-pzca)(PPh3)2Cl·B(OH)3·CH2Cl2 
 
Orange crystals. 
Analysis calculated for C41H36N2O5P2BCu·CH2Cl2·: C, 58.80; H, 4.46; N, 3.27. Found: 
C, 58.98; H, 4.78; N, 3.23%. 
IR υmax (KBr)/cm–1 3215 (br, O-H), 3053 (Ar C-H), 1637 (asymm. CO2⎯), 1434 (C-O) 
and 1357 (B–O).    
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Compound 3.4 Cu2(2,5-pzdca)(PPh3)4·2B(OH)3  
 
Orange crystals. 
Analysis calculated for C78H62N2O4P4Cu2·CH3B(OH)2·B(OH)3·C4H10O: C, 64.81; H, 
5.24; N, 1.82. Found: C, 64.31; H, 5.85; N, 1.81%. 
IR υmax (KBr)/cm–1 3226 (br, O-H), 3053 (Ar C-H), 1635 (asymm. CO2⎯), 1433 (C-O) 
and 1358 (B–O).    
 
Compound 3.5 Cu2(2,5-pzdca)(PPh3)4·C6H5{B(OH)2} 
 
Yellow crystals. 
Analysis calculated for C47H40N2O4P2BCu·0.5CH2Cl2·0.5C4H10O : C, 64.81; H, 5.00; N, 
3.02. Found: C, 64.65; H, 5.16; N, 3.06%. 
IR υmax (KBr)/cm–1 3421 (br, O-H), 3053 (Ar C-H), 1647 (asymm. CO2⎯), 1435 (C-O), 
1368 (B–O), 816 and 743 (Ar C-H).  
 
Compound 3.6 Cu2(2,5-pzdca)(PPh3)4·C6H4{1,4-B(OH)2}2 
 
Orange crystals. 
Analysis calculated for C84H70N2O8P4B2Cu2·0.5CH2Cl2: C, 64.36; H, 4.52; N, 1.75. 
Found: C, 64.72; H, 4.71; N, 2.07%. 
IR υmax (KBr)/cm–1 3275 (br, O-H), 3056 (Ar C-H), 1633 (asymm. CO2⎯), 1438 (C-O), 
1366 (B–O), 819 and 742 (Ar C-H).  
 
Compound 3.7 Cu2(2,5-pzdca)(PPh3)4·2C6H4{B(OH)2}2-Br 
 
Orange crystals. 
Analysis calculated for C84H68N2O6P4BBrCu2·H2O: C, 64.63; H, 4.52; N, 1.79. Found: 
C, 64.83; H, 4.92; N, 1.91%. 
IR υmax (KBr)/cm–1 3347 (br, O-H), 3056 (Ar C-H), 1635 (asymm. CO2⎯), 1434 (C-O) 
and 1380 (br, B–O).   
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Compound 3.8 Cu2(2,5-pzdca)(PPh3)4·C6H4{B(OH)2}4-Br 
 
Analysis calculated for C90H74N2O8P4B2Br2Cu2·2CH2Cl2·H2O: C, 57.20; H, 4.17; N, 
1.45. Found: C, 57.07; H, 4.35; N, 1.49%. 
IR υmax (KBr)/cm–1 3217 (br, O-H), 3054 (Ar C-H), 1637 (asymm. CO2⎯), 1424 (C-O) 
and 1352 (br, B–O).   
 
Compound 3.9 Cu2(2,5-pzdca)(PPh3)4·C6H4{B(OH)2}3-NH2·H2O·CH2Cl2 
 
Red crystals. 
Analysis calculated for C84H70N3O6P4BCu2·0.5CH2Cl2·2H2O·: C, 65.29; H, 4.83; N, 
2.69. Found: C, 65.68; H, 4.64; N, 2.33%. 
IR υmax (KBr)/cm–1 3372 (br, O-H/N-H), 3055 (Ar C-H), 1631 (asymm. CO2⎯/N-H), 
1436 (C-O), 1364 (B–O), 800 and 745 (Ar C-H).   
 
Compound 3.10 Cu2(2,5-pzdca)(PPh3)4·C6H4{B(OH)2}4-COOH 
 
Analysis calculated for C85H69N2O8P4BCu2·2CH2Cl2·2C4H10O: C, 62.48; H, 5.13; N, 
1.53. Found: C, 62.38; H, 5.38; N, 1.35%. 
IR υmax (KBr)/cm–1 3356-3057 (br, O-H), 1687 (C=O, acid), 1633 (asymm. CO2⎯), 1434 
(C-O), 1370 (B–O).   
   
Compound 3.11 Cu(2-pzca)(PPh3)2·C6H4{B(OH)2}2 
 
Analysis calculated for C47H40N2O4P2BCu: C, 67.76; H, 4.84; N, 3.36. Found: C, 67.38; 
H, 4.90; N, 3.07%. 
IR υmax (KBr)/cm–1 3420 (br, O-H), 3049 (Ar C-H), 1636 (asymm. CO2⎯/N-H), 1436 (C-
O), 1354 (br, B–O), 741 and 693 (Ar C-H).  
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3.5 Crystallographic Experimental 
 
Data for compound 3.1 were collected using a Bruker SMART 1000 CCD 
diffractometer using graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). Data 
for compounds 3.3, 3.4, 3.7 and 3.8 were collected using a Bruker APEX 2 CCD 
diffractometer using graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). Data 
for compound 3.5 was collected using a Bruker APEX 2 CCD diffractometer using 
synchrotron radiation (λ = 0.7848 Å) at Daresbury SRS Station 9.8. Data for compound 
3.6 was collected using a Bruker APEX 2 CCD diffractometer using synchrotron 
radiation (λ = 0.6911 Å) at Daresbury SRS Station 9.8. Data for compound 3.2 was 
collected using a Bruker-Nonius 95 mm CCD camera on κ-goniostat diffractometer 
using graphite-monochromated Mo- Kα radiation (λ = 0.71073 Å). 
 
All structures were solved by direct methods (except structures 3.1 and 3.2 which were 
solved using Patterson synthesis) and refined by full-matrix least-squares methods on 
F2. All H atoms which were placed in geometrically calculated position were refined 
using a riding model (aryl C–H 0.95 Å and hydroxyl O–H 0.84 Å). NH atoms in 
compound 3.8 were located in the difference Fourier map and were refined with 
restraints on the N–H bond length. Uiso(H) values were set to be 1.2 times Ueq of the 
carrier atom for aryl and 1.5 times Ueq of the carrier atom for OH, NH and CH3. 
Hydrogen atoms were not found on the water molecule in compound 3.8. The 
coordinates of OH hydrogen atoms in compounds 3.1, 3.2 and 3.4-3.6 were allowed to 
refine freely. 
 
Unless stated as follows, all structural determinations proceeded without the need for 
further restraints or disorder modelling. Compound 3.3 was found to contain a 
disordered phenyl ring, which was modelled with two sets of positions 
70.6(15):29.4(15)%, with C(55) and C(56) commons to the two rings. Compound 3.6 
also exhibits disorder in two phenyl rings which were modelled over two set of 
positions [50.2(14):49.8(14)%] and [67.6(9):32.4(9)%] and restraints were placed on the 
anisotropic displacements parameters of the atoms involved. The coordinates of OH 
hydrogen atoms in compound 3.6 were refined with restraints on the O–H bond length. 
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Programs used during data collection, refinement and production of graphics were 
Bruker SMART, Bruker APEX 2, SAINT, SHELXTL, COLLECT, DENZO and local 
programs.25,26,28,121-123    
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4. Synthesis and Supramolecular Coordination Chemistry of Ditertiary 
Phosphines Containing Nitrogen and Phosphorus Donor Atoms 
 
4.1. Introduction 
 
The chemistry of phosphorus(III) compounds is centred on the lone pair and its 
availability to form new bonds. The geometry of these compounds is pyramidal (Figure 
4.1) as would be expected and the pyramidal inversion is slow, with respect to its 
nitrogen analogues, and therefore they have a fixed pyramidal structure. 
 
P
Ph
Ph
R
 
 
Figure 4.1 The pyramidal geometry of phosphorus(III) compounds [R = alkyl, aryl]. 
 
The spatial disposition of substituents around the phosphorus(III) centre plays a crucial 
role in providing such important properties as chirality and geometric/steric constraints. 
Therefore, systematic variations of substituents on phosphorus(III) centres are an 
effective tool for tuning electronic effects in phosphine ligands and their metal 
complexes.187-191    
 
The connectivity between the P(III) atom and the lignad is often readily achieved by 
either P−C–N or P−C–C bond formation, and therefore a variety of substituents can be 
introduced at the R position (Figure 4.2). 
 
N
R
PPh2PPh2
R
PPh2PPh2  
 
Figure 4.2 General structure of P−C–N–C–P and P−C–C–C–P containing fragments. 
 
Many ditertiary phosphines containing the P−C–C–C–P fragment have been reported to 
date,192-196 with DPPP [DPPP = 1,3-(diphenylphosphino)propane] the simplest example 
which comprises a C3-connectivity between the two –PPh2 groups. Although there is 
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some literature precedence with P−C–C–C–P ligands bearing backbone functionalities 
[R = –CH2NHC6H5, –CONHC6H5],197  their multistep synthesis, in moderate yields 
and/or prior generation of a reactive phosphide intermediate lead us to investigate the 
use of the more easily prepared P−C–N–C–P ligands. Therefore in order to synthesise 
suitable new hybrid P−C–N–C–P type ditertiary phosphine ligands bearing backbone 
functionalities such as [R = –C6H4(OH)(CH2OH), –C6H5(COOH)],198,199 simple 
phosphorus based Mannich condensations have been used. 
 
4.1.1 Ph2PCH2N(R)CH2PPh2 Chemistry  
 
Phosphorus-based Mannich condensation reactions have been used to prepare new 
ditertiary phosphines, Ph2PCH2N(R)CH2PPh2, from cheap and commercially available 
starting materials.198,200 The method used involves the reaction of an appropriate 
primary amine with Ph2PCH2OH, readily preformed from equimolar amounts of 
(CH2O)n and Ph2PH, in methanol (Equation 4.1).191,199  This synthetic procedure is 
versatile and offers many advantages over more classical routes of nucleophilic 
substitutions using primary/secondary phosphides, palladium catalysed P–C couplings 
and free radical additions. 
 
R NH2 + 2 Ph2PCH2OH R N
PPh2
PPh2
MeOH
 
 
Equation 4.1 
 
Durran et al. have applied this method to synthesise a series of ditertiary phosphines 
4.1-4.3 bearing various functional groups (Equation 4.2).198 The reactions were 
completed in short times and no purification steps were required. 
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NH2
Y
X
N
Y
X
PPh2
PPh2
2 eq .Ph2PCH2OH
CH3OH or CH3OH/C7H8 
X = OH, Y =  H 4.1
X = H, Y = CH2OH 4.2
X = H, Y = COOH 4.3
 
 
Equation 4.2 
 
The crystal structure of 4.3 shows the Ph2P– groups to adopt an anti configuration with 
respect to each other (Figure 4.3). Compound 4.3 forms dimers through a strong head-
to-tail R22(8) interaction. 
 
 
 
Figure 4.3 Dimers of compound 4.3. Hydrogen atoms except OH and phenyl groups 
have been omitted for clarity. 
 
Brown and co-workers have been interested in developing novel nonsymmetric 
ditertiary phosphines, 4.4 and 4.5, using two consecutive Mannich-based condensation 
reactions (Equation 4.3).201  
 
R2P OH PR2 NHR-- R2P N PR-2
R--
H2NR-- R
-
2P OH
R' = Ph 
R = Ad  
R'' = C6H5 4.4; C6H4(4-CH3) 4.5  
 
Equation 4.3  
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Reaction of ligands 4.4 and 4.5 with the corresponding metal(II) complexes 
[MCl2(cod)] (M = Pd or Pt) afforded the corresponding Pt(II) and Pd(II) compounds in 
which the ligands adopt a chelating coordination mode (Figure 4.4).  
 
 
 
Figure 4.4 Molecular structure of the Pt(II) complex formed with ligand 4.4. Hydrogen 
atoms and solvent molecules have been removed for clarity. 
 
The metal centre is square-planar and the P(2)–Pt(1)–Cl(2) bond angle is contracted by 
10° with respect to P(1)–Pt(1)–Cl(1) reflecting the different steric effects of phenyl vs. 
adamantane groups.  
   
4.1.2 Coordination Chemistry of Ditertiary and Polytertiary 
Phosphines 
 
Polydentate phosphine ligands have a number of advantages compared with 
monodentate systems, including an increased nucleophilicity (or basicity) at the metal 
centre, more control of the coordination number, stoichiometry and stereochemistry of 
the resulting metal complexes and useful detailed structural and bonding information 
from phosphorus-phosphorus and metal-phosphorus coupling constants in NMR 
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spectroscopy.202 Numerous tridentate and tetradentate phosphines have been 
documented,191,202 these phosphines can be linear, tripodal or branched (Figure 4.5). 
 
(CH2)2Me2P P P PMe2
Me Me HC
PPh2
PMe2Me2P C C C
PPh2
PPh2Ph2P
Ph2P  
 
Figure 4.5 Examples of polydentate phosphine ligands. 
 
The phosphine ligands coordinate to various metal centres to afford mononuclear, 
binuclear or trinuclear complexes with different coordination numbers [four, five and 
six] and different structures such as, tetrahedral, square planar, square pyramidal or 
octahedral (Figure 4.6). 
 
P
Ph2P PPh2
Pd
Cl Cl
Ph
PMe2P P
Ph
PMe2
Ph
Mn
Cl Cl
OC CO
 
 
Figure 4.6 Examples of square planar and octahedral complexes.  
  
Fernández and co-workers reported an interesting example of tetranuclear 
(phosphine)(thiolato)gold(I) compounds (Equation 4.4).203 The tetradentate ligand 
(Ph2PCH2)2NCH2CH2N(CH2PPh2)2 was synthesised following a synthetic method first 
reported by Grim,204 by condensation of paraformaldehyde with diphenylphosphine and 
ethylenediamine. 
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N N
PPh2
PPh2
Ph2P
Ph2P
N N
Ph2
P
P
P
P AuAu
Ph2 Ph2
ClCl
N N
P
PP Au
Au
Au
Ph2 Ph2
Au S
S
S
S
X
X
X
X
(i)
(ii)
4.6 X = F
4.7 X = OMe
4.8 X = Me
4.9 X = NO2
Au Cl
PPh2
AuCl
PPh2
P
PPh2
 
 
Equation 4.4 (i) [Au(C6F5)(tht)]; (ii) NaOMe, SH–C6H4–X (X = F, OMe, Me or NO2). 
  
The crystal structure of complex 4.7 shows that the metal centres associate into pairs 
through weak intramolecular Au···Au interactions [3.1485(4) Å] (Figure 4.7). 
 
 
 
Figure 4.7 Molecular structure of compound 4.7. Phenyl groups and hydrogen atoms 
have been omitted for clarity. 
 
Kane and co-workers have described the crystal structure of another class of potentially 
tetradentate ligand, [P(Ph)CH2N(2-pyridyl)CH2]2 4.10, first synthesised by Märkl 
(Figure 4.8).205,206 The heterocycle adopts a crown configuration, with the two 
phosphorus atoms oriented syn to each other, suitable for metal chelation. 
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Figure 4.8 Molecular structure and crown conformation of ligand 4.10. Hydrogen 
atoms have been removed for clarity.  
 
The reaction of 4.10 with Mo(CO)4(nbd) in dichloromethane afforded the complex 4.11 
in which the ligand adopts a chair-boat conformation (Figure 4.9). Chelation to the 
Mo(CO)4 moiety led to a closing of the two phosphorus ring atoms compared with the 
free ligand [3.023(3) Å and 3.750(2) Å respectively]. 
 
 
 
Figure 4.9 View of compound 4.11. Phenyl groups and hydrogen atoms have been 
removed for clarity.  
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Elsegood and co-workers reported the synthesis and coordination studies of a terdentate 
carboxylic acid ditertiary phosphine C6H4(OCH3)(COOH)N(CH2PPh2)2 4.12 (Equation 
4.5).190 
 
NH2
CO2H
OCH3
+ Ph2P OH2
CH3OH
N
CO2H
OCH3
PPh2
PPh24.12  
 
Equation 4.5 
 
Treatment of 4.12 with one equivalent of Pd(CH3)Cl(cod) in dichloromethane and 
further metathesis with NaI in acetone afforded the 48-membered hexanuclear Pd6 
metallomacrocycle [PdI{2-{Ph2PCH2)2N}-6-(OCH3)C6H3CO2}]6 4.13 (Figure 4.10). 
Ligand 4.12 adopts a monoanionic form coordinating one Pd(II) centre through both 
phosphorus atoms and the second Pd(II) centre via a single oxygen-donor centre from 
the carboxylate group. 
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Figure 4.10 Molecular structure of 4.13. Phenyl groups on each phosphorus atom, all 
hydrogen atoms, methoxy groups and solvent molecules of crystallisation have been 
omitted for clarity. 
 
The work of Durran and co-workers aimed at studying the reactivity of an uncommon 
series of ditertiary phosphine ligands bearing the donor set combination P/N/Se 
(Equation 4.6) was reported.207 Compounds 4.14 and 4.15 were found to react with 
MCl2(cod) (M = Pt, Pd) to form 4.16-4.19 in good yield.  
 
N
(CH2)nSePh
P PPh2Ph2
N
(CH2)nSePh
P PPh2Ph2
M
ClCl
1 equiv. [MCl2(cod)]
CH2Cl2
n = 3  4.14
n = 4  4.15
M = Pt, n = 3  4.16
M = Pt, n = 4  4.17
M = Pd, n = 3 4.18
M = Pd, n = 4 4.19  
 
Equation 4.6 
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The crystal structure of 4.17 shows a cis configuration with respect to the two 
phosphorus donors. The Pt(II) displays a near square-planar coordination environment 
and the Pt–P–C–N–C–P six-membered ring adopts a boat conformation with the N(1) 
atom out of the plane [± 0.152 Å] (Figure 4.11). It is interesting to notice that the 
pendant phenylseleno group is amenable to further coordination chemistry. 
 
 
 
Figure 4.11 View of the asymmetric unit for compound 4.17. Phenyl groups and 
hydrogen atoms have been removed for clarity. 
 
Although heterofunctional phosphorus containing ligands bearing a soft phosphorus 
atom and a hard nitrogen donor atom have found important applications in catalysis and 
coordination chemistry,208-215 there is very little documented regarding the use of 
ditertiary phosphine ligands in supramolecular chemistry. A brief survey of some of 
these examples is discussed below. 
 
4.1.3 Applications of P−C−N−C−P Based Ligands 
 
Phosphine ligands have seldom been exploited in crystal engineering although they can 
readily be modified with various functional appendages such as polar carboxylic acid 
groups.198,216-218 Recently, Smith and co-workers synthesised and structurally 
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determined a range of isomeric Au(I) and Pd(II) complexes with ditertiary phosphines 
containing phenol and carboxylic acid appendages (Equation 4.7).187,189  
 
N
HO
PPh2
PPh2 N
HO
P
Ph2
PPh2
Pd
(ii)
COOH
Cl
Cl
COOH
N
HO
P
P
COOH
AuCl
AuCl
Ph2
Ph2
 
 
Equation 4.7 (i) 2 equiv. AuCl(tht), CH2Cl2; (ii) 1 equiv. PdCl2(cod), CH2Cl2. 
 
A range of supramolecular synthons have been observed and dictated by various factors 
including the nature, predisposition of the –OH and –COOH functional groups, the 
flexibility about the N–Carene bond and the choice of solvent used in recrystallisation. 
 
The gold(I) complexes crystallise as one-dimensional chain structures when a hydrogen 
bonding functional group (–COOH or –OH) is located in the 3- or 4-position on the 
phenyl group with respect to the N atom and the second hydrogen bonding functional 
group is located at least one carbon position away from the –COOH or –OH substituent 
(Figure 4.12). This example also shows intramolecular Au···Au aurophilic interactions 
[3.0722(9)].   
 
 
 
Figure 4.12 Example of one-dimensional polymeric chain. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity.  
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In contrast, when the –COOH or –OH functional groups are adjacent to each other on 
the arene core, dimeric species are preferred (Figure 4.13). This shows that the 
regioselective incorporation of functional appendages, –N(CH2PPh2)2, –COOH and –
OH around a central arene core has a pronounced effect on the structural motifs 
obtained. 
 
 
 
Figure 4.13 Example of dimer formation. Phenyl groups and hydrogen atoms not 
involved in hydrogen bonding have been omitted for clarity. 
 
Interestingly, for comparison with the gold(I) complex described above which 
aggregates as a dimer when the –COOH or –OH functional groups are adjacent to each 
other, the Pd(II) analogue 4.18, does not present the classic head-to-tail hydrogen 
bonded carboxylic acid synthon (Figure 4.14). Compound 4.18 crystallises showing the 
same intramolecular S(6) synthon observed above but a one-dimensional chain is 
formed instead through intermolecular O–H···Cl hydrogen bonding.   
 
 
 
Figure 4.14 View of 4.18 showing a portion of a hydrogen bonded chain. Phenyl 
groups and hydrogen atoms except OH have been omitted for clarity. 
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Complexes of (Ph2PCH2)2NC6H4X ligands with a number of metals such as palladium, 
rhodium, ruthenium and platinum have exhibited high activity in catalysis.219 Rhodium 
complexes were prepared in-situ using Rh(cod)BF4 with 
bis((diphenylphosphino)methyl)aniline ligands and used these in the hydroformylation 
of 1-octene and 2-vinylnaphthalene. The complexes formed with these ligands were 
more active than the equivalent complex using bis(diphenylphosphino)propane (4 to 10 
times more) (Equation 4.8).  
 
R R
CHO
R
CHOCO/H2
Rh cat
X
N
PPh2
PPh2
X= H, CF3, NMe2
+
 
 
Equation 4.8 Hydroformylation of 1-octene and 2-vinylnaphthalene using P-C-N-C-P 
ligands. 
 
Heterogeneous catalysis was also investigated; Alper and Bourque studied the use of 
silica-supported dendritic rhodium complexes in hydroformylation reactions using 
ligands with a –N[(CH2)nCONHCH2CH2N(CH2PPh2)2]2 chelating motif where n = 2, 4 
and 6.220 The use of bead-supported and activated carbon-supported catalysts was 
subsequently reported.221-223 
 
Palladium complexes with P-C-N-C-P ligands are versatile coupling reagents. Examples 
include carbonylation reactions using dendritic palladium(II) complexes immobilized 
on silica (using ligands with a –N[(CH2)2CONHCH2CH2N(CH2PPh2)2]2 chelating 
motif),224 Heck reaction between aryl halides and methyl acrylate under homogenous 
conditions using bis((diphenylphosphino)methyl)-alkyl (alkyl= methyl, tert-butyl) and -
arylamine ligands and a palladium(II) source,225 Suzuki and Sonogashira coupling using 
MCM-supported palladium(0) catalysts.226,227 Recently, Alper and Lu used a solid-
supported palladium(II) complex to prepare a series of heterocycles, precursors to 
enantiomerically enriched lactams.228 
 
 140
Del Zotto and co-workers reported the use of complexes of ruthenium(II) with 
P−C−N−C−P ligands in transfer hydrogenation reactions under homogeneous and 
heterogeneous conditions (Equation 4.9).229 
 
Si N PPh2
PPh2
Si N PPh2
PPh2
EtO
EtO
EtO
O
OH
OH
O
+ +
RuCl2-ampy-Ligand
 
 
Equation 4.9 Transfer hydrogenation reaction catalysed by Ru(II) complexes [ampy = 
(2-aminomethyl)pyridine]. 
 
Wu and Li used a N,N-bis((diphenylphosphino)methyl)butan-1-amine ligand complex 
with platinum(1,3-divinyl-1,1,3,3-tetramethyldisiloxane) to obtain high 
stereoselectivities and high yields in hydrogenation reactions of a wide range of 
alkynes.230 
 
Phosphines have been shown to play an important role in the design of radiometal-
antibody conjugates by their versatile ligating capability with transition metals.196,231,232 
Zhang and co-workers have investigated the cytotoxic activity against murine and 
human cancer cells of a series of bis(diphenylphosphinomethyl)amine rhenium(I) 
complexes.233 These compounds do not show activity against non-cancerous human 
fibroblast cells which is an important property for any chemotherapeutic agent since 
harmful side-effects of the treatment will be minimised. The authors also describe a 
probable mode of action based on ESMS (electrospray mass spectrometry) studies, in 
which the rhenium(I) complexes described would bind to DNA bases or side-chains of 
amino acid residues in peptides and proteins after displacement of the bromide ligands.  
  
Curtis, Das and Jacobsen reported independently the synthesis, structural analysis and 
electrochemical studies of Fe(II) or Ni(II) complexes containing P–C–N–C–R [R = 
C6H6, n-Bu, CH3 or CH2CH2OMe] ditertiary ligands with pendant amine bases.234-237 
Some of these complexes have been shown to mimic the active site of hydrogenases. 
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Dendrimers were originally referred to as cascade molecules and are best described as 
highly branched regular three dimensional, mono-dispersed macromolecules, with a 
branch occurring at each monomer unit. They are characterised by the presence of large 
numbers of functional groups on the surface, which results in solubility, viscosity and 
thermal behaviours different from more classical polymers. Commercial applications of 
these dendrimers have been identified and include medical diagnostics and 
catalysis.238,239  
 
Reetz and co-workers reported the synthesis of a dendritic diphosphine and the 
preparation of corresponding metal and bimetallic complexes.240 Double 
phosphinomethylation of each of the 16 primary amino end groups of the DAB-based 
(DAB = 1,4-diaminobutane) polyamino dendrimer DAB-dendr-(NH2)16 proceeds in 
essentially quantitative yield to give 4.20 upon use of Ph2PCH2OH prepared in situ from 
CH2O and HPPh2 (Equation 4.10). Dendrimer 4.20 was characterised by elemental 
analysis, IR and NMR spectroscopy. Compound 4.20 with 16 bidentate ligands on the 
outer surface, provides a suitable site for complexation to a variety of transition metals 
such as, Pd(II), Rh(I) and Ir(I).  
 
N
N
N
N
N
N
NH2
NH2
NH2
NH2
H2N
H2N
H2N
H2N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
R2P
R2P
R2P
R2P
R2P
R2P
R2P
R2P
PR2
PR2
PR2
PR2
PR2
PR2
PR2
PR2
CH2O/HPPh2
      4.20  
    R = Ph
 
 
Equation 4.10 
 
The limited previous investigations of isomeric series of ditertary phosphines bearing 
functional appendages with hydrogen bonding capability have identified them as 
suitable molecular building blocks for the creation of supramolecular arrays, 
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particularly those incorporating a combination of coordination and hydrogen bonding 
interactions. 
 
Analysis of the extensive coordination chemistry, particularly the formation of square 
planar, linear and octahedral complexes, shows the versatility of these ligands and also 
that the inclusion of potential hydrogen bonding acceptors such as Cl– and CO– bonded 
to the metal centre, [PtCl2], [AuCl] and [Mo(CO)4], may allow the extension of the 
hydrogen bonding arrays in a different manner than the ones observed in the free 
ligands and between different coordination geometries.  
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4.2 Results and Discussion 
 
Although phosphine ligands can be readily modified with various functional 
appendages with hydrogen-bonding capability such as polar carboxylic acid 
groups,187,189 they have seldom been exploited in supramolecular chemistry. Therefore, 
as part of ongoing studies aimed at exploiting highly functionalised phosphorus based 
ligands in crystal engineering, the synthesis, structural analysis and metal complexation 
studies with selected transition metals of an isomeric series of functionalised phenols 
(some of them containing Me or tBu groups) ditertiary phosphine ligands, (Figure 4.15), 
is presented. The structures of the new compounds have been elucidated by a 
combination of multinuclear NMR spectroscopy, IR spectroscopy, elemental analysis 
and in several cases, by X-ray crystallography. 
 
N
PPh2
PPh2
N
H
N PPh2
PPh2
O
OH
OH
N
H
N PPh2
PPh2
O
OH
N
PPh2
PPh2
OH
R
R
4.20-4.22     4.23-4.28
R = CH3 or tBu
4.77-4.79 4.80-4.85
R = CH3 or tBu  
 
Figure 4.15 Ditertiary functionalised bis(phosphino)amines prepared in this study. 
 
4.2.1 Syntheses of C6H4(OH)N(CH2PPh2)2 4.20-4.22, C6H3(OH)(CH3)N(CH2PPh2)2 
4.23-4.27 and C6H3(OH)(tBu)N(CH2PPh2)2 4.28 
 
The phenol functionalised ditertiary phosphine ligands C6H4(OH)N(CH2PPh2)2 4.20–
4.22, C6H3(OH)(CH3)N(CH2PPh2)2 4.23–4.27 and C6H3(OH)(tBu)N(CH2PPh2)2 4.28 
were prepared using a Mannich-based condensation reaction which is an efficient and 
versatile method for the synthesis of novel hybrid phosphine ligands.43-45 Two 
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equivalents of Ph2PCH2OH were reacted with one equivalent of the primary amine I-IX 
yielding the desired bis(phosphino)amine after 24 h at room temperature under N2 
(Equation 4.11).  
 
A = OH, B,C,D = H   I
B = OH, A,C,D = H   II 
C = OH, A,B,D = H   III
A = OH, D = CH3, B,C = H   IV
A = CH3, C = OH, B,D = H   V
A = OH, C = CH3, B,D = H   VI
B = OH, C = CH3, A,D = H   VII
C = OH, B = CH3, A,D = H   VIII
A = OH, D = tBu, B,C = H    IX
A
B
C
D
NH2
2 Ph2P OH
MeOH
A
B
C
D
N PPh2
PPh2
A = OH, B,C,D = H   4.20
B = OH, A,C,D = H   4.21
C = OH, A,B,D = H   4.22
A = OH, D = CH3, B,C = H  4.23
A = CH3, C = OH, B,D = H  4.24
A = OH, C = CH3, B,D = H  4.25
B = OH, C = CH3, A,D = H  4.26
C = OH, B = CH3, A,D = H  4.27
A = OH, D = tBu, B,C = H   4.28
 N2
 
 
Equation 4.11  
 
In all the syntheses, the solution was concentrated under reduced pressure and the white 
solid 4.20–4.28 filtered off. These compounds were found to be air stable in the solid 
state, but oxidised quickly in solution. Ligands 4.20–4.28 were obtained in 58-97% 
yields. They exhibited a single resonance in their 31P{1H} NMR spectra [(CD3)2SO] in 
the region of δ(P) −25.32 to −27.63 ppm, indicating the presence of only one 
phophorus(III) environment. These ligands were also characterised by 1H NMR 
spectroscopy. These data supported the double condensation inferred from the absence 
of an NH signal that would be expected if single substitution had occurred.  
 
4.2.1.1 Crystal Structures of Compounds 4.21–4.23 
 
X-ray quality crystals of compounds 4.21-4.23 were obtained by slow evaporation of 
the methanol filtrate. Structure analysis clearly shows approximate pyramidal 
geometries about both phosphorus centres (Table 4.1). There is little spread in the P−C 
and C−N bond lengths in ligands 4.21–4.23 and they are consistent with the values 
reported for other ditertiary phosphine ligands.190 The P(III) atoms are in the anti 
conformation presumably in order to reduce steric repulsions between the bulky phenyl 
groups. The geometry about each N(1) centre is approximately pyramidal for ligands 
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4.22 and 4.23 [Σ(C–N–C) angles about N(1) centre = 335.0(2)° and 337.1(4)° 
respectively] and approximately trigonal planar for 4.21 [Σ(C–N–C) = 359.03(11)°]. 
 
Table 4.1 Selected bond lengths (Å) and angles (°) for compounds 4.21–4.23. 
 4.21 4.22 4.23 
P(1)–C(1) 1.8748(14) 1.870(3) 1.850(5) 
P(2)–C(2) 1.8840(14) 1.855(3) 1.841(5) 
C(1)–N(1) 1.4517(16) 1.467(4) 1.471(6) 
C(2)–N(1) 1.4541(16) 1.469(4) 1.476(6) 
P(1)–C(1)–N(1) 113.72(9) 115.9(2) 113.7(3) 
P(2)–C(2)–N(1) 112.57(9) 112.3(2) 113.7(3) 
C(1)–N(1)–C(2) 117.28(11) 112.1(2) 112.5(3) 
C(1)–N(1)–C(3) 120.31(11) 110.3(2) 111.6(4) 
C(2)–N(1)–C(3) 121.45(11) 112.6(2) 113.0(4) 
 
Compounds 4.21–4.23 contain one molecule in the asymmetric unit, which differs in the 
disposition of the PCNCP fragment with respect to the functionalised phenyl ring 
(Figure 4.16). While in compounds 4.22 and 4.23, the functionalised phenyl rings are 
twisted almost perpendicular to the C(1)–N(1)–C(2) fragment, 88° and 86° respectively, 
for compound 4.21, the twist of the C(1)–N(1)–C(2) fragment lies within 9° of co-
planarity with the functionalised phenyl group, apparently as a result of the hydrogen 
bonding requirements. 
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Figure 4.16 Overlay view of structures 4.21–4.23, solvent molecule for compound 4.22 
has been omitted for clarity. Phenyl rings and hydrogen atoms except OH have been 
omitted for clarity. 
 
The supramolecular synthons observed in the solid state for these highly modular 
ligands may be dictated by various factors including the nature of the ligand, the 
PCNCP fragment flexibility, the predisposition of the OH/CH3 groups about the N-
arene and the solvent used in the crystallisation. 
  
4.2.1.2 Secondary Interactions in Compounds 4.21–4.23 
 
In order to probe the interplay due to the position of the OH/CH3 groups, the crystal 
structure of 4.23 with the –OH group in the ortho position with respect to the N atom is 
described first. Ligand 4.23 crystallises with an intramolecular S(5) hydrogen bond 
graph set which is favourable due to the disposition of the hydroxyl functional group 
(Figure 4.17). The intramolecular hydrogen bonding in 4.23 limits the dimensionality of 
the packing of the phosphine ligand. Therefore, the structure of 4.23 is essentially zero-
dimensional (Table 4.2).  
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Figure 4.17 View of the asymmetric unit of 4.23. Phenyl groups and hydrogen atoms 
except OH have been removed for clarity. 
 
Table 4.2 Selected hydrogen bonding parameters for 4.23. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···N(1) 2.746(5) 0.84 2.27 116.2 
 
Compound 4.21, where the −OH functional group is in the meta position with respect to 
the tertiary N atom, aggregates in the solid state in such a way that weak hydrogen 
bonds O−H···P [P···O length 3.46 Å, 166°] form between symmetry related molecules 
creating dimers in which the two ligands are held in a R22(16) motif (Figure 4.18).10 The 
distance between symmetry related nitrogen atoms is 8.26 Å.  
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Figure 4.18 Dimers of 4.21. Phenyl groups and hydrogen atoms not involved in 
hydrogen bonding have been removed for clarity. 
 
Compound 4.22, which contains the −OH group in a para position with respect to the 
tertiary N-arene functionality, crystallises with the inclusion of one molecule of 
methanol per ligand. The methanol molecule was found to be disordered over two sets 
of positions. This disorder can be explained by the fact that both components are 
involved in hydrogen bonding. While the first component C(34)–O(2) bonds to the 
hydroxyl O of one 4.22 molecule, the second component C(34X)–O(2X) is involved in 
a strong (component 2)O–H···O(component 1) interaction with a symmetry related 
solvent molecule (Figure 4.19).  The combination of strong O–H···O and weak 
(hydroxyl)O−H···P, [P···O bond distance 3.44 Å], hydrogen bonds creates one-
dimensional tapes.10 Selected hydrogen parameters for 4.22 are shown in Table 4.3. 
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Figure 4.19 View of the hydrogen bonded tapes formed in compound 4.22. Hydrogen 
atoms not involved in hydrogen bonding, phenyl and methyl groups have been omitted 
for clarity.  
 
Table 4.3 Selected hydrogen bonding parameters for 4.22. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(2)−H(2)···O(1) 2.825(8) 0.84 2.03 158 
O(2X)−H(2X)···O(2B)i 2.799(11) 0.84 1.96 172 
Symmetry operation: ix, -y+1/2, z-1/2. 
 
4.2.2 Coordination Chemistry of C6H3(OH)N(CH2PPh2)2 4.20–4.22, 
C6H4(OH)(CH3)N(CH2PPh2)2 4.23–4.27 and C6H3(OH)(tBu)N(CH2PPh2)2 4.28 
 
4.2.2.1 Syntheses of Square Planar Pt(II) Complexes 4.29-4.37 
 
The synthesis of P,P-chelate complexes PtCl2{P,P-C6H4(OH)N(CH2PPh2)2} 4.29–4.31, 
PtCl2{P,P-C6H3(OH)(CH3)N(CH2PPh2)2} 4.32–4.36 and PtCl2{P,P-
C6H3(OH)(tBu)N(CH2PPh2)2} 4.37 was achieved by stirring the ligands 4.20–4.28 and 
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PtCl2(cod) in CH2Cl2 for 1.5 h with displacement of the cyclooctadiene ligand 
(Equation 4.12). The products were isolated in good yields, 66-99%, as white solids 
obtained upon reduction of the volume of solvent in vacuo and addition of Et2O. 
 
N
A
B
C
D
PPh2
PPh2 N
A
PPh2
P
Ph2
Pt Cl
Cl
B
C
D
PtCl2(cod)
CH2Cl2
A = OH, B,C,D = H   4.29
B = OH, A,C,D = H   4.30
C = OH, A,B,D = H   4.31
A = OH, D = CH3, B,C = H  4.32
A = CH3, C = OH, B,D = H  4.33
A = OH, C = CH3, B,D = H  4.34
B = OH, C = CH3, A,D = H  4.35
C = OH, B = CH3, A,D = H  4.36
A = OH, D = tBu, B,C = H   4.37
A = OH, B,C,D = H   4.20
B = OH, A,C,D = H   4.21
C = OH, A,B,D = H   4.22
A = OH, D = CH3, B,C = H  4.23
A = CH3, C = OH, B,D = H  4.24
A = OH, C = CH3, B,D = H  4.25
B = OH, C = CH3, A,D = H  4.26
C = OH, B = CH3, A,D = H  4.27
A = OH, D = tBu, B,C = H   4.28  
 
Equation 4.12 
 
The complexation of the phosphine ligands was established by 31P NMR spectroscopy. 
In all cases, the resonance of the free phosphine ligands 4.20–4.28, observed in the 
range of δ −25.3 to −27.6 ppm, disappeared and the corresponding coordination-shifted 
signals were observed in the range of δ –4.0 to –11.7 for the Pt(II) complexes 4.29–
4.37. The coupling constants for 4.29–4.37 were approximately 3400 Hz which 
indicates that these complexes are in a cis conformation. In their infrared spectra, two 
vibrations in the range of 290-316 cm–1 were observed, indicative of ν(PtCl) (Table 
4.4). The presence of these two vibrations provides confirmation for the cis isomer, as 
opposed to the trans isomer, which would only give one Pt−Cl vibration. 
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Table 4.4 Selected 31P{1H} NMRa and IR datab for 4.29–4.37. 
 δ(P)/ppm 1J(PtP)/Hz υ(PtCl)/cm–1 
4.29 -8.71 3431 316; 282 
4.30 -4.02 3436 311; 289 
4.31 -7.93 3424 312; 287 
4.32 -9.43 3424 316; 289 
4.33 -4.88 3426 315; 282 
4.34 -8.55 3436 315; 286 
4.35 -11.70 3410 309; 290 
4.36 -7.89 3421 314; 290 
4.37 -8.54 3450 316; 284 
        a Spectra measured in (CD3)2SO. b Recorded as KBr pellets. 
 
4.2.2.2 Crystal Structures of Compounds 4.30, 4.32, 4.33, 4.35 and 4.36 
 
Structural analysis of complexes 4.30, 4.32, 4.33, 4.35 and 4.36 shows that the 
geometry about each Pt(II) centre is approximately square planar [P–Pt–P range 
94.84(3)-96.41(2)°] (Table 4.5). The Pt−Cl and Pt−P bond lengths are consistent with 
the values reported in the literature.189,191 
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Table 4.5 Selected bond lengths (Å) and angles (°) for compounds 4.30, 4.32, 4.33, 4.35 and 4.36. 
 4.32 4.30 4.33 4.36 4.35a
Pt(1)–Cl(1) 2.3624(6) 2.3421(9) 2.359(3) 2.3558(6) 2.3562(18)/[2.3576(17)] 
Pt(1)–Cl(2) 2.3484(6) 2.3617(10) 2.357(3) 2.3555(6) 2.3693(18)/[2.3616(18)] 
Pt(1)–P(1) 2.2226(6) 2.2220(9) 2.223(3) 2.2256(6) 2.2386(19)/[2.2352(18)] 
Pt(1)–P(2) 2.2186(7) 2.2288(9) 2.223(3) 2.2145(6) 2.2474(18)/[2.2465(18)] 
P(1)–Pt(1)–P(2) 96.30(3) 94.84(3) 96.29(11) 96.41(2) 96.16(7)/[95.95(7)] 
P(1)–Pt(1)–Cl(1) 86.12(2) 88.80(3) 87.91(11) 87.63(2) 87.30(7)/[86.87(7)] 
P(2)–Pt(1)–Cl(1) 176.08(3) 173.98(3) 174.95(12) 175.93(2) 176.51(7)/[176.84(7)] 
P(1)–Pt(1)–Cl(2) 174.73(2) 174.53(4) 176.45(12) 177.81(2) 169.15(7)/[170.73(7)] 
P(2)–Pt(1)–Cl(2) 88.94(2) 87.17(3) 86.70(10) 85.53(2) 88.55(7)/[90.04(7)] 
Cl(1)–Pt(1)–Cl(2) 88.68(2) 88.79(4) 89.01(11) 90.43(2) 88.13(7)/[87.34(7)] 
P(1)–C(1)–N(1) 111.90(17) 112.5(2) 112.3(7) 112.20(14) 108.6(5)/[110.5(5)] 
P(2)–C(2)–N(1) 114.03(17) 112.6(2) 112.6(7) 109.27(15) 107.9(5)/[109.3(5)] 
C(1)–N(1)–C(2) 110.0(2) 112.5(3) 111.5(9) 111.19(18) 114.7(6)/[111.2(6)] 
a Values in square brackets are for the second molecule in the asymmetric unit. 
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The conformation of the Pt–P–C–N–C–P six-membered ring in each complex is best 
described as a boat. The dihedral angle measured between the C–N–C and N-arene 
least-squares planes varies between 55° (in 4.30) and 88° (in 4.35), the difference of ca. 
33° may tentatively be explained by the predisposition of the –OH group about the N-
arene group and subsequent hydrogen bonding requirements (Figure 4.20). Upon metal 
chelation a degree of freedom compared with the free ligands 4.21–4.23 has been 
removed, as the PCNCP fragment is locked in a specific conformation. 
 
 
 
Figure 4.20 Overlay view of 4.30, 4.32, 4.33, 4.35 and 4.36. Phenyl rings, hydrogen 
atoms except OH and solvent molecules have been omitted for clarity. 
 
4.2.2.3 Secondary Interactions in Compounds 4.30, 4.32, 4.33, 4.35 and 4.36 
 
Suitable crystals of compound 4.32 for X-ray analysis were obtained from a chloroform 
solution, including one solvent molecule per complex in the structure. The CHCl3 
molecule hydrogen bonds to the terminal chlorides of the complex molecule through a 
weak bifurcated (solvent)C–H···Cl(complex) interaction, [C···Cl 3.66 and 3.86 Å]. 
Interestingly, despite the –OH group being in an ortho position with respect to the N-
arene, the intramolecular hydrogen bond seen in 4.23 is prevented by formation of an 
O–H···Cl hydrogen bond interaction between alternating Pt(II) complex molecules 
forming chains (Figure 4.21). Selected hydrogen parameters for 4.32 are shown in Table 
4.6. 
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Figure 4.21 View of the chains of 4.32, propagating in the crystallographic a direction. 
Phenyl groups and hydrogen atoms not involved in hydrogen bonding have been 
omitted for clarity.  
 
Table 4.6 Selected hydrogen bonding parameters for 4.32. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···Cl(1H)i 3.144(2) 0.84 2.44 143 
O(1A)−H(1A)···Cl(2)i 3.360(2) 0.84 2.74 132 
Symmetry operation: ix+1/2, -y+1/2, z+1/2. 
 
Compound 4.30, in which the –OH group is meta to the N-arene backbone, crystallises 
from vapour diffusion of hexane into a DMSO/CHCl3 solution with the inclusion of a 
molecule of DMSO per complex, which was found to be disordered over two sets of 
positions (Figure 4.22). An intermolecular (hydroxyl)O–H···O(solvent) hydrogen 
bonding interaction with the DMSO molecule effectively precludes any further 
interactions with other Pt(II) molecules, hence, resulting in a zero-dimensional structure 
(Table 4.7). 
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Figure 4.22 View of the asymmetric unit of complex 4.30. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity. Minor solvent 
disorder component shown with open bonds. 
 
Table 4.7 Selected hydrogen bonding parameters for 4.30. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(2) 2.620(5) 0.84 1.79 171 
 
Compound 4.36 has been crystallised from the slow evaporation of a 
CH2Cl2/Et2O/hexane solution including two highly disordered molecules of Et2O per 
cell. Compound 4.36 was determined using synchrotron radiation on station 9.8 at the 
SRS, Daresbury Laboratory, due to the small crystal dimensions. PLATON SQUEEZE 
was used to determine that 42 electrons were present in the unit cell unaccounted for in 
the point atom model.103 This approximated well to two very highly disordered Et2O 
molecules per unit cell. The hydroxyl group in the meta position to the N-arene moiety 
was hydrogen bonded to the disordered Et2O molecules. Therefore, compound 4.36 
does not present strong hydrogen bonding. Only weak (aromatic)C−H···Cl [2.852 Å] 
and (aliphatic)C−H···Cl [2.70 Å and 2.79 Å] interactions have been observed. These 
interactions are holding the molecules together forming sheets which extend in the ab 
plane, allowing the positioning of the functionalised N-arene groups between layers 
(Figure 4.23). 
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Figure 4.23 View of the hydrogen bonding motifs in 4.36. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been omitted for clarity. The molecules 
in one of the layers are shown using open bonds to show the hydrogen bonding pattern 
with clarity. 
 
Crystallisation of 4.33 from a DMSO containing solution results in simple hydrogen 
bonded solvent-complex pairs with no further significant intermolecular interactions 
due to the same type of hydrogen bonding seen previously for 4.30 (Figure 4.24). 
Selected hydrogen bonding parameters for 4.33 are shown in Table 4.8. 
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Figure 4.24 View of the asymmetric unit of complex 4.33. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity. 
 
Compound 4.33 again illustrates how polar solvents such as DMSO can disrupt any 
hydrogen bonded supramolecular assemblies as seen above for compound 4.30. 
 
Table 4.8 Selected hydrogen bonding parameters for 4.33. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(2) 2.697(13) 0.84 1.87 169 
 
Compound 4.35 crystallises from the vapour diffusion of Et2O into a MeOH solution 
with the inclusion of a molecule of MeOH per two molecules of Pt(II) complex in the 
asymmetric unit. Careful inspection of the two unique molecules shows that they 
present different one-dimensional hydrogen bonding patterns (Figure 4.25). While a 
single (hydroxyl)O–H···Cl hydrogen bond between symmetry related Pt(2) complex 
molecules creates chains propagating in the a direction, the MeOH molecule bridges 
two Pt(1) complex molecules via two strong, crystallographically independent hydrogen 
bonds, one (hydroxyl)O–H···O(solvent) and one (solvent)O–H···Cl with the metal-
bound chloride (Table 4.9). This creates chains of alternating molecules of Pt(1) 
complex molecules and MeOH anti-parallel to those observed for Pt(2) molecules. Here 
the inclusion of MeOH facilitates the formation of a supramolecular array, rather than 
limiting the dimensionality as has been seen in the isomeric DMSO solvates 4.30 and 
4.33. 
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Figure 4.25 View of the two different hydrogen bonding motifs of 4.35. Phenyl groups 
and hydrogen atoms not involved in hydrogen bonding have been removed for clarity.  
 
Table 4.9 Selected hydrogen bonding parameters for 4.35. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(3A)i 2.624(10) 0.84 1.82 160 
O(2)−H(2)···Cl(4B)ii 3.198(6) 0.84 2.40 159 
O(3)−H(3)···Cl(2) 3.131(7) 0.84 2.43 141 
Symmetry operations: ix, y-1, z; iix, y+1, z.  
 
Therefore, the factors which dictate the solid state architectures for complexes 4.30, 
4.32, 4.33, 4.35 and 4.36 are: the configuration of the chelate ring, the N-arene group 
disposition about the C–N–C plane, the position of the OH/CH3 groups with respect to 
the N-arene and the solvent used in the crystallisation. 
 
4.2.2.4 Syntheses of Linear Au(I) Complexes 4.38-4.46 
 
Reaction of ligands 4.20–4.28 with AuCl(tht) in a 1:2 stoichiometry proceeds with 
displacement of tht to afford the gold(I) complexes Au2Cl2{P,P-
C6H4(OH)N(CH2PPh2)2} 4.38–4.40, Au2Cl2{P,P-C6H3(OH)(CH3)N(CH2PPh2)2} 4.41–
4.45 and Au2Cl2{P,P-C6H3(OH)(tBu)N(CH2PPh2)2} 4.46 as air stable white solids. 
Complexes 4.38–4.46 were obtained in 50-94% yields (Equation 4.13).
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A = OH, B,C,D = H   4.20
B = OH, A,C,D = H   4.21
C = OH, A,B,D = H   4.22
A = OH, D = CH3, B,C = H   4.23
A = CH3, C = OH, B,D = H   4.24
A = OH, C = CH3, B,D = H   4.25
B = OH, C = CH3, A,D = H   4.26
C = OH, B = CH3, A,D = H   4.27
A = OH, D = tBu, B,C = H    4.28
A
B
C
D
N PPh2
PPh2
CH2Cl2
A
B
C
D
N P
Ph2
PPh2
AuCl
AuCl
2 AuCl(tht)
A = OH, B,C,D = H   4.38
B = OH, A,C,D = H   4.39
C = OH, A,B,D = H   4.40
A = OH, D = CH3, B,C = H  4.41
A = CH3, C = OH, B,D = H  4.42
A = OH, C = CH3, B,D = H  4.43
B = OH, C = CH3, A,D = H  4.44
C = OH, B = CH3, A,D = H  4.45
A = OH, D = tBu, B,C = H   4.46  
 
Equation 4.13 
 
The complexes exhibited the expected spectroscopic and analytical properties. A single, 
sharp resonance, in their 31P{1H} NMR spectra [in (CD3)2SO] in the region of δ(P) 
17.6−24.7 ppm was observed (Table 4.10). From the IR spectra, the ν(AuCl) bands are 
observed in the range of 324-328 cm–1. 
 
Table 4.10 Selected 31P{1H} NMRa and IR datab for 4.38–4.46. 
 δ(P)/ppm ν(AuCl)/cm–1 
4.38 20.02 328 
4.39 24.14 326 
4.40 22.12 325 
4.41 22.18 324 
4.42 21.93 328 
4.43 22.91 325 
4.44 17.59 326 
4.45 19.44 328 
4.46 24.74 328 
 a Spectra measured in (CD3)2SO. b Recorded as KBr pellets. 
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Suitable crystals of 4.41 for X-ray analysis were obtained by slow evaporation of the 
filtrate (CH2Cl2/Et2O/hexane). The X-ray structure of 4.41 showed the geometry about 
each gold(I) metal centre to be essentially linear [Cl(1)−Au(1)−P(1) 175.22(5)º 
Cl(2)−Au(2)−P(2) 177.03(5)º] (Figure 4.26). The P–C–N–C–P backbone is sufficiently 
flexible to promote a strong intramolecular aurophilic Au···Au [3.147 Å] interaction 
between the two AuCl units.187 There is also an S(5) intramolecular O−H···N hydrogen 
bond (Table 4.11), as the hydroxyl group is in the ortho position with respect to the 
pyramidal N atom. The same motif was seen in the free ligand 4.41 [O−H···N 2.746(5) 
Å, 116º]. 
 
 
 
Figure 4.26 View of the asymmetric unit of compound 4.41. Phenyl groups and 
hydrogen atoms not involved in hydrogen bonding have been omitted for clarity. 
 
Compound 4.41 crystallises including one molecule of dichloromethane per metal 
complex, forming a (solvent)C–H···Cl(complex) hydrogen bond [C···Cl 3.675 Å, 108°]. 
No further hydrogen bonding is observed. Interestingly, the crystal structure of 4.41 
represents another contribution to the extremely rare examples reported of 
crystallographically characterised M–P–C–N–C–P–M metallocycles. The other two 
examples were reported independently by Johnson and Smith.187,241    
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Table 4.11 Selected hydrogen bonding parameters for 4.41. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···N(1) 2.773(6) 0.84 2.31 115.3 
 
4.2.2.5 Syntheses of Octahedral Mo(0) Complexes 4.48–4.57 
 
In order to investigate the coordination preferences of ligands 4.20–4.28 towards low-
valent metal centres, neutral octahedral Mo(0) carbonyl complexes were synthesised 
under N2 by ligand displacement of the labile η4-norbornadiene from [Mo(CO)4(nbd)] 
with one equivalent of 4.20–4.28 and C6H5N(CH2PPh2)2 4.47 [synthesised by our 
research group] to afford complexes Mo(CO)4{P,P-C6H4(OH)N(CH2PPh2)2} 4.48–4.50, 
Mo(CO)4{P,P-C6H3(OH)(CH3)N(CH2PPh2)2} 4.51–4.55, Mo(CO)4{P,P-
C6H3(OH)(tBu)N(CH2PPh2)2} 4.56 and Mo(CO)4{P,P-C6H5N(CH2PPh2)2} 4.57, in 26-
55% yields,  after stiring for 48 h at room temperature (Equation 4.14). 
 
A = OH, B,C,D = H   4.20
B = OH, A,C,D = H   4.21
C = OH, A,B,D = H   4.22
A = OH, D = CH3, B,C = H   4.23
A = CH3, C = OH, B,D = H   4.24
A = OH, C = CH3, B,D = H   4.25
B = OH, C = CH3, A,D = H   4.26
C = OH, B = CH3, A,D = H   4.27
A = OH, D = tBu, B,C = H    4.28
A,B,C,D = H                         4.47
N
A
B
C
D
PPh2
PPh2 N
A
PPh2
P
Ph2
Mo
B
C
D
Mo(CO)4(nbd)
CH2Cl2
A = OH, B,C,D = H   4.48
B = OH, A,C,D = H   4.49
C = OH, A,B,D = H   4.50
A = OH, D = CH3, B,C = H  4.51
A = CH3, C = OH, B,D = H  4.52
A = OH, C = CH3, B,D = H  4.53
B = OH, C = CH3, A,D = H  4.54
C = OH, B = CH3, A,D = H  4.55
A = OH, D = tBu, B,C = H   4.56
A,B,C,D = H                        4.57
N2
CO
CO
CO
CO
 
 
Equation 4.14 
 
The 31P{1H} NMR spectra show single, sharp resonances, in the region of δ(P) 
15.0−20.9 ppm, a downfield shift of approximately 40 ppm with respect to the free 
phosphine ligands 4.20–4.28, observed in the range of δ −27.6 to −25.3 ppm. From the 
IR spectra, while complexes 4.48, 4.51 and 4.53 display four strong carbonyl 
absorptions in the region 1878−2020 cm–1, 4.49–4.50, 4.52, 4.55–4.57 exhibit only three 
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absorptions (one of the carbonyl absorptions may be overlapping), consistent with a cis 
tetracarbonyl metal complex (Table 4.12). 
 
Table 4.12 Selected 31P{1H} NMRa and IR datab for 4.48–4.56.  
 δ(P)/ppm ν(CO)/cm–1 
4.48 15.13 2019; 1926; 1896; 1888 
4.49 18.21 2020; 1921; 1897 
4.50 18.39 2019; 1919; 1895 
4.51 20.85 2018; 1927; 1892; 1888 
4.52 18.55 2019; 1917; 1897 
4.53 20.11 2020; 1924; 1905; 1878 
4.54 n.r. n.r. 
4.55 18.67 2019; 1921; 1898 
4.56 14.97 2018; 1921; 1897 
4.57 21.14 2020; 1926; 1894 
 a Spectra measured in CDCl3. b Recorded as KBr pellets. n.r. = not recorded. 
 
4.2.2.6 Crystal Structures of Compounds 4.50, 4.51, 4.53–4.55 and 4.57 
 
The six-membered chelate ring in compounds 4.50, 4.51, 4.53–4.55 and 4.57 adopts a 
chair conformation with the N atom, above the P2C2 plane, in a range of 0.762–0.736 Å 
and the Mo below the plane in the range 1.251–0.764 Å. The Mo–P–C–N–C–P 
metallacyclic ring conformation is similar to those M–P–C–N–C–P reported in the 
literature.233 The N-arene is twisted about the plane C(1)–N–C(2) in the range of 36–83° 
for hydrogen bonding requirements as seen previously (Figure 4.27). 
 
Structural analysis of complexes 4.50, 4.51, 4.53–4.55 and 4.57 shows that the Mo–P 
and Mo–C distances are consistent with the values reported for related compounds such 
as the Mo(0) complex Mo(CO)4{P,P-Ph2P(CH2)3PPh2} 4.58 structurally reported 
recently by our research group.242-244 The Mo–C–O bond angles are all close to linear 
(Table 4.13). The P–Mo–P bite angles for all the isomers are also similar to 4.58. As 
anticipated, this bite angle is enlarged with respect to those found in complexes of the 
type Mo(CO)4{P,P-Ph2PN(R)PPh2} [R = H, P–Mo–P 65.29(6)°; R = 2-MeOC6H4, P–
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Mo–P 65.78(2)°] in which the chelating Ph2PN(R)PPh2 ligands adopt near planar four-
membered ring conformations.245,246 
 
 
 
Figure 4.27 Overlay view of 4.50, 4.51, 4.53–4.55 and 4.57, solvent molecule for 
compound 4.54 has been omitted for clarity. Phenyl rings and hydrogen atoms except 
OH have been omitted for clarity. 
 
Table 4.13 Selected geometric parameters (Å, °) for compounds 4.50, 4.51, 4.53–4.55 
and 4.57, 4.58. 
 4.50 4.51 4.53 4.54 
Mo–C 
(trans to C) 
1.9918(5)/2.0283(5) 2.012(8)/2.024(8) 2.0002(16)/1.9867(16) 2.031(4)/2.041(4) 
Mo–C 
(trans to P) 
2.0279(5)/2.0010(5) 2.025(8)/2.033(5) 2.0290(15)/2.0500(15) 
 
1.990(3)/1.995(4) 
 
Mo–P 2.4989(11)/2.5096(11) 2.5134(18)/2.5153(19) 2.5155(4)/2.4985(4) 2.4866(9)/2.5090(8) 
C–Mo–C 
(trans to C) 
176.47(18)/173.77(17) 173.0(3)/173.7(3) 173.46(6) 
 
175.86(14) 
C–Mo–C 
(cis, av.) 
89.35(17)/88.77(17) 88.2(3)/88.9(3) 88.97(6) 90.12(15) 
P–Mo–P 85.32(4)/84.06(4) 84.24(6)/84.72(6) 86.265(11) 87.53(3) 
Mo–C–O 
(av.) 
177.2(4)/176.6(4) 177.8(7)/176.5(7) 177.22(15) 176.6(3) 
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Cont. Table 4.13 Selected geometric parameters (Å, °) for compounds 4.50, 4.51, 4.53–
4.55 and 4.57, 4.58. 
 4.55 4.57 4.58 
Mo–C 
(trans to C) 
2.019(2)/2.046(2) 
 
2.016(3)/2.043(3) 2.035(4)/2.052(5) 
Mo–C 
(trans to P) 
1.993(2)/2.004(2) 2.007(3)/1.994(3) 1.995(4)/1.985(5) 
Mo–P 2.5227(5)/2.5177(4) 2.5005(8)/2.4986(8) 2.5239(11)/2.5185(11) 
C–Mo–C 
(trans to C) 
174.40(7) 
 
178.21(12) 177.12(17) 
C–Mo–C 
(cis, av.) 
88.85(8) 89.72(13) 89.34(18) 
P–Mo–P 84.720(14) 86.75(2) 89.30(4) 
Mo–C–O 
(av.) 
177.5(2) 178.2(3) 177.4(4) 
 
4.2.2.7 Secondary Interactions in Compounds 4.50, 4.51, 4.53–4.55, 4.57 and 4.58 
 
Compound Mo(CO)4{P,P-Ph2P(CH2)3PPh2} 4.58 was obtained as a new polymorphic 
form differing from the previously reported orthorhombic form 4.58a described by 
Ueng and Hwang.242 Compound 4.58 was obtained by slow evaporation of a 
concentrated solution of 4.58 in CH2Cl2/Et2O/light petroleum ether and crystallises in 
the monoclinic space group P21/c, with one molecule in the asymmetric unit (Figure 
4.28).244 The orthorhombic form crystallises with one half-molecule in the asymmetric 
unit lying on a mirror plane.
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Figure 4.28 View of the asymmetric unit of compound 4.58. Phenyl groups and 
hydrogen atoms have been omitted for clarity. 
 
The packing plots of compounds 4.58 and 4.58a show substantial differences; in 4.58 
adjacent molecules are off-set and canted 26° with respect to the ab plane. In 4.58a, 
molecules lie directly stacked in parallel columns with individual molecules lying on 
mirror planes (Figure 4.29). 
 
 
 
Figure 4.29 Packing plot of 4.58 viewed parallel to the b crystallographic axis. 
Hydrogen atoms have been removed for clarity. Packing plot of 4.58a viewed parallel to 
the c crystallographic axis. Hydrogen atoms have been omitted for clarity. 
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 X-ray quality crystals of compound 4.57 were obtained as for 4.58 by slow evaporation 
of a concentrated solution of 4.57 in CH2Cl2/Et2O/light petroleum ether. Compound 
4.57 crystallises with one molecule in the asymmetric unit as a zero-dimensional 
structure due to the lack of potential hydrogen bonding donors (Figure 4.30).247    
 
 
 
Figure 4.30 View of the asymmetric unit of compound 4.57. Phenyl groups on 
phosphorus and hydrogen atoms have been omitted for clarity. 
 
The description of the different structural motifs in four isomeric Mo(0) complexes, 
obtained by regioselective incorporation of –OH and –CH3 functional groups around the 
central arene core is described. 
 
Compound 4.53 crystallises with the formation of the same type of S(5) intramolecular 
O–H···N hydrogen bond observed in 4.41 (Table 4.14). Although 4.41 crystallises as a 
zero-dimensional structure, the carbonyl groups in 4.53 provide additional hydrogen 
bond acceptors, allowing the formation of weak (aromatic)C–H···O interactions, C···O = 
3.527 Å,10 forming one-dimensional zigzag chains (Figure 4.31).  
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Figure 4.31 View of the hydrogen bonded chains in 4.53. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been omitted for clarity. 
 
Table 4.14 Selected hydrogen bonding parameters for 4.53. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···N(1) 2.7661(16) 0.84 2.29 115.9 
   
Compound 4.51 crystallises with two formula units in the asymmetric unit. Although 
they present similar structural parameters, they differ in their geometrical disposition 
(Figure 4.32). Both molecules present the same S(5) O–H···N intramolecular hydrogen 
bond as could be predicted from the isomeric structure 4.53 (Figure 4.32, Table 4.15). 
However a different hydrogen bonding pattern was observed: a combination of weak 
(aromatic)C–H···O(carbonyl) [C···O 3.44 Å and 3.48 Å] and (aromatic)C–
H···O(hydroxyl) [C···O 3.40 Å and 3.39 Å] interactions forming R22(8) ring motifs leads 
to hydrogen bonding ladders with 4.51 molecules residing in the cavities of the ladder.10 
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Figure 4.32 View of the hydrogen bonding pattern in 4.51. Some phenyl groups, 
carbonyl, methyl groups and hydrogen atoms not involved in hydrogen bonding have 
been removed for clarity.  
 
Table 4.15 Selected hydrogen bonding parameters for 4.51. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1A)−H(1A)···N(1A) 2.780(7) 0.84 2.34 113.4 
O(6)−H(6A)···N(2) 2.744(7) 0.84 2.29 114.1 
 
Unfortunately, compound 4.54 was obtained in very low yield (< 5%) and only the 
crystals obtained by slow evaporation of the methanolic/Et2O filtrate were analysed by 
single X-ray diffraction. The low yield did not allow additional analysis by IR, NMR, 
mass spectrometry and microanalysis methods. Compound 4.54 crystallises as a solvate 
structure including a half-molecule of Et2O per Mo(0) complex in the asymmetric unit. 
The Et2O molecule lies on a mirror plane and hydrogen bonds to two symmetry related 
metal complexes through O–H···O hydrogen bonds (Figure 4.33). The included Et2O 
molecules in 4.54 prevents any further hydrogen bonding interactions, therefore 4.54 is 
essentially a zero-dimensional structure. Selected hydrogen bonding parameters for 4.54 
are shown in Table 4.16.    
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Figure 4.33 Hydrogen bonding pattern in 4.54. Phenyl groups and hydrogen atoms not 
involved in hydrogen bonding have been omitted for clarity. 
 
Table 4.16 Selected hydrogen bonding parameters for 4.54. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(6) 2.945(3) 0.84 2.13 165 
 
In the X-ray structure of 4.55 (Figure 4.34), in which the –OH group is in an ortho 
position, molecules are arranged in a one-dimensional polymeric chain through 
(hydroxyl)O–H···O(carbonyl) intermolecular hydrogen bonding showing similarities 
with those observed for the Pt(2) complex molecules in compound 4.35.10 Molecules 
including Pt(1) also present a one-dimensional pattern due to the inclusion of MeOH 
molecules in the structure. Selected hydrogen bonding parameters for 4.55 are shown in 
Table 4.17.   
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Figure 4.34 View of the hydrogen bonded chains of 4.55. Phenyl rings and hydrogen 
atoms except OH have been removed for clarity. 
 
Table 4.17 Selected hydrogen bonding parameters for 4.55. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(4A)i 3.079(2) 0.89(3) 2.26(3) 151(2) 
Symmetry operation: ix+1, -y+3/2, z+1/2.    
 
Interestingly, compound 4.50 which differs from 4.55 by the absence of the methyl 
group on the functionalised N-phenyl ring, crystallises with two molecules of 4.50 
complex in the asymmetric unit producing a completely different hydrogen bonding 
motif than the one previously observed (Figure 4.35).  
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Figure 4.35 View of the hydrogen bonding motifs of 4.50. Phenyl groups and hydrogen 
atoms except OH and some carbonyl groups have been omitted for clarity. 
 
The two unique 4.50 molecules hydrogen bond together to form a network of cavities 
which interpenetrate through two (hydroxyl)O–H···O(carbonyl) interactions between 
symmetry related molecules forming an R42(12) star-shape motif (Table 4.18).  
 
Table 4.18 Selected hydrogen bonding parameters for 4.50. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(6)−H(6)···O(2) 2.789(4) 0.84 2.13 136 
O(1B)−H(1B)···O(10)i 3.033(5) 0.84 2.49 123 
O(1)−H(1)···O(7A)ii 3.283(5) 0.84 2.51 153 
Symmetry operations: ix-1, y, z; ii-x-1, -y+1, -z+1.    
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4.2.3 Syntheses of C6H5NHCOCH2NHCOOCH2C6H4(OH) 4.59–4.61, 
C6H5NHCOCH2NHCOOCH2C6H3(CH3)(OH) 4.62–4.66 and  
C6H5NHCOCH2NHCOOCH2C6H3(tBu)(OH) 4.67   
 
The range of ligands and complexes discussed previously in this chapter is somewhat 
limited in its hydrogen bonding potential due to the commercial availability of the 
primary amines bearing a hydroxyl group. The synthesis of ditertiary phosphines 
containing a flexible backbone, which presents extra potential donor and acceptor atoms 
with hydrogen bonding capability, in order to facilitate the formation of supramolecular 
arrays with greater complexity is described above.  
 
The precursors for the synthesis of the desired extended ditertiary phosphines were 
prepared using one equivalent of the corresponding primary amine I–IX with one 
equivalent of N-carbobenzyloxyglycine and one equivalent of dicyclohexylcarbodiimide 
in tetrahydrofuran yielding the desired products C6H5NHCOCH2NHCOOCH2C6H4(OH) 
4.59–4.61, C6H5NHCOCH2NHCOOCH2C6H3(CH3)(OH) 4.62–4.66 and  
C6H5NHCOCH2NHCOOCH2C6H3(tBu)(OH) 4.67 in 53-91% yields (Equation 4.15).     
 
O N COOH
O
H
Cy N C N Cy
NH2
N
H
H
N O
O
OA
B
C
D
A = OH, B,C,D = H   I
B = OH, A,C,D = H   II 
C = OH, A,B,D = H   III
A = OH, D = CH3, B,C = H   IV
A = CH3, C = OH, B,D = H   V
A = OH, C = CH3, B,D = H   VI
B = OH, C = CH3, A,D = H   VII
C = OH, B = CH3, A,D = H   VIII
A = OH, D = tBu, B,C = H    IX
THF
A
B
C
D
A = OH, B,C,D = H   4.59
B = OH, A,C,D = H   4.60
C = OH, A,B,D = H   4.61
A = OH, D = CH3, B,C = H  4.62
A = CH3, C = OH, B,D = H  4.63
A = OH, C = CH3, B,D = H  4.64
B = OH, C = CH3, A,D = H  4.65
C = OH, B = CH3, A,D = H  4.66
A = OH, D = tBu, B,C = H   4.67  
 
Equation 4.15 
 
All of the compounds 4.59–4.67 exhibit the expected spectroscopic and analytical 
properties. The 1H NMR spectra [in (CD3)2SO] displayed the anticipated resonances for 
the aromatic, hydroxy- and amide groups (See Experimental Section) indicating the 
formation of the desired precursors. The infrared spectra also showed the characteristic 
absorbing ν(NH) and ν(OH) bands in the range 3200-3400 cm–1 and bands in the range 
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1639-1692 cm–1 and 1310-1385 cm–1 indicative of ν(C=O amide) and ν(C−O), 
respectively. Microanalytical data were satisfactory for the new compounds. 
 
4.2.3.1 X-ray Crystal Structures of Compounds 4.59, 4.60, 4.64, 4.65 and 4.67 
 
Compounds 4.59 and 4.64 crystallise presenting the same hydrogen bonding motifs 
(Figure 4.36). Both present an intramolecular N−H···O hydrogen bond forming a S(5) 
graph set motif. Molecules of 4.59 and 4.64 pack through O–H···O and N–H···O in anti-
parallel one-dimensional ladders forming R44(18) and R22(10) alternating hydrogen 
bond motifs, (Figure 4.36). The presence of an extra –CH3 group did not change the 
packing of 4.64. Selected hydrogen bonding parameters for 4.59 and 4.64 are shown in 
Tables 4.19 and 4.20 respectively.  
 
 
 
 
 
 
 
 
 
                                      4.59              4.64 
 
Figure 4.36 Anti-parallel one-dimensional chains of compounds 4.59 and 4.64. 
Hydrogen atoms not involved in hydrogen bonding have been omitted for clarity. 
 
An expansion in the structure due to the incorporation of an extra –CH3 group is not 
observed when considering the unit cell dimensions of 4.59 and 4.64. 
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Table 4.19 Selected hydrogen bonding parameters for 4.59. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(1)−H(1A)···O(1) 2.6151(17) 0.85(2) 2.189(18) 111.0(15) 
O(1)−H(1)···O(3A)i 2.6995(16) 0.89(2) 1.82(2) 173(2) 
N(2)−H(2)···O(2B)ii 2.8323(17) 0.86(2) 1.99(2) 164.9(17) 
Symmetry operations: ix+1/2, -y-1/2, -z; iix+1/2, -y+1/2, -z.  
 
 Table 4.20 Selected hydrogen bonding parameters for 4.64. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(1)−H(1A)···O(1) 2.625(2) 0.89(2) 2.13(2) 114.0(18) 
O(1)−H(1)···O(3A)i 2.7230(19) 0.84 1.90 168 
N(2)−H(2)···O(2B)ii 2.826(2) 0.91(2) 1.93(2) 168(2) 
Symmetry operations: i-x-1/2, y+1/2, -z+1/2; ii-x+1/2, y+1/2, -z+1/2.    
  
Crystals of 4.67 suitable for X-ray crystallography were obtained by slow vapour 
diffusion of diethyl ether into a solution of 4.67 in THF (Figure 4.37). Compound 4.67 
crystallises as a solvent free structure, with the expected intramolecular N−H···O S(5) 
graph set hydrogen bond motif seen previously for compounds 4.59 and 4.64.19,20 In 
contrast with the extended conformation observed in compounds 4.59 and 4.64, the 
presence of a bulkier tBu group forces the 4.67 molecules to adopt a twisted 
conformation folding about carbon atoms C(11) and C(12).  
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Figure 4.37 View of the asymmetric unit of 4.67. Hydrogen atoms except NH and OH 
have been omitted for clarity. 
 
In order to accommodate the additional steric requirements of the bulky tBu functional 
group, compound 4.67 packs as spirals which propagate in the a direction. Strong 
(amide)N–H···O(amide) and (hydroxyl)O–H···O(amide) interactions between four 
symmetry related molecules of 4.67 form an R44(32) graph set motif (Figure 4.38). 
Selected hydrogen bonding parameters for 4.67 are shown in Table 4.21. 
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Figure 4.38 View of the hydrogen bonding motifs in 4.67. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been removed for clarity.  
  
Table 4.21 Selected hydrogen bonding parameters for 4.67. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(2B)i 2.6524(15) 0.86(2) 1.80(2) 177(2) 
N(2)−H(2)···O(3A)ii 2.8744(18) 0.884(18) 2.025(19) 160.8(16) 
N(1)−H(1ª)···O(1) 2.5967(18) 0.866(18) 2.156(17) 111.1(14) 
Symmetry operations: ix+1/2, y, -z+1/2; ii -x+1/2, y-1/2, z.    
 
Compound 4.65 has three potential acceptor and donor groups to be involved in 
hydrogen bonding interactions with symmetry related molecules. Therefore, a 
combination of strong hydrogen bonding between (amino)N−H···O(amide), 
(hydroxyl)O−H···O(amide) and weak (amide)N−H···O(hydroxyl) interactions, [3.77 Å], 
affords a thick, stepped sheet, two-dimensional structure (Figure 4.39). Selected 
hydrogen bonding parameters for 4.65 are shown in Table 4.22. 
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Figure 4.39 View of the hydrogen bonding motifs of 4.65. Phenyl groups and hydrogen 
atoms except NH and OH have been removed for clarity.  
 
Table 4.22 Selected hydrogen bonding parameters for 4.65. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(2A)i 2.6887(11) 0.869(17) 1.827(17) 170.7(16) 
N(1)−H(1A)···O(3B)ii 2.9358(12) 0.862(15) 2.080(15) 172.4(13) 
Symmetry operations: i-x+1, -y, -z; ii -x+1, y+1/2, -z+1/2.    
 
Interestingly, in contrast with that observed for compounds 4.59 and 4.64, where the 
presence or absence of the methyl group on the functionalised N-phenyl group does not 
affect the supramolecular arrangement obtained, in compounds 4.60 and 4.65 where the 
–OH functional group is in the meta position, the packing obtained is different. While 
the presence of –CH3 group yields a stepped sheet structure in 4.65; in the absence of 
the methyl group, a two-dimensional structure propagating along the ac plane was 
obtained through a combination of strong (amino)N−H···O(amide), 
(hydroxyl)O−H···O(amide) hydrogen bonding interactions (Figure 4.40). Selected 
hydrogen bonding parameters for 4.60 are shown in Table 4.23. 
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Figure 4.40 View of the hydrogen bonding motifs of 4.60 along the b axis. Phenyl 
groups and hydrogen atoms not involved in hydrogen bonding have been omitted for 
clarity.  
 
Table 4.23 Selected hydrogen bonding parameters for 4.60. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(3)i 2.870(5) 0.83(2) 2.07(3) 162(7) 
N(1)−H(1A)···O(2)ii 2.777(5) 0.83(2) 2.00(3) 156(5) 
N(2)−H(2)···O(3)iii 2.901(5) 0.83(2) 2.16(3) 149(5) 
Symmetry operations: ix+1/4, -y+1/4, z+1/4; iix-1/4, -y+1/4, z-1/4; iiix, y, z+1.        
 
4.2.4 Syntheses of C6H4(OH)NHCOCH2NH2 4.68–4.70, 
C6H3(CH3)(OH)NHCOCH2NH2 4.71–4.75 and C6H3(tBu)(OH)NHCOCH2NH2 4.76   
 
The functionalised extended primary amines C6H4(OH)NHCOCH2NH2 4.68–4.70, 
C6H3(CH3)(OH)NHCOCH2NH2 4.71–4.75 and C6H3(tBu)(OH)NHCOCH2NH2 4.76  
were obtained after cleavage of the carbamate group in precursors 4.59–4.67 using Pd/C 
and cyclohexane in ethanol (Equation 4.16). The mixture was heated under reflux for 
15-20 min at 110-120 ºC giving 4.68–4.76 in moderate to good yields, 32-99%. 
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N N O
O
OH
H
A
B
C
D
EtOH
Pd/C N NH2
O
HA
B
C
D
A = OH, B,C,D = H   4.68
B = OH, A,C,D = H   4.69
C = OH, A,B,D = H   4.70
A = OH, D = CH3, B,C = H  4.71
A = CH3, C = OH, B,D = H  4.72
A = OH, C = CH3, B,D = H  4.73
B = OH, C = CH3, A,D = H  4.74
C = OH, B = CH3, A,D = H  4.75
A = OH, D = tBu, B,C = H   4.76
A = OH, B,C,D = H   4.59
B = OH, A,C,D = H   4.60
C = OH, A,B,D = H   4.61
A = OH, D = CH3, B,C = H  4.62
A = CH3, C = OH, B,D = H  4.63
A = OH, C = CH3, B,D = H  4.64
B = OH, C = CH3, A,D = H  4.65
C = OH, B = CH3, A,D = H  4.66
A = OH, D = tBu, B,C = H   4.67  
 
Equation 4.16 
 
The new functionalised primary amines were isolated as white or yellow solids, soluble 
in a range of common organic solvents (e.g. MeOH, EtOH, DMSO). The 1H NMR 
spectra of 4.68–4.76 display a broad singlet around δ(H) 8.01–9.67 ppm assigned to the 
amide proton. The IR spectra of these compounds show absorptions in the 3300-3400 
cm–1 region, characteristic of ν(NH) and strong ν(C=O amide) vibration in the range 
1642-1675 cm–1 (Table 4.24). 
 
Table 4.24 Selected 31P{1H} NMRa and IR datab for 4.68–4.76.  
 δ(H) (NH)/ppm 
ν(C=O 
amide)/cm–1 
ν(NH)/cm–1 
4.68 8.18 1648 3420 
4.69 9.67 1674 3359 
4.70 9.63 1657 3455 
4.71 8.01 1648 3421 
4.72 9.04 1662 3371 
4.73 9.61 1653 3355 
4.74 9.57 1655 3375 
4.75 9.66 1675 3359 
4.76 9.48 1642 3420 
a Spectra measured in (CD3)2SO. b Recorded as KBr pellets. 
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4.2.5 Syntheses of C6H4(OH)NHCOCH2N(CH2PPh2)2 4.77–4.79, 
C6H3(OH)(CH3)NHCOCH2N(CH2PPh2)2 4.80–4.84 and 
C6H3(OH)(tBu)NHCOCH2N(CH2PPh2)2 4.85 
 
The functionalised extended ditertiary phosphines C6H4(OH)NHCOCH2N(CH2PPh2)2 
4.77–4.79, C6H3(OH)(CH3)NHCOCH2N(CH2PPh2)2 4.80–4.84 and 
C6H3(OH)(tBu)NHCOCH2N(CH2PPh2)2 4.85 were prepared by a Mannich-based 
condensation reaction as described previously for ligands 4.20–4.28, using one 
equivalent of the primary amines 4.68–4.76 and two equivalents of 
diphenylphosphinomethanol (Equation 4.17). The mixture was stirred in methanol at 
room temperature under nitrogen for 24 h giving the desired ligands 4.77–4.85 in good 
yields, 70-91%. Concentration of the solution under reduced pressure was sufficient to 
aid precipitation of the ligands 4.78, 4.79, 4.83 and 4.84, which were filtered and dried 
in vacuo. Compounds 4.77, 4.80–4.82 and 4.85 required the solvent to be evaporated to 
dryness, and yellow oils were obtained. The phosphines obtained were sufficiently pure 
to be used directly in complexation studies with metal precursors. The products 
obtained by this procedure were found to be air stable in the solid state, but were found 
to oxidise in solution. 
 
N NH2
O
HA
B
C
D
Ph2P OH2
MeOH
N N
O
HA
B
C
D
PPh2
PPh2N2
A = OH, B,C,D = H   4.77
B = OH, A,C,D = H   4.78
C = OH, A,B,D = H   4.79
A = OH, D = CH3, B,C = H  4.80
A = CH3, C = OH, B,D = H  4.81
A = OH, C = CH3, B,D = H  4.82
B = OH, C = CH3, A,D = H  4.83
C = OH, B = CH3, A,D = H  4.84
A = OH, D = tBu, B,C = H   4.85
A = OH, B,C,D = H   4.68
B = OH, A,C,D = H   4.69
C = OH, A,B,D = H   4.70
A = OH, D = CH3, B,C = H  4.71
A = CH3, C = OH, B,D = H  4.72
A = OH, C = CH3, B,D = H  4.73
B = OH, C = CH3, A,D = H  4.74
C = OH, B = CH3, A,D = H  4.75
A = OH, D = tBu, B,C = H   4.76  
 
Equation 4.17 
 
The infrared spectra for ligands 4.78, 4.79, 4.83 and 4.84 showed the characteristic 
ν(NH) and ν(OH) absorptions in the range 3200-3400 cm–1 and also a strong band in the 
range 1653-1659 cm–1 indicative of ν(C=O amide). All compounds exhibited a single 
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resonance in their 31P{1H} NMR spectra [(CD3)2SO] in the region of δ(P) −27.76 to 
−25.49 ppm, indicating the presence of only one phophorus(III) environment and 
similar to that previously observed for ligands 4.20–4.28. Evidently, the inclusion of an 
amide spacer has negligible effect on δ(P). In the case of 4.78, 4.79, 4.83 and 4.84, 
infrared spectra and microanalysis were also recorded. The microanalytical data are in 
good agreement with calculated values. 
 
4.2.5.1 Crystal Structures of Compounds 4.78 and 4.79 
 
X-ray quality crystals of compounds 4.78 and 4.79 were obtained by slow evaporation 
of the methanol filtrate. Structure analysis clearly shows approximate pyramidal 
geometries about both phosphorus centres (Table 4.25). As seen previously for ligands 
4.21-4.23, there is little spread in the P−C and C−N bond lengths in compounds 4.78 
and 4.79 and they are consistent with the values reported for other ditertiary phosphine 
ligands.197 The backbone spacer does not influence the geometric parameters around the 
pyramidal N atom. The P atoms are in an anti conformation as seen previously for 4.21-
4.23 in order to presumably reduce the steric repulsions between the bulky phenyl 
groups. 
 
Table 4.25 Selected geometric parameters (Å, °) for compounds 4.78 and 4.79. 
 4.78i 4.79 
P(1)–C(1) 1.862(3)/[1.867(3)] 1.855(2) 
P(2)–C(2) 1.860(3)/[1.856(3)] 1.858(2) 
C(1)–N(1)/N(2) 1.467(3)/[1.478(3)] 1.476(3) 
C(2)–N(1)/N(2) 1.476(3)/[1.483(4)] 1.466(3) 
P(1)–C(1)–N(1)/N(2) 111.36(17)/[108.66(18)] 113.10(14) 
P(1)–C(2)–N(1)/N(2) 109.61(18)/[109.77(18)] 113.80(15) 
C(1)–N(1)/N(2)–C(2) 110.4(2)/[111.7(2)] 111.19(17) 
 i Values in brackets are for the second molecule in the asymmetric unit for 4.78. 
  
The presence of the backbone in 4.78 and 4.79 compared with the ligands 4.21-4.23 is 
expected to increase flexibility and the presence of more potential donor and acceptor 
atoms with hydrogen bonding capability should facilitate the formation of 
 182
supramolecular arrays with increased complexity. Interestingly, even the two molecules 
of 4.78 in the asymmetric unit differ in the disposition of the PCNCP fragment with 
respect to the functionalised spacer indicating the degree of flexibility within the 
backbone (Figure 4.41).   
  
 
 
Figure 4.41 Overlay view of 4.78 and 479. Phenyl rings and hydrogen atoms except 
OH and NH have been omitted for clarity. 
 
4.2.5.2 Secondary Interactions in Compounds 4.78 and 4.79 
 
Compound 4.78 crystallises with two molecules in the asymmetric unit which form 
dimers using (hydroxyl)O–H···O(amide) hydrogen bonds, creating R22(16) ring motifs 
(Figure 4.42). The distance between symmetry related nitrogen atoms are 6.834 Å and 
6.925 Å for N(1) and N(3) respectively, shorter distances than observed in 4.21 which 
also possesses the –OH functional group in a meta position. The NH group from the 
amide functional group is involved in a S(5) N–H···N intramolecular hydrogen bond 
with the pyramidal N atom (Table 4.26). 
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Figure 4.42 Dimers of 4.78 forming R22(16) graph set motifs. Phenyl groups and 
hydrogen atoms not involved in hydrogen bonding have been omitted for clarity.  
 
Table 4.26 Selected hydrogen bonding parameters for 4.78. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(1)−H(1)···O(2A)i 2.670(3) 0.84 1.83 174 
N(1)−H(1A)···N(2) 2.694(3) 0.83(3) 2.24(3) 115(3) 
O(3)−H(3)···O(4B)ii 2.658(3) 0.84 1.83 167 
N(3)−H(3A)···N(4) 2.714(3) 0.73(3) 2.30(3) 117(3) 
Symmetry operations: i-x, -y+1, -z+1; ii-x+1, -y+1, -z.    
 
In preliminary work carried out within the research group, X-ray quality crystals of 
compound 4.79 were obtained directly from slow evaporation of a methanol filtrate. 
Compound 4.79 crystallises with one molecule in the asymmetric unit and presents the 
N–H···N intramolecular S(5) graph set hydrogen bond seen above in 4.78. In this case, 
the –OH functional group is in the ortho position with respect to the N-arene moiety, 
interacting with the carbonyl(amide) group through (hydroxyl)O–H···O(amide) 
hydrogen bonds forming one-dimensional chains propagating in the c direction (Figure 
4.43). Selected hydrogen bonding parameters for 4.79 are shown in Table 4.27.   
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Figure 4.43 Chains of 4.79. Phenyl groups and hydrogen atoms except OH and NH 
have been omitted for clarity. 
 
Table 4.27 Selected hydrogen bonding parameters for 4.79. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···N(1) 2.748(3) 0.85(2) 2.29(2) 114(2) 
O(2)−H(2A)···O(1B)i 2.706(3) 0.89(3) 1.83(3) 169(3) 
Symmetry operation: ix, -y+1/2, z-1/2. 
 
 
 
 
 
 
 
 
 
0
c
b
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4.2.6 Coordination Chemistry of C6H4(OH)NHCOCH2N(CH2PPh2)2 4.86–4.88, 
C6H3(OH)(CH3)NHCOCH2N(CH2PPh2)2 4.89–4.93 and 
C6H3(OH)(tBu)NHCOCH2N(CH2PPh2)2 4.94 
 
4.2.6.1 Syntheses of Square Planar Pt(II) Complexes 4.86–4.94 
 
The complexes PtCl2{P,P-C6H4(OH)NHCOCH2N(CH2PPh2)2} 4.86–4.88, PtCl2{P,P-
C6H3(OH)(CH3)NHCOCH2N(CH2PPh2)2} 4.89–4.93 and PtCl2{P,P-
C6H3(OH)(tBu)NHCOCH2N(CH2PPh2)2} 4.94 were prepared following the procedure 
used for related Pt(II) complexes 4.29–4.37. Hence addition of the appropriate ligand 
4.77–4.85 to a solution containing one equivalent of PtCl2(cod) in CH2Cl2 (Equation 
4.18) gave 4.86–4.94. After stirring for 30 min, the solution was concentrated to 
approximately 5 ml under reduced pressure and the required products precipitated by 
addition of Et2O. Yields for these complexes were in the range 57-99%. 
 
A = OH, B,C,D = H   4.77
B = OH, A,C,D = H   4.78
C = OH, A,B,D = H   4.79
A = OH, D = CH3, B,C = H   4.80
A = CH3, C = OH, B,D = H   4.81
A = OH, C = CH3, B,D = H   4.82
B = OH, C = CH3, A,D = H   4.83
C = OH, B = CH3, A,D = H   4.84
A = OH, D = tBu, B,C = H    4.85
N N
O
HA
B
C
D
PPh2
PPh2 PtCl2(cod)
CH2Cl2
N
N
A
O
H
P
P
Ph2
B
C
D
A = OH, B,C,D = H   4.86
B = OH, A,C,D = H   4.87
C = OH, A,B,D = H   4.88
A = OH, D = CH3, B,C = H  4.89
A = CH3, C = OH, B,D = H  4.90
A = OH, C = CH3, B,D = H  4.91
B = OH, C = CH3, A,D = H  4.92
C = OH, B = CH3, A,D = H  4.93
A = OH, D = tBu, B,C = H   4.94
Pt
Ph2
Cl
Cl
 
 
Equation 4.18 
 
All of the platinum(II) complexes 4.86–4.94 gave one phosphorus resonance around 
δ(P) -10 ppm, a downfield shift of approximately 20 ppm with respect to the free 
ligands and furthermore indicates both the phophorus(III) centres are equivalent. The 
coupling constants, 1J(PtP), for 4.86–4.94 are approximately 3400 Hz, which indicates 
that these complexes are in a cis conformation, as expected for this type of 
bis(phosphino)amino ligands. In their infrared spectra, there are two vibrations in the 
range 290-325 cm–1, indicative of ν(PtCl) (Table 4.28). The presence of these two 
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vibrations provides confirmation for the cis isomers. Compounds 4.86–4.94 present the 
characteristic ν(NH) and ν(OH) absorptions in the range 3200-3400 cm–1 and also a 
strong band in the range 1653-1675 cm–1 indicative of ν(C=O amide). 
 
     Table 4.28 Selected 31P{1H} NMRa and IRb data for 4.86–4.94. 
 δ(P)/ppm 1J(PtP)/Hz υ(PtCl)/cm–1 
4.86 -6.89 3422 308; 286 
4.87 -9.45 3425 304; 279 
4.88 -9.54 3405 311; 287 
4.89 -9.83 3398 305; 283 
4.90 -11.02 3397 316; 283 
4.91 -9.86 3405 315; 290 
4.92 -9.79 3398 309; 283 
4.93 -9.70 3406 312; 286 
4.94 -9.66 3418 309; 283 
      a Spectra measured in (CD3)2SO. b Recorded as KBr pellets. 
 
The solubility of complexes 4.86–4.94 was generally poor in common solvents such as 
diethyl ether, dichloromethane or chloroform but they are highly soluble in DMSO. 
Four of the complexes, 4.89–4.92, afforded crystals from solutions of 
DMSO/CHCl3/MeOH/diethyl ether and DMSO/CHCl3/MeOH/hexane. Unfortunately 
the other complexes 4.86–4.88, 4.93 and 4.94 formed powders under similar 
experimental conditions.  
 
4.2.6.2 Crystal Structures of Compounds 4.89–4.92 
   
Selected bond distances and angles for 4.89–4.92 are given in Table 4.29. The geometry 
about each platinum(II) centre is approximately square-planar P−Pt−P [range 91.3-96.5 
º], in order to fulfil the constraints imposed by ligand, with Pt−Cl [range 2.343–2.383 
Å] and Pt−P [range 2.217–2.233 Å] bond lengths.248-250 The conformation of the 
Pt−P−C−N−C−P six-membered ring in each complex is best described as a twisted-
chair.  
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There are close similarities between the solid state structures of 4.89–4.92 with all the 
compounds having the same overall features, a chelating P−C–N–C−P ligand and two 
chloride ligands forming a square planar geometry. 
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Table 4.29 Selected geometric parameters (Å, °) for compounds 4.89–4.92. 
 4.89i 4.90 4.91 4.92
Pt(1)−P(1) 2.2335(19)/[2.2172(9)] 
2.234(2) 
 
2.2263(15) 2.220(3) 
Pt(1)−P(2) 2.230(2)/[2.230(2)] 2.2249(9) 2.2200(14) 2.220(3) 
Pt(1)−Cl(1) 2.383(2)/[2.378(2)] 2.3685(9) 2.3447(17) 2.348(3) 
Pt(1)−Cl(2) 2.361(2)/[2.364(2)] 2.3426(9) 2.3643(15) 2.348(3) 
P(1)−Pt(1)−P(2) 95.72(8)/[95.79(8)] 96.52(3) 91.34(5) 92.63(17) 
Cl(1)−Pt(1)−Cl(2) 90.23(9)/[90.16(9)] 89.33(3) 88.65(6) 87.39(17) 
P(1)−Pt(1)−Cl(1) 86.31(7)/[86.49(7)] 85.73(3) 92.13(6) 89.97(12) 
P(2)−Pt(1)−Cl(1) 177.80(9)/[177.51(9)] 176.29(3) 178.73(6) 176.96(13) 
P(1)−Pt(1)−Cl(2) 175.76(9)/[175.64(8)] 174.72(3) 171.32(9) 176.96(13) 
P(2)−Pt(1)−Cl(2) 87.70(10)/[87.51(10)] 88.31(3) 87.75(5) 89.97(12) 
P(1)−C(1)−N(1) 111.5(5)/[112.0(5)] 108.7(2) 105.7(4) 109.1(10) 
P(2)−C(2)−N(1) 110.9(5)/[110.8(5)] 113.1(3) 114.9(4) 109.1(10) 
C(1)−N(1)−C(2) 112.5(6)/[111.3(7)] 109.7(3) 115.0(5) 113.0(16) 
i Values in brackets are for the second molecule in the asymmetric unit for 4.89
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4.2.6.3 Secondary Interactions in Compounds 4.89–4.92 
 
Complex 4.89 was crystallised from a diethyl ether solution, including one solvent 
molecule per complex molecule. Compound 4.89 crystallises with an intramolecular 
S(7) hydrogen bond graph set, a common motif in 1,2-disubstituted phenyl rings.116,189 
The intramolecular hydrogen bonding limits the dimensionality of the packing of the 
complex, with molecules of 4.89 packing in one-dimensional chains which propagate in 
the a direction through a single weak N−H···Cl interaction (Figure 4.44).10 
  
 
 
Figure 4.44 One-dimensional chain of 4.89 propagating in the a direction. Phenyl 
groups and hydrogen atoms not involved in hydrogen bonding have been omitted for 
clarity. Selected hydrogen bonding parameters for 4.89 are shown in Table 4.30. 
 
Table 4.30 Selected hydrogen bonding parameters for 4.89. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···Cl(3) 3.324(8) 0.88 2.46 167.6 
O(2)−H(2A)···O(1) 2.596(9) 0.84 1.80 156.4 
N(4)−H(4)···Cl(1A)i 3.318(8) 0.88 2.45 167.9 
O(4)−H(4A)···O(3) 2.607(9) 0.84 1.82 154.7 
Symmetry operations: i-y+1, x-y+1, z+2/3.  
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The X-ray structure of 4.91 is shown in Figure 4.45, in which the −OH is in the same 
ortho position as in 4.89, while the −CH3 group is now in the para position. Compound 
4.91 presents disorder along the backbone and the functionalised N-arene group and has 
been modelled over two equally-occupied sets of positions with a common C(9) and 
six-membered chelated ring. 
 
 
 
Figure 4.45 View of compound 4.91 showing both components of the disorder. Phenyl 
groups and hydrogen atoms except NH and OH have been omitted for clarity. 
 
Compound 4.91 shows an (amide)N−H···N(tertiary) S(5) intramolecular hydrogen bond 
(Figure 4.46). A strong O−H···O interaction links disordered component 1 of 4.91 to 
disordered component 2 of a symmetry related neighbouring molecule forming a one-
dimensional chain. Selected hydrogen bonding parameters for 4.91 are shown in Table 
4.31. 
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Figure 4.46 View of the one-dimensional chain of 4.91. Phenyl groups and hydrogen 
atoms not involved in hydrogen bonding have been omitted for clarity. 
 
Table 4.31 Selected hydrogen bonding parameters for 4.91. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···N(1) 2.755(14) 0.88 2.34 109 
O(1)−H(1)···O(2XA)i 2.647(16) 0.84 1.87 154 
Symmetry operation: ix+1, y, z.        
 
Compound 4.92, in which the –CH3 group is in the para position and the –OH group 
located in the meta position with respect to the amide N atom, crystallises with one 
molecule in the asymmetric unit of Pt(II) complex which lies on a mirror plane. Due to 
the poor quality of the diffraction data for 4.92, the −OH hydrogen atom could not be 
located. The structure of compound 4.92 contains solvent-accessible voids accounting 
for 3% of the total unit cell volume. The SQUEEZE program within Platon suite 
identified approximatly 50 unaccounted electrons in the unit cell, and this was assumed 
to be a diethyl ether molecule (42 electrons per molecule) which were taken into 
account in the refinement, improving the R1 by 1%.48 Compound 4.92 packs as a 
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stepped one-dimensional polymeric chain through a bifurcated intermolecular N−H···Cl 
hydrogen bonding (Table 4.32).49,50 This one-dimensional chain is propagating in the a 
direction (Figure 4.47).  
 
 
 
Figure 4.47 View of the one-dimensional stepped chain of 4.92. Phenyl groups and 
hydrogen atoms not involved in hydrogen bonding have been omitted for clarity.  
 
Table 4.32 Selected hydrogen bonding parameters for 4.92. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(1)−H(1A)···Cl(1)i 3.505(14) 0.88 2.76   144   
Symmetry operations: ix-1, y, -z+1/2.      
 
Compound 4.90, where the −OH and −CH3 functional groups are in para and ortho 
positions respectively to the amide N atom reveals an intramolecular S(5) 
(amide)N−H···N(tertiary) hydrogen bonding motif seen previously for 4.91 (Table 
4.33). As expected, the (amide)N−H···N(tertiary nitrogen centre) intermolecular 
hydrogen bond length in both complexes are very similar. The −OH functional group is 
involved in an intermolecular, single, weak O−H···Cl hydrogen bond that holds the 
molecules of 4.90 in undulating chains which propagate parallel to the a axis (Figure 
4.48). 
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Figure 4.48 View of the undulating chains of 4.90. Phenyl groups and hydrogen atoms 
not involved in hydrogen bonding have been omitted for clarity. 
 
The similarities between the structures of 4.90 and 4.91 are obvious, with the common 
(amide)N−H···N(tertiary) S(5) hydrogen bonding motif and the single hydrogen bond 
holding the molecules in one-dimensional structures. Compounds 4.90 and 4.91 only 
differ in the nature of the hydrogen bond acceptor (i.e. O−H···O in 4.91 compared to 
O−H···Cl in 4.90).  
 
Table 4.33 Selected hydrogen bonding parameters for 4.90. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(2)−H(2)···Cl(1A)i 3.068(3) 0.84 2.25 164 
N(2)−H(2A)···N(1) 2.711(5) 0.93(5) 2.29(5) 107(4) 
Symmetry operation: ix-1/2, -y+3/2, z-1/2.        
 
4.2.6.4 Syntheses of Linear Au(I) Complexes 4.95–4.103 
 
Following a similar procedure to that used in the synthesis seen previously for 
complexes 4.38-4.46, Au(I) complexes Au2Cl2{P,P-
C6H4(OH)NHCOCH2N(CH2PPh2)2} 4.95–4.97, Au2Cl2{P,P-
C6H3(OH)(CH3)NHCOCH2N(CH2PPh2)2} 4.98–4.102 and Au2Cl2{P,P-
C6H3(OH)(tBu)NHCOCH2N(CH2PPh2)2} 4.103 were synthesised by addition of the 
appropriate ligand 4.77–4.85 to a solution of AuCl(tht) in CH2Cl2. After stirring for 30 
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min, the solution was concentrated to approximately 5 ml under reduced pressure and 
the required products precipitated upon addition of Et2O (Equation 4.19). These 
complexes were obtained in 50-94% yield. 
 
A = OH, B,C,D = H   4.77
B = OH, A,C,D = H   4.78
C = OH, A,B,D = H   4.79
A = OH, D = CH3, B,C = H   4.80
A = CH3, C = OH, B,D = H   4.81
A = OH, C = CH3, B,D = H   4.82
B = OH, C = CH3, A,D = H   4.83
C = OH, B = CH3, A,D = H   4.84
A = OH, D = tBu, B,C = H    4.85
N N
O
HA
B
C
D
PPh2
PPh2 2 AuCl(tht)
CH2Cl2
N
N
A
O
H
P
Ph2
PPh2
AuCl
AuCl
B
C
D
A = OH, B,C,D = H   4.95
B = OH, A,C,D = H   4.96
C = OH, A,B,D = H   4.97
A = OH, D = CH3, B,C = H  4.98
A = CH3, C = OH, B,D = H  4.99
A = OH, C = CH3, B,D = H  4.100
B = OH, C = CH3, A,D = H  4.101
C = OH, B = CH3, A,D = H  4.102
A = OH, D = tBu, B,C = H   4.103  
 
Equation 4.19 
 
Compounds 4.95–4.103 were isolated as white or off-white solids, soluble in 
dimethylsulfoxide but insoluble in chloroform, alcohols or dichloromethane. All the 
gold complexes display a single phosphorus resonance in the range δ(P) 20.8 – 24.8 
ppm, a downfield shift of approximately 40 ppm with respect to the free ligands. The 
characteristic ν(AuCl) infrared band could be identified in the range of 324-328 cm–1 for 
the complexes 4.95–4.103 (Table 4.34). Compounds 4.95–4.103 showed the 
characteristic ν(NH) and ν(OH) absorptions in the range 3200-3400 cm–1 and also a 
strong band in the range 1613-1680 cm–1 indicative of ν(C=O amide).     
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Table 4.34 Selected 31P{1H} NMRa and IR datab for 4.95–4.103.  
 δ(P)/ppm ν(AuCl)/cm–1 
4.95 22.9 328 
4.96 24.2 328 
4.97 24.3 325 
4.98 21.2 328 
4.99 24.8 328 
4.100 20.8 328 
4.101 24.5 324 
4.102 24.1 324 
4.103 23.4 328 
a Spectra measured in (CD3)2SO. b Recorded as KBr pellets. 
 
Numerous attempts have been made to obtain crystals from these gold(I)  complexes 
4.95-4.103 and only powdered material was isolated. 
 
4.2.6.5 Syntheses of Octahedral Mo(0) Complexes 4.104–4.108 
 
Complexes Mo(CO)4{P,P-C6H4(OH)NHCOCH2N(CH2PPh2)2} 4.104, Mo(CO)4{P,P-
C6H3(OH)(CH3)NHCOCH2N(CH2PPh2)2} 4.105–4.107 and Mo(CO)4{P,P-
C6H3(OH)(tBu)NHCOCH2N(CH2PPh2)2} 4.108 were synthesised by addition of the 
appropriate ligand 4.78, 4.80 or 4.83–4.85 to a solution of Mo(CO)4(nbd) in CH2Cl2 
under N2 for 48 h (Equation 4.20). The solution was concentrated to approximately 10 
ml under reduced pressure. The required products precipitated upon addition of 
Et2O/hexane to give the complexes in good yields, 56-88%. 
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B = OH, A,C,D = H   4.78
A = OH, D = CH3, B,C = H   4.80
C = OH, B = CH3, A,D = H   4.83
B = OH, C = CH3, A,D = H   4.84
A = OH, D = tBu, B,C = H    4.85
N N
O
HA
B
C
D
PPh2
PPh2 Mo(CO)4(nbd)
CH2Cl2
N
N
A
O
H
P
P
Ph2
B
C
D
B = OH, A,C,D = H   4.104
A = OH, D = CH3, B,C = H  4.105
C = OH, B = CH3, A,D = H  4.106
B = OH, C = CH3, A,D = H  4.107
A = OH, D = tBu, B,C = H   4.108
N2
Mo
Ph2
CO
CO
CO
CO
 
 
Equation 4.20 
 
The 31P{1H} NMR spectra show single, sharp resonances, in the region of δ(P) 13.9 − 
20.9 ppm, a downfield shift of approximately 40 ppm with respect to the free phosphine 
ligands 4.78, 4.80 and 4.83–4.85. The OH and NH resonances in the 1H NMR spectra of 
4.78 were not observed. Complexes 4.104–4.108 display three strong carbonyl 
absorptions in the region 1894-2021 cm–1 in the IR spectra consistent with a cis 
tetracarbonyl metal complex (Table 4.35). The infrared spectra for compounds 4.104–
4.108 showed the characteristic band for ν(NH) and ν(OH) in the range 3300-3400 cm–1 
and also a strong band in the range 1654-1669 cm–1 indicative of ν(C=O amide). The 
31P{1H} NMR spectra for 4.108 could not be recorded due to fast oxidation in solution 
but IR spectroscopy, mass spectrometry and microanalyses all indicate formation of the 
desired compound. 
 
     Table 4.35 Selected 31P{1H} NMRa and IR datab for 4.104–4.108.a  
 δ(P)/ppm ν(CO)/cm–1 
4.104 20.97 2020; 1921; 1894 
4.105 13.93 2020; 1919; 1896 
4.106 19.69 2019; 1924; 1896 
4.107 19.95 2020; 1919; 1894 
4.108 n.r. 2021; 1919; 1902 
a Spectra measured in CDCl3. b Recorded as KBr pellets. n.r. = not recorded. 
 
Numerous attempts have been made to obtain crystals of Mo(0) complexes 4.104–4.108 
but only powdered material was isolated. 
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4.2.7 Novel Ditertiary Phosphines tBuOC(O)NH(CH2)2N(CH2PPh2)2 4.109, 
HO2C(CH2)2N(CH2PPh2)2 4.110, HO2CCH2NHCOCH2N(CH2PPh2)2 4.111 and 
HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2 4.112 
 
A similar family of ditertiary phosphines containing an amide backbone which is 
sufficiently flexible to adopt different conformations in order to access different types of 
supramolecular arrays is presented (Figure 4.49). Instead of a functionalised arene 
group as seen previously, other functionalities (e.g. carboxylic acid groups) were 
studied on the amide backbone. A CSD search shows that similar compounds to 4.109–
4.112 have not been reported, therefore compounds 4.109–4.112 represent first 
examples of novel highly functionalised phosphorus based ligands which can be 
exploited as building blocks in crystal engineering. The synthesis, structural analysis 
and metal complexation studies of 4.109–4.112 with selected transition metals, Pt(II), 
Ru(II) and Au(I) have been undertaken. The synthesis of compound 4.109 and its 
complexation studies were carried out by Benoit Genevier and structurally characterised 
by the Author of this thesis. 
 
NHO2C R
H
N
N
O
PPh2
PPh2
PPh2
PPh2
O
H
N
N
O
PPh2
PPh2
4.109 4.110 R = CO2H   4.111
R = CONHCH2CO2H   4.112  
 
Figure 4.49 Ditertiary functionalised bis(phosphino)amines 4.109–4.112 prepared. 
 
4.2.8 Syntheses and Charaterisation of tBuOC(O)NH(CH2)2N(CH2PPh2)2 4.109 
 
 Ligand tBuOC(O)NH(CH2)2N(CH2PPh2)2 4.109 was prepared using a Mannich-based 
condensation reaction (Equation 4.21). The precursor primary amine, (2-
aminoethyl)carbamic acid tert-butyl ester X, was synthesised from ethylenediamine and 
di-t-butyl Boc-anhydride following a literature procedure.251  
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O
H
N
NH2 + OHPh2P2
MeOH
N2O
O
H
N
N
O
PPh2
PPh2
X  
 
Equation 4.21 
 
Compound 4.109 displays a single phosphorus resonance in the 31P{1H} NMR spectrum 
(in CDCl3) at δ(P) -28.8 ppm. An infrared spectrum and microanalysis data were also 
recorded and are in good agreement with calculated values. 
 
Compound 4.109 represents the simplest example: only the amide group can participate 
in hydrogen bonding. However, the bulky tBoc group may interfere in the formation of 
any supramolecular array. Crystals of 4.109, suitable for X-ray crystallography, were 
obtained by slow evaporation of a methanol filtrate. Compound 4.109 crystallises with 
one molecule in the asymmetric unit (Figure 4.50). Despite 4.109 bearing potential 
hydrogen bonding donor and acceptor groups, no inter- or intramolecular hydrogen 
bonding was observed. Hence the structure of 4.109 is essentially zero-dimensional. 
  
 
 
Figure 4.50 View of the asymmetric unit of 4.109. Phenyl groups and hydrogen atoms 
except NH have been omitted for clarity.  
 
Structure analysis of 4.109 clearly shows approximate pyramidal geometries about the 
tertiary nitrogen atom [N(1)–C(1)–P(1) 109.08(15)°, N(1)–C(2)–P(2) 112.92(15)° and 
C(1)–N(1)–C(2) 111.78(18)°]. As seen for ligands 4.77–4.85, there is little variation in 
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the P−C and C−N bond lengths [C(1)–N(1) 1.467(3) Å, C(2)–N(1) 1.470(3) Å, C(1)–
P(1) 1.859(2) Å and C(2)–P(2) 1.859(2) Å] in 4.109 and they are consistent with the 
values already described for 4.77–4.85. Therefore, the geometric parameters around the 
pyramidal N atom are not influenced by this type of backbone. The phosphorus atoms 
are in an anti conformation presumably in order to reduce steric repulsions between the 
bulky phenyl groups. 
 
4.2.9 Coordination Chemistry of tBuOC(O)NH(CH2)2N(CH2PPh2)2 4.109 
 
Compound 4.109 reacts with PtCl2(cod), AuCl(tht) and [Ru(η6-p-cymene)Cl2]2 in 
CH2Cl2 to give PtCl2{tBuOC(O)NH(CH2)2N(CH2PPh2)2} 4.113, 
Au2Cl2{tBuOC(O)NH(CH2)2N(CH2PPh2)2} 4.114 and [RuCl2(η6-p-
cymene)]2{tBuOC(O)NH(CH2)2N(CH2PPh2)2} 4.115 as white or red solids in 81%, 
77% and 65% yield, respectively (Equation 4.22). 
 
O
H
N
N
O
PPh2
PPh2
(i) (ii)O
H
N
N
O
P
P
Ph2
O
H
N
N
O
P
PPt
Cl
Cl
Ph2
Au
Au
Cl
Cl
4.113 4.114(iii)
O
H
N
N
O
P
P
Ru
4.115
Cl
Cl
Ru
Cl
Cl
Ph2
Ph2
Ph2
Ph2
 
 
Equation 4.22 (i) PtCl2(cod), CH2Cl2, (ii) AuCl(tht), CH2Cl2, (iii) [Ru(η6-p-
cymene)Cl2]2, CH2Cl2. 
 
The 31P{1H} NMR spectra (in CDCl3) of the isolated solids 4.113–4.115 showed a 
single phosphorus resonance at δ(P) -10.1 ppm, 16.5 ppm and 19.2 ppm respectively. 
The 1J(PtP) coupling constant for 4.113 was ca. 3400 Hz suggesting cis isomer, similar 
to those observed for compounds 4.86–4.94. The IR spectra of 4.113–4.115 also show a 
characteristic N–H vibration and ν(C=O) stretch around 3400 cm–1 and 1700 cm–1 
respectively. 
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4.2.9.1 X-ray Crystal Structures of PtCl2{tBuOC(O)NH(CH2)2N(CH2PPh2)2} 4.113 
and [RuCl2(η6-p-cymene)]2{tBuOC(O)NH(CH2)2N(CH2PPh2)2} 4.115 
 
Crystals of 4.113 suitable for X-ray crystallography were obtained by slow vapour 
diffusion of Et2O into a dimethyl sulfoxide/chloroform solution of 4.113. The X-ray 
structure of 4.113 revealed an approximate square-planar coordination of the Pt(II) 
centre [P(1)–Pt(1)–P(2) 95.63(15)°, P(1)–Pt(1)–Cl(1) 88.52(15)°, P(2)–Pt(1)–Cl(2) 
86.91(15)°  and Cl(1)–Pt(1)–Cl(2) 88.84(14)°] (Figure 4.51). The Pt−Cl and Pt−P bond 
lengths [Pt(1)–Cl(1) 2.354(4) Å, Pt(1)–Cl(2) 2.366(4) Å, Pt(1)–P(1) 2.231(4) Å and 
Pt(1)–P(2) 2.234(4) Å] are consistent with values reported in the literature.189 
 
 
 
Figure 4.51 View of the asymmetric unit of 4.113. Phenyl groups and hydrogen atoms 
have been omitted for clarity. 
 
The conformation of the Pt–P–C–N–C–P six-membered ring in 4.113 is best described 
as a boat, with the N atom above the P2C2 plane by 0.860 Å. As seen for the free ligand 
4.109 no intramolecular hydrogen bonding between (amide)N–H···N(tertiary) or 
intermolecular interactions were observed. 
 
Numerous attempts have been made to obtain crystals of 4.114 without any success 
affording only powdered material. However, compound 4.115 dimerises through N–
H···Cl hydrogen bonds between the amide nitrogen atom and a chloride ligand 
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coordinated to the ruthenium(II), forming a quadrangular R22(18) motif (Figure 4.52). 
The distance between symmetry-related ruthenium ions is 9.253 Å. Selected hydrogen 
bonding parameters for 4.115 are shown in Table 4.36. 
 
 
 
Figure 4.52 Dimers of compound 4.115. Phenyl groups and hydrogen atoms not 
involved in hydrogen bonding have been omitted for clarity.  
 
Compound 4.115 includes one molecule of dichloromethane per ruthenium(II) complex. 
Additional weak (solvent)C–H···Cl, [C···Cl 3.61 Å] hydrogen bonding of two 
dichloromethane molecules to two of the terminal chlorides within the dimer is 
observed thereby potentially preventing any further hydrogen bonding associations.  
 
Table 4.36 Selected hydrogen bonding parameters for 4.115. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···Cl(2A)i 3.472(2) 0.80(3) 2.69(3) 166(3) 
Symmetry operation: i-x, -y+1, -z+2. 
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4.2.10 Syntheses and Characterisation of HO2C(CH2)2N(CH2PPh2)2 4.110, 
HO2CCH2NHCOCH2N(CH2PPh2)2 4.111 and 
HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2 4.112 
 
The ligands HO2C(CH2)2N(CH2PPh2)2 4.110, HO2CCH2NHCOCH2N(CH2PPh2)2 4.111 
and HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2 4.112 were prepared by Mannich-
based condensation reactions, between the primary amine, glycine, glycylglycine and 
triglycine, and two equivalents of diphenylphosphinomethanol (Equation 4.23). The 
mixture was stirred in methanol at room temperature under nitrogen for 24 h giving the 
desired ligands 4.110–4.112 in good yields 58-99%.  
 
NH2HO2C
HO2C
H
N
NH2
O
H
N
NH2
O
N
H
HO2C
O
+ OHPh2P2
NHO2C
HO2C
H
N
N
O
H
N
N
O
N
H
HO2C
O
PPh2
PPh2
PPh2
PPh2
PPh2
PPh2
4.110-4.112
MeOH
N2
 
 
Equation 4.23 
 
The isolation of 4.110–4.112, as yellow oils, was achieved upon evaporation of the 
solvent to dryness. Each compound displayed a single phosphorus resonance in the 
31P{1H} NMR spectra (in CDCl3) around  δ(P) -26 – -27 ppm.  
 
4.2.11 Syntheses and Characterisation of [PtCl2{HO2C(CH2)2N(CH2PPh2)2}] 4.116, 
[PtCl2{HO2CCH2NHCOCH2N(CH2PPh2)2}] 4.117 and 
[PtCl2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2}] 4.118 
 
The complexes [PtCl2{HO2C(CH2)2N(CH2PPh2)2}] 4.116, 
[PtCl2{HO2CCH2NHCOCH2N(CH2PPh2)2}] 4.117 and 
[PtCl2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2}] 4.118 were prepared in 90-84% 
yield by ligand substitution of cod from PtCl2(cod) in an analogous manner to the 
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synthesis of 4.113. The 31P{1H} NMR spectra [in (CD3)2SO] showed a single resonance 
around δ(P) -10 ppm with associated 195Pt satellites [1J(PtP) 3400 Hz] (Table 4.37). The 
IR spectra display bands in the regions 3400 cm–1, 1656-1668 cm–1 and 1730 cm–1 
typical of ν(NH)/ν(OH), ν(C=O amide) and ν(C=O acid) respectively. 
 
     Table 4.37 Selected 31P{1H} NMR data for 4.116–4.118.a  
 δ(P)/ppm 1J(PtP)/Hz 
4.116 -9.91 3411 
4.117 -10.64 3393 
4.118  -10.41 3474 
 aSpectra measured in (CD3)2SO. 
 
4.2.11.1 X-ray Crystal Structures of [PtCl2{HO2CCH2NHCOCH2N(CH2PPh2)2}] 
4.117 and [PtCl2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2}] 4.118 
 
Crystals of [PtCl2{HO2CCH2NHCOCH2N(CH2PPh2)2}] 4.117 were obtained by slow 
diffusion of Et2O into a CHCl3/DMSO solution. The addition of an extra carboxylic 
acid group, compared to 4.113, provides further hydrogen bonding groups resulting in 
the extension of the dimensionality of the supramolecular array formed in 4.117 (Figure 
4.53). Compound 4.117 forms a two-dimensional structure through a combination of 
intermolecular weak bifurcated (amide)N–H···Cl and strong (carboxylic acid)O–
H···O(amide) interactions (Table 4.38). 
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Figure 4.53 Hydrogen bonding motifs for 4.117. Phenyl groups and hydrogen atoms 
not involved in hydrogen bonding have been omitted for clarity. 
 
Table 4.38 Selected hydrogen bonding parameters for 4.117. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···Cl(2A)i 3.372(3) 0.76(4) 2.70(4) 150(4) 
N(2)−H(2)···Cl(1A)i 3.353(3) 0.76(4) 2.81(4) 130(4) 
O(2)−H(2A)···O(1B)ii 2.694(4) 0.84(5) 1.87(5) 169(5) 
Symmetry operations: i-x+1/2, -y+1, z-1/2; iix-1/2, -y+1/2, -z.    
 
Although the addition of a second amide group in the backbone in 
[PtCl2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2}] 4.118 affords more flexibility 
and potential donor/acceptor groups which can be involved in hydrogen bonding, 
compound 4.118 crystallises as a one-dimensional chain (Figure 4.54). While one of the 
amide groups of 4.118 forms a R22(10) dimer motif with a symmetry related molecule 
via strong N–H···O hydrogen bonds, the remaining NH(amide) links the dimers into 
chains through a single N–H···Cl hydrogen bond.10 Interestingly, the carboxylic acid 
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group is not involved in hydrogen bonding limiting the dimensionality of the 
supramolecular array. Selected hydrogen bonding parameters for 4.118 are shown in 
Table 4.39.  
 
 
 
 
Figure 4.54 Hydrogen bonding motifs for 4.118. Phenyl groups and hydrogen atoms 
not involved in hydrogen bonding have been omitted for clarity.  
 
Table 4.39 Selected hydrogen bonding parameters for 4.118. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···O(2A)i 3.859(4) 0.88 1.99 170 
N(3)−H(3)···Cl(1B)ii 3.359(3) 0.88 2.55 154 
Symmetry operations: i-x+3/2, -y+1/2, -z+2; ii-x+3/2, y-1/2, -z+3/2.    
 
Complexes 4.117 and 4.118 show an approximate square-planar coordination of the 
Pt(II) centre [P(1)–Pt(1)–P(2) 92.76(3)-92.89(3)°, P(1)–Pt(1)–Cl(1) 89.82(3)-89.97(3)°, 
P(2)–Pt(1)–Cl(2) 88.51(3)-88.93(3)°  and Cl(1)–Pt(1)–Cl(2) 88.65(3)-88.93°, 
respectively]. Analysis of the Pt−Cl and Pt−P bond lengths [Pt(1)–Cl(1) 2.3618(9)-
2.3689(8) Å, Pt(1)–Cl(2) 2.3593(7)-2.3520(9) Å, Pt(1)–P(1) 2.2248(7)-2.2293(9) Å and 
Pt(1)–P(2) 2.2283(8)-2.2210(8) Å] are consistent with values reported in the 
literature.189 
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4.2.11.2 Syntheses and Characterisation of [Au2Cl2{HO2C(CH2)2N(CH2PPh2)2}] 
4.119, [Au2Cl2{HO2CCH2NHCOCH2N(CH2PPh2)2} 4.120 and 
[Au2Cl2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2} 4.121 
 
Reaction of ligands 4.110-4.112 with AuCl(tht) in a 1:2 stoichiometry proceeds with 
displacement of tht to afford the gold(I) compounds 
[Au2Cl2{HO2C(CH2)2N(CH2PPh2)2}] 4.119, 
[Au2Cl2{HO2CCH2NHCOCH2N(CH2PPh2)2} 4.120 and 
[Au2Cl2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2} 4.121 as air stable white solids 
in 60-95% yield. The complexes exhibit the expected spectroscopic and analytical 
properties. Hence, a single sharp resonance, in their 31P{1H} NMR spectra [in 
(CD3)2SO] around δ(P) 23 ppm was observed in all cases. In the IR spectra, ν(NH) and 
ν(OH) bands and ν(C=O amide) are observed in the range of 3300-3400 cm–1 and 1658-
1670 cm–1 respectively. In addition a strong band around 1700 cm–1 was indicative of 
ν(C=O acid). 
 
Numerous attempts have been made to obtain crystals of these gold(I) complexes 
4.119–4.121 without any success, affording only powdered material. 
 
4.2.11.3 Syntheses and Characterisation of [RuCl2(η6-p-
cymene)]2{HO2C(CH2)2N(CH2PPh2)2} 4.122, [RuCl2(η6-p-
cymene)]2{HO2CCH2NHCOCH2N(CH2PPh2)2} 4.123 and [RuCl2(η6-p-
cymene)]2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2} 4.124 
 
Complexes [RuCl2(η6-p-cymene)]2{HO2C(CH2)2N(CH2PPh2)2} 4.122, [RuCl2(η6-p-
cymene)]2{HO2CCH2NHCOCH2N(CH2PPh2)2} 4.123 and [RuCl2(η6-p-
cymene)]2{HO2CCH2NHCOCH2NHCOCH2N(CH2PPh2)2} 4.124 were obtained by 
reaction of ligands 4.110–4.112 with [Ru(η6-p-cymene)Cl2]2, 1:1 stoichiometry 
respectively, in dichloromethane. After stirring for 30 min, the solution was 
concentrated to approximately 5 ml under reduced pressure and the required orange 
products precipitated upon addition of Et2O. These complexes were obtained in good 
yields 63-88%. All the ruthenium complexes display a single phosphorus resonance 
around δ(P) 15-18 ppm, a downfield shift of approximately 40 ppm with respect to the 
free ligands. The 1H NMR spectra of 4.122–4.124 show well resolved, distinct 
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resonances for the η6-p-cymene ancillary ligand. The infrared spectra for compounds 
4.122–4.124 showed the characteristic ν(NH) and ν(OH) and ν(C=O amide) 
absorbances in the range 3300-3400 cm–1 and 1664-1673 cm–1 respectively; also a 
strong band around 1700 cm–1 indicative of ν(C=O acid) (Table 4.40). 
 
     Table 4.40 Selected 31P{1H} NMRa and IR datab for 4.122–4.124.  
 δ(P)/ppm ν(CO)/cm–1 
4.122 19.60 1708 
4.123 15.69 1735 
4.124 18.24 1737 
a Spectra measured in (CD3)2SO. b Recorded as KBr pellets. 
 
4.2.11.4 X-ray Crystal Structures of 4.122 and 4.124 
 
The X-ray crystal structure of 4.122 has been determined within the group although not 
published. Compound 4.122 displays the classic “piano-stool” geometry formed by the 
η6-p-cymene ancillary ligand and the three “legs” being the two chlorides and the 
phosphorus donor atom of the P–C–N–C–P ligand. Molecules of 4.122 are associated in 
dimers through classic intermolecular carboxylic acid-carboxylic acid head-to-tail O–
H···O hydrogen bonding (Table 4.41) with the formation of the typical R22(8) graph set 
motif (Figure 4.55).252  
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Figure 4.55 View of the head-to-tail arrangement for compound 4.122. Phenyl groups 
and hydrogen atoms not involved in hydrogen bonding have been omitted for clarity.  
 
Table 4.41 Selected hydrogen bonding parameters for 4.122. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
O(2)−H(2)···O(1A)i 2.630(3) 0.84 1.79 178 
Symmetry operation: i-x, -y+1, -z+1.    
 
Compound 4.124 adopts an identical hydrogen bonding pattern to that found in 4.122 
with the carboxylic acid group forming head-to-tail R22(8) rings and arranging 
molecules of 4.124 into dimers (Figure 4.56). In contrast to 4.122, complex 4.124 
possesses two additional amide functional groups which are involved in two 
intramolecular N–H···Cl hydrogen bonds with two chlorides ligands forming S(9) and 
S(12) graph set hydrogen bond motifs (Table 4.42).  
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Figure 4.56 Hydrogen bonding motifs for 4.124. Phenyl groups and hydrogen atoms 
not involved in hydrogen bonding have been omitted for clarity. 
 
Interestingly, while in compound 4.117 the incorporation along the backbone of 
additional functional groups with potential hydrogen bonding capability allowed the 
extension of the dimensionality of the supramolecular array obtained, for compound 
4.124 a zero-dimensional structure was found. Instead of the common R22(8) motif 
observed in 4.124, compound 4.117 extends the dimensionality through a combination 
of intermolecular (amide)N–H···Cl and single (carboxylic acid)O–H···O(amide) 
interactions. 
 
Table 4.42 Selected hydrogen bonding parameters for 4.124. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(2)−H(2)···Cl(3) 3.306(9) 0.88 2.48 157 
N(3)−H(3A)···Cl(2) 3.464(7) 0.88 2.61 163 
O(3)−H(3)···O(4A)i 2.638(9) 0.84 1.80 175 
Symmetry operation: i-x-1, -y+1, -z.    
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4.3 Conclusions 
 
A range of new isomeric ditertiary phosphino(amines) 4.20–4.28 and 4.77–4.85 has 
been prepared either via a three-step or single step synthetic route which involves a well 
known method of reductive amination followed by an efficient Mannich-based 
condensation. Furthermore, the ditertiary phosphines 4.20–4.28 and 4.77–4.85 
synthesised in this Chapter act as cis-chelating P,P-bidentate ligands and have the 
ability to chelate to various transition metal centres such as Pt(II) and Mo(0), they can 
also act as bridging ligands for Ru(II) and Au(I). 
 
The regioselective incorporation of functional groups with potential hydrogen bonding 
capability such as hydroxyl and amide around a central arene core has been 
demonstrated to have a pronounced effect on the structural motifs observed in the 
isomeric series. In the isomeric series of compounds 4.20–4.57, while the S(5) 
intramolecular motif is observed in 4.41, 4.51 and 4.53 when the –OH functional group 
is located in the ortho-position on the arene ring with respect to –N(CH2PPh2)2, it is 
absent in 4.32 where an alternative O–H···Cl hydrogen bond interaction is formed 
extending the dimensionality of the supramolecular array from zero-dimensional 
discrete units to one-dimensional chains. When the –OH functional group is located in 
para-position on the arene ring with respect to –N(CH2PPh2)2, one-dimensional chain 
structures were adopted in 4.22, 4.35 and 4.55. Interestingly, compound 4.50, which 
differs from 4.55 only by the absence of a methyl group on the functionalised arene 
ring, crystallises with a different trend forming a network of cavities which 
interpenetrate through (hydroxyl)O–H···O(carbonyl) interactions forming R42(12) star-
shape motifs. The structures obtained with the –OH positioned in the meta-position on 
the arene ring with respect to –N(CH2PPh2)2 show a range of hydrogen bonded 
supramolecular structures with varying dimensionalities.      
 
The inclusion of polar DMSO molecules into the structures of 4.30 and 4.33 show that it 
can limit the dimensionality of the resulting solid-state structure compared with 4.35, 
where the inclusion of methanol molecules produced a more extended structure. 
Therefore the dimensionality of these systems will also depend on the nature of any co-
crystallised species.   
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For compounds 4.77–4.108 the incorporation of the amide-backbone is observed to 
increase the flexibility of the system compared with the ligands 4.21-4.57. Interestingly, 
in 4.90 where the –OH functional groups is located in para-position on the arene ring 
with respect to –NHCOCH2N(CH2PPh2)2, a one-dimensional chain is observed as seen 
for compounds 4.22, 4.35 and 4.55. The presence of the amide group in the backbone 
failed to extend the dimensionality of these systems. Although a Pt(II) complex with the 
–OH positioned in the meta-position on the arene ring with respect to –
NHCOCH2N(CH2PPh2)2 was successfully crystallised, due to the poor quality of the 
diffraction data for 4.92; the −OH hydrogen atom could not be located. 
 
Interestingly, while the common carboxylic acid R22(8) head-to-tail ring motif is 
observed in the Ru(II) complexes 4.122 and 4.124, it is absent in the Pt(II) complexes 
4.117 and 4.118. Instead a series of motifs in which strong hydrogen bonds (O–H···O) 
combine with weaker interactions (N–H···Cl and N–H···O) extending the dimensionality 
from zero-dimensional, observed in Ru(II) complexes 4.122 and 4.124, to one- and two-
dimensional, observed in Pt(II) complexes 4.117 and 4.118. This perhaps indicates a 
weakness in the predictability of the R22(8) synthon which is well known to be either 
disrupted or fail to form in competition with other hydrogen bonding possibilities.253 
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 4.4 EXPERIMENTAL 
 
Materials 
 
Unless otherwise stated, all reactions were performed in air. Standard Schlenk 
techniques were used for experiments carried out under an oxygen-free nitrogen 
atmosphere. The starting materials 2-hydroxyaniline, 3-hydroxyaniline, 4-
hydroxyaniline, 2-amino-4-methylphenol, 4-amino-3-methylphenol, 2-amino-5-
methylphenol, 4-amino-2-methylphenol, 3-amino-2-methylphenol, 2-amino-4-
tertbuthylphenol, dicyclohexylcarbodiimide, N-carbobenzyloxyglycine, cyclohexene, 
palladium/Carbon, di-t-butyl Boc-anhydridre, RuCl3·xH2O, glycine, glycylglycine and 
triglycine were purchased from Aldrich, Lancaster, Avocado or Acros. All solvents 
were purchased from Aldrich, Fisher or Lancaster. CH2Cl2 was distilled from CaH2 
under nitrogen, and diethyl ether distilled from Na under nitrogen. The transition metal 
precursors, PtCl2(COD), AuCl(tht) and [Ru(η6-p-cymene)Cl2]2 were prepared according 
to literature methods.254-256 The tertiary phosphine Ph2PCH2OH used in these reactions 
was readily preformed from equimol amounts of Ph2PH and (CH2O)n.198 Physical 
measurements were carried out using methods described in the preceding chapter.  
 
4.4.1 Characterisation Data 
 
The following general method was used for the synthesis of compounds 4.20–4.28: The 
mixture of hydroxymethyldiphenylphosphine (2 eq) and the primary amine I–IX (1 eq) 
in methanol (20 ml) was stirred under N2 for 24 h. In all the cases, except for compound 
4.28, the volume of the solution obtained was evaporated to ca. 2-3 ml under reduced 
pressure and a solid was obtained. The suspension was stirred for 10 min. The white 
solids obtained were collected by suction filtration and dried in vacuo. In the case of 
4.28, the solution was evaporated to dryness under reduced pressure yielding a yellow 
oil. 
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Compound 4.20 
Yield: 0.553 g, 97%. 
IR υmax (KBr)/cm–1 3364.1 (O−H), 746.4, 716.4 and 697.0 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 8.93 (1H, s, O−H), 7.39-7.29 (20H, m, Ar C−H), 6.98 
(1H, d, Ar C−H, J 7.6 Hz), 6.86 (1H, dd, Ar C−H, J 1.6 and 15.2 Hz), 6.83-6.65 (2H, m, 
Ar C−H), 4.27 (4H, d, CH2, J 3.2 Hz) ppm. 
31P NMR data: δ -27.63 ppm. 
Analysis calculated for C32H29ONP2: C, 76.03; H, 5.78; N, 2.77. Found:  C, 75.67; H, 
5.74; N, 2.83%. 
m/z 504 [C32H29ONP2]+. 
 
Compound 4.21  
Yield: 0.718 g, 53%. 
IR υmax (KBr)/cm–1 3376.0 (O−H), 742.4, 695.7 and 683.6 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 9.12 (1H, s, O−H), 7.38-7.31 (21H, m, Ar C−H), 6.92 
(1H, s, Ar C−H), 6.30 (2H, d, Ar C−H, J 16.8 Hz), 6.13 (1H, s, Ar C−H), 3.85 (4H, s, 
CH2) ppm. 
31P NMR data: δ -27.57 ppm. 
Analysis calculated for C32H29ONP2: C, 76.03; H, 5.78; N, 2.77. Found:  C, 75.67; H, 
5.71; N, 2.74%. 
m/z 504 [C32H29ONP2]+. 
 
Compound 4.22 
Yield: 0.534 g, 95%. 
IR υmax (KBr)/cm–1 3256.8 (O−H), 749.5, 732.3 and 696.5 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 8.81 (1H, s, O−H), 7.49-7.29 (21H, m, Ar C−H), 6.76 
(2H, d, Ar C−H, J 9.2 Hz), 6.59 (2H, d, Ar C−H, J 6.8 Hz), 4.01 (4H, d, CH2, J 3.6 Hz) 
ppm. 
31P NMR data: δ -27.41 ppm. 
Analysis calculated for C32H29ONP2: C, 76.03; H, 5.78; N, 2.77. Found:  C, 75.43; H, 
5.71; N, 2.84%. 
m/z 504 [C32H29ONP2]+. 
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Compound 4.23 
Yield: 0.464 g, 79%. 
IR υmax (KBr)/cm–1 3398.2 (O−H), 744.8, 715.9 and 699.1 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 8.62 (1H, s, O−H), 7.37-7.23 (20H, m, Ar C−H), 6.76 
(1H, s, Ar C−H), 6.69-6.57 (2H, m, Ar C−H), 4.15 (4H, d, CH2, J 2.4 Hz), 2.10 (3H, s, 
CH3) ppm. 
31P NMR data: δ -27.50 ppm. 
Analysis calculated for C33H31ONP2: C, 76.29; H, 6.01; N, 2.70. Found:  C, 76.07; H, 
6.13; N, 2.78%. 
m/z 518 [C33H31ONP2]+. 
 
Compound 4.24  
Yield: 0.323 g, 56%. 
IR υmax (KBr)/cm–1 3281.5 (O−H), 2920.3 (sp3 C−H), 740.7 and 694.2 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 9.06 (1H, s, O−H), 7.36-7.26 (20H, m, Ar C−H), 7.15 
(1H, d, Ar C−H, J 8.5 Hz), 6.50 (1H, dd, Ar C−H, J 2.4 and 8.4 Hz), 6.44 (1H, d, Ar 
C−H, J 2.4 Hz), 3.96 (4H, d, CH2, J 5.6 Hz), 1.74 (3H, s, CH3) ppm . 
31P NMR data: δ -27.30 ppm. 
Analysis calculated for C33H31ONP2·2CH3OH: C, 72.03; H, 6.74; N, 2.40. Found: C, 
72.45; H, 6.04; N, 2.58%. 
m/z 518 [C33H31ONP2]+. 
 
Compound 4.25  
Yield: 0.559 g, 97%. 
IR υmax (KBr)/cm–1 3389.3 (O−H), 2917.3 (sp3 C−H), 767.3, 748.6, 732.9 and 696.9 (Ar 
C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 8.77 (1H, s, O−H), 7.44-7.22 (20H, m, Ar C−H), 6.86 
(1H, d, Ar C−H, J 8 Hz), 6.54 (1H, s, Ar C−H), 6.48 (1H, d, Ar C−H, J 8 Hz), 4.09 (4H, 
d, CH2, J 3.4 Hz), 2.12 (3H, s, CH3) ppm. 
31P NMR data: δ -27.48 ppm. 
Analysis calculated for C33H31ONP2: C, 76.29; H, 6.01; N, 2.70. Found:  C, 75.99; H, 
6.00; N, 2.76%. 
m/z 518 [C33H31ONP2]+. 
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Compound 4.26  
Yield: 0.339 g, 38%. 
IR υmax (KBr)/cm–1 3431.9 (O−H), 736.7 and 691.9 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 8.63 (1H, s, O−H), 7.40-7.30 (21H, m, Ar C−H), 6.55 
(2H, m, Ar C−H), 4.02 (4H, d, CH2, J 3.2 Hz), 1.96 (3H, s, CH3) ppm. 
31P NMR data: δ -26.68 ppm. 
Analysis calculated for C33H31ONP2: C, 76.29; H, 6.01; N, 2.70. Found:  C, 75.53; H, 
6.05; N, 2.74%. 
m/z 518 [C33H31ONP2]+. 
 
Compound 4.27  
Yield: 0.587 g, 96%. 
IR υmax (KBr)/cm–1 3386.5 (O−H), 738.9 and 693.6 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 9.06 (1H, s, O−H), 7.49-7.33 (20H, m, Ar C−H), 6.85 
(1H, d, Ar C−H, J 8 Hz), 6.50 (1H, d, Ar C−H, J 2 Hz), 6.27 (1H, dd, Ar C−H, J 2.4 
and 8.4 Hz), 3.88 (4H, d, CH2, J 3.6 Hz), 2.08 (3H, s, CH3) ppm. 
31P NMR data: δ -26.41 ppm. 
Analysis calculated for C33H31ONP2·MeOH: C, 74.03; H, 6.40; N, 2.54. Found:  C, 
74.81; H, 5.93; N, 2.61%. 
m/z 518 [C33H31ONP2]+. 
 
Compound 4.28  
Yield: 0.556 g, 93%. 
1H NMR (400 MHz, (CD3)2SO) δ 8.77 (1H, s, O−H), 7.48-7.28 (20H, m, Ar C−H), 
6.90-6.87 (2H, m, Ar C−H), 6.66 (1H, dd, Ar C−H, J 3.2 and 5.6 Hz), 4.17 (4H, d, CH2, 
J 3.6 Hz), 2.56 (9H, s, CH3) ppm. 
31P NMR data: δ -25.32 ppm. 
 
The following general method was used for the synthesis of compounds 4.29–4.37: To a 
solution of PtCl2(COD) in dichloromethane (5 ml) was added a solution of 4.20–4.28 (1 
eq) in dichloromethane (5 ml). The pale yellow/colourless solutions obtained were 
stirred for 30 min at r.t., the solution was evaporated to ca. 2-3 ml under reduced 
pressure and diethyl ether (10 ml) added. The suspension was stirred for 10 min. The 
white solids obtained were collected by suction filtration and dried in vacuo. 
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Compound 4.29  
Yield: 0.097 g, 99%. 
IR υmax (KBr)/cm–1 3441.1 (O−H), 739.1 and 690.4 (Ar C−H), 315.8 and 281.9 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.65 (1H, s, O−H), 7.99-7.94 (8H, m, Ar C−H), 7.66-
7.52 (12H, m, Ar C−H), 7.04 (1H, m, Ar C−H), 6.87 (1H, dd, Ar C−H, J 0.8 and 8 Hz), 
6.57 (1H, m, Ar C−H), 6.30 (1H, dd, Ar C−H, J 1.6 and 8 Hz), 4.29 (4H, s, CH2) ppm. 
Analysis calculated for C32H29ONP2Cl2Pt: C, 49.82; H, 3.79; N, 1.82. Found: C, 49.61; 
H, 3.47; N, 1.82%. 
m/z 770 [C32H29ONP2Cl2Pt]+, 734 [M-Cl]+, 699 [M-2Cl]+. 
 
Compound 4.30  
Yield: 0.115 g, 89%. 
IR υmax (KBr)/cm–1 3355.5 (O−H), 735.8 and 689.3 (Ar C−H), 310.7 and 288.8 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 8.45 (1H, s, O−H), 7.45-7.05 (10H, m, Ar C−H), 
6.89-6.76 (14H, m, Ar C−H), 6.31 (1H, t, Ar C−H), 4.31 (4H, s, CH2) ppm. 
Analysis calculated for C32H29ONP2Cl2Pt: C, 49.82; H, 3.79; N, 1.82. Found: C, 49.31; 
H, 3.58; N, 1.79%. 
m/z 771 [C32H29ONP2Cl2Pt]+, 735 [M+-Cl], 700 [M+-2Cl]. 
 
Compound 4.31  
Yield: 0.089 g, 78%. 
IR υmax (KBr)/cm–1 3374.9 (O−H), 735.6 and 689.4 (Ar C−H), 312.2 and 286.5 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.11 (1H, s, O−H), 7.91-7.84 (8H, m, Ar C−H), 7.59-
7.44 (12H, m, Ar C−H), 6.50 (4H, m, Ar C−H), 4.28 (4H, s, CH2) ppm. 
Analysis calculated for C32H29ONP2Cl2Pt: C, 49.82; H, 3.79; N, 1.82. Found: C, 49.64; 
H, 3.74; N, 1.86%. 
Accurate mass for [C32H29ONP2Cl2Pt]+ 771.5828, requires 769.0885. m/z 771 
[C32H29ONP2Cl2Pt]+, 735 [M-Cl]+, 700 [M-2Cl]+. 
 
Compound 4.32  
Yield: 0.111 g, 98%. 
IR υmax (KBr)/cm–1 3313.9 (O−H), 741.8, 726.4 and 693.1 (Ar C−H), 316.1 and 288.8 
(Pt−Cl). 
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1H NMR (400 MHz, (CD3)2SO) δ 9.25 (1H, s, O−H), 7.89-7.80 (8H, m, Ar C−H), 7.64-
7.46 (12H, m, Ar C−H), 6.68 (2H, dd, Ar C−H, J 8 and 29.2 Hz), 5.90 (1H, s, Ar C−H), 
4.21 (4H, bs, CH2), 1.92 (3H, s, CH3) ppm. 
Analysis calculated for C33H31ONP2Cl2Pt·CH2Cl2: C, 46.91; H, 3.82; N, 1.61. Found: C, 
47.07; H, 3.77; N, 1.69%. 
m/z 784 [C33H31ONP2Cl2Pt]+, 749 [M+-Cl]. 
 
Compound 4.33  
Yield: 0.097 g, 81%. 
IR υmax (KBr)/cm–1 3373.1 (O−H), 734.0, 694.9 and 686.7 (Ar C−H), 314.9 and 282.4 
(Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.22 (1H, s, O−H), 7.96-7.53 (20H, m, Ar C−H), 6.96 
(1H, d, Ar C−H, J 8.8 Hz), 6.49 (1H, dd, Ar C−H, J 2.8 and 8.4 Hz), 6.33 (1H, d, Ar 
C−H, J 2.8 Hz), 4.19 (4H, bs, CH2), 1.29 (3H, s, CH3) ppm. 
Analysis calculated for C33H31ONP2Cl2Pt: C, 50.46; H, 3.98; N, 1.78. Found: C, 50.51; 
H, 4.13; N, 1.83%. 
m/z 785 [C33H31ONP2Cl2Pt]+, 750 [M+-Cl], 714 [M+-2Cl]. 
 
Compound 4.34  
Yield: 0.093 g, 78%. 
IR υmax (KBr)/cm–1 3432.5 (O−H), 739.1 and 690.5 (Ar C−H), 315.1 and 285.9 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.42 (1H, s, O−H), 7.89-7.84 (8H, m, Ar C−H), 7.56-
7.43 (12H, m, Ar C−H), 6.59 (1H, s, Ar C−H), 6.30 (1H, d, Ar C−H, J 8 Hz), 6.05 (1H, 
d, Ar C−H, J 8 Hz), 4.16 (4H, s, CH2), 2.06 (3H, s, CH3) ppm. 
Analysis calculated for C33H31ONP2Cl2Pt·0.5CH2Cl2: C, 48.96; H, 3.87; N, 1.68. Found: 
C, 49.42; H, 3.96; N, 1.73%. 
m/z 784 [C33H31ONP2Cl2Pt]+, 749 [M-Cl]+, 713 [M-2Cl]+. 
 
Compound 4.35  
Yield: 0.097 g, 99%. 
IR υmax (KBr)/cm–1 3420.5 (O−H), 743.9, 724.9 and 688.1 (Ar C−H), 308.9 and 289.9 
(Pt−Cl). 
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1H NMR (400 MHz, (CD3)2SO) δ 8.44 (1H, s, O−H), 7.94-7.87 (8H, m, Ar C−H), 7.78-
7.62 (12H, m, Ar C−H), 6.86 (1H, d, Ar C−H, J 8.4 Hz), 6.47 (2H, m, Ar C−H), 4.43 
(4H, s, CH2), 2.02 (3H, s, CH3) ppm. 
Analysis calculated for C33H31ONP2Cl2Pt: C, 50.46; H, 3.98; N, 1.78. Found: C, 50.24; 
H, 3.98; N, 1.85%. 
m/z [C33H31ONP2Cl2Pt]+: 749 [M+-Cl], 713 [M+-2Cl]. 
 
Compound 4.36  
Yield: 0.081 g, 67%. 
IR υmax (KBr)/cm–1 3415.9 (O−H), 735.7 and 692.3 (Ar C−H), 314.0 and 289.6 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.01 (1H, s, O−H), 7.96-7.85 (8H, m, Ar C−H), 7.59-
7.45 (12H, m, Ar C−H), 6.75 (1H, d, Ar C−H, J 8.4 Hz), 6.27 (1H, d, Ar C−H, J 2.4 
Hz), 6.03 (1H, dd, Ar C−H, J 2.4 and 8.4 Hz), 4.33 (4H, s, CH2), 2.09 (3H, s, CH3), 
ppm. 
Analysis calculated for C33H31ONP2Cl2Pt: C, 50.46; H, 3.98; N, 1.78. Found: C, 50.66; 
H, 4.61; N, 1.70%. 
m/z 785 [C33H31ONP2Cl2Pt]+, 750 [M+-Cl], 714 [M+-2Cl]. 
 
 
Compound 4.37  
Yield: 0.083 g, 66%. 
IR υmax (KBr)/cm–1 3284.6 (O−H), 736.8, 710.4 and 689.4 (Ar C−H), 316.3 and 284.0 
(Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.48 (1H, s, O−H), 8.01-7.92 (8H, m, Ar C−H), 7.67-
7.52 (12H, m, Ar C−H), 7.03 (1H, d, Ar C−H, J 2.4 Hz), 6.76 (1H, d, Ar C−H, J 8.4 
Hz), 6.07 (1H, s, Ar C−H), 4.01 (4H, s, CH2), 1.09 (9H, s, CH3) ppm.  
Analysis calculated for C36H37ONP2Cl2Pt·0.5CH2Cl2: C, 50.73; H, 4.37; N, 1.60. Found:  
C, 50.44; H, 4.40; N, 1.69%. 
m/z 826 [C36H37ONP2Cl2Pt]+, 790 [M+-Cl], 755 [M+-2Cl]. 
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The following general method was used for the synthesis of compounds 4.38–4.46: To a 
stirring solution of AuCl(tht) in dichloromethane (5 ml) solution of AuCl(tht) was 
added a solution of 4.20–4.28 (0.5 eq) in dichloromethane (5 ml). The pale 
yellow/colourless solutions obtained were stirred for 30 min at rt. The volume was 
evaporated to ca. 2-3 ml under reduced pressure and diethyl ether (10 ml) added. The 
suspension was stirred for 10 min. The white solids obtained were collected by suction 
filtration and dried in vacuo. 
 
Compound 4.38  
Yield: 0.077 g, 79%.  
IR υmax (KBr)/cm–1 3419.9.6 (O−H), 743.5 and 690.9 (Ar C−H), 328.1 (Au−Cl). 
1H NMR (400 MHz, CDCl3) δ 7.76-7.14 (20H, m, Ar C−H), 6.84 (2H, bs, Ar C−H), 
6.73 (2H, bs, Ar C−H), 4.54 (4H, s, CH2) ppm. 
Analysis calculated for C32H29NOP2Cl2Au2: C, 39.61; H, 3.01; N, 1.44. Found: C, 
40.79; H, 2.85; N, 1.49%. 
m/z [C32H29ONP2Cl2Au2]+: 934 [M+-Cl], 898 [M+-2Cl]. 
 
Compound 4.39  
Yield: 0.056 g, 70%.  
IR υmax (KBr)/cm–1 3326.5 (O−H), 743.0 and 691.2 (Ar C−H), 326.4 (Au−Cl). 
1H NMR (400 MHz, CDCl3) δ 9.28 (1H, s, O−H), 7.88-7.82 (8H, m, Ar C−H), 7.57-
7.46 (13H, m, Ar C−H), 7.14 (1H, d, Ar C−H, J 8.1 Hz), 6.86 (1H, d, Ar C−H, J 16.4 
Hz), 6.63 (1H, dd, Ar C−H, J 8.4 and 16.2 Hz), 4.75 (4H, s, CH2) ppm. 
Analysis calculated for C32H29NOP2Cl2Au2: C, 39.61; H, 3.01; N, 1.44. Found: C, 
39.52; H, 3.21; N, 2.52%. 
m/z 968 [C32H29ONP2Cl2Au2]+. 
 
Compound 4.40  
Yield: 0.055 g, 69%.  
IR υmax (KBr)/cm–1 3394.6 (O−H), 743.1 and 690.6 (Ar C−H), 324.8 (Au−Cl). 
1H NMR (400 MHz, CDCl3) δ 8.97 (1H, s, O−H), 7.73-7.69 (8H, m, Ar C−H), 7.60-
7.45 (12H, m, Ar C−H), 7.67 (2H, d, Ar C−H, J 8.8 Hz), 6.30 (2H, d, Ar C−H, J 8.4 
Hz), 4.84 (4H, s, CH2) ppm. 
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Analysis calculated for C32H29NOP2Cl2Au2·0.5Et2O: C, 40.22; H, 3.37; N, 1.38. Found: 
C, 40.54; H, 3.10; N, 1.53%. 
m/z [C32H29ONP2Cl2Au2]+: 934 [M+-Cl], 898 [M+-2Cl]. 
 
Compound 4.41  
Yield: 0.079 g, 79%.  
IR υmax (KBr)/cm–1 3384.6 (O−H), 2965.3 (sp3 C−H), 741.9 and 690.1 (Ar C−H), 323.9 
(Au−Cl).   
1H NMR (400 MHz, CDCl3) δ 9.35 (1H, s, O−H), 7.73-7.68 (8H, m, Ar C−H), 7.54-
7.32 (13H, m, Ar C−H), 7.47 (1H, dd, Ar C−H, J 7.2 Hz, J 20.4 Hz), 6.12 (1H, s, Ar 
C−H), 4.80 (4H, s, CH2), 1.78 (3H, s, CH3) ppm. 
Analysis calculated for C33H31NOP2Cl2Au2·Et2O: C, 41.40; H, 3.76; N, 1.34. Found: C, 
41.34; H, 3.62; N, 1.45%. 
m/z [Au2C33H31ONP2Cl2]+: 948 [M+-Cl], 912 [M+-2Cl]. 
 
Compound 4.42  
Yield: 0.068 g, 74%.  
IR υmax (KBr)/cm–1 3422.0 (O−H), 2940.2 (sp3 C−H), 743.3 and 690.9 (Ar C−H), 328.1 
(Au−Cl).   
1H NMR (400 MHz, CDCl3) δ 8.79 (1H, s, O−H), 7.58-7.53 (8H, m, Ar C−H), 7.36-
7.24 (12H, m, Ar C−H), 6.64 (1H, d, Ar C−H, J 8.4 Hz), 5.96-5.92 (2H, m, Ar C−H), 
4.64 (4H, s, CH2), 1.40 (3H, s, CH3) ppm. 
Analysis calculated for C33H31NOP2Cl2Au2: C, 40.26; H, 3.17; N, 1.42. Found: C, 
39.76; H, 3.32; N, 1.32%. 
m/z 983 [C33H31ONP2Cl2Au2]+, 948 [M+-Cl]. 
 
Compound 4.43  
Yield: 0.077 g, 79%.  
IR υmax (KBr)/cm–1 3411.7 (O−H), 741.9 and 690.0 (Ar C−H), 324.8 (Au−Cl).   
1H NMR (400 MHz, CDCl3) δ 9.59 (1H, s, O−H), 7.87-7.77 (8H, m, Ar C−H), 7.64-
7.48 (12H, m, Ar C−H), 6.44 (1H, s, Ar C−H), 6.26 (1H, d, Ar C−H, J 8 Hz), 6.06 (1H, 
d, Ar C−H, J 6.4 Hz, J 7.6 Hz), 4.87 (4H, s, CH2), 2.09 (3H, s, CH3) ppm. 
Analysis calculated for C33H31NOP2Cl2Au2: C, 40.26; H, 3.17; N, 1.42. Found: C, 
40.40; H, 3.41; N, 1.47%. m/z [C33H31ONP2Cl2Au2]+: 948 [M+-Cl], 912 [M+-2Cl].  
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Compound 4.44  
Yield: 0.067 g, 78%.  
IR υmax (KBr)/cm–1 3396.9 (O−H), 742.5 and 690.3 (Ar C−H), 325.5 (Au−Cl). 
1H NMR (400 MHz, CDCl3) δ 7.57-7.52 (8H, m, Ar C−H), 7.43-7.31 (13H, m, Ar 
C−H), 6.42 (2H, m, Ar C−H), 4.62 (4H, s, CH2), 1.98 (3H, s, CH3) ppm. 
Analysis calculated for C33H31NOP2Cl2Au2·CH2Cl2: C, 38.19; H, 3.11; N, 1.31. Found: 
C, 38.69; H, 3.22; N, 1.37%. 
m/z 983 [C33H31ONP2Cl2Au2]+, 948 [M+-Cl], 912 [M+-2Cl]. 
 
Compound 4.45  
Yield: 0.048 g, 57%.  
IR υmax (KBr)/cm–1 3420.2 (O−H), 743.2 and 690.9 (Ar C−H), 328.0 (Au−Cl). 
1H NMR (400 MHz, CDCl3) δ 8.86 (1H, s, O−H), 7.78-7.10 (20H, m, Ar C−H), 6.58 
(1H, bs, Ar C−H), 6.40 (1H, s, Ar C−H), 6.29 (1H, dd, Ar C−H, J 6.4 Hz, J 8.4 Hz), 
4.69 (4H, s, CH2), 1.96 (3H, s, CH3) ppm. 
Analysis calculated for C33H31NOP2Cl2Au2·Et2O: C, 41.98; H, 3.90; N, 1.32. Found: C, 
42.66; H, 3.42; N, 1.57%. 
m/z [C33H31ONP2Cl2Au2]+: 948 [M+-Cl], 912 [M+-2Cl]. 
 
Compound 4.46  
Yield: 0.029 g, 45%.  
IR υmax (KBr)/cm–1 3420.1 (O−H), 2957.2 (sp3 C−H), 743.8 and 691.3 (Ar C−H), 328.1 
(Au−Cl). 
1H NMR (400 MHz, CDCl3) δ 9.58 (1H, s, O−H), 7.73-7.16 (20H, m, Ar C−H), 6.68 
(1H, m, Ar C−H), 6.46 (2H, m, Ar C−H), 4.78 (4H, s, CH2), 1.98 (3H, s, CH3) ppm. 
Analysis calculated for C36H37NOP2Cl2Au2: C, 42.12; H, 3.63; N, 1.36. Found: C, 
42.92; H, 3.85; N, 1.53%. 
m/z [C36H37ONP2Cl2Au2]+: 990 [M+-Cl], 954 [M+-2Cl]. 
 
The following general method was used for the synthesis of compounds 4.48–4.57: To a 
solution of [Mo(CO)4(nbd)] in dichloromethane (5 ml) was added a solution of 4.20–
4.28 (1 eq) in dichloromethane (5 ml). The pale yellow solutions obtained were stirred 
for 24 h at r.t. under N2, the solution was evaporated to ca. 2-3 ml under reduced 
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pressure and diethyl ether (10 ml) added. The suspension was stirred for 10 min. The 
yellow/brown solids obtained were collected by suction filtration and dried in vacuo. 
 
Compound 4.48  
Yield: 0.045 g, 39%.  
IR υmax (KBr)/cm–1 3436.1 (O−H), 2018.8, 1926.4, 1896.3 and 1887.9 (CO), 736.2 and 
694.2 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 9.71 (1H, s, O−H), 7.58-7.48 (20H, m, Ar C−H), 7.07 
(1H, m, Ar C−H), 6.92 (1H, d, Ar C−H, J 8.8 Hz), 6.65 (1H, m, Ar C−H), 6.42 (1H, dd, 
Ar C−H,  J 2.4 Hz, J 6.8 Hz), 4.11 (4H, s, CH2) ppm. 
31P NMR data: δ 15.13 ppm. 
Analysis calculated for C36H29NO5P2Mo: C, 60.60; H, 4.10; N, 1.96. Found: C, 59.52; 
H, 4.42; N, 1.92%. 
m/z 715 [C36H29O5NP2Mo]+, 687 [M+-CO], 659 [M+-2CO], 631 [M+-3CO] and 603 
[M+-4CO]. 
 
Compound 4.49  
Yield: 0.048 g, 35%.  
IR υmax (KBr)/cm–1 3411.9 (O−H), 2019.7, 1920.5 and 1896.9 (CO), 741.4 and 693.8 
(Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.79-6.88 (24H, m, Ar C−H, O−H), 6.72 (1H, s, Ar 
C−H), 6.34 (1H, d, Ar C−H, J 8.4 Hz), 6.02 (1H, d, Ar C−H, J 8.4 Hz), 4.09 (4H, s, 
CH2) ppm. 
31P NMR data: δ 18.21 ppm. 
Analysis calculated for C36H29NO5P2Mo: C, 60.60; H, 4.10; N, 1.96. Found: C, 61.10; 
H, 4.10; N, 1.40%. 
m/z 715 [C36H29O5NP2Mo]+, 687 [M+-CO], 659 [M+-2CO], 631 [M+-3CO] and 603 
[M+-4CO]. 
 
Compound 4.50  
Yield: 0.036 g, 30%.  
IR υmax (KBr)/cm–1 3385.8 (O−H), 2019.1, 1919.1 and 1894.5 (CO), 740.8 and 694.1 
(Ar C−H). 
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1H NMR (400 MHz, CDCl3) δ 9.23 (1H, s, O−H), 7.68-7.24 (21H, m, Ar C−H), 6.83 
(1H, m, Ar C−H), 6.57 (2H, m, Ar C−H), 4.12 (4H, s, CH2) ppm. 
31P NMR data: δ 18.39 ppm. 
Analysis calculated for C36H29NO5P2Mo·CH2Cl2: C, 55.66; H, 3.91; N, 1.75. Found: C, 
55.21; H, 4.19; N, 1.34%. 
m/z 715 [C36H29O5NP2Mo]+, 687 [M+-CO], 659 [M+-2CO], 631 [M+-3CO] and 603 
[M+-4CO]. 
 
Compound 4.51  
Yield: 0.025 g, 26%.  
IR υmax (KBr)/cm–1 3450.8 (O−H), 2017.8, 1926.7, 1892.4 and 1888.1 (CO), 736.4 and 
694.4 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.39-7.19 (20H, m, Ar C−H), 6.90 (1H, s, Ar C−H), 6.78 
(1H, d, Ar C−H, J 8.4 Hz), 6.57 (1H, d, Ar C−H, J 8.4 Hz), 4.65 (4H, s, CH2), 2.20 (3H, 
s, CH3) ppm. 
31P NMR data: δ 20.85 ppm. 
Analysis calculated for C37H31NO5P2Mo·CH2Cl2: C, 56.18; H, 4.09; N, 1.72. Found: C, 
55.71; H, 4.25; N, 1.66%. 
 
Compound 4.52  
Yield: 0.043 g, 40%.  
IR υmax (KBr)/cm–1 3384.9 (O−H), 2018.8, 1916.5 and 1897.2 (CO), 741.2 and 693.6 
(Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.42-7.16 (20H, m, Ar C−H), 6.37 (2H, m, Ar C−H), 
6.28 (1H, s, Ar C−H), 3.65 (4H, s, CH2), 2.32 (3H, s, CH3) ppm. 
31P NMR data: δ 18.55 ppm. 
Analysis calculated for C37H31NO5P2Mo·0.5Et2O: C, 60.63; H, 4.70; N, 1.81. Found: C, 
59.57; H, 5.01; N, 1.93%. 
m/z 727 [C37H31O5NP2Mo]+, 701 [M+-CO], 674 [M+-2CO], 645 [M+-3CO]. 
 
Compound 4.53  
Yield: 0.048 g, 38%.  
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IR υmax (KBr)/cm–1 3432.0 (O−H), 2019.9, 1924.4, 1904.5 and 1878.2 (CO), 736.4 and 
693.7 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 9.50 (1H, s, O−H), 7.52-7.42 (20H, m, Ar C−H), 6.66 
(1H, s, Ar C−H), 6.41 (1H, d, Ar C−H, J 7.6 Hz), 6.25 (1H, d, Ar C−H, J 6.8 Hz), 4.03 
(4H, s, CH2), 2.16 (3H, s, CH3) ppm. 
31P NMR data: δ 20.11 ppm. 
Analysis calculated for C37H31NO5P2Mo: C, 61.08; H, 4.29; N, 1.93. Found: C, 60.81; 
H, 4.67; N, 1.98%. 
m/z 727 [C37H31O5NP2Mo]+, 673 [M+-2CO], 645 [M+-3CO]. 
 
Compound 4.54  
Yield: 0.049 g, 33%.  
IR υmax (KBr)/cm–1 3397.1 (O−H), 2018.7, 1920.5 and 1897.7 (CO), 741.4 and 693.9 
(Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.49-7.38 (20H, m, Ar C−H), 6.45 (1H, s, Ar C−H), 6.26 
(2H, m, Ar C−H), 3.54 (4H, s, CH2), 2.19 (3H, s, CH3) ppm. 
31P NMR data: δ 18.67 ppm. 
Analysis calculated for C37H31NO5P2Mo·CH2Cl2: C, 56.18; H, 4.09; N, 1.72. Found: C, 
56.88; H, 4.63; N, 1.73%. 
m/z 728 [C37H31O5NP2Mo]+, 701 [M+-CO], 672 [M+-2CO], 645 [M+-3CO] and 617 
[M+-4CO]. 
 
Compound 4.55  
Yield: 0.089 g, 55%.  
IR υmax (KBr)/cm–1 3422.3 (O−H), 2018.3, 1920.6 and 1897.3 (CO), 741.7 and 694.1 
(Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 7.98-7.57 (20H, m, Ar C−H), 6.98 (1H, d, Ar C−H, J 
2.4 Hz), 6.67 (1H, d, Ar C−H, J 8.4 Hz), 6.12 (1H, s, Ar C−H), 4.12 (4H, s, CH2), 2.09 
(9H, s, CH3) ppm. 
31P NMR data: δ 14.97 ppm. 
Analysis calculated for C40H37NO5P2Mo: C, 62.42; H, 4.85; N, 1.82. Found: C, 61.58; 
H, 5.26; N, 1.80%. 
m/z [C40H37O5NP2Mo]+: 741 [M+-CO], 713 [M+-2CO], 687 [M+-3CO] and 658 [M+-
4CO]. 
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Compound 4.56 
Yield: 0.071 g, 50%.  
IR υmax (KBr)/cm–1 2020.4, 1926.1 and 1893.8 (CO), 742.7 and 694.4 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.59-7.28 (20H, m, Ar C−H), 7.05 (2H, m, Ar C−H), 
6.56 (3H, m, Ar C−H), 3.98 (4H, s, CH2) ppm. 
31P NMR data: δ 21.14 ppm. 
Analysis calculated for C36H29NO4P2Mo: C, 63.25; H, 4.90; N, 1.89. Found: C, 63.09; 
H, 4.75; N, 1.87%. 
 
The following general method was used for the synthesis of compounds 4.59–4.67: To a 
stirring solution of N-carbobenzyloxyglycine in THF (60 ml), primary amines I–IX and 
dicyclohexylcarbodiimide were added respectively. The solution was stirred for 4 h at 
room temperature. The unwanted by-product was filtered and the solution obtained 
evaporated to dryness and a brown/white residue obtained. The residue was treated with 
ethyl acetate (50 ml) and petroleum ether b.p. 40-60 (50 ml) and left stirring for 1 h at 
room temperature. The solid obtained was filtered and dried under vacuum yielding a 
pale brown/white solid. 
 
Compound 4.59  
Yield: 2.265 g, 63%. 
IR υmax (KBr)/cm–1 3254.7 (O−H), 3391.6 (N−H), 2927.7 (sp3 C−H), 1663.5, 1661.9 
(C=O amide), 1323.1 (C−O), 900.3-690.7 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.87 (1H, s, O−H), 9.10 (1H, s, N−H), 7.90 (1H, d, 
Ar C−H), 7.58 (1H, s, N−H), 7.40-7.23 (5H, m, Ar C−H), 6.92 (1H, t, Ar C−H), 6.87 
(1H, d, Ar C−H), 6.77 (1H, t, Ar C−H), 5.07 (2H, s, CH2), 3.85 (2H, d, J 3.4 Hz, CH2) 
ppm.   
Analysis calculated for C16H16O4N2: C, 63.99; H, 5.37; N, 9.33. Found: C, 64.10; H, 
5.71; N, 9.45%. 
m/z 300 [C16H16O4N2]+. 
 
Compound 4.60  
Yield: 2.849 g, 80%. 
IR υmax (KBr)/cm–1 3312.3 (O−H), 3392.5 (N−H), 2934.7 (sp3 C−H), 1678.8, 1674.4 
(C=O amide), 1385.1 (C−O), 775.0, 732.2, 693.9 and 683.1 (Ar C−H).  
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1H NMR (400 MHz, (CD3)2SO) δ 9.87 (1H, s, O−H), 9.43 (1H, s, N−H), 7.48-6.99 (8H, 
m, Ar C−H), 6.50 (1H, d, Ar C−H, J 7.6 Hz), 5.11 (4H, s, CH2), 4.10 (1H, bs, N−H), 
3.83 (2H, d, CH2, J 3.2 Hz) ppm.   
Analysis calculated for C16H16O4N2: C, 63.99; H, 5.37; N, 9.33. Found: C, 64.23; H, 
5.66; N, 9.48%. 
 m/z 300 [C16H16O4N2]+. 
 
Compound 4.61  
Yield: 2.753 g, 77%. 
IR υmax (KBr)/cm–1 3331.5 (O−H), 2928.5 (sp3 C−H), 1691.7, 1668.1 (C=O amide), 
1374.8 (C−O), 831.4, 788.4, 736.6, 697.3 and 641.2 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.69 (1H, s, O−H), 9.18 (1H, s, N−H), 7.27-7.52 (5H, 
m, Ar C−H), 6.70 (4H, d, J 10 Hz, Ar C−H), 5.05 (2H, s, CH2), 3.75 (2H, d, J 6 Hz, 
CH2) ppm.   
Analysis calculated for C16H16O4N2: C, 63.99; H, 5.37; N, 9.33. Found: C, 64.40; H, 
5.85; N, 9.32%. 
Accurate mass for [C16H16O4N2]+ 300.1110, requires 300.1110. m/z 300 [C16H16O4N2]+.   
 
Compound 4.62 
Yield: 1.780 g, 53%. 
IR υmax (KBr)/cm–1 3266.2 (O−H), 3330.9 (N−H), 2924.8 (sp3 C−H), 1669.3, 1664.3 
(C=O amide), 1309.6 (C−O), 912.3-697.2 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.62 (1H, s, N−H), 9.05 (1H, s, O−H), 7.70 (1H, s, 
NH−C=O), 7.41-7.25 (5H, m, Ar C−H), 6.77-6.70 (3H, m, Ar C−H), 5.05 (2H, s, CH2), 
3.83 (2H, d, J 2.4 Hz, CH2), 2.14 (3H, s, CH3) ppm.   
Analysis calculated for C17H18O4N2: C, 64.96; H, 5.77; N, 8.91. Found: C, 65.07; H, 
5.95; N, 8.96%. 
m/z 314 [C17H18O4N2]+. 
 
Compound 4.63 
Yield: 2.003 g, 60%. 
IR υmax (KBr)/cm–1 3286.5 (O−H), 3343.4 (N−H), 2943.2 (sp3 C−H), 1669.4, 1652.9 
(C=O amide), 1352.0 (C−O), 872.4, 781.6, 693.7 (Ar C−H). 
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1H NMR (400 MHz, (CD3)2SO) δ 9.21 (1H, s, O−H), 9.10 (1H, s, N−H), 7.51 (1H, s, 
N−H), 7.40-7.27 (5H, m, Ar C−H), 7.05 (1H, d, Ar C−H), 6.60 (1H, s, Ar C−H), 6.55 
(1H, d, Ar C−H), 5.05 (2H, s, CH2), 3.77 (2H, d, CH2) 2.07 (3H, s, CH3) ppm.   
Analysis calculated for C17H18O4N2: C, 64.96; H, 5.77; N, 8.91. Found: C, 64.99; H, 
5.76; N, 9.06%. 
m/z 314 [C17H18O4N2]+. 
 
Compound 4.64  
Yield: 2.177 g, 66%. 
IR υmax (KBr)/cm–1 3292.3 (O−H), 3373.3 (N−H), 2900.1 (sp3 C−H), 1667.5, 1664.6 
(C=O amide), 1319.6 (C−O), 858.3-769.5 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.71 (1H, s, O−H), 9.05 (1H, s, N−H), 7.70 (1H, s, 
C−H), 7.67 (1H, s, NH−C=O), 7.40-7.25 (5H, m, Ar C−H), 6.70 (1H, s, Ar C−H), 6.58 
(1H, d, C−H), 5.05 (2H, s, CH2), 3.85 (2H, d, CH2), 2.20 (3H, s, CH3) ppm.   
Analysis calculated for C17H18O4N2: C, 64.96; H, 5.77; N, 8.91. Found: C, 65.07; H, 
5.94; N, 8.98%. 
m/z 314 [C17H18O4N2]+. 
 
Compound 4.65  
Yield: 2.263 g, 69%. 
IR υmax (KBr)/cm–1 3271.2 (O−H), 3365.9 (N−H), 1708.7, 1639.3 (C=O amide), 1363.7 
(C−O), 748.4, 696.6 and 594.2 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.69 (1H, s, N−H), 9.24 (1H, s, O−H), 7.54-7.17 (8H, 
m, Ar C−H), 6.69 (1H, d, Ar C−H, J 8.4 Hz), 5.05 (2H, s, CH2), 3.75 (2H, d, CH2, J 6 
Hz), 2.09 (3H, s, CH3) ppm. 
Analysis calculated for C17H18N2O4: C, 64.96; H, 5.77; N, 8.91. Found:  C, 65.13; H, 
6.06; N, 9.02%. 
Accurate mass for [C17H18O4N2]+ 314.1267, requires 314.1263. m/z 314 [C17H18O4N2]+.   
 
Compound 4.66  
Yield: 2.104 g, 64%. 
IR υmax (KBr)/cm–1 3316.0 (O−H), 3401.8 (N−H), 1695.1, 1673.8 (C=O amide), 1382.1 
(C−O), 779.5, 727.9 and 693.4 (Ar C−H).  
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1H NMR (400 MHz, (CD3)2SO) δ 9.64 (1H, s, N−H), 9.27 (1H, s, O−H), 7.47-7.11 (6H, 
m, Ar C−H), 6.89 (1H, d, Ar C−H, J 16.4 Hz), 6.76 (1H, dd, Ar C−H, J 1.7, 9.7 Hz), 
4.96 (2H, s, CH2), 3.68 (2H, d, CH2, J 6.4 Hz), 2.00 (3H, s, CH3) ppm. 
Analysis calculated for C17H18N2O4: C, 64.96; H, 5.77; N, 8.91. Found: C, 65.09; H, 
6.09; N, 9.01%. 
Accurate mass for [C17H18O4N2]+ 314.1267, requires 314.1266. m/z 314 [C17H18O4N2]+.  
 
Compound 4.67  
Yield: 3.894 g, 91%. 
IR υmax (KBr)/cm–1 3322.1 (O−H), 3431.2 (N−H), 2936.0 (sp3 C−H), 1776.2, 1663.0 
(C=O amide), 1356.8 (C−O), 737.6, 715.7 and 696.3 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ9.64 (1H, bs, N−H), 9.14 (1H, s, O−H), 7.92 (1H, s, 
N−H), 7.74-7.26 (6H, m, Ar C−H), 6.96 (1H, dd, Ar C−H, J 8.4, 2.3 Hz), 6.87 (1H, d, 
Ar C−H, J 6.5 Hz), 5.07 (2H, s, CH2), 3.85 (2H, d, CH2, J 6 Hz), 1.23 (9H, s, tBu) ppm. 
Analysis calculated for C20H24N2O4: C, 67.40; H, 6.79; N, 7.86. Found: C, 67.43; H, 
7.14; N, 8.05%. 
Accurate mass for [C20H24O4N2]+ 356.4212, requires 356.4221. m/z 356 [C20H24O4N2]+. 
   
The following general method was used for the synthesis of compounds 4.68–4.76: To a 
solution of compounds 4.59–4.67 in absolute ethanol (60 ml) were added cyclohexene 
(2.5 ml) and Pd/C (1.5 g). The solution was refluxed for 15 min (110-120 ºC). The Pd/C 
was filtered and the solution obtained was evaporated to dryness yielding the desired 
product.  
 
Compound 4.68  
Yield: 0.407 g, 73%. 
IR υmax (KBr)/cm–1 3419.6 (N−H), 3296.7 (O−H), 1648.1 (C=O amide), 902.6-760.9 
(Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 8.18 (1H, s, O−H), 6.95 (1H, s, NH−C=O), 6.80-6.73 
(4H, m, Ar C−H), 5.57 (2H, d, CH2, J 8 Hz).   
Analysis calculated for C8H10N2O2: C, 57.82; H, 6.07; N, 16.86. Found: C, 57.59; H, 
6.40; N, 15.83%. 
m/z 167 [C8H10O2N2]+, 136 [C7H6O2N]+. 
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Compound 4.69 
Yield: 0.177 g, 32%. 
IR υmax (KBr)/cm–1 3358.8 (N−H), 3312.7 (O−H), 1674.1 (C=O amide), 775.1, 762.3 
and 679.7 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.67 (1H, bs, N−H), 7.20 (1H, s, Ar C−H), 7.09-7.05 
(1H, m, Ar C−H), 6.98 (1H, d, Ar C−H, J 11.2 Hz), 6.45 (1H, dd, Ar C−H, J 1.2 and 8 
Hz), 5.56 (2H, d, CH2, J 10 Hz) ppm.   
Analysis calculated for C8H10N2O2: C, 57.82; H, 6.07; N, 16.86. Found: C, 57.26; H, 
6.37; N, 15.29%. 
m/z 167 [C8H10O2N2]+, 136 [C7H6O2N]+. 
 
Compound 4.70  
Yield: 0.494 g, 87%. 
IR υmax (KBr)/cm–1 3455.3 (N−H), 3291.5 (O−H), 1656.9 (C=O amide), 856.9 and 
830.8 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.63 (1H, s, N−H), 9.22 (1H, s, O−H), 7.47-7.43 (2H, 
m, C−H), 6.93-6.75 (2H, m, Ar C−H), 7.24 (1H, s, NH−C=O), 5.63 (2H, d, CH2, J 8 
Hz) ppm.  
Analysis calculated for C8H10N2O2: C, 57.82; H, 6.07; N, 16.86. Found: C, 57.70; H, 
6.48; N, 16.60%. 
m/z 167 [C8H10O2N2]+, 136 [C7H6O2N]+. 
 
Compound 4.71  
Yield: 0.450 g, 78%. 
IR υmax (KBr)/cm–1 3420.5 (N−H), 3254.7 (O−H), 2924.8 (sp3 C−H), 1648.1 (C=O 
amide), 937.3-722.3 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 8.01 (1H, s, O−H), 6.76 (1H, s, NH−C=O), 6.74-6.67 
(3H, m, Ar C−H), 5.57 (2H, d, CH2, J 8 Hz), 1.99 (3H, s, CH3) ppm.   
Analysis calculated for C9H12O2N2: C, 59.99; H, 6.71; N, 15.55. Found: C, 59.64; H, 
6.77; N, 14.35%. 
m/z 181 [C9H12O2N2]+. 
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Compound 4.72  
Yield: 0.570 g, 99%. 
IR υmax (KBr)/cm–1 3371.1 (N−H), 3269.1 (O−H), 2900.2 (sp3 C−H), 1661.6 (C=O 
amide), 889.7-668.3 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.04 (1H, s, O−H), 7.13-6.24 (3H, m, C−H), 7.15 
(1H, s, NH−C=O), 5.34 (2H, d, CH2, J 7.6 Hz), 4.01 (3H, s, CH3) ppm. 
Analysis calculated for C9H12O2N2: C, 59.98; H, 6.71; N, 15.55. Found: C, 58.32; H, 
6.97; N, 13.35%. 
m/z 181 [C9H12O2N2]+. 
 
Compound 4.73  
Yield: 0.410 g, 71%. 
IR υmax (KBr)/cm–1 3354.9 (N−H), 3276.8 (O−H), 2915.2 (sp3 C−H), 1652.9 (C=O 
amide), 928.7-668.3 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.61 (1H, s, O−H), 7.83 (1H, s, Ar C−H), 7.75 (1H, s, 
NH−C=O), 6.60-6.32 (2H, m, Ar C−H), 5.34 (2H, d, CH2, J 8 Hz), 2.26 (3H, s, CH3) 
ppm.   
Analysis calculated for C9H12O2N2: C, 59.98; H, 6.71; N, 15.55. Found: C, 59.77; H, 
6.74; N, 14.92%. 
m/z 181 [C9H12O2N2]+. 
 
Compound 4.74  
Yield: 0.472 g, 82%. 
IR υmax (KBr)/cm–1 3374.7 (N−H), 3280.2 (O−H), 2926.3 (sp3 C−H), 1654.5 (C=O 
amide), 916.9, 868.8, 821.8, 747.5 and 697.3 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.57 (1H, bs, N−H), 9.11 (1H, bs, O−H), 7.35 (1H, d, 
Ar C−H, J 2 Hz), 7.27 (1H, dd, Ar C−H, J 2.8 Hz, J 8.8 Hz), 6.74 (1H, d, Ar C−H, J 8.4 
Hz), 3.48 (2H, s, CH2), 2.19 (3H, s, CH3) ppm. 
Analysis calculated for C9H12N2O2: C, 59.99; H, 6.71; N, 15.55. Found:  C, 60.08; H, 
7.06; N, 14.29%. 
m/z 180 [C9H12O2N2]+.   
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Compound 4.75  
Yield: 0.451 g, 78%. 
IR υmax (KBr)/cm–1 3359.1 (N−H), 3197.0 (O−H), 2917.2 (sp3 C−H), 1674.9 (C=O 
amide), 799.1, 768.9, 752.4 and 692.5 (Ar C−H).   
1H NMR (400 MHz, (CD3)2SO) δ 9.66 (1H, bs, N−H), 9.35 (1H, bs, O−H), 7.33 (1H, d, 
Ar C−H, J 2 Hz), 7.00 (1H, d, Ar C−H, J 8 Hz), 6.89 (1H, dd, Ar C−H, J 2 Hz, J 8.4 
Hz), 3.23 (2H, s, CH2), 2.11 (3H, s, CH3) ppm. 
Analysis calculated for C9H12N2O2: C, 59.99; H, 6.71; N, 15.55. Found:  C, 59.98; H, 
7.18; N, 14.05%. 
m/z 180 [C9H12O2N2]+.  
 
Compound 4.76  
Yield: 0.552 g, 93%. 
IR υmax (KBr)/cm–1 3419.7 (N−H), 3072.7 (O−H), 2953.1 (sp3 C−H), 1642.4 (C=O 
amide), 819.8, 773.9 and 642.1 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.48 (1H, bs, N−H), 8.30 (1H, d, O−H, J 2.4 Hz), 
6.96 (2H, dd, Ar C−H, J 2.4 and 8.4 Hz), 6.83 (1H, d, Ar C−H, J 2 and 8.4 Hz), 3.18 
(2H, s, CH2), 2.15 (9H, s, CH3) ppm. 
Analysis calculated for C12H18N2O2: C, 64.82; H, 8.16; N, 12.60. Found:  C, 64.32; H, 
8.18; N, 11.78%. 
m/z 210 [C11H18O2N2]+ .   
 
The following general method was used for the synthesis of compounds 4.77–4.85: The 
mixture of hydroxymethyldiphenylphosphine (2 eq) and the primary amine 4.68–4.76 (1 
eq) in methanol (20 ml) was stirred under N2 for 24 h. In all the cases, except for 
compound 4.78, 4.79, 4.83, 4.84, the solution was evaporated to dryness under reduced 
pressure yielding yellow/white oils. In the case of 4.78, 4.79, 4.83, 4.84, the volume of 
the solution obtained was evaporated to ca. 2-3 ml under reduced pressure and a solid 
was obtained. The suspension was stirred for 10 min. The white solids obtained were 
collected by suction filtration and dried in vacuo. 
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Compound 4.77  
Yield: 0.502, 82%. 
1H NMR (400 MHz, (CD3)2SO) δ 9.37 (1H, s, O−H), 8.48 (1H, s, N−H) 7.96-7.85 (8H, 
m, Ar C−H), 7.54-7.46 (12H, m, Ar C−H), 7.04-6.99 (1H, m, Ar C−H), 6.84 (1H, dd, 
Ar C−H, J 1.2 Hz, J 8 Hz), 6.76-6.73 (1H, m, Ar C−H), 3.76 (4H, s, CH2), 3.46 (2H, s, 
CH2) ppm. 
31P NMR data: δ -25.77 ppm. 
 
Compound 4.78  
Yield: 0.391, 70%. 
IR υmax (KBr)/cm–1 3283.4 (N−H), 3162.6 (O−H), 1653.2 (C=O amide), 741.9 and 
694.9 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.31 (1H, s, O−H), 9.07 (1H, s, N−H), 7.41-7.03 
(21H, m, Ar C−H), 6.94 (1H, t, Ar C−H), 6.40 (1H, dd, Ar C−H, J 2 and 8.4 Hz), 6.30 
(1H, dd, Ar C−H, J 0.8 and 8 Hz), 3.77 (4H, d, CH2, J 4.4 Hz), 3.69 (2H, s, CH2) ppm. 
31P NMR data: δ -27.51 ppm. 
Analysis calculated for C34H32O2N2P2: C, 72.59; H, 5.73; N, 4.98. Found: C, 72.10; H, 
5.80; N, 4.95%. 
m/z 561 [C34H32O2N2P2]+. 
 
Compound 4.79  
Yield: 0.521, 85%. 
IR υmax (KBr)/cm–1 3294.3 (N−H), 3176.3 (O−H), 1667.1 (C=O amide), 745.9 and 
696.3 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.14 (1H, s, O−H), 8.83 (1H, s, N−H), 7.50-7.29 
(20H, m, Ar C−H), 6.88 (2H, d, Ar C−H, J 9.2 Hz), 6.56 (2H, d, Ar C−H, J 12 Hz), 
6.30 (1H, dd, Ar C−H, J 0.8 and 8 Hz), 3.77 (4H, d, CH2, J 4.4 Hz), 3.69 (2H, s, CH2) 
ppm. 
31P NMR data: δ -27.38 ppm. 
Analysis calculated for C34H32O2N2P2: C, 72.59; H, 5.73; N, 4.98. Found: C, 72.15; H, 
5.72; N, 4.95%. 
m/z 561 [C34H32O2N2P2]+. 
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Compound 4.80  
Yield: 0.521 g, 81%.  
1H NMR (400 MHz, DMSO) δ 8.15 (1H, s, O−H), 7.19-7.77 (23H, m, Ar C−H), 5.06 
(2H, s, CH2), 1.19 (3H, s, CH3), 3.62 (4H, d, CH2 J 8 Hz) ppm. 
31P NMR data: δ -25.99 ppm. 
  
Compound 4.81  
Yield: 0.554 g, 89%. 
1H NMR (400 MHz, (CD3)2SO) δ 7.83 (1H, s, O−H), 7.60-7.21 (23H, m, Ar C−H), 5.07 
(2H, s, CH2), 1.63 (3H, s, CH3), 3.69 (4H, d, CH2 J 3.6 Hz) ppm. 
31P NMR data: δ -25.49 ppm.  
 
Compound 4.82  
Yield: 0.547 g, 88%.  
1H NMR (400 MHz, CDCl3) δ 9.34 (1H, s, O−H), 8.17 (1H, s, N−H), 7.19-7.71 (23H, 
m, Ar C−H), 5.27 (4H, d, CH2, J 8 Hz), 1.63 (3H, s, CH3), 3.61 (2H, d, CH2, J 4.8 Hz) 
ppm. 
31P NMR data: δ -26.46 ppm. 
 
Compound 4.83  
Yield: 0.422 g, 65%. 
IR υmax (KBr)/cm–1 3228.3 (N−H), 3047.2 (O−H), 2938.7 (sp3 C−H), 1645.2 (C=O 
amide), 742.2, 734.7 and 692.7 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.05 (1H, s, O−H), 8.68 (1H, s, N−H), 7.55-7.32 
(20H, m, Ar C−H), 6.95 (1H, dd, Ar C−H, J 2.4 Hz, J 8.4 Hz), 6.61 (1H, d, Ar C−H, J 
8.8 Hz), 6.41 (1H, d, Ar C−H, J 2.4 Hz), 3.81 (4H, d, CH2, J 4.8 Hz), 3.69 (2H, s, CH2), 
2.04 (3H, s, CH3) ppm. 
31P NMR data: δ -27.13 ppm. 
Analysis calculated for C35H34O2N2P2: C, 72.91; H, 5.94; N, 4.86. Found: C, 72.72; H, 
5.95; N, 4.88%. 
Accurate mass for [C35H34O2N2P2]+ 576.2096, requires 577.2179. m/z 576 
[C20H24O4N2]+. 
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Compound 4.84  
Yield: 0.537 g, 80%. 
IR υmax (KBr)/cm–1 3316.9 (N−H), 3178.1 (O−H), 2918.7 (sp3 C−H), 1659.5 (C=O 
amide), 753.3, 743.1 and 696.5 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 9.29 (1H, s, O−H), 9.08 (1H, s, N−H), 7.46-7.35 
(20H, m, Ar C−H), 7.29 (1H, d, Ar C−H, J 2 Hz), 6.86 (1H, d, Ar C−H, J 8.8 Hz), 6.15 
(1H, dd, Ar C−H, J 1.6 Hz, J 8 Hz), 3.82 (4H, d, CH2, J 4.4 Hz), 3.73 (2H, s, CH2), 2.08 
(3H, s, CH3) ppm. 
31P NMR data: δ -27.52 ppm. 
Analysis calculated for C35H34O2N2P2: C, 72.91; H, 5.94; N, 4.86. Found: C, 72.71; H, 
5.94; N, 4.82%. 
m/z 575 [C35H34O2N2P2]+. 
 
Compound 4.85  
Yield: 0.645 g, 91%. 
1H NMR (400 MHz, (CD3)2SO) δ 9.52 (1H, s, O−H), 9.03 (1H, s, N−H), 7.83-7.28 
(21H, m, Ar C−H), 6.94 (1H, dd, Ar C−H, J 7.6 and 10 Hz), 6.77 (1H, d, Ar C−H, J 6.8 
Hz), 3.73 (4H, d, CH2, J 2 Hz), 3.68 (2H, s, CH2), 1.22 (9H, s, CH3) ppm. 
31P NMR data: δ -27.76 ppm. 
 
The following general method was used for the synthesis of compounds 4.86–4.94: To a 
stirring solution of PtCl2(COD) in dichloromethane (5 ml) was added a solution of 
4.77–4.85 (1 eq) in dichloromethane (5 ml). The pale yellow/colourless solutions 
obtained were stirred for 30 min. The volume was evaporated to ca. 2-3 ml under 
reduced pressure and diethyl ether (10 ml) added. The suspension was stirred for 10 
min. The white solids obtained were collected by suction filtration and dried in vacuo. 
 
Compound 4.86  
Yield: 0.086 g, 57%. 
IR υmax (KBr)/cm–1 3243.5 (N−H), 3051.6 (O−H), 1653.0 (C=O amide), 743.9 and 
688.7 (Ar C−H), 307.6 and 285.8 (Pt−Cl). 
1H NMR (400 MHz, CDCl3) δ 9.35 (1H, s, O−H), 8.50 (1H, s, N−H) 7.87-7.82 (8H, m, 
Ar C−H), 7.50-7.41 (12H, m, Ar C−H), 7.01-6.97 (1H, m, Ar C−H), 6.87 (1H, dd, Ar 
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C−H, J 1.2 Hz, J 8 Hz), 6.78-6.75 (1H, m, Ar C−H), 3.72 (4H, s, CH2), 3.42 (2H, s, 
CH2) ppm. 
31P NMR data: δ -6.89 ppm, 1JPtP 3422 Hz. 
Analysis calculated for C34H30N2O2P2Cl2Pt·0.5CH2Cl2: C, 48.63; H, 3.74; N, 3.15. 
Found: C, 48.87; H, 3.90; N, 3.26%. 
m/z [C34H30O2N2P2Cl2Pt]+: 791 [M+-Cl], 756 [M+-2Cl]. 
 
Compound 4.87  
Yield: 0.102 g, 85%. 
IR υmax (KBr)/cm–1 3311.5 (N−H), 3052.5 (O−H), 1679.5 (C=O amide), 740.4 and 
688.8 (Ar C−H), 303.5 and 279.3 (Pt−Cl). 
1H NMR (400 MHz, CDCl3) δ 9.62 (1H, s, O−H), 9.36 (1H, s, N−H) 7.91-7.86 (8H, m, 
Ar C−H), 7.60-7.42 (12H, m, Ar C−H), 7.05 (2H, m, Ar C−H), 6.83 (1H, d, Ar C−H, J 
8.4 Hz), 6.45 (1H, dd, Ar C−H, J 1.6 Hz, J 8 Hz), 4.18 (4H, s, CH2), 3.47 (2H, s, CH2) 
ppm. 
31P NMR data: δ -9.45 ppm, 1JPtP 3425 Hz. 
Analysis calculated for C34H32N2O2P2Cl2Pt: C, 49.29; H, 3.89; N, 3.38. Found: C, 
48.98; H, 3.68; N, 3.37%. 
m/z 827 [C34H32O2N2P2Cl2Pt]+, 792 [M+-Cl], 757 [M+-2Cl]. 
  
Compound 4.88   
Yield: 0.104 g, 84%. 
IR υmax (KBr)/cm–1 3325.1 (N−H), 3053.7 (O−H), 1672.3 (C=O amide), 739.1 and 
695.5 (Ar C−H), 310.7 and 287.1 (Pt−Cl). 
1H NMR (400 MHz, CDCl3) δ 9.52 (1H, s, O−H), 9.31 (1H, s, N−H) 8.01-7.97 (8H, m, 
Ar C−H), 7.70-7.61 (12H, m, Ar C−H), 7.34 (2H, d, Ar C−H, J 8.8 Hz), 6.78 (2H, d, Ar 
C−H, J 9.2 Hz), 4.26 (4H, s, CH2), 3.49 (2H, s, CH2) ppm. 
31P NMR data: δ -9.54 ppm, 1JPtP 3405 Hz. 
Analysis calculated for C34H32N2O2P2Cl2Pt: C, 49.29; H, 3.89; N, 3.38. Found: C, 
48.72; H, 3.66; N, 3.33%. 
m/z 827 [C34H32O2N2P2Cl2Pt]+, 792 [M-Cl]+. 
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Compound 4.89  
Yield: 0.115 g, 89%. 
IR υmax (KBr)/cm–1 3248.5 (N−H), 3051.4 (O−H), 1654.6 (C=O amide), 739.3 and 
688.4 (Ar C−H), 305.4 and 283.0 (Pt−Cl). 
1H NMR (400 MHz, CDCl3/CD3OD) δ 9.45 (1H, s, O−H), 8.91 (1H, s, N−H) 7.84-7.80 
(8H, m, Ar C−H), 7.53-7.44 (13H, m, Ar C−H), 6.69 (2H, s, Ar C−H), 4.05 (4H, s, 
CH2), 3.49 (2H, s, CH2), 2.22 (3H, s, CH3) ppm. 
31P NMR data: δ -9.83 ppm, 1JPtP 3398 Hz. 
Analysis calculated for C35H34O2N2P2Cl2Pt·0.5CH2Cl2: C, 48.63; H, 3.74; N, 3.15. 
Found: C, 49.00; H, 4.07; N, 3.13%.  
m/z 841 [C35H34O2N2P2Cl2Pt]+, 806 [M-Cl]+, 771 [M-2Cl]+. 
 
Compound 4.90  
Yield: 0.092 g, 65%. 
IR υmax (KBr)/cm–1 3349.6 (N−H), 3049.7 (O−H), 1679.8 (C=O amide), 739.2 and 
691.2 (Ar C−H), 316.2 and 283.3 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.16 (1H, s, O−H), 8.61 (1H, s, N−H) 7.83-7.80 (8H, 
m, Ar C−H), 7.57-7.41 (13H, m, Ar C−H), 7.05 (1H, d, Ar C−H, J 8.4 Hz), 6.48 (1H, 
dd, Ar C−H, J 2.4 Hz, J 11.2 Hz), 4.03 (6H, s, CH2), 1.80 (3H, s, CH3) ppm. 
31P NMR data: δ -11.02 ppm, 1JPtP 3397 Hz. 
Analysis calculated for C35H34N2O2P2Cl2Pt: C, 49.89; H, 4.07; N, 3.32. Found: C, 
49.32; H, 4.17; N, 3.25%.  
m/z 842 [C35H34O2N2P2Cl2Pt]+, 807 [M+-Cl].  
 
Compound 4.91  
Yield: 0.098 g, 73%. 
IR υmax (KBr)/cm–1 3346.5 (N−H), 3075.1 (O−H), 1654.1 (C=O amide), 738.7 and 
696.9 (Ar C−H), 315.0 and 290.0 (Pt−Cl). 
1H NMR (400 MHz, (CD3)2SO) δ 9.56 (1H, s, O−H), 8.94 (1H, s, N−H) 7.85-7.77 (8H, 
m, Ar C−H), 7.59-7.38 (13H, m, Ar C−H), 6.63 (1H, d, Ar C−H, J 1.2 Hz), 6.51 (1H, 
dd, Ar C−H, J 1.4 Hz, J 8.4 Hz), 4.05 (4H, s, CH2), 3.17 (2H, s, CH2), 2.17 (3H, s, CH3) 
ppm. 
31P NMR data: δ -9.86 ppm, 1JPtP 3405 Hz. 
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Analysis calculated for C35H34N2O2P2Cl2Pt: C, 49.89; H, 4.07; N, 3.32. Found: C, 
49.28; H, 4.05; N, 2.91%. 
m/z 841 [C35H34O2N2P2Cl2Pt]+, 807 [M+-Cl], 771 [M+-2Cl].  
 
Compound 4.92  
Yield: 0.137 g, 99%. 
IR υmax (KBr)/cm–1 3465.3 (N−H), 3323.0 (O−H), 1674.8 (C=O amide), 740.9 and 
695.9 (Ar C−H), 309.4 and 282.8 (Pt−Cl). 
1H NMR (400 MHz, CDCl3) δ 9.17 (1H, s, O−H), 8.90 (1H, s, N−H), 7.98-7.50 (20H, 
m, Ar C−H), 6.97-6.84 (2H, m, Ar C−H), 6.68 (1H, d, Ar C−H, J 8 Hz), 4.66 (4H, s, 
CH2), 3.20 (2H, s, CH2), 2.13 (3H, s, CH3) ppm. 
31P NMR data: δ -9.79 ppm, 1JPtP 3398 Hz. 
Analysis calculated for C35H34N2O2P2Cl2Pt·0.5C4H10O: C, 50.52; H, 4.47; N, 3.19. 
Found: C, 50.91; H, 4.53; N, 3.61%. 
m/z 806 [M-Cl]+, 770 [M-2Cl]+. 
 
Compound 4.93  
Yield: 0.120 g, 90%. 
IR υmax (KBr)/cm–1 3439.0 (N−H), 3286.9 (O−H), 1612.6 (C=O amide), 734.9, 708.5 
and 688.4 (Ar C−H), 311.9 and 285.9 (Pt−Cl).  
1H NMR (400 MHz, CDCl3) δ 9.46 (1H, s, O−H), 9.21 (1H, s, N−H) 7.94-7.78 (8H, m, 
Ar C−H), 7.54-7.42 (12H, m, Ar C−H), 7.09 (1H, d, Ar C−H, J 2 Hz), 6.87 (1H, d, Ar 
C−H, J 8 Hz), 6.69 (1H, dd, Ar C−H, J 2 Hz, J 8 Hz), 4.12 (4H, s, CH2), 3.43 (2H, s, 
CH2), 2.02 (3H, s, CH3) ppm.  
31P NMR data: δ -9.7 ppm, 1JPtP 3406 Hz. 
Analysis calculated for C35H34N2O2P2Cl2Pt: C, 49.89; H, 4.07; N, 3.32. Found: C, 
49.77; H, 3.95; N, 3.38%.  
m/z 806 [M-Cl]+, 771[M-2Cl]+. 
 
Compound 4.94  
Yield: 0.112 g, 81%. 
IR υmax (KBr)/cm–1 3479.7 (N−H), 3312.4 (O−H), 2950.0 (sp3 C−H), 1653.3 (C=O 
amide), 738.6, 698.9 and 688.9 (Ar C−H), 308.9 and 283.1 (Pt−Cl).  
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1H NMR (400 MHz, CDCl3) δ 9.44 (1H, s, O−H), 8.95 (1H, s, N−H) 7.86-7.81 (8H, m, 
Ar C−H), 7.54-7.45 (13H, m, Ar C−H), 6.91 (1H, dd, Ar C−H, J 2.4 Hz, J 8.4 Hz), 6.73 
(1H, d, Ar C−H, J 8.4 Hz), 4.09 (4H, bs, CH2), 3.50 (2H, s, CH2), 2.00 (9H, s, CH3) 
ppm. 
31P NMR data: δ -9.66 ppm, 1JPtP 3418 Hz. 
Analysis calculated for C39H42N2O2P2Cl2Pt·CH2Cl2: C, 51.34; H, 4.52; N, 2.92. Found:  
C, 51.14; H, 4.63; N, 3.10%. 
m/z 847 [M-Cl]+. 
 
The following general method was used for the synthesis of compounds 4.95–4.103: To 
a stirring solution of AuCl(tht) in dichloromethane (5 ml) was added a solution of 4.77–
4.85 (0.5 eq) in dichloromethane (5 ml). The pale yellow/colourless solutions obtained 
were stirred for 30 min. The volume was evaporated to ca. 2-3 ml under reduced 
pressure and diethyl ether (10 ml) added. The suspension was stirred for 10 min. The 
white solids obtained were collected by suction filtration and dried in vacuo. 
 
Compound 4.95  
Yield: 0.066 g, 62%.  
IR υmax (KBr)/cm–1 3344.7 (N−H), 3002.2 (O−H), 2958.9 (sp3 C−H), 1654.9 (C=O 
amide), 744.6 and 690.5 (Ar C−H), 328.4 (Au−Cl).  
1H NMR (400 MHz, CDCl3) δ 9.62 (1H, s, O−H), 8.81 (1H, s, N−H), 7.97-7.53 (21H, 
m, Ar C−H), 6.96 (1H, t, Ar C−H), 6.87 (1H, d, Ar C−H, J 8 Hz), 6.78 (1H, t, Ar C−H), 
4.70 (4H, s, CH2), 2.72 (2H, s, CH2) ppm. 
31P NMR data: δ 22.9 ppm. 
Analysis calculated for C34H32N2O2P2Cl2Au2·CH2Cl2: C, 37.79; H, 3.08; N, 2.52. 
Found: C, 38.13; H, 3.22; N, 2.38%. 
m/z [C34H32O2N2P2Cl2Au2]+: 991 [M+-Cl], 955 [M+-2Cl]. 
 
Compound 4.96  
Yield: 0.085 g, 81%.  
IR υmax (KBr)/cm–1 3326.7 (N−H), 3052.4 (O−H), 2959.3 (sp3 C−H), 1675.2 (C=O 
amide), 742.5 and 689.9 (Ar C−H), 328.0 (Au−Cl).  
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1H NMR (400 MHz, CDCl3) δ 9.30 (1H, s, O−H), 9.13 (1H, s, N−H), 7.89-7.84 (8H, m, 
Ar C−H), 7.58-7.38 (12H, m, Ar C−H), 6.99 (2H, m, Ar C−H), 6.71 (1H, d, Ar C−H, J 
8 Hz), 6.41 (1H, dd, Ar C−H, J 1.6 Hz, J 8 Hz), 4.64 (4H, s, CH2), 3.10 (2H, s, CH2) 
ppm. 
31P NMR data: δ 24.2 ppm. 
Analysis calculated for C34H32N2O2P2Cl2Au2·0.5CH2Cl2: C, 39.07; H, 3.09; N, 2.60. 
Found: C, 38.65; H, 2.87; N, 2.64%. 
m/z [C34H32O2N2P2Cl2Au2]+: 991 [M+-Cl], 955 [M+-2Cl]. 
 
Compound 4.97  
Yield: 0.093 g, 96%.  
IR υmax (KBr)/cm–1 3326.7 (N−H), 3329.0 (O−H), 2965.1 (sp3 C−H), 1664.1 (C=O 
amide), 742.9 and 691.1 (Ar C−H), 325.3 (Au−Cl).  
1H NMR (400 MHz, CDCl3) δ 9.12 (1H, s, O−H), 8.92 (1H, s, N−H), 7.87-7.81 (8H, m, 
Ar C−H), 7.55-7.46 (12H, m, Ar C−H), 7.07 (2H, d, Ar C−H, J 12.4 Hz), 6.60 (2H, d, 
Ar C−H, J 10 Hz), 4.61 (4H, s, CH2), 3.07 (2H, s, CH2) ppm. 
31P NMR data: δ 24.3 ppm. 
Analysis calculated for C34H32N2O2P2Cl2Au2: C, 39.75; H, 3.14; N, 2.73. Found: C, 
39.55; H, 2.98; N, 2.65%. 
m/z [C34H32O2N2P2Cl2Au2]+: 991 [M+-Cl], 955 [M+-2Cl]. 
 
Compound 4.98  
Yield: 0.059 g, 63%. 
IR υmax (KBr)/cm–1 3447.2 (N−H), 3113.8 (O−H), 2923.1 (sp3 C−H), 1653.2 (C=O 
amide), 744.2 and 691.7 (Ar C−H), 328.1 (Au−Cl).  
1H NMR (400 MHz, CDCl3) δ 8.29 (1H, s, O−H), 7.42-7.85 (23H, m, Ar C−H), 3.35 
(4H, d, CH2, J 3.2 Hz), 3.45 (2H, s, CH2), 2.27 (3H, s, CH3) ppm. 
31P NMR data: δ 21.21 ppm.  
Analysis calculated for C35H34N2O2P2Cl2Au2·CH2Cl2: C, 38.39; H, 3.22; N, 2.49. 
Found: C, 38.60; H, 3.27; N, 2.41%. 
m/z [C35H34O2N2P2Cl2Au2]+: 1005 [M+-Cl], 969 [M+-2Cl]. 
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Compound 4.99  
Yield: 0.056 g, 60%. 
IR υmax (KBr)/cm–1 3358.2 (N−H), 3052.9 (O−H), 2951.2 (sp3 C−H), 1669.3 (C=O 
amide), 743.9 and 691.2 (Ar C−H), 328.3 (Au−Cl).  
1H NMR (400 MHz, CDCl3) δ 9.16 (1H, s, O−H), 8.54 (1H, s, N−H), 7.90-7.85 (8H, m, 
Ar C−H), 7.60-7.52 (12H, m, Ar C−H), 7.02 (1H, d, Ar C−H, J 8.4 Hz), 6.52 (2H, m, 
Ar C−H), 4.75 (4H, s, CH2), 3.67 (2H, s, CH2), 1.93 (3H, s, CH3) ppm. 
31P NMR data: δ 24.84 ppm. 
Analysis calculated for C35H34N2O2P2Cl2Au2·0.5CH2Cl2: C, 39.67; H, 3.24; N, 2.57. 
Found: C, 39.15; H, 3.38; N, 2.51%. 
m/z 1041 [C35H34O2N2P2Cl2Au2]+, 1005 [M+-Cl], 970 [M+-2Cl]. 
 
Compound 4.100  
Yield: 0.065 g, 58%. 
IR υmax (KBr)/cm–1 3383.9 (N−H), 3051.3 (O−H), 2918.6 (sp3 C−H), 1653.1 (C=O 
amide), 742.3 and 690.7 (Ar C−H), 327.9 (Au−Cl).  
1H NMR (400 MHz, CDCl3) δ 8.13 (1H, s, O−H), 8.10 (1H, s, N−H), 7.42-7.76 (23H, 
m, Ar C−H), 4.36 (2H, d, CH2, J 3.2 Hz), 3.47 (4H, s, CH2), 2.29 (3H, s, CH3) ppm. 
31P NMR data: δ 20.76 ppm. 
Analysis calculated for C35H34N2O2P2Cl2Au2·0.5CH2Cl2: C, 39.67; H, 3.24; N, 2.57. 
Found: C, 39.20; H, 3.32; N, 2.47%. 
m/z [C35H34O2N2P2Cl2Au2]+: 1005 [M+-Cl], 970 [M+-2Cl]. 
 
Compound 4.101 
Yield: 0.114 g, 94%.  
IR υmax (KBr)/cm–1 3398.4 (N−H), 3052.8 (O−H), 2961.3 (sp3 C−H), 1669.1 (C=O 
amide), 742.7 and 690.8 (Ar C−H), 324.2 (Au−Cl).   
1H NMR (400 MHz, CDCl3) δ 9.07 (1H, s, O−H), 8.90 (1H, s, N−H), 7.96-7.91 (8H, m, 
Ar C−H), 7.65-7.49 (12H, m, Ar C−H), 7.02-6.97 (2H, m, Ar C−H), 6.67 (1H, d, Ar 
C−H, J 8.4 Hz), 4.65 (4H, s, CH2), 3.17 (2H, s, CH2), 2.13 (3H, s, CH3) ppm. 
31P NMR data: δ 24.46 ppm. 
Analysis calculated for C35H34N2O2P2Cl2Au2: C, 40.36; H, 3.29; N, 2.69. Found:  C, 
40.13; H, 3.37; N, 2.60%. 
m/z [C35H34O2N2P2Cl2Au2]+: 1005 [M+-Cl], 969 [M+-2Cl]. 
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Compound 4.102  
Yield: 0.111 g, 50%.  
IR υmax (KBr)/cm–1 3446.2 (N−H), 3048.8 (O−H), 2963.9 (sp3 C−H), 1675.2 (C=O 
amide), 743.1 and 690.8 (Ar C−H), 324.0 (Au−Cl).   
1H NMR (400 MHz, CDCl3) δ 9.21 (1H, s, O−H), 9.05 (1H, s, N−H), 7.94-7.44 (20H, 
m, Ar C−H), 7.05 (1H, d, Ar C−H, J 1.6 Hz), 6.89 (1H, d, Ar C−H, J 8.4 Hz), 6.62 (1H, 
dd, Ar C−H, J 1.6 Hz, J 7.6 Hz), 4.64 (2H, s, CH2), 3.09 (4H, s, CH2), 2.09 (3H, s, CH3) 
ppm. 
31P NMR data: δ 24.14 ppm. 
Analysis calculated for C35H34N2O2P2Cl2Au2: C, 39.82; H, 2.95; N, 2.73. Found: C, 
39.93; H, 3.31; N, 2.67%. 
m/z [C35H34O2N2P2Cl2Au2]+: 1005 [M+-Cl].  
 
Compound 4.103  
Yield: 0.046 g, 52%.  
IR υmax (KBr)/cm–1 3455.3 (N−H), 3053.8 (O−H), 2955.5 (sp3 C−H), 1653.2 (C=O 
amide), 742.1 and 690.9 (Ar C−H), 328.1 (Au−Cl).   
1H NMR (400 MHz, CDCl3) δ 9.40 (1H, s, O−H), 8.76 (1H, s, N−H), 7.95-7.84 (8H, m, 
Ar C−H), 7.61-7.50 (13H, m, Ar C−H), 6.94 (1H, dd, Ar C−H, J 2.4 and 8.4 Hz), 6.73 
(1H, d, Ar C−H, J 8.4 Hz), 4.64 (4H, s, CH2), 4.04 (2H, s, CH2), 1.23 (3H, s, CH3) ppm. 
31P NMR data: δ 23.40 ppm. 
Analysis calculated for C38H39N2O2P2Cl2Au2: C, 42.16; H, 3.63; N, 2.59. Found: C, 
42.18; H, 3.92; N, 2.48%. 
m/z [C38H40O2N2P2Cl2Au2]+: 1047 [M+-Cl], 1011 [M+-2Cl]. 
 
The following general method was used for the synthesis of compounds 4.104–4.108: 
To a solution of [Mo(CO)4(nbd)] in dichloromethane (5 ml) was added a solution of 
4.78, 4.80 and 4.83–4.85 (1 eq) in dichloromethane (5 ml). The pale yellow solutions 
obtained were stirred for 24 h at r.t. under N2, the solution was evaporated to ca. 2-3 ml 
under reduced pressure and diethyl ether (10 ml) added. The suspension was stirred for 
10 min. The yellow/brown solids obtained were collected by suction filtration and dried 
in vacuo. 
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Compound 4.104  
Yield: 0.065 g, 56%.  
IR υmax (KBr)/cm–1 3335.1 (O−H), 2019.4, 1924.4 and 1895.6 (CO), 1663.1 (C=O 
amide), 741.2 and 694.2 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 9.72 (1H, s, O−H), 9.26 (1H, s, N–H), 7.60-7.21 (21H, 
m, Ar C−H), 6.95 (1H, d, Ar C−H, J 8 Hz), 6.85 (1H, dd, Ar C−H, J 3.2 Hz, J 9.2 Hz),  
3.99 (4H, s, CH2), 3.79 (2H, s, CH2), 2.07 (3H, s, CH3) ppm. 
31P NMR data: δ 19.69 ppm. 
Analysis calculated for C39H34N2O6P2Mo: C, 59.70; H, 4.37; N, 3.57. Found: C, 58.86; 
H, 4.58; N, 3.65%. 
m/z 758 [M+-CO], 730 [M+-2CO], 702 [M+-3CO], 674 [M+-4CO]. 
 
Compound 4.105  
Yield: 0.098 g, 88%.  
IR υmax (KBr)/cm–1 3332.5 (O−H), 2019.8, 1920.5 and 1894.1 (CO), 1669.6 (C=O 
amide), 741.6 and 694.3 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.48-6.98 (20H, m, Ar C−H), 6.53 (1H, d, Ar C−H, J 4 
Hz), 6.35 (1H, Ar C−H), 5.94 (1H, d, Ar C−H, J 8 Hz), 3.63 (4H, s, CH2), 3.33 (2H, s, 
CH2) ppm. 
31P NMR data: δ 20.97 ppm. 
Analysis calculated for C38H32N2O6P2Mo·0.5CH2Cl2: C, 57.19; H, 4.06; N, 3.42. Found: 
C, 57.41; H, 4.37; N, 3.53%. 
m/z 773 [C38H32O6N2P2Mo]+, 744 [M+-CO], 716 [M+-2CO], 688 [M+-3CO] and 660 
[M+-4CO]. 
 
Compound 4.106  
Yield: 0.084 g, 84%.  
IR υmax (KBr)/cm–1 3328.0 (O−H), 2019.7, 1919.1 and 1893.9 (CO), 1657.1 (C=O 
amide), 741.3 and 694.5 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.56 (1H, s, O−H), 9.49 (1H, s, N–H), 7.57-7.16 
(21H, m, Ar C−H), 7.08 (1H, dd, Ar C−H, J 4 Hz, J 12 Hz), 6.63 (1H, d, Ar C−H, J 12 
Hz),  3.92 (4H, s, CH2), 3.73 (2H, s, CH2), 2.10 (3H, s, CH3) ppm. 
31P NMR data: δ 19.95 ppm. 
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Analysis calculated for C39H34N2O6P2Mo: C, 59.70; H, 4.37; N, 3.57. Found: C, 59.85; 
H, 4.86; N, 3.16%. 
m/z 786 [MoC39H34O6N2P2]+, 758 [M+-CO], 730 [M+-2CO], 702 [M+-3CO] and 674 
[M+-4CO]. 
 
Compound 4.107  
Yield: 0.088 g, 86%.  
IR υmax (KBr)/cm–1 3332.5 (O−H), 2019.8, 1919.1 and 1895.9 (CO), 1663.8 (C=O 
amide), 741.3 and 694.8 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 9.75 (1H, s, O−H), 9.29 (1H, s, N–H), 7.63-7.21 
(20H, m, Ar C−H), 6.98 (1H, Ar C−H), 6.94 (1H, Ar C−H), 6.85 (1H, dd, Ar C−H, J 4 
Hz, J 8 Hz), 3.97 (4H, s, CH2), 3.76 (2H, s, CH2), 2.09 (3H, s, CH3) ppm. 
31P NMR data: δ 13.93 ppm. 
Analysis calculated for C39H34N2O6P2Mo: C, 59.70; H, 4.37; N, 3.57. Found: C, 60.52; 
H, 4.66; N, 3.64%. 
m/z 758 [M+-CO], 730 [M+-2CO], 702 [M+-3CO] and 674 [M+-4CO]. 
 
Compound 4.108  
Yield: 0.054 g, 61%.  
IR υmax (KBr)/cm–1 3330.6 (O−H), 2020.8, 1919.1 and 1901.5 (CO), 1654.4 (C=O 
amide), 741.4 and 694.2 (Ar C−H). 
Analysis calculated for C42H40N2O6P2Mo: C, 61.02; H, 4.88; N, 3.39. Found: C, 60.41; 
H, 5.37; N, 2.99%. 
m/z 828 [C42H40O6N2P2Mo]+, 800 [M+-CO], 772 [M+-2CO], 744 [M+-3CO] and 716 
[M+-4CO]. 
 
The following general method was used for the synthesis of compounds 4.109–4.112: 
The mixture of hydroxymethyldiphenylphosphine (2 eq) and the primary amine (2-
aminoethyl)carbamic acid tert-butyl ester X, glycine, glycylglycine and triglycine(1 eq) 
in methanol (20 ml) respectively, was stirred under N2 for 24 h. In all the cases, except 
for compound 4.109, the solution was evaporated to dryness under reduced pressure 
yielding yellow/white oils. In the case of 4.109, the volume of the solution obtained was 
evaporated to ca. 2-3 ml under reduced pressure and a solid was obtained. The 
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suspension was stirred for 10 min. The white solid obtained was collected by suction 
filtration and dried in vacuo. 
 
Compound 4.109  
Yield: 0.336 g, 48%. 
IR υmax (KBr)/cm–1 3417.9 (N−H), 2785.3 (sp3 C–H), 1701.3 (C=O), 735.4 and 686.3 
(Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.40-7.18 (20H, m, Ar C−H), 4.30 (1H, s, N−H), 3.49 
(4H, m, CH2), 2.87 (2H, s, CH2), 1.65 (2H, s, CH2), 1.36 (9H, s, CH3) ppm. 
31P NMR data: δ -28.80 ppm. 
Analysis calculated for C33H38O2N2P2: C, 71.21; H, 6.88; N, 5.03. Found: C, 71.09; H, 
6.78; N, 5.60%. 
m/z 555 [C33H38O2N2P2]+. 
 
Compound 4.110  
Yield: 0.415 g, 94%. 
1H NMR (400 MHz, CDCl3) δ 10.82 (1H, s, O−H), 7.40-7.32 (20H, m, Ar C−H), 2.69 
(2H, s, CH2), 2.44 (4H, s, CH2), 2.32 (4H, s, CH2) ppm. 
31P NMR data: δ -27.26 ppm. 
 
Compound 4.111  
Yield: 0.331 g, 58%. 
1H NMR (400 MHz, CDCl3) δ 10.76 (1H, s, O−H), 8.07 (1H, s, N–H), 7.39-7.34 (20H, 
m, Ar C−H), 4.16 (2H, s, CH2), 3.29 (2H, s, CH2), 2.17 (4H, s, CH2) ppm. 
31P NMR data: δ -26.75 ppm. 
 
Compound 4.112  
Yield: 0.436 g, 99%. 
1H NMR (400 MHz, CDCl3) δ 10.64 (1H, s, O−H), 8.12 (1H, s, N–H), 8.23 (1H, s, N–
H), 7.42-7.31 (20H, m, Ar C−H), 4.19 (2H, s, CH2), 3.98 (2H, s, CH2), 3.27 (2H, s, 
CH2), 2.38 (4H, s, CH2) ppm. 
31P NMR data: δ -26.81 ppm. 
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The following general method was used for the synthesis of compounds 4.113–4.124: 
To a stirring solution of PtCl2(COD) (1 eq),  AuCl(tht) (2 eq) or [Ru(η6-p-cymene)Cl2]2 
(2 eq),  in dichloromethane (5 ml) was added a solution of 4.110–4.112 (1 eq) 
respectively, in dichloromethane (5 ml). The pale solutions obtained were stirred for 30 
min. The volume was evaporated to ca. 2-3 ml under reduced pressure and diethyl ether 
(10 ml) added. The suspension was stirred for 10 min. The solids obtained were 
collected by suction filtration and dried in vacuo. 
 
Compound 4.113 
Yield: 0.094 g, 82%. 
IR υmax (KBr)/cm–1 3429.6 (N−H), 2862.5 (sp3 C–H), 1701.3 (C=O), 734.6 and 688.4 
(Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.83-7.47 (20H, m, Ar C−H), 6.25 (1H, s, N−H), 3.83 
(4H, s, CH2), 2.87 (2H, s, CH2), 2.65 (2H, s, CH2), 1.26 (9H, s, CH3) ppm. 
31P NMR data: δ -10.14 ppm, 1JPtP 3400 Hz. 
Analysis calculated for C33H38O2N2P2Cl2Pt·1.5Et2O: C, 50.60; H, 5.77; N, 3.03. Found: 
C, 50.17; H, 5.51; N, 2.94%. 
m/z [C33H38O2N2P2Cl2Pt]+: 787 [M+-Cl], 731 [M+-2Cl]. 
 
Compound 4.114  
Yield: 0.059 g, 77%. 
IR υmax (KBr)/cm–1 3427.6 (N−H), 1705.1 (C=O), 736.3 and 688.4 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.66-7.19 (20H, m, Ar C−H), 5.23 (1H, s, N−H), 4.23 
(4H, s, CH2), 1.54-1.20 (9H, m, CH3) ppm. 
31P NMR data: δ 16.45 ppm. 
Analysis calculated for C33H37O2N2P2Cl2Au2·CH2Cl2: C, 36.94; H, 3.56; N, 2.53. 
Found: C, 36.60; H, 3.32; N, 2.49%. 
m/z [C33H37O2N2P2Cl2Au2]+: 985 [M+-Cl]. 
 
Compound 4.115  
Yield: 0.091 g, 65%. 
IR υmax (KBr)/cm–1 3344.7 (N−H), 2870.2 (sp3 C–H), 1705.1 (C=O), 735.4 and 688.2 
(Ar C−H). 
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1H NMR (400 MHz, CDCl3) δ 7.79-7.35 (28H, m, Ar C−H), 3.90 (1H, s, N−H), 3.57 
(4H, s, CH2), 2.87 (2H, s, CH2), 2.30 (2H, s, CH2), 2.09 (2H, m, CH2), 1.54 (18H, s, 
CH3), 1.22 (9H, s, CH3) ppm. 
31P NMR data: δ 19.16 ppm. 
Analysis calculated for C53H70O2N2P2Cl4Ru2·CH2Cl2: C, 51.56; H, 5.77; N, 2.23. 
Found: C, 52.00; H, 5.63; N, 2.31%. 
m/z [C53H70O2N2P2Cl4Ru2]+: 1103 [M+-2Cl]. 
 
Compound 4.116  
Yield: 0.102 g, 90%. 
IR υmax (KBr)/cm–1 3387.1 (N−H), 3054.4 (O−H), 1730.2 (C=O, acid), 738.8 and 691.5 
(Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 12.55 (1H, s, O−H), 7.88-7.36 (20H, m, Ar C−H), 
2.51 (6H, s, CH2), 2.09 (2H, s, CH2) ppm. 
31P NMR data: δ -9.91 ppm, 1JPtP 3411 Hz. 
Analysis calculated for C29H29O2NP2Cl2Pt·0.5CH2Cl2: C, 45.04; H, 3.78; N, 1.75. 
Found: C, 45.33; H, 3.98; N, 1.85%. 
 
Compound 4.117  
Yield: 0.090 g, 85%. 
IR υmax (KBr)/cm–1 3312.9 (N−H), 3023.5 (O−H), 1661.6 (C=O, amide), 1739.4 (C=O, 
acid), 1655.9 (C=O amide), 743.6 and 695.4 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 12.63 (1H, s, O−H), 8.12 (1H, s, N–H), 7.84-7.41 
(20H, m, Ar C−H), 4.01 (2H, s, CH2), 3.70 (2H, s, CH2), 2.53 (4H, s, CH2) ppm. 
31P NMR data: δ -10.64 ppm, 1JPtP 3393 Hz. 
Analysis calculated for C30H30O3N2P2Cl2Pt: C, 45.35; H, 3.81; N, 3.53. Found: C, 
45.82; H, 3.99; N, 3.63%. 
m/z [C30H30O3N2P2Cl2Pt]+: 759 [M+-Cl], 723 [M+-2Cl]. 
 
Compound 4.118  
Yield: 0.091 g, 84%. 
IR υmax (KBr)/cm–1 3328.2 (N−H), 3054.4 (O−H), 1672.1 (C=O, amide), 1737.9 (C=O, 
acid), 1667.5 (C=O amide), 741.7 and 691.5 (Ar C−H).  
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1H NMR (400 MHz, (CD3)2SO) δ 12.69 (1H, s, O−H), 8.21 (1H, s, N–H), 8.09 (1H, s, 
N–H), 7.90-7.44 (20H, m, Ar C−H), 4.04 (2H, s, CH2), 3.79 (2H, s, CH2), 3.66 (2H, s, 
CH2), 2.34 (4H, s, CH2) ppm. 
31P NMR data: δ -10.41 ppm, 1JPtP 3474 Hz. 
Analysis calculated for C32H33O4N3P2Cl2Pt: C, 45.90; H, 4.28; N, 4.46. Found: C, 
45.50; H, 4.30; N, 4.69%. 
m/z [C32H33O4N3P2Cl2Pt]+: 816 [M+-Cl]. 
 
Compound 4.119  
Yield: 0.124 g, 60%. 
IR υmax (KBr)/cm–1 3483.6 (O−H), 1716.7 (C=O, acid), 744.6 and 694.4 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 7.89-7.45 (20H, m, Ar C−H), 2.93 (6H, s, CH2), 2.09 
(2H, s, CH2) ppm. 
31P NMR data: δ 23.79 ppm. 
Analysis calculated for C29H29O2NP2Cl2Au2·0.5CH2Cl2: C, 35.69; H, 3.05; N, 1.41. 
Found: C, 35.59; H, 3.02; N, 1.32%. 
 
Compound 4.120  
Yield: 0.180 g, 95%. 
IR υmax (KBr)/cm–1 3387.1 (N−H), 3055.4 (O−H), 1732.1 (C=O, acid), 1670.4 (C=O 
amide), 744.6 and 694.4 (Ar C−H).  
1H NMR (400 MHz, (CD3)2SO) δ 12.61 (1H, s, O−H), 7.96-7.22 (21H, m, Ar C−H, N–
H), 4.62 (2H, s, CH2), 3.23 (2H, s, CH2), 2.52 (4H, s, CH2) ppm. 
31P NMR data: δ 23.05 ppm. 
Analysis calculated for C30H30O3N2P2Cl2Au2·C4H10O: C, 38.27; H, 3.78; N, 2.62. 
Found: C, 38.51; H, 3.51; N, 2.55%. 
m/z [C30H30O3N2P2Cl2Au2]+: 957 [M+-Cl]. 
 
Compound 4.121  
Yield: 0.078 g, 64%. 
IR υmax (KBr)/cm–1 3325.4 (N−H), 3055.4 (O−H), 1728.3 (C=O, acid), 1662.1 (C=O 
amide), 744.6 and 694.4 (Ar C−H).  
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1H NMR (400 MHz, (CD3)2SO) δ 12.69 (1H, s, O−H), 8.19 (1H, s, N–H), 8.03 (1H, s, 
N–H), 7.83-7.41 (20H, m, Ar C−H), 4.53 (2H, s, CH2), 3.77 (2H, s, CH2), 3.61 (2H, s, 
CH2), 2.46 (4H, s, CH2) ppm. 
31P NMR data: δ 23.40 ppm. 
Analysis calculated for C32H33O4N3P2Cl2Au2·C4H10O: C, 38.45; H, 3.85; N, 3.74. 
Found: C, 38.17; H, 3.44; N, 4.17%. 
m/z [C32H33O4N3P2Cl2Au2]+: 1014 [M+-Cl], 978 [M+-2Cl]. 
 
Compound 4.122  
IR υmax (KBr)/cm–1 3484.5 (N−H), 3054.2 (O−H), 2960.8 and 2923.9 (sp3 C–H), 1707.6 
(C=O, acid), 746.5 and 696.5 (Ar C−H), 290.8 (Ru−Cl). 
31P NMR (400 MHz, CDCl3) data: δ 19.60 ppm. 
Analysis calculated for C49H57O2NP2Cl4Ru2: C, 53.60; H, 5.24; N, 1.28. Found: C, 
52.96; H, 5.64; N, 1.32%. 
m/z 1098 [C49H57O2NP2Cl4Ru2]+, 1063 [M+-Cl], 1027 [M+-2Cl]. 
 
Compound 4.123  
Yield: 0.088 g, 88%. 
IR υmax (KBr)/cm–1 3387.1 (N−H), 3056.3 (O−H), 2960.8, 2925.1 and 2871.1 (sp3 C–
H), 1736.9 (C=O, acid), 1663.7 (C=O amide), 745.5 and 696.3 (Ar C−H).  
1H NMR (400 MHz, CDCl3) δ 7.84-7.33 (20H, m, Ar C−H), 5.44-5.41 (2H, m, CH), 
5.19 (1H, s, CH), 5.01 (1H, s, CH), 2.55 (2H, s, CH2), 2.24 (9H, s, CH3), 2.03 (2H, s, 
CH2), 1.64 (18H, s, CH3) ppm. 
31P NMR data: δ 15.69 ppm. 
Analysis calculated for C50H58O3N2P2Cl4Ru2·0.5CH2Cl2: C, 51.26; H, 5.03; N, 2.37. 
Found: C, 51.36; H, 5.31; N, 2.42%. 
m/z [C50H58O3N2P2Cl4Ru2]+: 1104 [M+-Cl]. 
 
Compound 4.124  
Yield: 0.041 g, 63%. 
IR υmax (KBr)/cm–1 3374.6 (N−H), 3056.3 (O−H), 2960.8, 2927.1 and 2871.1 (sp3 C–
H), 1737.0 (C=O, acid), 1673.3 (C=O amide), 747.4 and 697.3 (Ar C−H).  
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1H NMR (400 MHz, CDCl3) δ 7.92-7.20 (20H, m, Ar C−H), 5.42 (2H, d, CH, J 16 Hz), 
5.28 (2H, d, CH, J 9.2 Hz), 4.95 (2H, d, CH2, J 14 Hz), 3.82 (4H, s, CH2), 2.82 (2H, s, 
CH2), 2.24 (9H, s, CH3), 1.61 (18H, s, CH3) ppm. 
31P NMR data: δ 18.24 ppm. 
Analysis calculated for C52H61O4N3P2Cl4Ru2·CH2Cl2: C, 49.62; H, 4.95; N, 3.28. 
Found: C, 49.68; H, 5.21; N, 3.29%. 
m/z [C52H61O4N3P2Cl4Ru2]+, 1162 [M+-Cl], 1125 [M+-2Cl]. 
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4.5 Crystallographic Experimental 
 
Data for compounds 4.21, 4.23, 4.30, 4.32, 4.33, 4.50, 4.53–4.55, 4.60, 4.64, 4.65, 4.67, 
4.92, 4.109 and 4.118 were collected using a Bruker APEX 2 CCD diffractometer using 
graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). Data for compounds 4.36, 
4.41, 4.57, 4.90 and 4.91 were collected using a Bruker APEX 2 CCD diffractometer 
using synchrotron radiation (λ = 0.6710 Å) at Daresbury SRS Station 9.8. Data for 
compounds 4.113, 4.115 and 4.117 were collected using a Bruker APEX 2 CCD 
diffractometer using synchrotron radiation (λ = 0.6943 Å) at Daresbury SRS Station 9.8. 
Data for compound 4.51 and 4.124 were collected using a Bruker APEX 2 CCD 
diffractometer using synchrotron radiation (λ = 0.6884 Å or 0.6939 Å respectively) at 
Daresbury SRS Station 9.8. Data for compounds 4.89 was collected using a Bruker 
APEX 2 CCD diffractometer using synchrotron radiation (λ = 0.7848 Å) at Daresbury 
SRS Station 16.2 SMX. Data for compounds 4.58 was collected using a Bruker-Nonius 
95 mm CCD camera on κ-goniostat diffractometer using graphite-monochromated Mo-
Kα radiation (λ = 0.71073 Å). Data for compounds 4.22, 4.35 and 4.78 were collected 
using a Bruker-Nonius Apex 2 CCD camera on κ-goniostat diffractometer using 
graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). Data for compounds 4.59, 
4.79 and 4.122 were collected using a Bruker SMART 1000 CCD diffractometer using 
graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å).  
 
All structures were solved by direct methods (except structures 4.33, 4.89, 4.90 and 
4.113 which were solved using Patterson synthesis) and refined by full-matrix least-
squares methods on F2. All H atoms were placed in geometrically calculated positions 
and were refined using a riding model (aryl C–H 0.95 Å, methyl C–H 0.98 Å, 
methylene C–H 0.99 Ǻ and hydroxyl O–H 0.84 Å). Uiso(H) values were set to be 1.2 
times Ueq of the carrier atom for aryl CH and NH, and 1.5 times Ueq of the carrier atom 
for OH and CH3. The hydroxyl hydrogen atom in compound 4.92 could not be located 
due to the poor quality of the diffraction data. The coordinates of OH and NH hydrogen 
atoms in compounds 4.55, 4.59, 4.60, 4.65, 4.67, 4.79, 4.109, 4.115 and 4.117 were 
allowed to refine freely. 
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Unless stated below, all structural determinations proceeded without the need for 
restraints or disorder modelling. Compound 4.22 was found to contain a disordered 
methanol and was modelled over two sets of positions, each at half weight. Methanolic 
H(2) and H(2X) atoms in 4.22 were located in the difference Fourier map and the 
coordinates allowed to freely refine. The remaining OH hydrogen atoms were placed in 
geometric positions.  
 
Compound 4.30 was modelled with disorder in the DMSO molecule with atoms split 
over two sets of positions [72.6(6):27.4(6)%] with the C(33) coincident for both 
components and restraints were placed on the geometry and the anisotropic 
displacement parameters of the atoms involved.  
 
Compounds 4.41 and 4.64 were found to contain a disordered phenyl ring which was 
modelled with atoms split over two sets of positions [major occupancy 50.4(4)%] and 
[56.5(17)%] respectively and restraints were placed on the geometry and the anisotropic 
displacements parameters of the atoms involved.  
 
 
Compounds 4.35 and 4.118 were found to contain disorder in one chloroform molecule, 
while in 4.118 the Cl3H2 fragment was modelled split over two sets of positions, with 
refined occupancies 85.4(4):14.6(4)% with C(33) coincident to the two fragments; in 
4.35 the solvent molecule was modelled across two alternative positions without any 
coincident atoms [56.9(7):43.1(7)%]. 
 
Compound 4.91 was found to be highly disordered; the backbone and functionalised 
methyl-/hydroxyl- arene group were modelled with atoms split over two sets of 
positions, with refined occupancies 51.1(7):48.9(7)% without any coincident atoms 
across the two alternative positions. 
 
Compound 4.89 contained three disordered phenyl groups; one modelled with three 
consecutive coincident atoms across the two sets of positions [major occupancy 
51.1(12)%] and two with only two C atoms coincident [major occupancy 53.4(12) and 
52.2(2)%] respectively. Restraints on the geometric and anisotropic displacement 
parameters were used on the three phenyl rings. The refinement of 4.122 led to the 
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modelling of two of the three chloroform molecules as disordered, the Cl3H2 fragment 
was modelled over two sets of positions, with major occupancies 85.1(4) and 63.8(5)% 
with C(50) and C(51) coincident to the two fragments, respectively.  
 
The structure of compound 4.124 contains solvent-accessible voids accounting for 9.5% 
of the total unit cell volume. The SQUEEZE program within Platon suite identified 
approximatly 70 unaccounted electrons in the unit cell, and this was assumed to be four 
methanol molecules per cell (18 electrons per molecule) which were taken into account 
in the refinement.48 
 
Programs used during data collection, refinement and production of graphics were 
Bruker SMART, Bruker APEX 2, SAINT, SHELXTL, COLLECT, DENZO and local 
programs.25,26,28,121-123 
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5. Synthesis and Supramolecular Coordination Chemistry of New      
H-bonded Functionalised Phosphines 
 
5.1 Introduction 
 
The process of catalyst discovery and development is the most important tool to obtain 
effective transition-metal catalysis. However, this process has suffered from the difficult 
access to structurally diverse and large libraries of ligands. A new approach to this 
problem has been the use of structurally less complicated monodentate ligands that self-
assemble in the coordination sphere of the metal centre through non-covalent attractive 
ligand-ligand interactions to generate bidentate, chelating ligands.257-260 Irrespective of 
the strength of the ligand-ligand interaction, from weak van der Waals, π stacking, 
charge-transfer, and dipole-dipole interactions to hydrogen bonding, the specific 
formation of heterodimeric ligands requires two different sets of monodentate ligands 
with complementary binding sites.261 A brief survey of monodentate phosphine ligands 
used in homogeneous catalysis is discussed below. 
 
5.1.1 Weak Ligand-Ligand Interactions: van der Waals, π Stacking and Dipole-
Dipole Interactions 
 
Reetz and co-workers reported a Pt(II) complex with a binol-derived phosphonite 
ligand. Interestingly, the two monodentate phosphorus ligands coordinated in a cis 
orientation around the Pt(II) centre, which is supposed to be sterically less favourable 
than the alternative trans orientation. The formation of the cis complex may be 
explained by the establishment of weak attractive ligand-ligand interactions based on 
van der Waals, π stacking, and/or dipole-dipole interactions of the P–O bond dipoles. 
As a consequence of the cis coordination mode, a conformational locking of the two 
monodentate ligands is achieved mimicking the conformational properties of a bidentate 
ligand. Reetz and co-workers have reported the asymmetric hydrogenation of N-acyl 
enamines using the homocombination of two monodentate ligands 5.1–5.4 (Equation 
5.1).262-265   
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Ar N
H
Me
O H2
[L2Rh(COD)]BF4 Ar N
H
Me
OMe
*
O
O
P R
5.1 R = Me
5.2 R = tBu
5.3 R = Et
5.4 R = OMe
 
 
Equation 5.1 
 
5.1.2 Attractive Ligand-Ligand Interactions through Hydrogen Bonding 
 
Breit and Seiche described the in situ generation of bidentate ligands based on self-
assembly through hydrogen bonding of monodentate ligands in the coordination sphere 
of a Rh(I) centre.266 The Rh(I) catalyst displayed the behaviour of a bidentate ligand in 
the hydroformylation of terminal alkenes (Equation 5.2). 
 
NH
PPh2
O
N
PPh2
OH
N
Ph2P
O
N
PPh2
OH
H
[Rh]
R
R
O
+
R
O
Me
97            :              3
H2/CO
 
 
Equation 5.2  
 
Excellent regioselectivity in favour of the linear aldehyde was obtained for 
hydroformylation of a range of functionalised terminal alkenes such as R = Br(CH2)3–, 
AcO(CH2)3–,  MeO2C(CH2)7–,  MeCO(CH2)–, HO(CH2)–,  HO(CH2)8–. The hydrogen-
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bonding network in the ligands and thus the chelating binding mode can be disrupted by 
employing either temperatures above 110°C or protic solvents such as methanol and 
acetic acid resulting in lower regioselectivities.     
   
5.1.3 Attractive Ligand-Ligand Interactions through Coordinative Bonding 
  
Reek and van Leeuwen used Zn(II) porphyrin complexes for the supramolecular 
construction of bidentate ligands (Figure 5.1).267  
 
N
N
N
N
Zn
R  
 
Figure 5.1 Zn(II) porphyrin complexes. 
 
A set of Zn(II) porphyrin functionalised phosphites, 5.13-5.18, and eight monodentate 
phosphorus donor ligands equipped with N-donor functions, 5.5-5.12, were used by 
Slagt and co-workers to generate a library of chelating ligands (Figure 5.2).268 
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O
P
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O
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5.14 meta-
tBu
t
t
5.5 meta-
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Figure 5.2 Library of heterodimeric bidentate ligands. 
 
These combinations were tested by application to the asymmetric allylic alkylation of 
1,3-diphenylallyl acetate (Equation 5.3).  
 
Ph Ph
OAc
+
CO2Me
CO2Me
Ph Ph
MeO2C CO2Me
{Pd(allyl)Cl}2
Dx, Dy
 KOAc
CH2Cl2, -20 °C  
 
Equation 5.3 
 
The best heterodimer combinations were 5.5·5.15 and 5.5·5.16 which gave up to 60% ee 
of either the R or S product depending on the absolute configuration of the ligand 
employed. Optimal enantioselectivities (96-97% ee) were obtained for the monodentate 
Zn(II)-porphyrin substituted phosphite ligands 5.15 and 5.16. 
 
The chemistry in Chapter V explores the synthesis of new phosphorus donor ligands 
and their coordination studies with a range of metal centres such as Pt(II) and Cu(I). 
This work and any future phosphorus donor ligands generated by this approach may 
have important uses in coordination chemistry and in supramolecular based 
homogeneous catalysis.    
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5.2 Test Reactions Leading to Ideas for Future Work 
 
The unexpected monodentate phosphine ligand 2-amino-3-CH2PPh2-4-1H-quinolinone 
5.19 was synthesised using a Mannich-based condensation reaction which is an efficient 
and versatile method for the synthesis of phosphine ligands. One equivalent of 
Ph2PCH2OH was reacted with one equivalent of 2-amino-4-1H-quinolinone in MeOH 
yielding the mono(phosphino) ligand after 3 h under reflux and N2 (Equation 5.4). The 
solution was concentrated under reduced pressure and a white crystalline solid 5.19 was 
filtered off. This compound was found to be air stable in the solid state, but oxidised 
quickly in solution. Interestingly, the expected Mannich condensation proceeding at the 
primary amine group yielding the mono(phosphino) ligand 5.20 was not observed here. 
 
N
H
NH2
O
+ Ph2P OH
MeOH
N2  Reflux N
H
NH2
O
PPh2
MeOH
N2  Reflux
N
H
N
H
O
PPh2
5.19
5.20
N
H
NH
O
PPh2
PPh2
Ph2P OH
 
 
Equation 5.4 
 
Compound 5.19 was obtained in a 70% yield and exhibits a single resonance in its 
31P{1H} NMR spectrum ((CD3)2SO) at δ(P) −19.05 ppm. This ligand was also 
characterised by 1H NMR spectroscopy, data obtained supporting the condensation at 
the 3-position of the quinolinone ring as inferred from the presence of an NH signal 
from the primary amine (Experimental Section). 
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Condensation of a second Ph2PCH2OH (1eq) on the free primary amine site in 5.19 
failed to produced the desired phosphine ligand yielding only starting material 
(Equation 5.4).  
 
5.2.1 Crystal Structure of Compound 5.19 
 
X-ray quality crystals for compound 5.19 were obtained by slow evaporation of the 
methanol filtrate and included one methanol solvent molecule per ligand in the structure 
(Figure 5.3). The two ligand molecules in the asymmetric unit crystallise in two 
different conformations.  
  
 
 
Figure 5.3 View of the asymmetric unit of 5.19. Phenyl groups and hydrogen atoms 
except NH and OH have been omitted for clarity. 
 
Each molecule of 5.19 is hydrogen bonded to two symmetry related molecules through 
N–H···O interactions forming perpendicular stacked layers. Neighbouring layers close-
pack to form cavities within which the solvent molecules reside (Figure 5.4). Selected 
hydrogen bonding parameters for 5.19 are shown in Table 5.1.    
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Figure 5.4 View of the hydrogen bonding motifs in compound 5.19. Phenyl groups and 
hydrogen atoms except OH and NH have been removed for clarity. 
 
Table 5.1 Selected hydrogen bonding parameters for 5.19. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(1)−H(1)···O(2) 3.178(3) 0.793(17) 2.46(2) 150(3) 
N(2)−H(2A)···O(2) 2.823(3) 0.82(3) 2.02(3) 167(3) 
N(2)−H(2B)···O(3)i 3.026(4) 0.84(3) 2.39(3) 134(3) 
N(3)−H(3)···O(3)ii 3.176(4) 0.757(18) 2.48(2) 154(3) 
N(4)−H(4B)···O(1)ii 2.848(3) 0.84(4) 2.01(4) 174(3) 
O(4)−H(4A)···O(4)iii 2.935(4) 0.87(3) 2.14(4) 152(3) 
O(3)−H(3ª)···O(1) 2.590(3) 0.84 1.75 175.1 
O(4)−H(4)···O(2) 2.667(3) 0.84 1.83 178.3 
Symmetry operations: i-x+1, -y+1, -z+1, iix, y, z+1, iii –x, -y+1, -z+2. 
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5.2.2 Coordination Chemistry of 2-amino-3-CH2PPh2-4-1H-
quinolinone 5.19 
 
5.n Syntheses of Square Planar Pt(II) Complexes 5.21 and 5.22 
 
The synthesis of complex Pt(5.19)2Cl2 5.21 was achieved by stirring a suspension of 
5.19 and PtCl2(COD) in CH2Cl2 for 1.5 h, to displace the cyclooctadiene ligand 
(Equation 5.5). The product was isolated in 73% yield, as a white precipitate obtained 
upon reduction of the volume of solvent in vacuo and addition of Et2O. The isolated 
product 5.21 was treated with tBuOK in MeOH for 1 h under reflux yielding the P,N-
bidentate chelate complex 5.22 as colourless crystals after cooling the solution. 
 
N
H
O
PPh2
NH2
2 + PtCl2(COD)
CH2Cl2 N
Ph2
P
NH2
Pt
Cl
ClP
Ph2
O
N
NH2
O
H
H
tBuOK
MeOH Reflux
5.21
N
H
P
N
H
Pt
N
H
N
H
P
O O
Ph2 Ph2
5.22  
 
Equation 5.5 
 
The coupling constant 1J(PtP) for 5.21 is approximately 3300 Hz, which indicates that 
this complex is in a cis conformation. Compound 5.21 exhibits the characteristic strong 
ν(NH) absorption in the range 3350-2800 cm–1 and also a strong band at 1633 cm–1 
indicative of ν(C=O). Crystals of 5.22 were obtained by slow evaporation of the 
methanolic solution and analysed by single X-ray diffraction. Further work would 
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clearly be required in order to obtain the characterisation of 5.22 by IR, NMR, mass 
spectrometry and microanalysis methods. 
 
Compound 5.22 crystallised from the slow evaporation of a methanolic solution 
including one water molecule per complex. The diffraction data was collected using 
synchrotron radiation on station 9.8 at the SRS, Daresbury Laboratory, due to the small 
crystal dimensions. PLATON SQUEEZE was used to determine that 74 electrons were 
present in the unit cell unaccounted for in the point atom model.103 This approximated 
well to four very highly disordered MeOH molecules per unit cell. Ligand 5.22 acts as a 
bidentate ligand through the amino-N and the P atoms (Figure 5.5). The two phosphorus 
atoms are cis coordinated at the Pt(II) centre, which is supposed to be a sterically less 
favourable arrangement than the alternative trans orientation. 
 
 
 
Figure 5.5 View of the asymmetric unit of 5.22. Phenyl groups and hydrogen atoms 
except NH and OH have been omitted for clarity.  
 
Each 5.22 molecule forms a trifurcated N–H···O hydrogen bond with a symmetry 
related Pt(II) complex (Figure 5.6). The water molecules extend the dimensionality of 
the structure by linking 5.22 into a three-dimensional supramolecular array through N–
H···O(water) and (water)O–H···O hydrogen bonds (Table 5.2). 
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Figure 5.6 View of the hydrogen bonding motifs in compound 5.22. Phenyl groups and 
hydrogen atoms except OH and NH have been removed for clarity. 
 
Table 5.2 Selected hydrogen bonding parameters for 5.22. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(1)−H(1)···O(2A)i 2.874(3) 0.88(3) 2.01(3) 170(3) 
N(3)−H(3)···O(2A)i 3.204(3) 0.77(3) 2.48(3) 156(3) 
N(2)−H(2)···O(2A)i 3.001(4) 0.84(3) 2.26(3) 148(3) 
N(4)−H(4)···O(3A)i 2.790(3) 0.74(3) 2.08(3) 163(4) 
O(3)−H(3A)···O(1B)ii 2.715(3) 0.83(4) 1.89(4) 174(4) 
O(3)−H(3B)···O(2) 2.775(3) 0.85(4) 1.94(4) 167(4) 
Symmetry operations: iy-1/4, -x+3/4, z-1/4, iiy-1/4, -x+1/4, -z+1/4. 
 
5.3 Further Investigation of Copper(I) Complexes     
 
Preliminary investigations have been carried out into the coordination of the 
mono(phosphine) ligand 5.23, synthesised within the Smith group, to the [Cu(PPh3)2]+ 
fragment. One equivalent of 5.23 was reacted with one equivalent of Cu(PPh3)2(BH4). 
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The reaction was performed at r.t. in CH2Cl2 and under N2 because 5.23 is air-sensitive 
(Equation 5.6). 
 
Cu(PPh3)2(BH4) +
COOH CH2Cl2
N
H
PPh2
N2
5.23
N Cu
PPh3
PPh3
Ph2P
H
O
O
5.24  
 
Equation 5.6  
 
It was anticipated that 5.23 would adopt a similar coordination mode to that observed in 
Chapter II for the range of pyridine- and pyrazine-carboxylic acids studied. Therefore in 
the expected compound 5.24 the copper(II) ion is bonded to two triphenylphosphine 
ligands and chelated to one 5.23 ligand through the amine nitrogen and carboxylate 
oxygen atoms. 
 
Interestingly, crystals obtained from slow vapour diffusion of diethyl ether into a 
methanol/dichloromethane solution of the solid obtained in Equation 5.6, exhibit an 
unexpected dimeric crystal structure 5.25 (Figure 5.7). Two deprotonated 
[Ph2PCH2NHC6H4(2-CO2)]– ligands bridge two copper(I) ions, with a distance of 5.087 
Å between symmetry-related copper ions, forming a fourteen-membered 
metallomacrocycle. The two carboxylate oxygen atoms act as a bidentate ligand being 
coordinated to the metal forming a four-membered chelated ring. The dimer is stabilised 
by two strong N–H···O(carboxylate) hydrogen bonds, one within each ligand (Table 
5.3).  
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Figure 5.7 View of (PPh3)2Cu2{Ph2PCH2NHC6H4(2-CO2)}2 5.25.  
Phenyl groups and hydrogen atoms except NH have been removed for clarity.  
 
Table 5.3 Selected hydrogen bonding parameters for 5.25. 
D–H···A D···A/Å D−H/Å H···A/Å D−H···A/º 
N(1)−H(1)···O(1) 2.667(3) 0.91(3) 1.91(3) 140(3) 
 
A selection of key bond lengths is given in Table 5.4. The Cu−P interatomic distances 
and P−Cu−P angle [125.16(3)º] are similar to those previously seen for almost all the 
complexes of copper(I) with pyridine and pyrazine carboxylic acids studied. The 
different Cu−O bonds lengths for the chelate ring suggest that the carboxylate group is 
not delocalised. The ligand O(1)−Cu(1)−O(2) bite angle is 57.82(8)º, smaller than 
previously found in Chapter II, (79.77-80.16º), in accord with the formation of a four-
membered ring. 
 
Table 5.4 Selected bond lengths (Å) for 5.25. 
 Cu(1)−P(1) Cu(1)−P(2) Cu(1)−O(1) Cu(1)−O(2) 
5.25 2.2278(8) 2.2533(8) 2.069(2) 2.414(2) 
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The crystal structure of the compound reveals that one molecule of triphenylphosphine 
per metal centre has been displaced by a carboxylate moiety leading to the formation of 
the dimer. The crystals of 5.25 were obtained only once; in several other attempts, the 
crystals obtained were of triphenylphosphine alone. The crude material was cleaned 
several times with diethyl ether, but the crystallisation of 5.25 failed to give any further 
crystals. Characterisation of the crude material also failed to show which products were 
obtained in this reaction showing a mixture of non-identified by-products. Further work 
would clearly be required in order to fully understand the chemistry presented here.  
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5.4 Experimental 
 
5.4.1 Characterisation Data 
 
Compound 5.19 
A mixture of hydroxymethyldiphenylphosphine (1 eq, 0.466 g) and 2-amino-4-1H-
quinolinone (1 eq, 0.347 g) in methanol (20 ml) was refluxed under N2 for 3 h. The 
volume of the solution obtained was evaporated to ca. 10 ml under reduced pressure and 
a white crystalline solid was obtained. The suspension was stirred for 10 min. The white 
solid obtained was collected by suction filtration and dried in vacuo. 
 
Yield: 0.539 g, 70%.  
IR υmax (KBr)/cm-1 3345.2–2870.2 (N−H), 1634.6 (C=O), 740.9 and 692.3 (Ar C−H). 
1H NMR (400 MHz, CDCl3) δ 7.32-7.19 (12H, m, Ar C−H), 6.24 (2H, bs, Ar C−H), 
3.42 (1H, s, NH), 2.84 (2H, s, NH2), 2.50 (2H, s, CH2) ppm. 
31P NMR data: δ -19.05 ppm. 
Analysis calculated for C22H18N2OP: C, 73.73; H, 5.34; N, 7.82. Found: C, 73.94; H, 
5.08; N, 7.84%. 
m/z 359 [C22H18ON2P]+. 
 
Compound 5.21 
To a solution of PtCl2(COD) (0.053 g) in dichloromethane (5 ml) was added a solution 
of 5.19 (0.102 g) in dichloromethane (5 ml). The pale colourless solution was stirred for 
1.5 h at r.t., the solution was evaporated to ca. 2-3 ml under reduced pressure and 
diethyl ether (10 ml) added. The suspension was stirred for 10 min. The white solid 
obtained was collected by suction filtration and dried in vacuo. 
 
Yield: 0.122 g, 73%.  
IR υmax (KBr)/cm-1 3353.4–2863.2 (N−H), 1632.8 (C=O), 740.7 and 690.5 (Ar C−H). 
1H NMR (400 MHz, (CD3)2SO) δ 12.73 (2H, s, NH), 7.57-7.25 (28H, m, Ar C−H), 5.46 
(2H, s, NH), 2.51 (4H, s, CH2) ppm. 
31P NMR data: δ 20.57 ppm, 1JPtP 3297.8 Hz. 
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Analysis calculated for C44H38N4O2P2Cl2Pt·CH2Cl2: C, 50.62; H, 3.78; N, 5.25. Found: 
C, 51.02; H, 3.92; N, 5.29%. 
m/z [PtC44H38O2N4P2Cl2]+: 910 [M+-2Cl]. 
 
Compound 5.22 
The isolated product 5.21 (0.043 g) was then treated with tBuOK (2.5 eq, 0.016 g) in 
MeOH (10 ml). The solution obtained was refluxed for 1 h yielding 5.22 as white 
crystals after cooling the solution. 
Yield: 0.029 g, 87%.  
 
Compound 5.25 
Under nitrogen, a solution of Ph2PCH2NHC6H4(2-CO2H) 5.23 (1 eq, 0.048 g) and 
Cu(PPh3)2(BH4) (1 eq, 0.087 g) in dichloromethane (10 ml) was stirred for 24 h. The 
solvent was evaporated to dryness under reduced pressure to give a crystalline yellow 
solid. Diethyl ether (20 ml) was added to the solid and the mixture was stirred at room 
temperature for 30 min. The solid was filtered and dried yielding a yellow solid. Yield 
0.087 g, 66%. 
 
X-ray quality crystals of 5.25 were grown by the vapour diffusion of diethyl ether into a 
methanol/dichloromethane solution of the yellow solid obtained in the synthesis 
described above. 
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5.5 Crystallographic Experimental 
 
Data for compound 5.19 was collected using a Bruker APEX 2 CCD diffractometer 
using graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å). Data for compound 
5.22 was collected using a Bruker APEX 2 CCD diffractometer using synchrotron 
radiation (λ = 0.6943 Å) at Daresbury SRS Station 9.8. Data for compound 5.25 was 
collected using a Bruker-Nonius 95 mm CCD camera on κ-goniostat diffractometer 
using graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å).  
 
All the structures were solved by direct methods and refined by full-matrix least-squares 
methods on F2. All H atoms were placed in geometrically calculated positions and were 
refined using a riding model (aryl C–H 0.95 Å). Uiso(H) values were set to be 1.2 times 
Ueq of the carrier atom for aryl and 1.5 times Ueq of the carrier atom for CH3. The 
coordinates of OH and NH hydrogen atoms in all compounds were allowed to refine 
freely apart from O3 and O4 coordinates of OH hydrogen atoms in 5.19 which were 
placed in geometrically calculated positions and were refined using a riding model 
(hydroxyl O–H 0.84 Ǻ). Uiso(H) values were set to be 1.5 times Ueq of the carrier atom 
for OH. 
 
Compound 5.19 was found to contain a disordered phenyl ring, and was modelled over 
two sets of positions 75.5(12):24.5(12)% with C(11) and C(14) common for both rings.  
 
Programs used during data collection, data reduction, refinement and production of 
graphics were Bruker SMART, Bruker APEX 2, SAINT, SHELXTL, COLLECT, 
DENZO and local programs.25,26,28,121-123  
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